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This	   thesis	   is	   the	   compilation	   of	   published	   and	   unpublished	   work	   towards	   reducing	   the	  
mysteries	   of	   sulfur	   metabolism	   in	   Mycobacterium	   tuberculosis.	   	   In	   particular,	   we	   elucidate	  
mechanistic	  details	  of	  sulfonucleotide	  reductases	  (SRs)	  that	  catalyze	  the	  first	  committed	  step	  of	  
reductive	  sulfur	  assimilation	  en	  route	  to	  the	  biosynthesis	  of	  all	  sulfur-­‐containing	  metabolites	  in	  
plants	   and	   bacteria.	   	   SRs	   have	   no	   human	   homolog	   and	   represent	   promising	   targets	   for	  
therapeutic	  intervention.	  	  
	  
In	  Chapter	  1,	  we	  discuss	   sulfur	  metabolism	  enzymes	   that	   facilitate	  mycobacterial	   survival	   and	  
introduce	   adenosine-­‐5'-­‐phosphosulfate	   reductase	   (APR)	   as	   an	   iron-­‐sulfur	   cluster	   protein	  
essential	   for	   the	   survival	   of	   persistent	   M.	   tuberculosis.	   	   Functions	   of	   iron-­‐sulfur	   clusters	   in	  
different	  proteins	  are	  summarized	  with	  a	  view	  to	  understanding	  the	  role	  of	  the	  cluster	  in	  APR.	  	  A	  
portion	  of	  this	  discussion	   is	  published	  as	  a	  review	  for	  which	  the	  citation	   is	  Bhave,	  D.	  P.,	  Muse,	  
W.B.,	  and	  Carroll,	  K.S.,	  "Drug	  Targets	  in	  Mycobacterial	  Sulfur	  Metabolism,"	  (2007)	  Infect.	  Disord.	  
Drug	  Targets	  7;	  140-­‐158.	  
	  
Chapter	  2	  details	   the	  molecular	  determinants	   that	  underlie	  binding	  and	   specificity	   in	  APR	  and	  
provides	  an	  active	  site	  model	  as	  a	  pharmacological	  roadmap	  for	  the	  rational	  design	  of	  potential	  
inhibitors	   of	   APR.	   	   This	   study	   was	   published	   as	   Hong,	   J.A.,	   Bhave,	   D.P.,	   and	   Carroll,	   K.S.,	  
"Identification	   of	   Critical	   Ligand	   Binding	   Determinants	   in	   Mycobacterium	   tuberculosis	  
Adenosine-­‐5'-­‐phosphosulfate	  Reductase,"	  (2009)	  J.	  Med.	  Chem.	  52;	  5485-­‐95.	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Chapter	  3	  focuses	  on	  the	  spectroscopic	  characterization	  of	  the	  [4Fe-­‐4S]	  cluster	  in	  APR	  from	  M.	  
tuberculosis.	   	   A	   paramagnetic	   state	   of	   the	   cluster	   has	   been	   generated	   for	   the	   first	   time	  
permitting	   the	   application	   of	   electron	   paramagnetic	   resonance	   and	   other	   forms	   of	  
spectroscopies.	   	   Further,	   an	   essential	   role	   has	   been	   identified	   for	   active	   site	   residue	   Lys144,	  
whose	  side	  chain	  serves	  as	  a	  link	  between	  with	  the	  [4Fe-­‐4S]	  cluster	  and	  the	  substrate.	  	  Based	  on	  
these	  findings,	  a	  role	  for	  the	  cluster	  in	  the	  catalytic	  mechanism	  of	  APR	  has	  been	  discussed.	  	  The	  
citation	  for	  this	  article	   is	  Bhave,	  D.P.,	  Hong,	  J.A.,	  Lee,	  M.,	  Jiang,	  W.,	  Krebs,	  C.,	  and	  Carroll,	  K.S.,	  
"Spectroscopic	  Studies	  on	  the	  [4Fe-­‐4S]	  Cluster	   in	  Adenosine	  5'-­‐Phosphosulfate	  Reductase	  from	  
Mycobacterium	  tuberculosis,"	  (2010)	  J.	  Biol.	  Chem.	  286;	  1216-­‐1226.	  
	  
In	  Chapter	  4,	  we	  present	  density	  functional	  theory	  calculations	  and	  extended	  x-­‐ray	  fine	  structure	  
spectroscopic	  analyses	   that	   reveals	   insights	   into	   the	  coordination,	  geometry	  and	  electrostatics	  
of	  the	  [4Fe-­‐4S]	  cluster	  in	  APR.	  	  Additionally,	  a	  comparison	  between	  models	  with	  and	  without	  the	  
tandem	  cysteine	  pair	  coordination	  of	  the	  cluster	  suggests	  a	  role	  for	  the	  unique	  coordination	  in	  
facilitating	   a	   compact	   geometric	   structure	   and	   modulating	   the	   electrostatics	   of	   the	   cluster.	  	  
These	  findings	  are	  published	  as	  Bhave,	  D.P.,	  Han,	  W.-­‐G.,	  Pazicni,	  S.,	  Penner-­‐Hahn,	  J.	  E.,	  Carroll,	  
K.S.,	   and	   Noodleman,	   L.,	   "Geometric	   and	   Electrostatic	   Study	   of	   the	   [4Fe-­‐4S]	   Cluster	   of	  
Adenosine-­‐5'-­‐Phosphosulfate	  Reductase	  from	  Broken	  Symmetry	  Density	  Functional	  Calculations	  
and	   Extended	   X-­‐ray	   Absorption	   Fine	   Structure	   Spectroscopy,"	   (2011)	   Inorg.	   Chem.	   50;	   6610-­‐
6625.	  
	  
Chapter	   5	   examines	   substrate	   specificity	   in	   the	   family	   of	   SRs	   and	   reports	   that	   contrary	   to	  
prevailing	   view	   the	   phosphate-­‐binding	   loop	   in	   SRs	   has	   a	   modest	   effect	   on	   substrate	  
discrimination.	   	   Instead,	   by	   means	   of	   metalloprotein	   engineering,	   spectroscopic	   and	   kinetic	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analyses,	  we	  demonstrate	  that	  the	  iron-­‐sulfur	  cluster	  plays	  a	  pivotal	  role	  in	  substrate	  specificity	  
and	  catalysis.	  	  The	  findings	  offer	  new	  insights	  into	  the	  evolution	  of	  this	  enzyme	  family,	  and	  have	  
broader	   implications	  regarding	  the	  function	  of	  protein-­‐bound	   iron-­‐sulfur	  clusters.	   	  This	  work	   is	  
under	  review	  as	  Bhave,	  D.P.,	  Hong,	  J.A.,	  Keller,	  R.L.,	  M.,	  Krebs,	  C.,	  and	  Carroll,	  K.S.,	  "Iron-­‐Sulfur	  
Cluster	  Engineering	  Provides	  Insight	  into	  the	  Evolution	  of	  Substrate	  Specificity	  among	  the	  Family	  
of	  Sulfonucleotide	  Reductases,"	  (2011),	  manuscript	  under	  review	  in	  ACS	  Chem.	  Bio.	  	  
	  
Finally,	  Chapter	  6	  summarizes	  the	  key	  findings	  of	  this	  thesis	  and	  provides	  a	  discussion	  of	  future	  
directions	  for	  understanding	  mechanistic	  details	  of	  APR	  and	  the	   involvement	  of	  the	   iron-­‐sulfur	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Sulfur	  metabolic	  pathways	  are	  fundamental	  for	  survival	  and	  the	  expression	  of	  virulence	  in	  many	  
pathogenic	   bacteria,	   including	   Mycobacterium	   tuberculosis.	   	   In	   addition,	   microbial	   sulfur	  
metabolic	  pathways	  are	   largely	  absent	   in	  humans	  and	   therefore,	   represent	  unique	   targets	   for	  
therapeutic	   intervention.	   	  However,	  many	  aspects	  of	  mycobacterial	  sulfur	  metabolism,	  such	  as	  
mechanistic	   details	   of	   sulfonucleotide	   reductases	   (SRs)	   involved	   in	   assimilatory	   sulfate	  
reduction,	   remain	   poorly	   understood	   and	   represent	   exciting	   areas	   of	   new	   or	   continued	  
investigation.	  	  SRs	  catalyze	  the	  first	  committed	  step	  of	  reductive	  sulfur	  assimilation	  en	  route	  to	  
the	  biosynthesis	  of	  all	  sulfur-­‐containing	  metabolites.	   	   In	  this	  study,	  we	  elucidate	  the	  molecular	  
binding	   determinants	   that	   underlie	   ligand	   binding	   and	   specificity	   of	   SRs	   and	   provide	   a	  
pharmacological	  roadmap	  for	  the	  rational	  design	  of	  potential	  inhibitors	  of	  SRs.	  	  Next,	  we	  present	  
a	   spectroscopic	   characterization	   of	   the	   iron-­‐sulfur	   cofactor	   essential	   to	   one	   class	   of	   SRs	   and	  
reveal	  mid-­‐range	  electrostatic	  interactions	  between	  the	  iron-­‐sulfur	  cluster	  and	  the	  substrate	  in	  
the	  active	  site.	  	  Based	  on	  these	  data,	  we	  propose	  a	  role	  for	  the	  cluster	  in	  pre-­‐organizing	  active	  
xxiii	  
site	  residues	  and	   in	  substrate	  activation.	   	  Computational	  modeling	  and	  theoretical	  calculations	  
corroborate	   these	   findings	   and	   in	   addition,	   suggest	   a	   role	   for	   the	   unique	   coordination	   of	   the	  
iron-­‐sulfur	  cluster	  in	  facilitating	  a	  compact	  geometric	  structure	  and	  modulating	  its	  electrostatic	  
nature.	   	   Furthermore,	   metalloprotein	   engineering,	   kinetic	   and	   spectroscopic	   analyses	  
demonstrate	  that	  the	  iron-­‐sulfur	  cluster	  plays	  a	  pivotal	  role	  in	  substrate	  specificity	  and	  catalysis,	  
and	  yield	  important	  structural	  information	  that	  can	  be	  used	  for	  the	  design	  of	  cluster-­‐targeted	  SR	  
inhibitors.	   	  The	  findings	  also	  provide	  new	  perspectives	   into	  the	  evolution	  of	  the	  SR	  family,	  and	  
have	   broader	   implications	   regarding	   the	   function	   of	   protein-­‐bound	   iron-­‐sulfur	   clusters.	  	  
Collectively,	  the	  work	  presented	  in	  this	  thesis	  contributes	  towards	  a	  better	  understanding	  of	  the	  
catalytic	   mechanism	   of	   this	   unique	   class	   of	   enzymes	   and	   offers	   insights	   into	   strategies	   for	  














Identification	  of	  Drug	  Targets	  in	  Mycobacterial	  Sulfur	  Metabolism	  with	  a	  
Focus	  on	  Adenosine-­‐5'-­‐phosphosulfate	  Reductase	  
	  
This	   work	   has	   in	   part	   been	   published	   as	   "Drug	   Targets	   in	  Mycobacterial	   Sulfur	  Metabolism."	  
2007	  Infectious	  Disorders	  -­‐	  Drug	  Targets	  7;	  140-­‐158.	  	  	  
	  
1.1	  Abstract	  
The	  identification	  of	  new	  antibacterial	  targets	  is	  urgently	  needed	  to	  address	  multidrug	  resistant	  
and	   latent	  tuberculosis	   infection.	   	  Sulfur	  metabolic	  pathways	  are	  essential	   for	  survival	  and	  the	  
expression	  of	  virulence	  in	  many	  pathogenic	  bacteria,	   including	  Mycobacterium	  tuberculosis.	   	   In	  
addition,	   microbial	   sulfur	   metabolic	   pathways	   are	   largely	   absent	   in	   humans	   and	   therefore,	  
represent	  unique	  targets	  for	  therapeutic	  intervention.	  	  In	  this	  review,	  we	  summarize	  our	  current	  
understanding	  of	   the	  enzymes	  associated	  with	   the	  production	  of	   sulfated	  and	   reduced	   sulfur-­‐
containing	  metabolites	  in	  Mycobacteria.	  	  In	  particular,	  we	  focus	  on	  adenosine-­‐5'-­‐phosphosulfate	  
reductase,	  which	  catalyzes	  the	  first	  committed	  step	  of	  reductive	  sulfur	  assimilation	  and	  is	  absent	  
in	   humans.	   	   Adenosine-­‐5'-­‐phosphosulfate	   reductase	   harbors	   an	   iron-­‐sulfur	   cluster	   that	   is	  
essential	   for	   its	   catalytic	   activity;	   however,	   the	   precise	   role	   of	   the	   cluster	   is	   unknown.	  	  
Investigation	  of	  the	  role	  of	  the	  cluster	  in	  the	  catalytic	  mechanism	  of	  this	  enzyme	  will	  lead	  to	  new	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fundamental	  insights	  into	  iron-­‐sulfur	  biochemistry	  and	  bacterial	  sulfur	  metabolism.	  	  In	  addition,	  
the	  study	  would	  pave	  the	  way	  for	  the	  development	  of	  drugs	  for	  tuberculosis	  based	  on	  inhibitors	  
that	  inactivate	  the	  enzyme	  by	  disrupting	  the	  biological	  function	  of	  the	  iron-­‐sulfur	  cluster.	  	  
	  
1.1.1	  Mycobacterium	  Tuberculosis	  
Mycobacterium	  tuberculosis,	  the	  causative	  agent	  of	  tuberculosis	  (TB),	   is	  one	  of	  the	  most	   lethal	  
infectious	  agents	  affecting	  humans	  [1-­‐3].	  	  The	  disease	  infects	  almost	  two	  billion	  people	  or	  one-­‐
third	  of	   the	  world’s	  population,	  and	  accounts	   for	  an	  estimated	  2	  million	  deaths	  per	  year.	   	  The	  
majority	  of	  people	  afflicted	  with	  TB	  live	  in	  developing	  countries,	  where	  lethal	  synergy	  with	  HIV	  
infection	  also	  fuels	  the	  TB	  pandemic.	  
	  
M.	   tuberculosis	   infection	   is	   difficult	   to	   treat,	   requiring	   6-­‐9	   months	   of	   chemotherapy	   with	   a	  
cocktail	   of	   four	   antibiotics	   –	   isoniazid,	   rifampin,	   pyrazinamide	   and	   ethambutol	   [4,5].	   	   In	   large	  
part,	   the	   lengthy	   drug	   therapy	   is	   necessary	   because	   mycobacteria	   exist	   as	   a	   metabolically	  
diverse	  population	  within	  the	  human	  host	  [5].	  	  Some	  bacteria	  will	  be	  actively	  dividing,	  rendering	  
them	   susceptible	   to	   antibiotic	   treatment.	   	   However,	   less	   active	   subpopulations	   also	   exist	   in	  
stationary	   phase	   or	   as	   dormant	   bacteria	   [6,7].	   	   Since	   TB	   drugs	   target	   biological	   processes	  
required	  for	  bacterial	  growth	  (e.g.,	  cell	  wall	  biosynthesis),	  they	  are	  far	  less	  effective	  at	  killing	  the	  
persistent	  population	  [5,8,9].	  	  	  
	  
In	  addition	  to	  toxic	  side	  effects,	  the	  lengthy	  treatment	  regime	  results	  in	  poor	  patient	  compliance	  
and	   drug	   resistant	   strains	   are	   beginning	   to	   emerge	   [10].	   	   The	   World	   Health	   Organization	  
estimates	  that	  up	  to	  50	  million	  persons	  worldwide	  are	  infected	  with	  multidrug	  resistant	  strains	  
of	  M.	  tuberculosis	  (MDR-­‐TB)	  [11].	  	  This	  number	  continues	  to	  grow	  as	  300,000	  new	  MDR-­‐TB	  cases	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are	   diagnosed	   each	   year	   with	   79	   percent	   of	   individuals	   showing	   resistance	   to	   three	   or	  more	  
frontline	  drugs	  [11].	  	  Taken	  together,	  the	  growing	  problem	  of	  MDR-­‐TB	  and	  the	  lack	  of	  drugs	  that	  
effectively	   target	   persistent	   bacteria,	   stress	   the	   urgent	   need	   for	   identification	   of	   new	  
antimicrobial	  targets	  [12,13].	  	  
	  
Many	   fundamental	   aspects	   of	   mycobacterial	   metabolism	   and	   pathogenesis	   are	   poorly	  
understood,	   in	   part	   because	   of	   the	   technical	   difficulties	   inherent	   to	   studying	  M.	   tuberculosis.	  
The	  organism	  must	  be	  manipulated	  in	  a	  biosafety	  level	  3	  laboratory,	  and	  the	  slow	  growth	  rate	  (3	  
weeks	   for	   colonies,	   up	   to	   1	   year	   for	   completion	   of	   animal	   models)	   imposes	   limitations	   on	  
apparent	   research	   productivity.	   	   However,	   the	   availability	   of	   complete	  mycobacterial	   genome	  
sequences	   [14-­‐17]	   and	   the	  maturation	  of	  methods	   for	   disrupting	  mycobacterial	   genes	   [18-­‐20]	  
have	   provided	   tools	   that	   can	   accelerate	   the	   discovery	   of	   potential	   drug	   targets	   and	   elucidate	  
metabolic	  pathways	  that	  are	  essential	  for	  mycobacterial	  survival.	  
	  
1.1.2	  Overview	  Of	  TB	  Infection	  
M.	  tuberculosis	   infection	  is	  a	  complex	  process	  that	   initiates	  with	  aerosol	   inhalation	  to	  the	  host	  
lung	   [6,21,22].	   	   Therein,	   the	  mycobacteria	   are	   phagocytosed	  by	   alveolar	  macrophages.	   	  Upon	  
entry	   into	   a	   macrophage,	   the	   TB	   bacilli	   interfere	   with	   normal	   phagosomal	   maturation,	  
preventing	   fusion	   with	   lysosomes	   [23].	   	   The	   ability	   of	  M.	   tuberculosis	   to	   side-­‐step	   lysosomal	  
degradation	  allows	  the	  bacilli	   to	  take	  up	  residence	   in	  an	  endosomal	  environment	  and	  multiply	  
within	   the	   host	   cell.	   	   In	   response	   to	   the	   infection,	   macrophages	   produce	   pro-­‐inflammatory	  
signals	  –	  cytokines	  and	  chemokines	  –	  that	  recruit	  T-­‐cells	  and	  neutrophils	  to	  the	  infected	  tissue	  
[22,24-­‐27].	   	   These	   cells	   encircle	   the	   infected	  macrophage,	  walling	   it	   off	   from	   the	   surrounding	  
tissue	   in	  a	   structure	  called	  a	  granuloma	   [28-­‐31].	   	  Within	   the	  context	  of	   the	  granuloma,	  T-­‐cells	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can	   proliferate	   in	   response	   to	   specific	   mycobacterial	   antigens	   and	   some	   may	   leave	   the	  
granuloma	   to	   reenter	   the	   circulation;	   thus,	   the	   granuloma	   is	   a	   dynamic	   structure	   [32].	  	  
Activation	   of	   the	   immune	   response	   and	   induction	   of	   lung	   inflammation	   is	   part	   of	   the	   M.	  
tuberculosis	   lifecycle	   [6,21,22].	   	   The	   lung	   tissue	   damage	   caused	   by	   activated	   immune	   cells	  
induces	  coughing	  and	  provides	  an	  exit	  strategy	  for	  the	  bacteria	  to	  spread	  to	  another	  host.	  
	  
Less	  than	  10%	  of	  infected	  individuals	  will	  develop	  active	  TB	  infection.	  	  In	  the	  rest,	  mycobacteria	  
residing	  within	  granulomas	  enter	  into	  a	  persistent	  or	  “latent”	  state	  characterized	  by	  a	  lack	  of	  cell	  
division	  and	  a	  change	  in	  basic	  metabolism	  [6,7,33,34].	  	  These	  latent	  mycobacteria	  are	  difficult	  to	  
eradicate	  since	   they	  are	  not	   reliant	  on	  machinery	   targeted	  by	  conventional	  antibiotics	   [5].	   	  By	  
unknown	  mechanisms,	  the	  infection	  can	  be	  reactivated	  after	  many	  years	  or	  decades	  to	  produce	  
active,	  infectious	  TB.	  	  This	  event	  is	  often	  associated	  with	  compromised	  immune	  function	  due	  to	  
coinfection	  with	  HIV,	  drug	  use,	  or	  aging.	   	  Hence,	  effective	  treatment	  of	  TB	  will	  require	  efficacy	  
against	   persistent	  M.	   tuberculosis,	   or	   at	   the	   least	   a	   better	   understanding	   of	   the	  mechanisms	  
underlying	   immune	   cell	   activation,	   bacterial	   adaptation	   and	   survival	   within	   the	   granuloma	  
[5,13,31].	  	  
	  
1.1.3	  Sulfur	  and	  Mycobacterial	  Survival	  
To	   complete	   its	   lifecycle,	  M.	   tuberculosis	   must	   survive	   within	   the	   hostile,	   nutrient-­‐poor	   and	  
oxidizing	   environment	   of	   the	   host	  macrophage	   [7,30,35].	   	   At	   the	   same	   time,	  M.	   tuberculosis	  
must	  activate	  sufficient	   immune	  effector	   functions	   to	   induce	  granuloma	   formation	   in	   the	   lung	  
[21,22].	   	   This	   complex	   interplay	   between	   mycobacteria	   and	   the	   host	   immune	   system	   likely	  
requires	   several	   host-­‐pathogen	   interaction	   mechanisms	   and,	   once	   the	   granuloma	   has	   been	  
formed,	   induction	  of	  metabolic	  pathways	  that	  allow	  the	  organism	  to	  persist.	   	  At	  present	  time,	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the	   metabolic	   requirements	   of	   mycobacteria	   in	   the	   context	   of	   the	   granuloma	   are	   not	   fully	  
understood.	   	   However,	   genes	   involved	   in	   the	   metabolism	   of	   sulfur	   have	   consistently	   been	  
identified	   as	   up-­‐regulated	   in	   response	   to	   oxidative	   stress,	   nutrient	   starvation	   and	   dormancy	  
adaptation	   (culture	  conditions	   that	  model	  aspects	  of	  mycobacterial	   life	   in	   the	  granuloma)	  and	  
during	  macrophage	  infection	  [36-­‐45].	  
	  
Sulfur	   is	  an	  essential	  element	  for	   life	  and	  plays	  a	  central	  role	   in	  numerous	  microbial	  metabolic	  
processes	  [46].	  	  In	  its	  reduced	  form,	  sulfur	  is	  used	  in	  the	  biosynthesis	  of	  the	  amino	  acids	  cysteine	  
and	  methionine.	   	  Cysteine	   is	   incorporated	   into	  biomolecules	  such	  as	  proteins,	  coenzymes,	  and	  
mycothiol	   (the	   mycobacterial	   equivalent	   of	   glutathione)	   (Figure	   1.1).	   	   Found	   in	   all	  
	  	  
Figure	  1.1	  Reduced	  sulfur-­‐containing	  metabolites	  in	  mycobacteria	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actinomycetes,	   mycothiol	   regulates	   cellular	   redox	   status	   and	   is	   essential	   for	  M.	   tuberculosis	  
survival	   [47].	   	   Another	   reduced	   sulfur-­‐containing	   metabolite,	   coenzyme	   A	   (CoA),	   is	   heavily	  
utilized	   for	   lipid	  metabolism	   (a	   process	   that	   is	   central	   to	  mycobacterial	   cell	  wall	  maintenance	  
and	  remodeling)	  [48].	  	  	  
	  
In	  its	  oxidized	  form,	  sulfur	  is	  present	  as	  a	  sulfuryl	  moiety	  (–SO3–)	  that	  can	  modify	  hydroxyls	  and	  
amines	  in	  proteins,	  polysaccharides	  and	  lipids	  (Figure	  1.2)	  [49,50].	  	  Extracellular	  presentation	  of	  
sulfated	   metabolites	   plays	   important	   regulatory	   roles	   in	   cell-­‐cell	   and	   host-­‐pathogen	  
communication	  [50].	  	  Hence,	  acquisition	  and	  metabolism	  of	  sulfur	  is	  essential	  for	  mycobacterial	  
virulence	  and	  survival.	  
	  
Figure	  1.2	  Sulfated	  metabolites	  in	  mycobacteria	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The	   identification	   of	   new	   antibacterial	   targets	   is	   essential	   to	   address	   MDR-­‐	   and	   latent-­‐TB	  
infection	   [13,51].	   	   Toward	   this	   end,	   mycobacterial	   sulfur	   metabolism	   represents	   a	   promising	  
new	   area	   for	   anti-­‐TB	   therapy	   [50,52,53].	   	   Numerous	   studies	   have	   validated	   amino	   acid	  
biosynthetic	  pathways	  and	  downstream	  metabolites	  as	  antimicrobial	  targets	  [54-­‐57]	  and	  sulfur	  
metabolic	   pathways	   are	   required	   for	   the	   expression	  of	   virulence	   in	  many	  pathogenic	   bacteria	  
[58-­‐62].	  	  In	  particular,	  mutants	  in	  mycobacterial	  sulfur	  metabolism	  genes	  are	  severely	  impaired	  
in	  their	  ability	  to	  persist	  and	  cause	  disease	  [41,43,61,63-­‐66].	  	  Furthermore,	  most	  microbial	  sulfur	  
metabolic	   pathways	   are	   absent	   in	   humans	   and	   therefore,	   represent	   unique	   targets	   for	  
therapeutic	  intervention.	  	  	  
	  
1.2.	  Sulfate	  Assimilation	  in	  Mycobacteria:	  An	  Overview	  
Sulfate	   assimilation	   begins	   with	   the	   active	   transport	   of	   inorganic	   sulfate	   (SO42–)	   across	   the	  
mycobacterial	  cell	  membrane	  by	  the	  CysTWA	  SubI	  ABC	  transporter	  complex	  (Figure	  1.3)	  [67,68].	  	  	  
Once	  sulfate	  is	  imported,	  it	  is	  activated	  by	  ATP	  sulfurylase	  (encoded	  by	  cysND)	  via	  adenylation	  to	  
produce	  adenosine-­‐5'-­‐phosphosulfate	  (APS)	  [39,53,69].	  	  In	  mycobacteria,	  APS	  lies	  at	  a	  metabolic	  
branch	   point	   [53].	   	   For	   sulfation	   of	   biomolecules	   such	   as	   proteins,	   lipids	   and	   polysaccharides,	  
APS	   is	   phosphorylated	   at	   the	   3'-­‐hydroxyl	   by	   APS	   kinase	   (encoded	   by	   cysC)	   to	   form	   3'-­‐
phosphoadenosine-­‐5'-­‐phosphosulfate	   (PAPS),	   the	   universal	   sulfate	   donor	   for	   sulfotransferases	  
(STs)	   [53,69,70].	   	   Transfer	   of	   –SO3–	   to	   hydroxyl	   or	   amino	   functionalities	   of	   biomolecules	   plays	  
important	  roles	  in	  regulation	  of	  cell-­‐cell	  communication	  and	  metabolism	  [50].	  	  Alternatively,	  for	  
production	   of	   reduced	   sulfur-­‐containing	  metabolites,	   the	   sulfate	  moiety	   in	   APS	   is	   reduced	   to	  
sulfite	  (SO32–)	  by	  APS	  reductase	  (APR),	  the	  gene	  product	  of	  cysH	  [53,61,71,72].	  	  Sulfite	  is	  further	  
reduced	  to	  sulfide	  (S2–)	  by	  sulfite	  reductase	  (encoded	  by	  nirA)	  [73]	  and	  is	  the	  form	  of	  sulfur	  that	  
is	   used	   for	   the	   biosynthesis	   of	   sulfur-­‐containing	   metabolites	   including	   cysteine,	   methionine,	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coenzymes,	  and	  mycothiol	  [46,47,49].	  	  Each	  branch	  of	  sulfate	  assimilation	  is	  discussed	  in	  terms	  
of	  the	  available	  genetic	  and	  biochemical	  data	  below.	  	  	  
	  
1.2.1	  Sulfate	  Import	  and	  Activation	  
Present	  at	  300-­‐500	  µM,	   inorganic	  sulfate	   is	   the	   fourth	  most	  abundant	  anion	   in	  human	  plasma	  
[74].	  	  Sulfate	  transporters	  have	  been	  identified	  in	  all	  major	  human	  tissues	  investigated	  to	  date,	  
and	   of	   particular	   relevance	   to	   the	   intracellular	   lifestyle	   of	  M.	   tuberculosis,	   the	   existence	   of	  
endosomal-­‐associated	  transporters	  has	  also	  been	  demonstrated	  [74].	   	  The	  genes	  encoding	  the	  
	  
Figure	  1.3	  The	  sulfate	  assimilation	  pathway	  in	  mycobacteria	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CysTWA	   SubI	   ABC	   transporter	   complex	   in	  mycobacteria	   have	   been	   identified	   by	   homology	   to	  
Escherichia	   coli	   and	   Salmonella	   typhimurium	   [68],	   are	   essential	   [41],	   robustly	   up-­‐regulated	  
during	   oxidative	   stress	   [37],	   dormancy	   adaptation	   [36],	   and	   expressed	   in	   macrophages	   [44].	  	  
Consistent	  with	  this	  annotation,	  cysA	  or	  subI	  mutants	  (∆cysA	  or	  ∆subI,	  respectively)	  in	  M.	  bovis	  
bacillus	  Calmette-­‐Guérin	  (BCG)	  –	  an	  attenuated,	  vaccine	  strain	  of	  M.	  bovis	  –	  are	  compromised	  in	  
their	   ability	   to	   transport	   sulfate	   [68,75].	   	  When	  grown	   in	  media	   supplemented	  with	   casamino	  
acids,	  the	  rate	  of	  sulfate	  transport	  in	  ∆cysA	  is	  ~1.1%	  relative	  to	  wild-­‐type	  M.	  bovis	  BCG	  [68].	  	  The	  
minor	   amount	   of	   transport	   is	   not	   enough	   to	   meet	   bacterial	   sulfur	   requirements	   and	   hence,	  
these	  sulfate	  transport	  mutants	  are	  auxotrophic	  for	  reduced	  sulfur.	  	  	  
	  
Interestingly,	  no	  significant	  difference	  in	  the	  number	  of	  viable	  bacilli	  was	  observed	  in	  the	  organs	  
of	  mice	  infected	  with	  ∆cysA	  and	  wild-­‐type	  M.	  bovis	  BCG	  up	  to	  63	  days	  post-­‐infection	  [68].	  	  These	  
data	   indicate	   that	  M.	   bovis	   BCG	  may	   scavenge	   sufficient	   amounts	   of	   reduced	   sulfur	   from	   the	  
host	   for	   survival.	   	   However,	   an	   important	   question	   raised	   from	   the	   findings	   of	   this	   study	   is	  
whether	   the	   sulfur	   requirements	   for	   an	   attenuated	   M.	   bovis	   strain	   reflect	   those	   of	   M.	  
tuberculosis	  known	  to	  elicit	  a	  more	  potent	  host	  immune	  response	  [21,22,32].	  	  It	  is	  also	  possible	  
that	   the	   mycobacterial	   genome	   encodes	   for	   an	   additional	   sulfate	   transporter	   which	   is	   not	  
expressed	   under	   culture	   conditions,	   but	   is	   specifically	   up-­‐regulated	   during	   infection	   [52].	   	   In	  
support	  of	  this	  hypothesis,	  mRNA	  array	  analysis	  shows	  significant	  up-­‐regulation	  of	  hypothetical	  
protein	  1739c	  (annotated	  as	  a	  putative	  high	  affinity	  sulfate	  transporter)	  during	  M.	  tuberculosis	  
infection	  of	  macrophages	  in	  response	  to	  nitric	  oxide	  [38]	  or	  hypoxia	  [45].	  	  Additional	  studies	  will	  
be	   required	   to	   confirm	   the	   function	   of	   the	   putative	   sulfate	   transporter	   and	   its	   relevance	   to	  
sulfate	  acquisition	  in	  vivo.	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Once	  sulfate	  is	  transported	  to	  the	  cytosol,	  ATP	  sulfurylase	  (encoded	  by	  cysD)	  catalyzes	  the	  first	  
committed	  step	  in	  sulfate	  assimilation	  (Figure	  1.3)	  [39,69].	  	  In	  this	  reaction,	  the	  adenylyl	  moiety	  
of	  adenosine	  5'-­‐triphosphate	  (ATP)	  is	  coupled	  to	  sulfate.	  	  The	  product	  that	  results,	  APS,	  contains	  
a	  unique	  high-­‐energy	  phosphoric-­‐sulfuric	  acid	  anhydride	  bond	  –	  the	  biologically	  activated	  form	  
of	   sulfate	   [49].	   	   Formation	   of	   APS	   is	   energetically	   unfavorable	   (Keq	   of	   10-­‐7	   –	   10-­‐8	   near	  
physiological	   conditions)	   [49]	   and	   in	   prokaryotes,	   the	   hydrolysis	   of	   guanosine-­‐5'-­‐triphosphate	  
(GTP)	   is	   coupled	   to	   sulfurylation	   of	   ATP	   to	   surmount	   this	   energetic	   hurdle	   [76].	   	   The	   GTPase	  
(encoded	   by	   cysN)	   forms	   a	   heterodimer	   with	   ATP	   sulfurylase	   (CysD)	   and	   synthesis	   of	   APS	   is	  
driven	  1.1	  x	  106-­‐fold	  further	  during	  GTP	  hydrolysis	  [69].	  	  Notably,	  eukaryotic	  ATP	  sulfurylases	  do	  
not	   bear	   any	   sequence	   or	   structural	   similarity	   to	   their	   prokaryotic	   counterparts,	   nor	   do	   they	  
employ	  a	  GTPase	   for	  PAPS	  biosynthesis	   [77].	   	   These	  mechanistic	  and	   structural	  differences,	   in	  
particular	  the	  unique	  G	  protein	  subunit,	  could	  be	  exploited	  to	  develop	  small	  molecule	  inhibitors	  
of	  bacterial	  sulfate	  activation	  [52].	  	  
	  
The	  final	  step	  in	  PAPS	  biosynthesis	  is	  catalyzed	  by	  APS	  kinase	  (encoded	  by	  cysC)	  [53,70].	  	  In	  this	  
reaction,	  ATP	   is	  utilized	  to	  phosphorylate	  the	  3’-­‐hydroxyl	  of	  APS.	   	  Depending	  on	  the	  organism,	  
APS	  kinase	  can	  be	  encoded	  as	  a	   separate	  protein	  or	  as	  a	   fusion	  with	  ATP	   sulfurylase,	  without	  
significant	   variation	   in	   catalytic	   mechanism	   [53,78].	   	   Most	   eukaryotes	   (including	   humans)	  
encode	   for	   ATP	   sulfurylase	   (CysD)	   and	   APS	   kinase	   (CysC)	   on	   a	   single	   polypeptide.	   	   In	   M.	  
tuberculosis,	   however,	  APS	  kinase	   (Cys	  C)	   is	   genetically	   fused	   to	   the	  GTPase	   subunit	   (CysN)	  of	  
ATP	  sulfurylase	   [53].	   	  The	  APS	  kinase	  domain	  of	  M.	   tuberculosis	  CysNC	  was	   identified	   through	  
sequence	  homology	  and	  confirmed	  by	  genetic	  complementation	  [53].	  	  In	  a	  subsequent	  report,	  a	  
mutant	  strain	  of	  M.	  tuberculosis	  that	  removes	  the	  APS	  kinase	  domain	  of	  the	  bifunctional	  cysNC	  
gene	  was	  constructed	  [70].	  	  As	  expected,	  the	  cysC	  knockout	  (∆cysC)	  was	  able	  to	  grow	  on	  sulfate	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as	   a	   sole	   sulfur	   source	   (indicating	   a	   functional	   ATP	   sulfurylase),	   but	  was	   unable	   to	   synthesize	  
PAPS	  [70].	  
	  
Fusion	  of	  APS	  kinase	  to	  the	  GTPase	  domain	  of	  ATP	  sulfurylase	  raised	  the	  interesting	  possibility	  of	  
substrate	  channeling	  between	  subunits	  [52,78].	  	  In	  this	  scenario,	  the	  final	  product	  PAPS,	  and	  not	  
the	   APS	   intermediate,	   would	   be	   released	   into	   solution.	   	   Leyh	   and	   colleagues	   have	   recently	  
tested	  this	  hypothesis	  for	  M.	  tuberculosis	  ATP	  sulfurylase	  [78].	  	  Although	  PAPS	  synthesis	  is	  5,800	  
times	   more	   efficient	   than	   APS	   synthesis	   [69],	   these	   studies	   demonstrate	   that	   APS	   is	   not	  
channeled	   from	   the	   M.	   tuberculosis	   adenylyltransferase	   to	   the	   APS	   kinase	   domain	   [78],	  
consistent	  with	  the	  domain	  arrangement	  proposed	  from	  a	  recent	  crystal	  structure	  of	  the	  CysNC	  
complex	  [77].	  
	  
Collectively,	  CysNC	  and	  D	  proteins	  form	  a	  multifunctional	  enzyme	  complex	  ~300	  KDa	  (consistent	  
with	   a	   trimer	   of	   CysNC•D	   heterodimers),	   referred	   to	   as	   the	   sulfate-­‐activating	   complex	   (SAC)	  
[39,69].	   	   In	  M.	  tuberculosis,	  expression	  of	  the	  SAC	  operon	   is	   induced	  by	  conditions	   likely	  to	  be	  
encountered	   by	   pathogenic	   mycobacteria	   within	   the	   macrophage,	   including	   sulfur	   limitation,	  
oxidative	   stress,	   and	   is	   repressed	   by	   cysteine	   [37,39].	   	   The	   SAC	   operon	   is	   also	   up-­‐regulated	  
during	   stationary	  phase	  growth,	   an	   in	   vitro	  model	  of	  persistent	  M.	   tuberculosis	   infection	   [36].	  	  
M.	  tuberculosis	  SAC	  gene	  expression	  is	  also	  augmented	  within	  the	  intracellular	  environment	  of	  
the	  macrophage	   [44,79].	   	   Taken	   together,	   these	  data	  are	   consistent	  with	   increased	  activity	  of	  
sulfate-­‐activating	   enzymes	   and	   flux	   through	   the	   sulfate	   assimilation	   pathway	   during	  




1.2.2	  Sulfotransferases	  and	  Sulfation	  	  
Sulfotransferases	   (STs),	   the	   enzymes	   that	   install	   sulfate	   esters,	   transfer	   sulfate	   from	   PAPS	  
(produced	  by	   the	  SAC)	   to	  a	  hydroxyl	  or,	   less	   frequently,	   to	  an	  amide	  moiety	  on	  glycoproteins,	  
glycolipids	   and	   metabolites	   (Figure	   1.3)	   [50].	   	   Sulfated	   metabolites	   are	   abundant	   in	   higher	  
eukaryotes,	  particularly	  mammals,	  where	  they	  function	  primarily	  in	  cell-­‐cell	  communication.	  	  For	  
example,	  sulfated	  glycoproteins	  mediate	  interactions	  of	  leukocytes	  with	  endothelial	  cells	  at	  sites	  
of	  chronic	  inflammation,	  sulfated	  peptides	  such	  as	  hirudin	  and	  cholecystokinin	  act	  as	  hormones,	  
and	  sulfated	  glycolipids	  are	   involved	   in	  neuronal	  development	   [80,81].	   	   In	   contrast,	   reports	  of	  
sulfated	  metabolites	  in	  prokaryotes	  have	  been	  rare.	  	  In	  1992,	  Long	  and	  colleagues	  reported	  the	  
first	  functionally	  characterized	  sulfated	  metabolite	  from	  the	  prokaryotic	  world	  –	  the	  nodulation	  
factor	  NodRm-­‐1	  from	  Sinorhizobium	  meliloti	   [82].	   	  This	  sulfated	  glycolipid	   is	  secreted	  from	  the	  
bacterium	  and	  acts	  on	  host	  plant	  cell	  receptors	  thereby	  initiating	  symbiotic	  infection	  [83].	  
	  
Among	  pathogenic	  bacteria,	  only	  one	  family	  has	  been	  reported	  to	  produce	  sulfated	  metabolites	  
–	   the	  Mycobacteria.	   	   More	   than	   40	   years	   ago,	   Goren	   and	   coworkers	   isolated	   an	   abundant	  
sulfated	  glycolipid	   from	  the	  M.	  tuberculosis	   cell	  wall	  and	  characterized	   the	  structure	  shown	   in	  
(Figure	  1.2)	  [84-­‐86].	  	  Termed	  sulfolipid-­‐1	  or	  SL-­‐1,	  this	  compound	  has	  only	  been	  observed	  in	  the	  
tuberculosis	   complex;	   it	   is	   absent	   from	   non-­‐pathogenic	  mycobacteria	   such	   as	  M.	   smegmatis.	  	  
Comprising	  a	  trehalose-­‐2-­‐sulfate	  (T2S)	  core	  modified	  with	  four	  fatty	  acyl	  groups,	  SL-­‐1	  accounts	  
for	  almost	  1%	  of	  the	  dry	  weight	  of	  M.	  tuberculosis.	   	  Early	  studies	  found	  a	  correlation	  between	  
the	  abundance	  of	  SL-­‐1	  and	  the	  virulence	  of	  different	  clinical	  M.	  tuberculosis	  isolates	  [87,88]	  and	  
its	   location	   in	   the	   outer	   envelope	   has	   prompted	   speculation	   that	   it	  may	   be	   involved	   in	   host-­‐
pathogen	  interactions	  [89].	  	  The	  exact	  function	  of	  SL-­‐1,	  however,	  remains	  elusive	  (see	  [52]	  and	  
references	   therein).	   	   Nonetheless,	   the	   biosynthetic	   pathway	   for	   SL-­‐1	   has	   recently	   been	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elucidated	   [52,90-­‐92]	   and	  a	   comprehensive	   study	  of	  mutants	   in	   SL-­‐1	  biosynthesis	   should	  help	  
clarify	  the	  role	  of	  this	  sulfated	  glycolipid	  in	  the	  mycobacterial	  lifecycle.	  
	  
In	   addition	   to	   SL-­‐1,	   other	   novel	   sulfated	   metabolites	   have	   been	   identified	   in	  M.	   tuberculosis	  
using	   an	   innovative	   metabolomic	   approach	   that	   combines	   genetic	   engineering,	   metabolic	  
labeling	   with	   a	   stable	   sulfur	   isotope	   (34SO42-­‐)	   together	   with	   mass	   spectrometry	   analysis	   [70]	  
(Figure	  1.2).	  	  Structurally	  distinct	  sulfated	  metabolites	  have	  also	  been	  identified	  in	  several	  other	  
mycobacterial	   species,	   including	   M.	   smegmatis,	   M.	   fortuitum,	   and	   the	   HIV-­‐associated	  
opportunistic	  pathogen	  M.	  avium	   (Figure	  1.2)	  [70,93-­‐95].	   	   Interestingly,	   in	  M.	  avium	  a	  sulfated	  
cell	  wall	  glycopeptidolipid	  was	  recently	  found	  to	  be	  up-­‐regulated	  in	  HIV	  patients	  with	  acquired	  
drug	  resistance	  [93].	  	  Significant	  work	  remains	  to	  fully	  characterize	  and	  elucidate	  the	  biological	  
significance	  of	  sulfated	  metabolites	  found	  in	  mycobacteria.	  	  A	  major	  step	  toward	  this	  objective	  
is	  to	  define	  the	  biosynthetic	  pathways	  of	  mycobacterial	  sulfated	  metabolites,	   including	  the	  STs	  
responsible	  for	  installing	  the	  sulfuryl	  moiety.	  
	  
In	  2002,	  an	  analysis	  of	  mycobacterial	  genomes	  reported	  by	  Mougous	  and	  colleagues	  revealed	  a	  
large	   family	   of	   open	   reading	   frames	  with	   homology	   to	   human	   carbohydrate	   sulfotransferases	  
[50].	   	  The	  predicted	  proteins	  shared	  regions	  of	  sequence	  homology	  associated	  with	  binding	  to	  
their	   common	   substrate,	   PAPS.	   	   Presently,	   four	   such	   genes	   have	   been	   identified	   in	   M.	  
tuberculosis	  (annotated	  as	  stf0-­‐3)	  and	  the	  M.	  avium	  genome	  encodes	  nine	  putative	  STs	  (stf0,	  1,	  
4-­‐10)	   [52].	   	   To	   date,	   of	   the	   11	   predicted	   STs	   found	   in	   mycobacterial	   genomes,	   genetic	   and	  
biochemical	  studies	  have	  only	  been	  reported	  for	  Stf0	  and	  Stf3.	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Stf0	  is	  present	  in	  a	  number	  of	  other	  pathogenic	  bacteria	  and	  initiates	  the	  biosynthesis	  of	  SL-­‐1	  by	  
sulfating	  the	  disaccharide,	   trehalose,	   to	  form	  T2S	  (Figure	  1.2)	   [92].	   	  A	  knockout	  mutant	  of	  stf0	  
has	  been	  reported	  in	  M.	  tuberculosis	  [96].	  	  This	  study	  demonstrates	  that	  Stf0	  is	  not	  required	  for	  
survival	  in	  liquid	  culture,	  hinting	  toward	  a	  specific	  role	  in	  host	  infection.	  	  The	  structure	  of	  stf0	  in	  
complex	  with	  trehalose	  has	  recently	  been	  reported	  and	  has	  revealed	  several	  interesting	  features	  
[92].	   	   In	   the	   presence	   of	   trehalose,	   Stf0	   forms	   a	   dimer	   both	   in	   solution	   and	   in	   the	   crystal	  
structure.	   	  Moreover,	   Stf0-­‐bound	   trehalose	   participates	   in	   the	   dimer	   interface,	   with	   hydroxyl	  
groups	   from	   a	   glucose	   residue	   bound	   in	   one	   monomer	   forming	   interactions	   with	   the	   other	  
monomer.	  	  Residues	  involved	  in	  substrate	  binding	  and	  dimerization	  have	  been	  identified,	  along	  
with	  a	  possible	  general	  base	  (i.e.,	  Glu36)	  that	  may	  facilitate	  nucleophilic	  attack	  of	  the	  2’-­‐hydroxyl	  
group	   on	   PAPS.	   	   A	   panel	   of	   synthetic	   glucose	   and	   trehalose	   analogs	   has	   also	   been	   tested	   for	  
binding	   and	   found	   that	   any	   modification	   to	   the	   parent	   disaccharide	   compromises	   substrate	  
sulfation	  [92].	  	  Finally,	  a	  kinetic	  study	  of	  the	  enzyme	  using	  MS	  has	  also	  been	  reported	  [97].	  	  The	  
results	   address	   the	   order	   of	   substrates	   binding	   and	   are	   consistent	   with	   a	   random	   sequential	  
mechanism	  involving	  a	  ternary	  complex	  with	  both	  PAPS	  [or	  3'-­‐phosphoadenosine-­‐5'-­‐phosphate,	  
(PAP)]	  and	  trehalose	  (or	  T2S)	  bound	  in	  the	  active	  site.	  
	  
Stf3	   may	   play	   a	   regulatory	   role	   in	  M.	   tuberculosis	   virulence	   [98].	   	   In	   a	   mouse	   model	   of	   TB	  
infection,	  a	  mutant	  strain	  in	  which	  Stf3	  was	  disrupted	  (∆stf3)	  was	  unable	  to	  produce	  a	  sulfated	  
molecule	   termed,	   “S881”.	   	   Interestingly,	   when	   compared	   to	   wild-­‐type	  M.	   tuberculosis,	   ∆stf3	  
exhibited	   a	   hypervirulent	   phenotype.	   	   No	   relatives	   of	   the	   remaining	   stf	   family	   members	   are	  
found	   in	   any	   other	   prokaryotic	   genomes,	   suggesting	   that	   they	   are	   unique	   to	   mycobacteria.	  	  
Substrates	  for	  the	  majority	  of	  mycobacterial	  STs	  remain	  to	  be	  elucidated.	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1.3	  Oxidative	  Macrophage	  Antimicrobial	  Activity	  
In	   order	   to	   replicate	   and	   persist	   in	   its	   human	   host,	  M.	   tuberculosis	   must	   survive	   within	   the	  
hostile	   environment	   of	   the	   macrophage,	   where	   bactericidal	   oxidants	   –	   superoxide	   (O2·∙–)	   and	  
nitric	   oxide	   (NO·∙)	   –	   are	   generated	   in	   response	   to	   infection	   [35].	   	   Two	   enzymes,	   nicotinamide	  
adenine	   dinucleotide	   phosphate-­‐oxidase	   (NADPH	   oxidase)	   and	   inducible	   nitric	   oxide	   synthase	  
(NOS2),	   are	   largely	   responsible	   for	   production	   of	   these	   reactive	   oxygen	   and	   nitrogen	  
intermediates	  (termed	  ROI	  and	  RNI,	  respectively)	  [99,100].	  	  	  
	  
NADPH	   oxidase	   is	   a	   membrane	   protein	   that	   generates	   O2·∙–	   by	   transferring	   electrons	   from	  
NADPH	   inside	   the	   cell	   across	   the	   phagosomal	   membrane;	   the	   electrons	   are	   coupled	   to	  
molecular	   oxygen	   to	   produce	   O2·∙–	   [101].	   	   Subsequently,	   O2·∙–	   can	   accept	   an	   electron	  
spontaneously	  or	  be	  reduced	  by	  superoxide	  dismutase	  (SOD)	  to	  form	  hydrogen	  peroxide	  (H2O2)	  
[102].	   	   In	   turn,	   H2O2	   can	   oxidize	   cellular	   targets	   or	   be	   converted	   into	   the	   highly	   damaging	  
hydroxyl	   radical	   (OH·∙)	   through	   the	   iron-­‐catalyzed	   Fenton-­‐Haber-­‐Weiss	   reaction	   [103].	   	   In	   the	  
NOS2	  reaction,	  the	  guanidino	  nitrogen	  of	  arginine	  undergoes	  a	  five-­‐electron	  oxidation	  via	  a	  N-­‐ω-­‐
hydroxy-­‐L-­‐arginine	   (NOHLA)	   intermediate	   to	   yield	   ·∙NO	   [104].	   	   The	   combination	   of	   the	   two	  
oxidant-­‐generating	  systems	  can	  also	  exert	  a	  synergistic	  effect	  in	  bacterial	  killing	  as	  macrophages	  
can	   generate	   O2·∙–	   simultaneously	  with	   ·∙NO,	   yielding	   the	  more	   reactive	   peroxynitrite	   (ONOO–)	  
[105].	   	   A	   consequence	   of	   NADPH	   and	   NOS2	   enzymatic	   activities	   and	   the	   resulting	   “oxidative	  
burst”	   is	   that	  phagocytosed	  bacteria	  are	  killed	  by	  oxidative	  damage	   to	  a	   range	  of	  protein	  and	  
DNA	  targets	  [35,104,106].	  	  
	  
In	   mice,	   activation	   of	   macrophages	   induces	   production	   of	   NOS2	   and	   phagosomal	   NADPH	  
oxidase,	  via	  ligation	  of	  toll-­‐like	  receptors	  (TLRs),	  or	  via	  stimulation	  by	  the	  cytokines	  IFN-­‐γ	  or	  TNF-­‐
 16	  
α	  [107,108].	  	  In	  mouse	  models	  of	  TB,	  numerous	  studies	  have	  demonstrated	  that	  NOS2	  plays	  an	  
essential	  role	  in	  controlling	  persistent	  infection.	  	  Macrophages	  can	  inhibit	  mycobacterial	  growth	  
via	  NOS2-­‐generated	  RNI,	   inhibition	  of	  NOS2	  during	  persistent	   infection	   leads	  to	  reactivation	  of	  
disease,	   and	   NOS2	   gene-­‐disrupted	   mice	   are	   extremely	   susceptible	   to	   TB	   infection	   [107,108].	  	  
More	  recently,	  a	  proteomics	  study	  has	  identified	  proteins	  in	  M.	  tuberculosis	  that	  are	  targeted	  by	  
RNI	   stress	   [109].	   	   Notably,	   many	   essential	   metabolic	   and	   antioxidant	   defense	   enzymes	   are	  
among	  those	  proteins	  found	  modified	  for	  RNI.	  
	  
While	   good	   evidence	   exists	   for	   ROI-­‐mediated	   bacterial	   killing	   of	   other	   bacterial,	   fungal	   and	  
parasitic	   pathogens,	   their	   bactericidal	   effect	   on	   mycobacteria	   has	   been	   less	   clear.	   	   Studies	  
demonstrate	  that	  M.	  tuberculosis	  resists	  killing	  by	  ROI	  in	  vitro	  and	  that	  mice	  with	  defects	  in	  p47	  
or	  gp91	  subunits	  of	  phagocyte	  NADPH	  oxidase	  (Phox)	  are	  also	  relatively	  resistant	  to	  TB	  infection	  
[107,110].	   	   However,	   NADPH	   oxidase	   is	   highly	   active	   during	   the	   persistent	   phase	   of	   M.	  
tuberculosis	  infection	  in	  mice	  [111].	  	  This	  observation	  suggests	  that	  M.	  tuberculosis	  must	  possess	  
extremely	   effective	   detoxification	   pathways	   to	   counter	   ROI	   stress.	   	   Consistent	   with	   this	  
hypothesis,	  mice	  deficient	  in	  the	  KatG	  catalase-­‐peroxidase	  survived	  better	  in	  pg91phox-­‐deficient	  
mice	   [111].	   	  More	   recently,	   it	  was	   shown	   that	  macrophages	   deficient	   in	   early	   stages	   of	   Phox	  
assembly	  exhibited	  reduced	  bacterial	  killing,	  correlating	  with	  decreased	  production	  of	  ROI	  [112].	  	  
Taken	  together,	  these	  observations	  indicate	  that	  survival	  of	  M.	  tuberculosis	  within	  macrophages	  
depends	  upon	  the	  ability	  of	  the	  bacterial	  to	  counter	  oxidative	  assault.	  
	  
Mycobacteria	  produce	  enzymes	  such	  as	  SOD,	  peroxidases,	  catalase,	  and	  nitrosothiol	  reductase	  
to	  help	   counteract	   the	  effect	  of	  ROI/RNI	  and	  promote	   intracellular	   survival	   and	  persistence	   in	  
the	  host	   [35,113-­‐115].	   	   In	  addition	  to	  enzymatic	  detoxification	  of	  ROI	  and	  RNI,	   reduced	  sulfur-­‐
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containing	   metabolites	   are	   an	   essential	   component	   of	   bacterial	   antioxidant	   defense	   systems	  
[116-­‐120].	   	  Specifically	   in	  mycobacteria,	   low	  molecular-­‐weight	   thiols	   such	  as	  mycothiol	   (Figure	  
1.1),	  play	  a	  central	  role	   in	  maintaining	  a	  reducing	  cellular	  environment	  [47,116].	   	  Proper	  redox	  
homeostasis	   is	   essential	   for	   normal	   cellular	   function	   and	   to	   mitigate	   the	   effects	   of	   oxidative	  
stress.	   	   Hence,	   the	   metabolic	   route	   used	   for	   the	   production	   of	   reduced	   sulfur-­‐containing	  
metabolites	   (Figure	   1.3)	   is	   predicted	   to	   be	   important	   for	   mycobacterial	   survival	   [52,53,61].	  	  
Consistent	  with	  this	  hypothesis,	  expression	  of	  mycobacterial	  genes	  involved	  in	  reductive	  sulfate	  
assimilation	  are	  induced	  by	  oxidative	  stress	  and	  within	  the	  environment	  of	  the	  macrophage	  [36-­‐
45].	  	  	  
	  
1.4	  Sulfate	  Reduction	  
APS	  reductase	  (APR,	  encoded	  by	  cysH)	  catalyzes	  the	  first	  committed	  step	  in	  the	  biosynthesis	  of	  
reduced	  sulfur	  compounds	  (Figure	  1.3).	  	  In	  this	  reaction,	  APS	  is	  reduced	  to	  SO32-­‐	  and	  adenosine-­‐
5'-­‐phosphate	   (AMP)	   [121].	   	   Thioredoxin	   (Trx),	   a	  12.7	   kDa	  protein	  with	  a	   redox-­‐active	  disulfide	  
bond,	  supplies	  the	  reducing	  potential	  necessary	  for	  this	  two-­‐electron	  reduction	  [122].	  	  The	  SO32-­‐	  
product	  of	  this	  reaction	  is	  reduced	  further	  to	  S2-­‐,	  which	  is	  used	  for	  the	  biosynthesis	  of	  reduced	  
sulfur-­‐containing	   metabolites,	   such	   as	   cysteine,	   methionine,	   CoA,	   iron-­‐sulfur	   clusters	   and	  
mycothiol	  [46,67]	  (Figure	  1.1).	  	  Consistent	  with	  its	  important	  metabolic	  role,	  APR	  was	  identified	  
in	  a	   screen	   for	  essential	   genes	   in	  M.	  bovis	   BCG	   [41]	  and	  cysH	   is	   actively	  expressed	  during	   the	  
dormant	  phase	  of	  M.	  tuberculosis	  and	  in	  the	  environment	  of	  the	  macrophage	  [36,44].	  	  	  
	  
Humans	  do	  not	   reduce	  sulfate	   for	  de	  novo	   cysteine	  biosynthesis	  and	  therefore,	  do	  not	  have	  a	  
CysH	   equivalent.	   	   Thus,	   APR	  would	   be	   an	   attractive	   drug	   target	   if	   the	   enzyme	   is	   required	   for	  
bacterial	   survival	   or	   virulence	   in	   vivo	   [52,53,61,72].	   	   To	   test	   this	   hypothesis,	   Senaratne	   and	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coworkers	  generated	  an	  M.	  tuberculosis	  mutant	  strain	  lacking	  CysH	  (∆cysH)	  [61].	  	  As	  predicted,	  
the	  mutant	  strain	  was	  auxotrophic	  for	  cysteine	  and	  could	  only	  be	  grown	  in	  media	  supplemented	  
with	   this	   amino	   acid,	   methionine	   or	   glutathione	   (from	   which	   cysteine	   can	   be	   generated	  
catabolically).	   	   The	   cysH	   mutant	   exhibited	   attenuated	   virulence	   in	   BALB/c	   and	   C57BL/6	  
immunocompetent	  mice.	   	  Growth	  kinetics	   in	   the	   lungs,	   spleen	  and	   liver	  of	  mice	   infected	  with	  
∆cysH	   or	   wild-­‐type	  M.	   tuberculosis	   were	   also	   quantified.	   	   Strikingly,	   the	   number	   of	   colony-­‐
forming	   units	   recovered	   from	   the	   ∆cysH	   mutant	   mirrored	   those	   of	   wild-­‐type	  M.	   tuberculosis	  
during	  the	  acute	  stage	  of	  infection	  [up	  to	  16	  days	  post-­‐infection	  (pi)].	  	  However,	  the	  number	  of	  
viable	  bacteria	  in	  the	  mutant	  became	  significantly	  less	  (i.e.,	  by	  3	  orders	  of	  magnitude)	  coincident	  
with	  the	  emergence	  of	  adaptive	  TH1-­‐mediated	  immunity	  and	  the	  induction	  of	  persistence	  in	  the	  
mouse	   (between	  16	   and	   42	  days	   pi)	   [123].	   	   In	   addition,	   ∆cysH	  was	  most	   compromised	   in	   the	  
liver,	   where	   the	   host’s	   oxidative	   antimicrobial	   response	   is	   thought	   to	   play	   an	   especially	  
important	  role	  in	  antimicrobial	  defense.	  	  Since	  the	  replication	  of	  ∆cysH	  in	  mouse	  tissues	  during	  
the	  first	  16	  days	  pi	  was	  identical	  to	  that	  of	  wild-­‐type,	  these	  data	  suggest	  that	  mouse	  tissues	  can	  
provide	  M.	  tuberculosis	  with	  sufficient	  reduced	  sulfur-­‐containing	  amino	  acids	  (e.g.,	  cysteine	  and	  
methionine),	   for	   initial	   growth	   (see	   discussion	   below)	   [52,61,68,124].	   	   Hence,	   APR	   activity	  
appears	   to	  be	  dispensable	  during	   the	  acute	  phase	  of	   infection,	  but	   indispensable	   in	   the	   later,	  
persistence	   phase	   where	   access	   to	   or	   supply	   of	   reduced	   sulfur-­‐containing	   nutrients	   becomes	  
limiting	  [61].	  
	  
As	  discussed	  above,	  NOS2	  plays	  a	  vital	  role	  in	  controlling	  persistent	  M.	  tuberculosis	  infection	  in	  
mice	  [6,125,126].	  	  In	  order	  to	  test	  the	  role	  of	  APR	  in	  protecting	  the	  bacteria	  against	  the	  effects	  
of	  NOS2,	  NOS2-­‐/-­‐	  mice	  were	  infected	  with	  wild-­‐type	  and	  ∆cysH	  M.	  tuberculosis	  [61].	  	  In	  contrast	  
to	  the	  observation	  made	  in	  wild-­‐type	  mice,	  ∆cysH	  did	  not	  lose	  viability	  after	  the	  first	  21	  days	  pi	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in	  NOS-­‐/-­‐	  mice;	  all	  mice	  succumbed	  to	  infection	  within	  26	  to	  31	  days.	  	  Thus,	  ∆cysH	  is	  significantly	  
more	   virulent	  when	  NOS2	   is	   absent.	   	   Taken	   together,	   these	   studies	   indicate	   that	   APR	   plays	   a	  
central	   role	   in	   protecting	   M.	   tuberculosis	   against	   the	   effects	   of	   reactive	   nitrogen	   species	  
produced	  by	  NOS2	  and	   is	   critical	   for	  bacterial	   survival	   in	   the	  persistence	  phase	  of	   infection	   in	  
mice	  [61].	  	  Furthermore,	  a	  follow-­‐up	  study	  demonstrates	  that	  immunization	  of	  mice	  with	  ∆cysH	  
generates	  protection	  equivalent	  to	  that	  of	  the	  BCG	  vaccine	  in	  mice	  infected	  with	  M.	  tuberculosis	  
[127].	  
	  
The	  final	  step	  in	  sulfate	  reduction,	  the	  six	  electron	  reduction	  of	  SO32-­‐	  to	  S2-­‐,	  is	  catalyzed	  by	  sulfite	  
reductase	   (encoded	  by	  nirA)	   (Figure	  1.3)	   [73].	   	   Like	  cysH,	  nirA	   is	   an	  essential	   gene	   [41]	   and	   is	  
active	   during	   the	   dormant	   phase	   of	   M.	   tuberculosis	   [36,44].	   	   The	   sulfite	   reductase	   in	   M.	  
tuberculosis	  belongs	  to	  the	  family	  of	  ferredoxin-­‐dependent	  sulfite/nitrite	  reductases	  [73].	  	  These	  
enzymes	  contain	  a	  [4Fe-­‐4S]	  center	  and	  a	  siroheme.	  	  In	  this	  reaction,	  the	  external	  electron	  donor	  
(likely	   ferredoxin)	  binds	   transiently	   to	  sulfite	   reductase	  and	   transfers	  electrons	   to	   the	   [4Fe-­‐4S]	  
center,	  one	  at	  a	  time.	  	  Subsequently,	  sulfite	  reduction	  is	  accomplished	  by	  transferring	  electrons	  
from	  the	  cluster	  to	  the	  siroheme,	  which	  coordinates	  the	  sulfite	  substrate.	   In	  2005,	  Schnell	  and	  
coworkers	   reported	   the	   structure	   of	   M.	   tuberculosis	   NirA	   [73].	   	   Interestingly,	   the	   structure	  
depicts	  a	  covalent	  bond	  between	  the	  side	  chains	  of	  residues	  Tyr69	  and	  Cys161	  adjacent	  to	  the	  
siroheme	   in	   the	   active	   site	   of	   sulfite	   reductase.	   	   Site-­‐directed	   mutagenesis	   of	   either	   residue	  
impairs	   catalytic	   activity,	   though	   their	   involvement	   in	   the	   mechanism	   of	   sulfite	   reduction	   is	  





1.5	  Adenosine-­‐5'-­‐Phosphosulfate	  Reductase	  	  
Attenuation	  of	  ∆cysH	  in	  a	  mouse	  model	  of	  M.	  tuberculosis	  infection	  and	  the	  importance	  of	  APR	  
in	   mycobacterial	   persistence	   further	   motivated	   investigation	   of	   the	   molecular	   details	   of	   the	  
reaction	  catalyzed	  by	  APR	   [61].	   	  Biochemical,	   spectroscopic,	  mass	   spectrometry	  and	  structural	  
investigation	  of	  APR	  support	  a	  two-­‐step	  mechanism,	  in	  which	  APS	  undergoes	  nucleophilic	  attack	  
by	  an	  absolutely	  conserved	  cysteine	  to	  form	  an	  enzyme	  S-­‐sulfocysteine	  intermediate,	  E-­‐Cys-­‐Sγ–
SO3–	   [61,71,72,128,129].	   	   In	   a	   subsequent	   step,	   SO32–	   is	   released	   in	   a	   Trx-­‐dependent	   reaction.	  	  
During	   the	   catalytic	   cycle,	   nucleophilic	   attack	   at	   Sγ	   atom	   of	   the	   S-­‐sulfocysteine	   intermediate	  
results	   in	  the	  transient	  formation	  of	  a	  mixed	  disulfide	  between	  Trx	  and	  APR,	  with	  concomitant	  
release	  of	  sulfite.	  	  The	  structure	  of	  this	  complex	  has	  recently	  been	  reported	  and	  reveals	  a	  unique	  
protein-­‐protein	   interface	  as	   a	  potential	   candidate	   for	  disruption	  by	   small	  molecule	  or	  peptide	  
inhibitors	  [130].	  
	  
In	  addition	  to	  the	  conserved	  catalytic	  cysteine,	  the	  primary	  sequence	  of	  APR	  is	  also	  distinguished	  
by	   the	   presence	   of	   a	   conserved	   iron-­‐sulfur	   cluster	   motif,	   -­‐CysCys-­‐X~80-­‐CysXXCys-­‐	   [53,71].	  	  
Biochemical	   studies	   demonstrate	   that	   the	   four	   cysteines	   in	   this	   motif	   coordinate	   a	   [4Fe-­‐4S]	  
cluster,	  and	  that	  this	  cofactor	  is	  essential	  for	  catalysis	  [71,72].	  	  However,	  the	  specific	  role	  of	  the	  
cluster	   in	   APS	   reduction	   has	   remained	   elusive.	   	   In	   general,	   iron-­‐sulfur	   clusters	   are	   protein	  
cofactors	   that	   play	   critical	   roles	   in	   electron	   transfer,	   mediating	   cellular	   response	   through	  
transcriptional	   or	   translational	   regulation,	   disulfide	   reduction	   or	   substrate	   binding	   and	  
activation,	   among	  others	   [131-­‐136].	   	   The	  nature	  of	   these	  metal	   centers	   is	   briefly	   discussed	   in	  




1.5.1	  Iron-­‐sulfur	  Proteins	  
It	   has	  been	  estimated	   that	  nearly	  one-­‐third	  of	   all	   known	  proteins	   require	  metal	   ions	   for	   their	  
biological	  structure	  or	  function	  [137].	   	  Metalloproteins	  associate	  with	  metal	   ions	  such	  as	  Mg2+,	  
Zn2+,	   Fe2+,	   Cu2+	   etc.	   directly,	   through	   cofactors	   such	   as	   porphyrin	   or	   cobalamins,	   or	   by	  
coordinating	   to	   metal-­‐clusters	   via	   ligands	   such	   as	   O,	   N,	   S	   or	   C	   [138,139].	   	   Iron	   is	   the	   most	  
abundant	   transition	  metal	   in	  biology,	   commonly	  used	   for	  diverse	   redox-­‐related	   functions	  as	   it	  
can	   form	   a	   range	   of	   oxidation	   states.	   	   As	   such,	   the	   family	   of	   proteins	   containing	   iron	   is	  
ubiquitous	  in	  living	  organisms	  where	  these	  proteins	  have	  been	  shown	  to	  incorporate	  from	  one	  
to	  eight	   iron	  atoms	   in	  a	  single	  metal-­‐binding	  site	   [140].	   	  The	  simplest	   iron	  centers	  consist	  of	  a	  
single	   iron	  atom	  coordinated	   to	   the	  protein	  by	   four	   cysteine	   residues	   as	   found	   in	   rubredoxin.	  	  
On	  the	  other	  hand,	  ferredoxins	  have	  the	  more	  commonly	  found	  clusters	  with	  two,	  three	  or	  four	  
iron	  centers	  bridged	  by	  either	  two	  or	  four	   inorganic	  sulfides	  [141,142].	   	  These	  iron	  centers	  are	  
typically	  coordinated	  to	  the	  protein	  scaffold	  by	  cysteine	  or	  histidine	  residues	  or	  less	  commonly	  
by	   ligands	   such	   as	   aspartate,	   arginine	   and	   serine	   [139].	   	   Both	   the	   nature	   of	   the	   ligands	   and	  
solvent	  exposure	  has	  a	  strong	  influence	  on	  the	  redox	  potentials	  of	  these	  iron-­‐centers	  [143].	  	  	  
	  
Iron-­‐sulfur	   clusters	   are	   versatile	   cofactors	   that	   mediate	   the	   biological	   function	   of	   numerous	  
proteins	  (Figure	  1.4).	  	  The	  most	  common	  role	  of	  iron-­‐sulfur	  clusters	  is	  in	  electron	  transfer,	  based	  
on	  the	  propensity	  of	  Fe	  to	  access	  multiple	  oxidation	  states	  by	  donating	  and	  accepting	  electrons	  
in	  biological	   reactions	   [140].	   	  Under	  physiological	   conditions,	   iron-­‐sulfur	   clusters	   cover	   a	  wide	  
range	  of	  reduction	  potentials,	  with	  midpoint	  reduction	  potentials	  varying	  from	  –700	  mV	  to	  +500	  
mV	   [144,145].	   	   Examples	   are	   found	   in	   bacterial	   and	  mitochondrial	   respiratory	   complexes	   I-­‐III,	  
photosystem	   I,	   ferredoxins	   and	   hydrogenases	   [139].	   	   Amongst	   the	   non-­‐electron	   transfer	  
functions,	   iron-­‐sulfur	  clusters	  can	  serve	  as	  active	  sites	  within	  enzymes.	   	  The	  classic	  example	   is	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mitochondrial	  aconitase	  in	  which	  one	  of	  the	  irons	  within	  a	  [4Fe-­‐4S]	  cluster	  serves	  as	  a	  Lewis	  acid	  
catalyzing	  the	  abstraction	  of	  water	  from	  the	  substrate,	  citrate,	  which	  is	  converted	  to	  isocitrate	  
[144].	  	  	  
	  
Another	   function	  of	   iron-­‐sulfur	   clusters	  was	  discovered	   in	   the	   family	  of	  S-­‐adenosylmethionine	  
(SAM)	   enzymes	   wherein	   [4Fe-­‐4S]	   clusters	   are	   involved	   in	   the	   initiation	   of	   radical	   chemistry	  
[146,147].	  	  Iron-­‐sulfur	  clusters	  have	  also	  been	  exploited	  in	  nature	  to	  play	  a	  role	  in	  regulatory	  and	  
sensing	   mechanisms.	   	   For	   instance,	   transcriptional	   regulators	   like	   FNR	   (fumarate	   nitrate	  
	  
Figure	   1.4	  Diverse	   biological	   functions	  mediated	  by	   iron-­‐sulfur	   clusters.	   Abbreviation	  used	   are	  APR,	  
adenosine-­‐5’-­‐phosphosulfate	   reductase;	   SAM,	   S-­‐adenosylmethionine;	   PRPP,	  
phosphoribosylpyrophosphate.	  The	  clusters	  are	   represented	  by	  ball-­‐and-­‐stick	  models	  and	  are	   color-­‐
coded	  by	  atom	  type,	  with	  iron	  in	  red	  and	  sulfur	  in	  green.	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reductase)	  proteins	  incorporate	  two	  [4Fe-­‐4S]2+	  clusters	  per	  dimer	  which	  favor	  the	  binding	  of	  the	  
protein	  to	  DNA	  and	  expression	  of	  proteins	  required	  for	  anaerobic	  metabolism.	  	  Upon	  exposure	  
to	   oxygen,	   the	   [4Fe-­‐4S]2+	   clusters	   are	   converted	   to	   [2Fe-­‐2S]2+	   clusters	   and	   the	   resulting	  
apoprotein	  is	  rendered	  transcriptionally	  inactive	  [148].	  	  Iron-­‐sulfur	  clusters	  have	  been	  attributed	  
with	   several	   other	   catalytic	   functions	   in	   bacterial	   and	   eukaryotic	   enzymes	   involved	   in	  
metabolism	  [142,145].	  
	  
Additionally,	  iron-­‐sulfur	  clusters	  have	  been	  shown	  to	  serve	  a	  structural	  role	  contributing	  to	  the	  
stability	   of	   the	   protein.	   	   This	   role	   has	   been	   accomplished	   in	   Endonuclease	   III,	   the	  DNA	   repair	  
enzyme	   in	   E.	   coli,	   where	   the	   iron-­‐sulfur	   cluster	   straddles	   structural	   elements	   and	   stabilizes	  
functionally	  important	  features	  of	  the	  enzyme	  [149,150].	  	  Alternatively,	  the	  presence	  of	  an	  iron-­‐
sulfur	   center	   has	   been	   shown	   to	   protect	   an	  
enzyme	   such	   as	   the	   amidotransferase	   of	  Bacillus	  
subtilis	   from	   degradation	   by	   intracellular	  
proteases	   [151].	   	   Thus	   iron-­‐sulfur	   clusters	   have	  
been	   employed	  by	  myriad	   of	   proteins	   to	   serve	   a	  
wide	  range	  of	  functions.	  
	  
However,	   there	   are	   numerous	   proteins	   in	   which	  
the	   iron-­‐sulfur	   cluster	   is	   essential	   for	   biological	  
activity	  but	  its	  precise	  role	  is	  still	  to	  be	  discovered.	  	  
Recently	   the	   ATP-­‐dependent	   DNA	   helicase,	   XPD	  
(Rad3	   in	   Saccharomyces	   cerevisiae)	   involved	   in	  
nucleotide	   excision	   repair	   enzyme	  was	   shown	   to	  
	  
Figure	   1.5.	   Structure	   of	   PaAPR	   bound	   to	  
substrate	  APS.	  The	  [4Fe-­‐4S]	  cluster	  is	  ligated	  
by	   four	   cysteine	   residues	   at	   positions	   139,	  
140,	   228	   and	   231	   (PDB	   code	   2GOY).	   	   The	  
shortest	   distances	   between	   the	   terminal	  
sulfate	   moiety	   of	   APS	   and	   Fe	   and	   Sγ	   of	  
Cys140	  are	  6.09	  Å	  (blue	  dashes)	  and	  7.03	  Å	  
(green	   dashes).	   C	   and	   N	   indicate	   the	  
carboxyl-­‐	  and	  amino-­‐	  termini	  of	  the	  protein,	  
respectively.	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harbor	   essential	   iron	   sulfur	   clusters	   that	   may	   function	   in	   a	   way	   similar	   to	   glycosylases	   like	  
endonuclease	  III	  [152,153].	  	  Another	  example	  is	  the	  mammalian	  ferrochelatase,	  which	  catalyzes	  
the	   insertion	   of	   ferrous	   iron	   into	   protoprophyrin	   during	   heme	   biosynthesis.	   The	   enzyme	   is	  
strongly	   inhibited	   by	   nitric	   oxide,	   which	   destroys	   its	   [2Fe-­‐2S]	   cluster,	   suggesting	   a	   possible	  
regulatory	  role	  for	  the	  cluster	  as	  a	  NO	  sensor	  [154].	   	  Similarly,	  the	  exact	  role	  of	  the	  iron-­‐sulfur	  
clusters	   in	   the	   eukaryotic	   ATP-­‐binding	   cassette	   protein	   Rli1p	   involved	   in	   ribosome	   biogenesis	  
and	   function	   is	   unknown,	   despite	   the	   availability	   of	   the	   crystal	   structure	   of	   the	   holoprotein	  
[155,156].	   	  The	  focus	  of	  our	  study	   is	  the	  sulfonucleotide	  reductase,	  APR,	  which	  poses	  a	  similar	  
challenge.	  	  	  
	  
The	  first	  structure	  of	  an	  assimilatory	  APR	  was	  recently	  reported,	  with	  its	  [4Fe-­‐4S]	  cluster	  intact	  
and	   APS	   bound	   in	   the	   active	   site	   [128]	   (Figure	   1.5).	   	   While	   the	   iron-­‐sulfur	   cluster	   in	   APR	   is	  
required	   for	   catalytic	   activity	   it	   does	   not	   appear	   to	   function	   as	   a	   structural	   anchor	   or	   as	   an	  
electron	  transfer	  conduit	  [128,157].	  	  Studies	  reported	  by	  Carroll	  et	  al.	  in	  2005	  provided	  evidence	  
that	   the	   cluster	  may	  play	   a	   role	   in	   substrate	  binding	   and	   activation	   [71].	   	   In	   this	  work,	   it	  was	  
shown	   that	   substrate	   binding,	   with	   concomitant	   formation	   of	   the	   thiosulfate-­‐enzyme	  
intermediate,	   protected	   the	   cluster	   against	   oxidation.	   	   Consistent	   with	   the	   biochemical	  
observations,	  the	  x-­‐ray	  crystal	  structure	  of	  APR	  revealed	  that	  APS	  binds	  in	  close	  proximity	  to	  the	  
iron-­‐sulfur	   center.	   	   Collectively,	   these	   observations	   highlight	   the	   unusual	   nature	   of	   this	   iron-­‐
sulfur	  cluster	  and	  set	  the	  stage	  for	  detailed	  investigation	  into	  the	  structure	  and	  function	  of	  this	  
essential	  cofactor	  in	  APR.	  	  Specifically,	  our	  goal	  is	  to	  determine	  whether	  the	  iron-­‐sulfur	  cluster	  in	  
APR	   comes	   into	  direct	   contact	   or	   communicates	  with	   the	   substrate	  during	   the	   catalytic	   cycle.	  	  
Results	   from	  these	   investigations	  would	  provide	   insights	   into	   the	   function	  of	   this	  cofactor	  and	  
facilitate	  the	  rational	  design	  of	  inhibitors	  that	  target	  the	  metal	  site	  and	  inactivate	  APR.	  	  From	  a	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fundamental	   perspective,	   these	   studies	   would	   advance	   our	   understanding	   of	   the	   catalytic	  
mechanism	  of	  APR,	  which	  represents	  a	  promising	  target	  for	  antitubercular	  therapy.	  
	  
1.6	  Outlook	  
The	   emergence	   of	   antibiotic	   resistance	   and	   the	   problem	   of	   mycobacterial	   persistence	   in	  M.	  
tuberculosis	   urgently	   stress	   the	   need	   for	   new	   target	   identification.	   	   Toward	   this	   end,	  
mycobacterial	   sulfur	  metabolic	  pathways	   represent	  a	  promising	  new	  area	   for	  anti-­‐TB	   therapy.	  	  
In	   the	   last	   several	   years’	   excellent	   progress	   has	   been	  made,	   leading	   to	   the	   identification	   and	  
validation	  of	  several	  potential	  drug	  targets	  in	  sulfate	  assimilation	  and	  MSH	  metabolism.	  	  At	  the	  
same	   time,	   many	   aspects	   of	   mycobacterial	   sulfur	   metabolism	   remain	   poorly	   understood	   and	  
represent	  exciting	  areas	  of	  new	  or	  continued	  investigation.	  	  One	  such	  challenge	  is	  presented	  by	  
APR,	  which	  catalyzes	  the	  first	  committed	  step	  of	  sulfate	  reduction	  and	  has	  been	  validated	  as	  a	  
drug	   target	   against	   latent	   phase	   tuberculosis.	   	   Elucidation	   of	   the	   function	   of	   the	   iron-­‐sulfur	  
cofactor	   of	   APR,	   a	   central	   unsolved	   question	   in	   this	   unique	   class	   of	   enzymes,	   is	   extremely	  
relevant	  to	  the	  catalytic	  mechanism	  of	  the	  enzyme.	  	  Additionally,	  this	  investigation	  would	  yield	  
important	   structural	   information	   that	   can	   be	   used	   for	   the	   design	   of	   cluster-­‐targeted	   APR	  
inhibitors.	   In	   a	   broader	   sense,	   the	   knowledge	   gained	   from	   this	   study	   would	   have	   important	  
implications	  for	  the	  structural	  and	  electronic	  features	  of	  protein-­‐associated	  iron-­‐sulfur	  clusters.	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Identification	  of	  Critical	  Ligand	  Binding	  Determinants	  in	  Mycobacterium	  
tuberculosis	  Adenosine-­‐5'-­‐phosphosulfate	  Reductase	  
	  
This	  work	  has	  been	  partially	  published	  as	  "Identification	  of	  Critical	  Ligand	  Binding	  Determinants	  
in	   Mycobacterium	   tuberculosis	   Adenosine-­‐5'-­‐phosphosulfate	   Reductase"	   2009	   Journal	   of	  
Medicinal	  Chemistry	  52;	  5485-­‐5495.	  	  My	  contributions	  to	  this	  work	  include	  optimization	  of	  the	  
protocol	  for	  recombinant	  expression	  and	  purification	  of	  MtAPR,	  resulting	  in	  improved	  yield	  and	  
stability	  of	   the	  protein,	   synthesis	  of	   two	  key	   ligands,	   and	   calculations	   for	   electrostatic	   surface	  
potential	  of	  ligands.	  	  
	  
2.1	  Abstract	  
Mycobacterium	   tuberculosis	   adenosine	   5ʹ′-­‐phosphosulfate	   (APS)	   reductase	   is	   an	   iron-­‐sulfur	  
protein	   and	   a	   validated	   target	   to	   develop	   new	   anti-­‐tubercular	   agents,	   particularly	   for	   the	  
treatment	  of	  latent	  infection.	  	  To	  facilitate	  the	  development	  of	  potent	  and	  specific	  inhibitors	  of	  
APS	   reductase	   (APR),	   we	   have	   probed	   the	  molecular	   determinants	   that	   underlie	   binding	   and	  
specificity	   through	   a	   series	   of	   substrate	   and	   product	   analogs.	   	   Our	   study	   highlights	   the	  
importance	  of	  specific	  substituent	  groups	  for	  substrate	  binding	  and	  provides	  functional	  evidence	  
for	   ligand-­‐specific	   conformational	   states.	   	   An	   active	   site	   model	   has	   been	   developed	   for	  M.	  
tuberculosis	  APR	  that	  is	  in	  accord	  with	  the	  results	  presented	  here	  as	  well	  as	  prior	  structural	  data	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reported	   for	   Pseudomonas	   aeruginosa	   APR	   and	   related	   enzymes.	   	   This	   model	   illustrates	   the	  
functional	   features	   required	   for	   the	   interaction	   of	   APR	   with	   a	   ligand	   and	   provides	   a	  
pharmacological	   road	  map	   for	   the	   rational	  design	  of	   small-­‐molecules	  as	  potential	   inhibitors	  of	  
APR	  present	  in	  human	  pathogens,	  including	  M.	  tuberculosis.	  
	  
2.2	  Introduction	  
Reduced	   sulfur	   appears	   in	   organic	   compounds	   essential	   to	   all	   organisms	   as	   constituents	   of	  
proteins,	   coenzymes,	   and	   cellular	   metabolites	   [1-­‐3].	   	   In	   the	   amino	   acid	   cysteine,	   the	   thiol	  
functional	   group	   plays	   important	   biological	   roles	   in	   redox	   chemistry,	   metal	   binding,	   protein	  
structure	  and	  catalysis	  [4].	  	  In	  many	  human	  pathogens	  such	  as	  Mycobacterium	  tuberculosis	  and	  
Pseudomonas	   aeruginosa,	   activation	   of	   inorganic	   sulfur	   for	   the	   biosynthesis	   of	   cysteine	  
proceeds	   via	   adenosine	   5’-­‐phosphosulfate	   (APS)	   [5,6].	   	   This	   high-­‐energy	   intermediate	   is	  
produced	   by	   the	   action	   of	   ATP	   sulfurylase,	   which	   condenses	   sulfate	   and	   adenosine	   5’-­‐
triphosphate	   (ATP)	   to	  
form	   APS	   [1].	   	   The	   iron-­‐
sulfur	   protein,	   APR	  
catalyzes	   the	   first	  
committed	  step	   in	  sulfate	  
reduction	   and	   is	   a	  
validated	   target	   to	  
develop	   new	   anti-­‐
tubercular	   agents,	  
particularly	   for	   the	  
treatment	   of	   latent	  
	  	  
Figure	   2.1	   	   Sulfate	   assimilation	   pathway	   in	   M.	   tuberculosis.	   	   The	  
majority	  of	  sulfate	  reducing	  bacteria	  use	  APS	  as	  their	  source	  of	  sulfite.	  	  
In	   this	   reaction,	   APS	   is	   reduced	   to	   sulfite	   and	   adenosine-­‐5'-­‐
monophosphate	   (AMP)	   by	   APR.	   	   Sulfite,	   in	   turn,	   is	   reduced	   by	   later	  
enzymes	   in	   this	   metabolic	   pathway,	   forming	   first	   sulfide	   before	  
incorporation	   into	   cysteine	   and,	   ultimately,	   to	   methionine	   and	   other	  
essential	  reduced	  sulfur-­‐containing	  biomolecules.	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infection	  [7-­‐9].	  	  
	  
APR	  catalyzes	   the	  reduction	  of	  APS	  to	  sulfite	   (HSO3–)	  and	  adenosine	  5’-­‐monophosphate	   (AMP)	  
using	  reduction	  potential	  supplied	  by	  the	  protein	  cofactor,	   thioredoxin	  as	  shown	  in	  Figure	  2.1.	  	  
Functional	   and	   structural	   studies	   have	   been	   used	   to	   investigate	   the	  mechanism	   of	   APR	   from	  
sulfate-­‐assimilating	   bacteria	   [10-­‐12].	   	   The	   proposed	   mechanism	   in	   Figure	   2.2	   involves	  
nucleophilic	  attack	  by	  cysteine	  2561	  on	  the	  sulfur	  atom	  in	  APS	  to	  form	  an	  enzyme	  S-­‐sulfocysteine	  
intermediate,	   E-­‐Cys-­‐Sγ–SO3–,	  
which	   is	   then	   reduced	   through	  
intermolecular	   thiol-­‐disulfide	  
exchange	   with	   thioredoxin.	   	   The	  
iron-­‐sulfur	   cluster	   in	   APR	   is	  
essential	   for	   activity;	   however,	   it	  
is	  not	  involved	  in	  redox	  chemistry	  and	  its	  exact	  role	  remains	  unknown	  [6,11].	  	  	  
	  
Crystal	  structure	  determination	  at	  2.7	  Å	  of	  P.	  aeruginosa	  APR	  in	  complex	  with	  APS	  provided	  the	  
first	  insight	  into	  the	  molecular	  basis	  for	  substrate	  recognition	  (Figure	  2.3)	  [12].	  	  M.	  tuberculosis	  
and	  P.	  aeruginosa	  APRs	  are	  related	  by	  high	  sequence	  homology	  (27.2%	  of	  sequence	  identity	  and	  
41.4%	  of	  sequence	  similarity),	  particularly	   in	  the	  residues	  that	   line	  the	  active	  site.	   	  The	  protein	  
monomer	  folds	  as	  a	  single	  domain	  with	  a	  central	  six-­‐stranded	  β	  sheet,	  interleaved	  with	  seven	  α-­‐
helices	  (Figure	  2.3).	  	  Opposite	  the	  nucleotide	  at	  one	  end	  of	  the	  active	  site	  is	  the	  [4Fe-­‐4S]	  cluster.	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Residue	  numbers	   throughout	  manuscript	  correspond	  to	  the	  APS	  reductase	  sequence	   from	  P.	  
aeruginosa	  (Appendix	  2.5.3).   
	  	  
Figure	  2.2	  Mechanism	  of	  sulfonucleotide	  reduction	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Three	   additional	   elements	   define	   the	   active	   site:	  
the	   P-­‐loop	   (residues	   60-­‐66),	   the	   LDTG	   motif	  
(residues	   85-­‐88)	   and	   the	   Arg-­‐loop	   (residues	   162-­‐
173).	   	  APS	   fits	   into	  the	  active	  site	  cavity	  with	  the	  
phosphosulfate	   moiety	   extending	   toward	   the	  
protein	  surface	  and	  ten	  residues	  interact	  directly,	  
via	  hydrogen	  bonding	  or	  hydrophobic	  interactions	  
with	   the	   substrate.	   	   The	   C-­‐terminal	   segment	   of	  
residues	   250-­‐267,	   which	   carries	   the	   catalytically	  
essential	   Cys256,	   is	   disordered	   in	   this	   structure,	  
but	   would	   be	   positioned	   above	   the	   active	   site	  
cleft.	  	  	  
	  
Not	  all	  organisms	  that	  assimilate	  sulfate	  reduce	  APS	  as	  the	  source	  of	  sulfite.	  	  Through	  divergent	  
evolution,	   some	   organisms,	   such	   as	   Escherichia	   coli	   and	   Saccharomyces	   cerevisiae	   reduce	   the	  
related	  metabolite	   3’-­‐phosphoadenosine-­‐5’-­‐phosphosulfate	   (PAPS)	   [10],	   which	   is	   produced	   by	  
APS	  kinase	  from	  ATP	  and	  APS	  [13].	  	  PAPS	  reductases	  lack	  the	  iron-­‐sulfur	  cofactor,	  but	  utilize	  the	  
same	   two-­‐step	   mechanism	   shown	   in	   Figure	   2.2	   [10,11].	   	   S.	   cerevisiae	   PAPS	   reductase,	  
crystallized	  in	  the	  presence	  of	  the	  product,	  3’-­‐phosphoadenosine	  5’-­‐phosphate	  (PAP)	  [14]	  has	  a	  
fold	   similar	   to	   APR	   (1.6-­‐Å	   rms	   deviation	   over	   117	   residues).	   	   In	   the	   structure	   of	   yeast	   PAPS	  
reductase,	   the	   Arg-­‐loop	   and	   C-­‐terminal	   segment	   are	   folded	   over	   the	   active	   site	   and	   this	  
conformation	  reveals	  additional	  enzyme-­‐ligand	  contacts,	  which	  may	  also	  form	  between	  APR	  and	  
its	  substrate,	  APS.	  	  
	  	  
Figure	  2.3	  The	  structure	  of	  P.	  aeruginosa	  APS	  
reductase	   in	   complex	   with	   substrate,	   APS	  
(PDB	   2GOY).	   	   The	   C-­‐terminal	   segment	   of	  
residues	   starting	   at	   Glu249	   carries	   the	  




Even	  though	  M.	  tuberculosis	  has	  plagued	  humans	  for	  millennia,	  the	  antibiotic	  regime	  is	  complex	  
and	   effective	   drugs	   that	   specifically	   target	   latent	   TB	   infection	   are	   yet	   to	   be	   developed	   [15].	  	  
Novel	   targets	   [16,17]	   and	   treatment	   strategies	   [18,19]	   are	   emerging,	   but	   new	   avenues	   for	  
therapeutic	   intervention	  must	  continue	   to	  be	  explored	   in	  order	   to	  combat	  multidrug-­‐resistant	  
strains	   of	   TB,	   which	   pose	   a	   significant	   threat	   to	   global	   human	   health	   [20].	   	   To	   this	   end,	   APR	  
represents	   an	   attractive	   target	   for	   therapeutic	   intervention	   because	   it	   is	   essential	   for	  
mycobacterial	   survival	   in	   the	   latent	   phase	   of	   TB	   infection	   [9]	   and	   humans	   do	   not	   possess	   an	  
analogs	   metabolic	   pathway.	   	   Recently,	   we	   have	   discovered	   small-­‐molecule	   inhibitors	   of	   APR	  
through	  virtual	   ligand	  screening	   [21].	   	  However,	   the	  development	  of	  more	  specific	  and	  potent	  
inhibitors	  will	  be	  greatly	  aided	  through	  knowledge	  of	  the	  functional	  importance	  of	  interactions	  
between	  the	  substrate	  and	  enzyme	  at	  the	  active	  site,	  which	  have	  not	  yet	  been	  experimentally	  
addressed.	  
	  
Herein,	  we	   probe	   binding	   determinants	   of	   the	  M.	   tuberculosis	   APR	   active	   site	   using	   synthetic	  
ligand	   analogs.	   	   These	   studies	   define	   chemical	   groups	   that	   are	   essential	   for	   molecular	  
recognition	  and	  reveal	  a	  network	  of	  electrostatic	   interactions,	  which	  play	  an	   important	   role	   in	  
substrate	  discrimination.	  	  An	  active	  site	  model	  has	  been	  developed	  for	  M.	  tuberculosis	  APR	  that	  
is	   in	   accord	   with	   the	   results	   presented	   here	   as	   well	   as	   prior	   structural	   data	   reported	   for	   P.	  
aeruginosa	  APR	  and	  related	  enzymes.	  	  This	  model	  illustrates	  the	  functional	  features	  required	  for	  
the	   interaction	  of	  APR	  with	  a	   ligand	  and	  provides	  a	  pharmacological	  road	  map	  for	  the	  rational	  




2.3	  Results	  and	  Discussion	  
The	  substrate	  and	  fragments	  studied	  and	  results	  obtained	  in	  these	  experiments	  are	  summarized	  
in	  Tables	  2.1-­‐2.3	  and	  Figures	  2.4-­‐2.9.	  
	  
2.3.1	  Substrate	  Affinity.	   	  As	  a	  starting	  point	  to	  explore	  the	  molecular	  recognition	  properties	  of	  
APR,	  we	  determined	  the	  Kd	  value	  of	  substrate	  APS	  for	  M.	  tuberculosis	  APR	  from	  the	  dependence	  
of	   the	   observed	   rate	   constant	   for	   S-­‐sulfocysteine	   formation	   (Appendix	   2.5.4),	   as	   described	   in	  
Experimental	  procedures.	  	  The	  substrate	  APS	  binds	  to	  APR	  with	  a	  Kd	  value	  of	  0.2	  µM	  (Table	  2.1),	  
which	  is	  ~3-­‐fold	  lower	  than	  the	  value	  of	  the	  reported	  substrate	  Km	  	  [22].	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Table	  2.1	  Ligand	  dissociation	  constants	  for	  substrate-­‐fragments	  with	  APR.	  
	  
Ligand	   Structure	   Kd	  
[µM][c]	  
∆∆G	  



































































≥	  310000	   ≥	  8.6	   -­‐3	  (O),	  1.89	  (O)	  [27]	  
[a]	   The	   Kd	   of	   APS	   was	   measured	   under	   single	   turnover	   conditions,	   in	   the	   absence	   of	   thioredoxin,	   as	  
described	  in	  the	  methods	  section.	  	  [b]	  Due	  to	  the	  limits	  of	  solubility	  or	  solution	  ideality	  the	  reported	  values	  
are	   lower	   limits.	   	   [c]	   For	   substrate-­‐fragments	   in	   this	   table	   values	   of	   Ki	   were	   determined	   under	   single	  
turnover	  conditions	  from	  the	  dependence	  of	  the	  observed	  rate	  constant	  at	  a	  given	  inhibitor	  concentration	  
under	  conditions	  of	  subsaturating	  APS,	  such	  that	  Ki	  is	  equal	  to	  the	  Kd.	  	  Each	  value	  reflects	  the	  average	  of	  at	  
least	   two	   independent	   experiments,	   and	   the	   standard	  deviation	  was	   less	   than	   15%	  of	   the	   value	  of	   the	  
mean.	   	  Kinetic	  data	  were	  nonlinear-­‐least	   squares	   fit	   to	  a	  model	  of	   competitive	   inhibition.	   	   	   [d]	   Energetic	  
difference	  in	  affinity	  of	  APS	  relative	  to	  inhibitor,	  ∆∆G	  =	  -­‐RTln(Kd
APS/Kd
Fragment).	  	  [e]	  pKa	  estimated	  from	  value	  
measured	   for	   2’-­‐deoxy-­‐5’-­‐phosphoribose	   (Hirota,	   1984).	   	   [f]	   pKa	   estimated	   from	   value	  measured	   for	   3’-­‐
phospho-­‐5’-­‐adenosinephosphosulfate	  (Falany,	  1997).	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2.3.2	  Affinity	  of	  Substrate	  Fragments.	   	  To	  gain	  further	   insight	   into	  substrate	  recognition	  of	  M.	  
tuberculosis	   APR,	  we	   analyzed	   the	   energetic	   contribution	   of	   individual	   portions	   of	   APS	   to	   the	  
enzyme-­‐binding	  interaction.	  	  The	  results	  obtained	  in	  these	  experiments	  are	  summarized	  in	  Table	  
2.1.	  	  The	  product	  AMP	  differs	  chemically	  from	  the	  natural	  substrate,	  APS,	  by	  the	  absence	  of	  the	  
	  
Figure	   2.4	   Effects	   of	   cutting	   the	   substrate,	   APS	   and	   the	   product,	   AMP	   into	   fragments	   on	   ligand	   Kd	  
values.	  	  The	  energetic	  effect	  that	  results	  from	  connectivity	  was	  calculated	  based	  on	  the	  affinity	  of	  the	  
parent	   ligand	   ‘XY’,	   compared	  with	   the	  affinities	  of	   its	  pieces,	   ‘X’	   and	   ‘Y’:	  ΔGconn	  =	   -­‐RTln(KXY/KXKY),	   as	  
previously	  reported	  (Dzingeleski,	  1993).	  
	  
 43	  
sulfate	  moiety.	  	  The	  loss	  of	  sulfate	  from	  APS	  reduced	  binding	  to	  APR	  about	  30-­‐fold	  (2	  kcal/mol),	  
demonstrating	   that	   the	   AMP	   moiety	   makes	   a	   substantial	   contribution	   (7.3	   kcal/mol)	   to	   the	  
overall	  binding	  affinity	  (9.3	  kcal/mol)	  of	  APS.	  	  Deletion	  of	  the	  adenine	  or	  phosphate	  group	  from	  
AMP	   decreased	   binding	   to	   APR	   by	   ~170-­‐fold	   (3.1	   kcal/mol)	   and	   ~550-­‐fold	   (3.8	   kcal/mol),	  
respectively.	  	  Fragments	  of	  adenosine	  –	  D-­‐ribose	  and	  adenine	  –	  exhibited	  weak	  binding	  activity	  
toward	   APR	   (0.2	   and	   ≤1.5	   kcal/mol).	   	   The	   respective	   free	   energy	   of	   binding	   to	   sulfate	   and	  
phosphate	  dianions	  was	  ≤0.7	  and	  1.6	  kcal/mol.	  	  Figure	  2.4	  summarizes	  the	  binding	  properties	  of	  
the	   substrate,	   APS	   and	   product,	   AMP	   for	  M.	   tuberculosis	   APR	   as	   compared	  with	   those	   of	   the	  
fragments	  obtained	  by	  cutting	  these	  ligands	  at	  several	  positions,	   including	  the	  glycosidic	  bond,	  
and	  at	  α-­‐	  or	  β-­‐positions	  within	  the	  diester	  moiety.	  	  In	  all	  cases,	  the	  Kd	  value	  of	  APS	  or	  AMP	  was	  
lower	   than	   those	   of	   its	   pieces.	   	   However,	   the	   free	   energies	   (∆Gconn)	   associated	   with	   these	  
connectivity	  effects	  for	  APR	  are	  modest	  (≤2.2	  kcal/mol),	  as	  compared	  to	  values	  that	  have	  been	  
determined	  for	  adenosine	  [28]	  and	  cytidine	  deaminases	  [29]	  (~10	  kcal/mol).	  	  	  
	  
2.3.3	  Affinity	  of	  Substrate	  Analogs	  
2.3.3.1	  β -­‐Nucleotide	  Substitution.	   	  The	   results	  above	  suggest	   that	   the	  β-­‐sulfate	  group	  plays	  a	  
modest	   role	   (≤2.0	   kcal/mol)	   in	   molecular	   recognition	   of	   APS.	   	   To	   probe	   this	   observation	   in	  
further	   detail,	   we	   investigated	   binding	   affinities	   for	   a	   panel	   of	   nucleotide	   analogs	   containing	  
systematic	  modifications	  at	  the	  β-­‐position	  (Table	  2.2	  and	  Figure	  2.5).	  	  A	  phosphate	  oxyanion	  has	  
nearly	  the	  same	  size	  and	  shape	  as	  a	  sulfate	  oxyanion,	  four	  atoms	  arranged	  tetrahedrally	  around	  
a	  sulfur	  instead	  of	  a	  phosphorous	  [30,31].	  	  However,	  the	  overall	  charge	  of	  these	  analogs	  differs	  
since	  the	  β-­‐sulfate	  is	  monoanionic,	  whereas	  the	  β-­‐phosphate	  is	  dianionic.	   	  Replacement	  of	  the	  
β-­‐sulfate	  moiety	  with	  β-­‐phosphate,	  as	  in	  adenosine	  5’-­‐diphosphate	  (ADP),	  diminished	  binding	  to	  
APR	  about	  20-­‐fold	  (1.8	  kcal/mol).	  	  To	  determine	  whether	  this	  decrease	  in	  binding	  affinity	  is	  due	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to	   additional	   negative	   charge	   at	   the	   β-­‐position	   of	   ADP,	   relative	   to	   APS,	   we	   examined	   sulfur	  
(ADPβS),	   fluorine	   (ADPβF),	   or	   amine	   (AMPPN)	   substitution	   of	   the	   β-­‐phosphate	   nonbridging	  
oxygen	  atom	  in	  ADP	  (Table	  2.2	  and	  Figure	  2.5).	   	  Sulfur	  substitution	   is	  considered	  to	  be	  a	  good	  
mimic	  of	  the	  phosphate	  moiety	  since	  it	  is	  isosteric,	  pseudoisoelectronic,	  and	  has	  a	  similar	  charge	  
distribution	  and	  similar	  net	  charge	  at	  physiological	  pH	  [32,33].	  	  Fluorine	  substitution	  replaces	  an	  
ionizable	  hydroxyl	  group,	  thereby	  mimicking	  the	  protonated	  nucleotide	  species	  in	  net	  charge	  at	  
all	   pH	   values	   [34]	   and,	   at	   neutral	   pH,	   amine	   substitution	   neutralizes	   the	   -­‐1	   charge	   at	   the	   β-­‐
position.	   	   Compared	   to	   ADP,	   substitution	   by	   sulfur	   increased	   binding	   affinity	   by	   2.0	   kcal/mol,	  
fluorine	   increased	  binding	  by	   less	   than	   two-­‐fold	   (0.3	  kcal/mol),	   and	   introduction	  of	   the	  amine	  
group	  decreased	  the	  free	  energy	  of	  binding	  for	  APR	  by	  2.8	  kcal/mol.	  	  	  
	  
Taken	  together,	  the	  above	  data	  suggest	  that	  a	  net	  charge	  of	  -­‐2	  correlates	  with	  potent	  enzyme-­‐
ligand	  interactions.	  	  The	  negative	  charge	  can	  be	  localized	  entirely	  to	  the	  α-­‐position,	  as	  in	  AMP,	  
or	  it	  can	  be	  distributed	  across	  the	  diester,	  as	  in	  ADPβF.	  	  The	  similarity	  of	  Kd	  values	  for	  AMP	  and	  
ADP	  could	  reflect	  different	  modes	  of	  nucleotide	  binding.	  	  For	  example,	  the	  α-­‐phosphate	  of	  AMP	  
could	   occupy	   the	   same	   position	   as	   the	   β-­‐phosphate	   in	   ADP,	   thereby	   establishing	   key	  
electrostatic	   interactions	  with	   Lys144,	   Arg242,	   and	  Arg245	   (Figure	   2.3).	   	   However,	   an	   upward	  
shift	   in	   the	  position	  of	  AMP	  would	   likely	  weaken	   important	  enzyme-­‐binding	  contacts	  with	   the	  
adenine	  ring	  and	  ribose	  sugar	  of	  AMP	  (Figure	  2.3).	  
	  
	  
Figure	   2.5	   Electrostatic	   potential	   surfaces	   of	   substrate,	   APS	   and	   related	   nucleotide	   analogs.	   	   Color	  
gradient:	  red	  corresponds	  to	  most	  negative	  and	  blue	  corresponds	  to	  most	  positive.	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Table	  2.2	  Ligand	  dissociation	  constants	  for	  substrate	  analogs	  with	  APR.	  
	  
Ligand	   Structure	   Kd	  
[µM][a]	  
∆∆G	  


































































































































































700	   4.9	   ~3.7	  (O)[g]	  
[a]	   For	   substrate	   analogs	   in	   this	   table	   values	   of	   Ki	   were	   determined	   under	   single	   turnover	  
conditions	   from	   the	   dependence	   of	   the	   observed	   rate	   constant	   at	   a	   given	   inhibitor	  
concentration	  under	  conditions	  of	   subsaturating	  APS,	   such	   that	  Ki	   is	  equal	   to	   the	  Kd.	   	  Each	  
value	   reflects	   the	   average	   of	   at	   least	   two	   independent	   experiments,	   and	   the	   standard	  
deviation	  was	   less	   than	   15%	   of	   the	   value	   of	   the	  mean.	   	   Kinetic	   data	  were	   nonlinear-­‐least	  
squares	   fit	   to	   a	  model	   of	   competitive	   inhibition.	   	   [b]	   Energetic	   difference	   in	   affinity	   of	   APS	  
relative	  to	  inhibitor,	  ∆∆G	  =	  -­‐RTln(Kd
APS/Kd
Analog).	  	  [c]	  Kd	  value	  for	  the	  diastereoisomeric	  mixture	  
of	   Rp	   and	   Sp	   isomers.	   	  
[d]	   pKa	   estimated	   from	   value	   for	   mono-­‐	   and	   difluoro-­‐substituted	  
benzylphosphonic	   acid	   (Rye,	   2005)	   .	   	   [e]	   pKa	   estimated	   from	   effect	   of	   thio-­‐substitution	   on	  
ADPαS	   (Cullis	   1992).	   	   [f]	   pKa	   estimated	   from	   value	   measured	   for	   phosphoramidic	   acid	  
(Chanley,	  1963).	  	  [g]	  pKa	  estimated	  from	  effect	  of	  β-­‐methylene-­‐substitution	  on	  AMPCP	  (Vogel,	  
1982).	  
	  
An	   alternative	   possibility	   is	   that	   the	   C-­‐terminus	   and	   Arg-­‐loop	   of	   APR	   could	   adopt	   different	  
conformations,	  depending	  on	  whether	  ADP	  or	  AMP	  is	  bound	  at	  the	  active	  site.	  	  In	  other	  words,	  
binding	  energy	  gained	  through	  additional	  charge-­‐charge	  interactions	  between	  the	  β-­‐phosphate	  
moiety	   of	   ADP,	   Lys144,	   Arg242	   and	   Arg245	   could	   be	   cancelled	   by	   a	   decrease	   in	   favorable	  
interactions	  with	  residues	  in	  the	  C-­‐terminus	  and	  the	  Arg-­‐loop.	  	  Evidence	  in	  support	  for	  the	  latter	  
proposal	  is	  provided	  in	  Section	  2.5	  below.	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Interestingly,	   substitution	  of	   fluorine	  by	  an	  oxyanion	  had	  a	  marginal	  effect	  on	  binding	  affinity,	  
whereas	  thiolate	  substitution	  increased	  binding	  potency	  by	  almost	  30-­‐fold.	  	  The	  larger	  size	  and	  
polarizability	  of	  the	  sulfur	  atom	  could	  enhance	  binding	  affinity	  by:	  i)	  shortening	  the	  distance	  to	  
residues	  that	  directly	  contact	  the	   ligand,	  and/or	   ii)	  enabling	  additional	  electrostatic	  or	  stacking	  
interactions	  with	  APR	  [38].	  	  Finally,	  we	  note	  that	  neutralizing	  the	  -­‐1	  charge	  of	  the	  β-­‐phosphate,	  
as	   in	   AMPPN,	   is	   clearly	   unfavorable.	   	   This	   significant	   energetic	   penalty	   likely	   results	   from	  
repulsive	   electrostatic	   interactions	   between	   the	   amine	   group,	   which	   is	   protonated	   at	  
physiological	  pH	  (Figure	  2.5),	  and	  adjacent	  positively	  charged	  residues	  (Figure	  2.3).	  	  In	  line	  with	  
this	   hypothesis,	   the	   binding	   affinity	   of	   AMPPN	   for	   APR	   increased	   at	   elevated	   pH	   (Appendix	  
2.5.1).	  	  
	  
2.3.3.2	   α -­‐β 	   Bridging	   Oxygen	   Substitution.	   	   Interactions	   between	   the	   5’-­‐phosphate	   and	   two	  
highly	  conserved	  residues	  –	  Arg171	  and	  His259	  –	  are	  observed	  in	  the	  structure	  of	  S.	  cerevisiae	  
PAPS	   reductase	   bound	   to	   PAP	   [14].	   	   However,	   owing	   to	   the	  mobility	   of	   the	   Arg-­‐loop	   and	   C-­‐
terminal	   residues,	  no	  direct	  contacts	   to	   the	  α-­‐phosphate	  are	  observed	   in	   the	  structure	  of	  APR	  
[12]	   (Figure	   2.3).	   	   To	   gain	   insight	   into	   the	   functional	   importance	   of	   these	   contacts	   for	   M.	  
tuberculosis	   APR	  we	   examined	   the	   contribution	   of	   the	  α-­‐β	   bridging	   oxygen	   to	   binding	   affinity	  
(Table	  2.2).	  	  Replacing	  the	  Pα-­‐O-­‐Sβ	  bridging	  oxygen	  in	  APS	  with	  a	  methylene	  group	  (Pα-­‐CH2-­‐Sβ)	  
significantly	  decreased	  binding	  affinity	  by	  ~3,500-­‐fold	   (4.9	  kcal/mol).	   	  Comparison	  of	  ADP	  with	  
AMPNP	   (Pα-­‐NH–Pβ),	   AMPCF2P	   (Pα-­‐CF2-­‐Pβ),	   and	   AMPCP	   (Pα-­‐CH2-­‐Pβ)	   shows	   that	   imino,	  
difluoromethylene,	   or	  methylene	   substitutions	   reduced	  binding	  potency	  by	   approximately	   60-­‐








































[a]	   For	   analogs	   in	   this	   table	   values	   of	   Ki	   were	   determined	   under	   single	   turnover	  
conditions	   from	   the	   dependence	   of	   the	   observed	   rate	   constant	   at	   a	   given	   inhibitor	  
concentration	   under	   conditions	   of	   subsaturating	   APS,	   such	   that	   Ki	   is	   equal	   to	   the	   Kd.	  	  
Each	   value	   reflects	   the	   average	   of	   at	   least	   two	   independent	   experiments,	   and	   the	  
standard	   deviation	   was	   less	   than	   15%	   of	   the	   value	   of	   the	   mean.	   	   Kinetic	   data	   were	  
nonlinear-­‐least	  squares	  fit	  to	  a	  model	  of	  competitive	  inhibition.	  	   [b]	  Energetic	  difference	  
in	  affinity	  of	  AMP	  relative	  to	  inhibitor,	  ∆∆G	  =	  -­‐RTln(Kd
AMP/Kd
Analog).	  	  [c]	  pKa	  estimate	  from	  
value	  measured	  for	  phosphoramidic	  acid	  (Chanley,	  1963).	  
	  
The	   above	   findings	   demonstrate	   that	   the	   α-­‐β	   bridging	   oxygen	   does	   contribute	   to	   ligand	  
recognition.	  	  Nonetheless,	  these	  data	  pose	  several	  questions:	  Why	  is	  the	  methylene	  substitution	  
more	  detrimental	  for	  APS	  binding,	  relative	  to	  the	  energetic	  penalty	  paid	  for	  analogs	  modification	  
Ligand	   Structure	   Kd	  
[µM][a]	  
∆∆G	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   5.92	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of	  ADP?	  	  And,	  why	  does	  AMPNP	  bind	  more	  weakly	  to	  APR	  compared	  to	  AMPCF2P?	  Replacing	  the	  
bridging	   oxygen	  with	   a	  methylene	   group	   decreases	   the	   S/P–X–P	   bond	   angle,	   increases	   S/P–X	  
bond	   length,	   increases	   the	   negative	   charge	   density	   on	   nonbridging	   oxygens,	   but	   makes	   the	  
phosphate	  and	  sulfate	  groups	   less	  acidic	   [40,41].	   	   It	   is	  possible	   that	  methylene	  substitution	  of	  
ADP	   is	   less	   detrimental	   to	   binding	   because	   i)	   the	   phosphonate	   moiety	   has	   more	   torsional	  
freedom,	   allowing	   the	   nucleotide	   to	   adopt	   an	   alternative	   favorable	   binding	   mode,	   and/or	   ii)	  
conformational	   differences	   in	   the	   C-­‐terminal	   and	   Arg-­‐loop	   segments	   minimize	   unfavorable	  
contacts	  to	  the	  α-­‐β	  bridging	  position	  of	  AMPCP.	  	  NMR	  studies	  show	  that	  AMPPNP	  and	  PNP	  exist	  
in	   solution	   primarily	   as	   the	   imido	   tautomers	   [37].	   	   Thus,	   the	   observed	   decrease	   in	   binding	  
affinity	  could	  be	  due	  to	  restricted	  rotation	  about	  the	  Pα-­‐NH–Pβ	  bonds.	  	  	  
	  
2.3.3.3	  α -­‐Nucleotide	  Substitution.	  	  Next,	  we	  examined	  the	  effect	  of	  sulfur	  substitution	  at	  the	  α-­‐
nonbridging	  oxygen	  atom	  using	  the	  analogs,	  APSαS2	  and	  ADPαS	  (Table	  2.2).	  	  Comparison	  of	  APS	  
and	  APSαS	  shows	  that	  sulfur	  substitution	  for	  oxygen	  decreased	  binding	  by	  more	  than	  200-­‐fold	  
(3.2	   kcal/mol).	   	   However,	   compared	   to	   ADP,	   the	   binding	   potency	   of	   ADPαS	   increased	   by	  
approximately	  5-­‐fold	  (1	  kcal/mol).	  	  The	  larger	  energetic	  penalty	  for	  α-­‐sulfur	  substitution	  of	  APS	  
could	   result	   from	   ligand-­‐related	   differences	   in	   enzyme	   conformation,	   analogs	   to	   the	   scenario	  
presented	  in	  the	  subsection	  above.	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2	   In	   principle,	   APSαS	   could	   be	   utilized	   as	   a	   substrate	   by	   APS	   reductase.	   	   However,	   under	  
saturating	   conditions,	  no	  evidence	   for	   formation	  of	   the	  S-­‐sulfocysteine	   intermediate	  has	  been	  
obtained	   (data	   not	   shown).	   	   At	   present,	   it	   is	   not	   understood	   why	   APS	   reductase	   does	   not	  
effectively	   reduce	   APSαS.	   	   One	   possible	   explanation	   is	   that	   the	  α-­‐sulfur	   substitution	   disrupts	  
contact	   with	   residues	   that	   could	   be	   important	   for	   stabilizing	   charge	   development	   in	   the	  
transition	  state,	  such	  as	  Arg171	  and	  His259.	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2.3.4	  Affinity	  of	  Product	  AMP	  Analogs	  
2.3.4.1	  α -­‐Nucleotide	  Substitution.	  	  To	  probe	  the	  molecular	  binding	  determinants	  of	  APR	  at	  the	  
α-­‐position	  in	  greater	  detail,	  we	  compared	  the	  Kd	  value	  for	  the	  product,	  AMP	  to	  values	  measured	  
for	  related	  analogs	  (Table	  2.3).	  	  The	  respective	  effects	  of	  substitution	  at	  the	  α-­‐oxygen	  by	  sulfur	  
(AMPS)	  or	  amine	  (AMPN)	  are	  -­‐0.3	  and	  +1.8	  kcal/mol,	  compared	  to	  AMP.	  	  The	  modest	  increase	  in	  
binding	   energy	   that	   results	   from	   sulfur	   modification	   is	   similar	   to	   the	   effect	   observed	   with	  
ADPαS.	   	   The	   reduction	   in	   binding	   affinity	   of	   AMPN	   also	   parallels	   the	   decrease	   observed	   for	  
AMPPN.	  	  	  
	  
In	   PAPS	   reductase,	   residues	   in	   the	   P-­‐loop	   interact	   with	   the	   3’-­‐phosphate	   of	   PAP	   [14,42].	  	  
However,	  in	  APR	  the	  acidic	  residue,	  Asp66,	  interacts	  with	  amide	  groups	  of	  the	  P-­‐loop	  and	  thus,	  
appears	  to	  mimic	  the	  interaction	  of	  the	  negatively	  charged	  3’-­‐phosphate	  group.	  	  To	  investigate	  
the	   role	   of	   the	   3’-­‐hydroxyl	   group	   in	   ligand	   discrimination	   (see	   also	   Section	   2.4.2	   below)	   we	  
determined	  the	  binding	  affinity	  for	  3’-­‐AMP,	  which	  reverses	  the	  position	  of	  the	  5’-­‐phosphate	  and	  
3’-­‐hydroxyl	   groups	   (Table	   2.3).	   	   Switching	   the	   position	   of	   the	   phosphate	   moiety	   decreased	  
binding	   by	   ~600-­‐fold	   (3.8	   kcal/mol)	   indicating	   that,	   while	   the	   analog	   binds	   poorly,	   the	   3’-­‐
phosphate	  does	  not	  impact	  binding	  to	  APR,	  as	  compared	  to	  adenosine.	  	  By	  contrast,	  addition	  of	  
a	   3’-­‐phosphate	   group	   to	   AMP,	   as	   in	   PAP,	   decreased	   binding	   affinity	   by	   3.0	   kcal/mol.	   	   The	  
energetic	   penalty	   for	   3’-­‐phosphate	   in	   PAP,	   but	   not	   3’-­‐AMP,	   likely	   reflects	   additional	   binding	  
interactions	   to	   the	   5’-­‐phosphate,	  which	   could	   decrease	   conformational	   freedom	   and	   increase	  




2.3.4.2	  Purine	  and	  Ribose	  Substitution.	  	  Next,	  we	  analyzed	  the	  relative	  energetic	  contributions	  
of	   individual	  purine	  and	  ribose	  substitutents	   to	   the	  enzyme-­‐binding	   interaction.	   	  Owing	  to	   the	  
relative	   difficulties	   traditionally	   associated	  
with	   the	  preparation	  of	  ADP	  analogs	  and	   the	  
weak	   binding	   of	   adenosine,	   we	   determined	  
affinities	   for	   a	   series	   of	   compounds	   derived	  
from	   the	   AMP	   scaffold.	   	   As	   shown	   in	   Figure	  
2.6,	   energetic	   penalties	   for	   individual	  
substitutions	  ranged	  from	  0.6	  to	  4.7	  kcal/mol.	  	  
First,	  we	  probed	  interactions	  between	  the	  N6	  
amine	   and	   N1	   of	   adenine	   and	   Leu85	   (Figure	  
2.3),	   the	   first	   residue	   in	   the	   conserved	   LDTG	  
motif.	   	   Loss	   of	   the	   N6	   amine	   from	   AMP	  
reduced	  the	  free	  energy	  of	  binding	  to	  APR	  by	  
1.8	  kcal/mol.	  	  Replacing	  hydrogen	  atoms	  with	  
methyl	   groups	   at	   the	  N6	  position	   of	   adenine	  
decreased	   binding	   affinity	   by	   35-­‐fold	   (2.1	   kcal/mol)	   per	   substitution.	   	   Inverting	   the	   hydrogen	  
bond	  donor	  and	  acceptor,	  as	   in	   inosine	  5’-­‐monophosphate,	  was	  also	  disfavored	  (4.7	  kcal/mol),	  
presumably	  due	  to	  electrostatic	  repulsion	  between	  the	  O6-­‐keto	  and	  the	  Leu85	  carbonyl,	  and	  the	  
N1	  by	  the	  Leu85	  amine.	  	  Likewise,	  introduction	  of	  an	  N1	  amine	  markedly	  reduced	  the	  affinity	  of	  
this	   analog	   for	   APR	   (4.7	   kcal/mol).	   	   In	   subsequent	   experiments,	   we	   determined	   the	   binding	  
potency	   of	   AMP	   analogs	   with	   substitutions	   at	   the	   2,	   7	   and	   8-­‐positions	   of	   the	   purine	   ring.	  	  
Methylation	  at	  N2	  had	  a	  detrimental	  effect	  on	  binding	  (3.4	  kcal/mol),	  likely	  due	  to	  steric	  clashes	  
with	  the	  surrounding	  adenine-­‐binding	  pocket	  (Figure	  2.3).	   	  The	  structure	  of	  APR	  bound	  to	  APS	  
	  
Figure	  2.6	  Free	  energy	  of	  binding	  for	  purine	  and	  
ribose-­‐modified	   analogs	   of	   product,	   AMP.	  	  
Numbers	   represent	   the	   energetic	   effect	   of	   a	  
given	   substitution	   in	   kcal/mol,	   relative	   to	   AMP	  
(ΔΔG	   =	   -­‐RTln(Kd
Analog/Kd
AMP).	   	   Positive	   ΔΔG’s	  
indicate	  a	  penalty	  for	  substitution.	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shows	   that	   C8-­‐H	   group	   is	   directed	   toward	   the	   5’-­‐phosphosulfate	   moiety	   (Figure	   2.3).	   	   Not	  
surprisingly	  then,	  amine	  substitution	  at	  this	  position	  decreased	  the	  free	  energy	  of	  binding	  by	  3.7	  
kcal/mol.	   	   No	   contacts	   are	   formed	   between	   N7	   and	   APR	   (Figure	   2.3).	   	   Consistent	   with	   this	  
observation,	   replacing	  N7	  with	  a	  carbon	  atom	  had	  a	   relatively	  minor	  effect	  on	  binding	  affinity	  
(0.6	  kcal/mol).	   	  Finally,	  we	   investigated	  the	   influence	  of	  modification	  at	   the	  2’	  and	  3’-­‐hydroxyl	  
groups	  of	  the	  ribose	  sugar.	  	  2’-­‐deoxy	  and	  methoxy	  group	  substitutions	  reduced	  the	  free	  energy	  
of	   binding	   by	   a	   respective	   4.0	   and	   3.6	   kcal/mol,	   whereas	   3’-­‐deoxy	   substitution	   had	   only	   a	  
modest	  effect	  on	  binding	  affinity	   (0.9	  kcal/mol).	   	   This	   indicates	   that	  hydrogen	  bonds	  between	  
the	  2’-­‐hydroxy	  group	  and	  Ser60	  and	  Gly161	   residues	   (Figure	  2.3)	  play	  a	   vital	   role	   in	   substrate	  
recognition.	  	  	  
	  
2.3.5	   pH	   Dependence	   of	   Ligand	   Binding.	   	   The	   pH	   dependence	   for	   ligand	   binding	   provides	  
information	  about	   the	   relative	  affinities	  of	   the	  different	  nucleotide	   ionization	   states,	   and	   thus	  
provides	   information	   about	   the	   active	   site	   environment.	   	   Initially,	   we	   investigated	   the	   pH	  
dependence	   for	  APS	  binding.	   	  However,	   the	   substantial	   increase	   in	   reaction	   rate	  at	  higher	  pH	  
precludes	  measurement	  by	  conventional	  kinetic	  methods	  (data	  not	  shown).	   	  As	  an	  alternative,	  
we	   determined	   the	   affinities	   of	   APR	   for	   the	   substrate	   analog,	   ADP,	   and	   product,	   AMP,	   as	   a	  
function	  of	  pH	  to	  investigate	  whether	  ionizations	  at	  α	  and	  β-­‐positions	  are	  important	  for	  binding	  
affinity	  (Figure	  2.7).	  	  The	  pH	  dependence	  for	  ADP	  binding	  is	  best	  fit	  by	  a	  pKa	  of	  6.4	  ±	  0.2,	  which	  
could	  reflect	  ionizations	  of	  the	  free	  enzyme	  and	  ligand	  (Figure	  2.7a).	  	  The	  most	  likely	  candidate	  
for	  this	   ionization	  is	  the	  ligand,	  as	  the	  second	  pKa	  values	  of	  phosphate	  esters	  fall	   in	  this	  region	  
[35].	  	  If	  this	  were	  true,	  the	  pH	  profile	  would	  be	  expected	  to	  shift	  to	  lower	  pH	  for	  an	  ADP	  analog	  
with	  lower	  pKa	  values.	  	  To	  test	  this,	  we	  determined	  the	  pH	  dependence	  for	  ADPβS,	  which	  differs	  
in	   its	   respective	  pKa	  value	  by	  approximately	  one	  pH	  unit	   [32].	   	  The	  pH	  dependence	   for	  ADPβS	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binding	  is	  best	  fit	  by	  a	  pKa	  of	  5.8	  ±	  0.2	  (Appendix	  2.5.5a).	  	  The	  dependence	  of	  the	  pKa	  upon	  the	  
identity	  of	  the	  ligand	  suggests	  that	  deprotonation	  of	  the	  ligand	  is	  responsible	  for	  the	  increase	  in	  
binding	  at	  higher	  pH.	  	  	  
	  
The	  pH	  dependence	   for	  AMP	  binding	  
is	  best	  to	  best	  fit	  by	  a	  pKa	  of	  8.1	  ±	  0.1	  
(Figure	   2.7b),	   which	   could	   reflect	  
ionizations	   of	   the	   free	   enzyme	   and	  
ligand,	   as	   described	   above.	   	   The	  
simplest	  model	  to	  explain	  the	  weaker	  
binding	  of	  AMP	  below	  pH	  8	  is	  that	  the	  
dianion	   binds	   more	   tightly	   than	   the	  
monoanion.	   	   However,	   the	   apparent	  
pKa	  for	  AMP	  differs	  from	  the	  expected	  
pKa	  of	  6.8	  by	  more	  than	  one	  unit.	  	  The	  
discrepancy	   between	   the	  
experimental	   data	   and	   the	   simplest	  
model	   is	   most	   likely	   due	   to	  
concurrent	   ionization	   of	   the	   enzyme	  
that	  affects	   ligand	  binding,	   leading	  to	  shift	   in	  the	  apparent	  pKa	  of	  AMP.	   	  One	  model	  that	  could	  
account	  for	  this	  upward	  deviation	  is	  that	  an	  enzymatic	  group	  with	  a	  pKa	  of	  ~6	  contributes	  slightly	  
(~5-­‐fold)	  to	  AMP	  binding	  when	  protonated.	   	  The	  most	   likely	  residue	  to	  exert	  such	  an	  effect	  on	  
ligand	   binding	   is	   His259,	   which	   interacts	   with	   the	   5’-­‐phosphate	   of	   PAP	   in	   the	   structure	   of	   S.	  
cerevisiae	  PAPS	  reductase	  [14].	  	  Since	  a	  stimulatory	  effect	  is	  not	  observed	  for	  ADP	  binding,	  the	  
	  
Figure	   2.7	   pH	   dependence	   for	   ADP	   (a)	   and	   AMP	   (b)	  
binding.	  	  The	  association	  equilibrium	  constant,	  (Ka	  =	  1/Kd)	  
is	   plotted	   as	   a	   function	   of	   pH.	   	   Values	   of	   Kd	   were	  
determined	   by	   inhibition	   of	   APR	   (pH	   6.0-­‐9.5).	   	   Buffers	  
were	   as	   follows:	   MES	   (pH	   6.0-­‐6.5),	   BisTris	   (pH	   6.5-­‐7.5),	  
TrisHCl	   (pH	   7.5-­‐9.5),	   CAPS	   (pH	   9-­‐9.5).	   	   See	   Experimental	  
procedures	  for	  additional	  details.	  	  (a)	  The	  pH	  dependence	  
for	  ADP	  binding.	  	  Nonlinear-­‐least-­‐squares	  fit	  of	  the	  data	  to	  
a	  model	  for	  a	  single	  ionization	  gave	  pKa	  values	  of	  6.4	  ±	  0.2.	  	  
(b)	  The	  pH	  dependence	  for	  AMP	  binding.	  	  The	  dashed	  line	  
represents	   the	  best	   fit	   of	   a	  model	   for	   a	   single	   ionization	  
and	  yields	  a	  pKa	  of	  7.9	  ±	  0.1.	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C-­‐terminal	   segment	   containing	   His259,	   and	   possibly	   the	   Arg-­‐loop,	   may	   adopt	   different	  
conformations	   depending	   on	   whether	   ADP	   or	   AMP	   is	   bound	   at	   the	   active	   site.	   	   To	   further	  
confirm	  that	  the	  apparent	  pKa	  measured	  for	  AMP	  depends	  upon	  the	   identity	  of	  the	   ligand,	  we	  
measured	  the	  pH	  dependence	  for	  AMPS	  binding	  (Appendix	  2.5.5b).	  	  The	  resulting	  data	  are	  best	  
fit	  by	  a	  pKa	  of	  7.7	  ±	  0.1.	  	  The	  downward	  shift	  in	  apparent	  pKa	  suggests	  that	  deprotonation	  of	  the	  
ligand	  is	  responsible	  for	  the	  increase	  in	  binding	  at	  higher	  pH.	  	  
	  
The	  observed	  pH	  dependence	  for	  ADP	  and	  AMP	  binding	   indicates	  that	  the	  dianion	  binds	  more	  
tightly	   to	   APR	   than	   the	  monoanion.	   	   These	   data	   seemingly	   contradict	   our	   earlier	   comparison	  
between	  ADP	  and	  ADPβF,	  whose	  net	   charges	  differ	   by	  one	  unit,	   but	  bind	   to	  APR	  with	   similar	  
affinity	   (Table	   2.2	   and	   Figure	   2.5).	   	   Indeed,	   fluorine	   modification	   is	   often	   used	   to	   determine	  
whether	   binding	   of	   mono-­‐	   or	   dianionic	   phosphate	   is	   favored	   [43].	   	   However,	   hydroxyl	   and	  
fluorine	  groups	  are	  distinguished	  by	  unique	  chemical	  properties.	  	  For	  example,	  the	  high	  electron	  
density	   of	   fluorine	   gives	   rise	   to	   the	   ability	   to	   act	   as	   an	   acceptor	   in	   hydrogen	   bonds	   [44].	   	   By	  
contrast,	   the	   hydroxyl	   group	   is	   a	   strong	   dipole,	   with	   spatially	   separated	   partial	   positive	   and	  
negative	   charges	   that	   can	   donate	   as	  well	   as	   accept	   hydrogen	   bonds	   (Figure	   2.5).	   	   Hence,	   the	  
weaker	   binding	   observed	   for	   the	   monoanion	   may	   not	   reflect	   a	   loss	   of	   charge-­‐charge	  
interactions,	   but	   rather	   an	   energetic	   penalty	   that	   results	   from	   unfavorable	   charge-­‐dipole	  
interactions	  with	  the	  hydroxyl	  group.	  
	  
2.3.6	   Effect	   of	   Mg2+	   on	   Ligand	   Affinity.	   	   In	   the	   absence	   of	   metal	   ions,	   APS	   binds	   ~20-­‐times	  
tighter	   to	   APR,	   compared	   to	   ADP	   and	   AMP.	   	   However,	   the	   cellular	   concentrations	   of	   these	  
nucleotides	   are	   higher	   than	   APS	   [45]	   and	   thus,	   raise	   an	   important	   question:	   How	   does	   APS	  
compete	  against	  binding	  of	  ADP	  or	  AMP	  to	  the	  active	  site	  of	  APR	  in	  the	  cell?	  	  For	  the	  majority	  of	  
 55	  
biochemical	  reactions	  using	  ATP	  and,	  related	  nucleotides,	  the	  active	  species	  is	  the	  Mg2+	  complex	  
rather	  than	  the	  free	  nucleotide	  [46].	  	  To	  gain	  insight	  into	  ligand	  discrimination	  by	  	  
	  
APR	   in	  vivo,	  we	  measured	  the	  Kd	  values	  for	  APS,	  ADP	  and	  AMP	  in	  the	  presence	  of	  Mg2+.	  	  These	  
studies	  show	  that	  the	  Kd	  value	  of	  APS	  was	  independent	  of	  Mg2+	  concentration	  (data	  not	  shown).	  	  
This	   observation	   is	   consistent	   with	   weak	   formation	   constants	   of	   APS	   with	  Mg2+	   [47]	   and	   the	  
general	   observation	   that	   other	   sulfonucleotide	   binding	   enzymes,	   such	   sulfokinases	   and	  
sulfotransferases	  also	  do	  not	  require	  Mg2+	  as	  a	  cofactor	  [11].	  	  However,	  Mg•ADP	  and	  Mg•AMP	  
complexes	   bind	   approximately	   5-­‐6	   times	  weaker	   to	   APR,	   as	   compared	   to	   the	   free	   nucleotide	  
(Appendix	   2.5.2).	   	   The	   observed	   reduction	   in	   binding	   energy	   is	   most	   likely	   due	   to	   repelling	  
interactions	   with	   multiple	   positively	   charged	   amino	   acids	   in	   the	   enzyme	   active	   site,	   such	   as	  
Lys144,	   Arg242	   and	   Arg245	   (Figure	   2.3).	   	   Together,	   these	   findings	   indicate	   that	   APR	  
discriminates	   against	   noncognate	   adenosine	   nucleotides	   through	   favourable	   interactions	  with	  
the	  sulfate	  moiety	  of	  APS	  and	  by	  disfavouring	  the	  binding	  of	  Mg2+-­‐nucleotide	  complexes.	  
	  
2.3.7	  Implications	  for	  Rational	  Inhibitor	  Design.	  
Given	   that	   APR	   is	   essential	   for	   mycobacterial	   survival	   during	   persistent	   infection	   [9],	   small-­‐
molecule	  inhibitors	  of	  APR	  might	  be	  a	  source	  for	  new	  drugs	  to	  treat	  latent	  tuberculosis	  infection.	  	  
The	   increasing	   number	   of	   antibiotic-­‐resistant	   strains	   suggests	   that	   the	   availability	   of	   such	  
compounds	   could	   play	   an	   important	   role	   in	   treating	   the	   disease	   and	  minimizing	   the	   negative	  
impact	   on	   human	   health.	   	   By	   defining	   chemical	   groups	   that	   are	   essential	   for	   molecular	  
recognition,	  the	  work	  described	  here	  sets	  the	  stage	  for	  the	  development	  of	  such	  drugs.	  	  Figure	  
2.8	  summarizes	  the	  network	  of	  interactions	  predicted	  to	  occur	  between	  APR	  active	  site	  residues	  
and	   substrate,	  APS.	   	   The	   structural	  model	  was	   constructed	  by	  homology	   to	  S.	   cerevisiae	   PAPS	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reductase	   [14]	   and	   systematically	  
tested	   in	   the	  present	  study,	   from	  the	  
perspective	   of	   the	   ligand.	   	   The	   total	  
binding	   energy	   of	   APS	   resulting	   from	  
these	   collective	   interactions	   is	   9.3	  
kcal/mol	   and	   our	   data	   indicate	  
several	  features	  that	  are	  essential	  for	  
optimized	   substrate	   and	   inhibitor	  
binding.	   	   The	   hydrophobic	   adenine-­‐
binding	   pocket,	   pyrimidine	   ring,	   2’-­‐
hydroxyl	   and	   the	   α-­‐position	   are	   the	  
main	   determinants	   for	   strong	   target	  
affinity	   (Figure	   2.9).	   	   The	   significant	  
losses	   of	   binding	   affinity	   that	   are	  
found	  to	  result	  from	  apparently	  minor	  
structural	   modifications	   of	   ligands	   at	  
these	  key	  positions	  have	  encouraging	  
implications	   for	   inhibitor	   design	   and	  
suggests	   that,	   in	   some	   cases,	   the	  
potency	  of	  a	  weak	   inhibitor	  might	  be	  
greatly	   enhanced	   by	   one	   or	   two	  
simple	   modifications.	   	   Our	   studies	  
also	  suggest	  that	  small-­‐molecules	  that	  
target	   dynamic	   elements	   within	   the	  
	  	  
Figure	  2.8	   	  APR	   interactions	  with	   substrate,	  APS	   inferred	  
from	   P.	   aeruginosa	   APR	   (PDB	   deposition	   2GOY)	   and	   S.	  
cerevisiae	   PAPS	   reductase	   (PDB	   deposition	   2OQ2)	  
structures	   and	   functional	   data	   obtained	   in	   the	   present	  
study.	   	   (a)	   Summary	   of	   proposed	   active	   site	   contacts	   to	  
APS.	  	  (b)	  Summary	  of	  proposed	  active	  site	  contacts	  to	  APS,	  
plotted	   in	   two	   dimensions.	   	   A	   total	   of	   nine	   protein	  
residues	   are	   shown	   in	   proximity	   around	   the	   ligand,	  with	  
hydrogen	   bonding	   interactions	   shown	   where	   detected.	  	  
Hydrogen	   bonds	   are	   draw	   as	   dotted	   lines	   with	   arrows	  
denoting	   the	   direction	   of	   the	   bond.	   	   Interactions	   from	  
substrate	   or	   the	   residue	   backbones	   of	   the	   enzyme	   are	  
distinguished	   from	   the	   interactions	   with	   residue	   side	  
chains	   by	   a	   solid	   dot	   at	   the	   end	   of	   the	   interaction	   line.	  	  
Active	   site	   residues	   between	   P.	   aeruginosa	   and	   M.	  
tuberculosis	  APS	  reductase	  are	  largely	  conserved,	  with	  the	  
exception	   of	   residues	   implicated	   in	   hydrophobic	  
interactions	   (Ser65	   to	  Met67,	   Ser84	   to	   Phe87,	   Phe61	   to	  
Ala44).	   	   The	   corresponding	   numbers	   for	   residues	  
conserved	  between	  M.	  tuberculosis	  and	  P.	  aeruginosa	  APS	  
reductase	   are:	   Ser65	   (Ser60),	   Leu88	   (Leu85),	   Lys145	  
(Lys144),	   Gly162	   (Gly161),	   Arg171	   (Arg171),	   Arg237	  
(Arg242),	   Arg240	   (Arg245)	   Cys249	   (Cys256),	   and	   His252	  
(His259).	  	  See	  also	  Appendix	  2.5.3.	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active	   site	   –	   particularly	   Arg171,	   Cys256	   and	   His259	   –	   may	   lead	   to	   inhibitors	   with	   improved	  
binding	  affinity.	   	  Alternatively,	  molecules	   that	   trap	  an	   inactive,	   ‘open’	   conformational	   state	  of	  
APR	  may	  also	  represent	  new	  opportunities	  for	  inhibitor	  design	  [16].	  	  
	  
	  
2.4	  Experimental	  Procedures	  
2.4.1	   Materials.	   Adenosine,	   2-­‐aminoadenosine,	   3’-­‐deoxyadenosine,	   2’-­‐deoxyadenosine,	   1-­‐
methyladenosine	   and	   inosine-­‐5’-­‐O-­‐monophosphate,	   were	   purchased	   from	   Sigma.	   	   5’-­‐
Phosphoribose,	  3’-­‐phosphoadenosine,	  3’5’-­‐diphosphoadenosine,	  adenine	  and	   ribose	  were	  also	  
purchased	   from	   Sigma.	   	   7-­‐Deazaadenosine-­‐5’-­‐O-­‐monophosphate	   and	   purine	   riboside-­‐5’-­‐O-­‐
monophosphate	   were	   from	   Biology	   Life	   Science	   Institute.	   	   Purchased	   nucleosides	   and	   other	  
analogs	  were	  of	  the	  highest	  purity	  available	  (≥	  95%)	  and	  were	  used	  without	  further	  purification.	  	  
Additional	  reagents	  and	  solvents	  were	  purchased	  from	  Sigma	  or	  other	  commercial	  sources	  and	  
were	  used	  without	  further	  purification.	  	  
	  
2.4.2	  General	  Synthetic	  Methods.	   	  Reactions	   that	  were	  moisture	  sensitive	  or	  using	  anhydrous	  
solvents	   were	   performed	   under	   a	   nitrogen	   or	   argon	   atmosphere.	   	   Analytical	   thin	   layer	  
	  
	  
Figure	   2.9	   Pharmacophore	   model	   of	   substrate,	   APS.	   	   Chemical	   structure	   of	   APS	   highlighting	   key	  
hydrogen	  bond	  accepting	  (HBA)	  and	  donating	  (HBD)	  interactions,	  ionic	  interactions,	  and	  van	  der	  Waals	  
interaction,	  based	  on	  functional	  data	  obtained	  in	  the	  present	  study.	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chromatography	   (TLC)	   was	   performed	   on	   pre-­‐coated	   silica	   plates	   obtained	   from	   Analtech.	  	  
Visualization	   was	   accomplished	   with	   UV	   light	   or	   by	   staining	   with	   ethanolic	   H2SO4	   or	   ceric	  
ammonium	  molybdate.	   	  Nucleosides	  were	  purified	  by	  flash	  chromatography	  using	  Merck	  silica	  
gel	  (60-­‐200	  mesh).	  	  
	  
2.4.3	   Preparation	  of	  Nucleoside	   and	  Nucleotide	  Analogs.	   	  N6,	  N6-­‐Dimethyl-­‐5’-­‐adenosine	  was	  
prepared	  from	  inosine	  by	  the	  procedure	  described	  by	  Veliz	  and	  Beal	   [48]	  and	  purified	  by	  flash	  
chromatography	   developed	   in	   60:40	   ethyl	   acetate:hexanes.	   	   N6-­‐Methyl-­‐5’-­‐adenosine	   was	  
prepared	   via	   reaction	   of	   6-­‐bromoinosine	   with	   methylamine	   as	   previously	   described	   [49].	   	   8-­‐
Aminoadenosine	   was	   prepared	   by	   selective	   bromination	   of	   adenosine	   at	   the	   C8	   position,	  
exchange	   of	   bromine	   for	   azide,	   followed	   by	   reductive	   hydrogenation	   to	   afford	   the	   amine,	   as	  
previously	   described	   [50].	   	   2’-­‐Methoxyadenosine	   was	   prepared	   from	   adenosine,	   by	   reaction	  
with	  methyl	  iodide	  under	  alkaline	  conditions	  as	  previously	  described	  [51].	  	  Adenosine	  5’-­‐O-­‐a,b,-­‐
imidodiphosphate	   (AMPNP)	   was	   synthesized	   by	   reaction	   of	   5’-­‐tosyladenosine	   [52]	   with	  
imidodiphosphate	  salt	  [52,53].	  	  Adenosine	  5’-­‐O-­‐a,b-­‐difluoromethylenediphosphate	  (ADPβF)	  was	  
prepared	  by	  coupling	  5’-­‐tosyladenosine	  to	  difluoro	  substituted	  methylenediphosphonic	  acid,	  as	  
previously	   reported	   [52,54].	   	   Adenosine	   5’-­‐O-­‐thiophosphosulfate	   (APSaS)	   was	   synthesized	   by	  
reacting	   pyridine-­‐N-­‐sulfonic	   acid	   with	   adenosine	   5’-­‐O-­‐thiopshophate	   (AMPS),	   as	   previously	  
described	   [55].	   	   Structures	   and	   purity	   (≥	   95%)	   were	   confirmed	   by	   1H,	   31P	   NMR	   and	   HPLC	  
analysis	  (data	  not	  shown).	  
	  
2.4.4	   Nucleoside	   Phosphorylation.	   	   Nucleotide	   analogs	   (2’-­‐deoxy-­‐5’-­‐phosphoadenosine,	   2’-­‐
methoxy-­‐5’phosphoadenosine,	   N6,	   N6-­‐dimethyl-­‐5’-­‐phosphoadenosine,	   N6-­‐methyl-­‐5’-­‐
phosphoadenosine,	   8-­‐amino-­‐5’-­‐phosphoadenosine,	   1-­‐methyl-­‐5’-­‐phosphoadenosine,	   and	   2-­‐
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amino-­‐5’-­‐phosphoadenosine)	   were	   synthesized	   by	   chemical	   phosphorylation	   of	   the	  
corresponding	  adenosine	  analog,	  followed	  by	  purification	  via	  reversed	  phase	  HPLC.	  Nucleosides	  
were	   phosphorylated	   by	   reaction	   of	   nucleoside	  with	   POCl3	   as	   described	   [56].	   	   The	   nucleoside	  
(0.15	  mmole)	  was	  suspended	  in	  triethylphosphate	  at	  0	  °C	  (0.65	  ml).	  	  Water	  (1	  equiv)	  was	  added	  
to	  the	  reaction.	  	  Subsequently,	  POCl3	  (3-­‐5	  equivalents,	  42	  ml-­‐70	  ml)	  was	  added	  over	  a	  period	  of	  
30	  min	  with	  constant	  stirring.	  	  The	  suspension	  was	  kept	  stirring	  for	  an	  additional	  1.5	  h,	  when	  the	  
white	  suspension	  became	  a	  clear	  solution.	  	  Water	  (1	  mL)	  was	  added	  to	  hydrolyze	  the	  phosphoryl	  
chloride	  and	  terminate	  the	  reaction.	  	  The	  pH	  was	  neutralized	  to	  ~7	  by	  dropwise	  addition	  of	  1	  M	  
NH4OH.	   	  The	  reaction	  was	  passed	  over	  a	  2	  g	  C18	  SPE	  column	  (Fisher)	   that	  was	  conditioned	   in	  
acetonitrile	  (6	  ml)	  followed	  by	  H2O	  (6	  ml).	  	  The	  nucleotide	  was	  eluted	  from	  the	  C18	  SPE	  column	  
with	  H2O.	  	  Nucleotides	  were	  purified	  by	  reversed	  phase	  HPLC	  employing	  isocratic	  separation	  in	  
20	   mM	   ammonium	   acetate,	   pH	   7	   on	   a	   semi-­‐preparative	   (10	   x	   25	   cm)	   C18	   column	   and	   the	  
solvent	  was	   removed	   from	   the	   solution	   by	   repeated	   lyophilization.	   	   The	  physical	   and	   spectral	  
data	   for	   these	   analogs	   (confirmed	   by	   1H,	   13C	   and	   31P	   NMR	   and	   mass	   spectrometry)	   were	  
consistent	  with	  those	  previously	  reported	  for	  these	  compounds	  [56-­‐58].	  	  The	  purity	  (≥	  95%)	  was	  
confirmed	  by	  HPLC	  analysis	  using	  the	  conditions	  described	  above.	   	  The	  retention	  time	  of	  each	  
nucleotide	  analog	  (N6,	  N6-­‐Dimethyl-­‐5’-­‐phosphoadenosine,	  N6-­‐Methyl-­‐5’-­‐phosphoadenosine,	  2’-­‐
methoxy-­‐5’phosphoadenosine,	   2’-­‐deoxy-­‐5’-­‐phosphoadenosine,	   8-­‐amino-­‐5’-­‐phosphoadenosine,	  
1-­‐methyl-­‐5’-­‐phosphoadenosine,	  and	  2-­‐amino-­‐5’-­‐phosphoadenosine)	  was	  19.7	  min,	  19.6	  min,	  8.5	  
min,	  6.1	  min,	  4.4	  min,	  4	  min,	  3.5	  min,	   respectively.	   	   The	  concentrations	  of	  nucleotide	  analogs	  
was	  determined	  by	  absorbance	  at	  260	  nm,	  assuming	  ε260	  =	  15,400	  M-­‐1	  cm-­‐1	  [23].	  	  	  
	  
2.4.5	  Enzyme	  purification.	  	  Purification	  of	  APR	  was	  carried	  out	  as	  described	  in	  Chapter	  3.	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2.4.6	   General	   Kinetic	   Methods.	   	   35S-­‐labeled	   APS	   was	   synthesized	   and	   purified	   as	   previously	  
described	   	  with	   the	   inclusion	  of	   an	  additional	   anion	  exchange	  purification	   step	  on	  a	  5-­‐ml	   FFQ	  
column	  (GE	  Healthcare)	  eluting	  with	  a	   linear	  gradient	  of	  ammonium	  bicarbonate,	  pH	  8.0.	   	  The	  
reduction	  of	  APS	  to	  sulfite	  and	  AMP	  was	  measured	  in	  a	  35S-­‐based	  assay	  as	  previously	  described	  
[59].	  	  Reactions	  were	  quenched	  by	  the	  addition	  of	  charcoal	  solution	  (2%	  w/v)	  containing	  Na2SO3	  
(20	   mM).	   	   The	   suspension	   was	   vortexed,	   clarified	   by	   centrifugation	   and	   an	   aliquot	   of	   the	  
supernatant	  containing	  the	  radiolabeled	  sulfite	  product	  was	  counted	   in	  scintillation	  fluid.	   	  APR	  
activity	  was	  measured	  in	  single	  turnover	  reactions,	  with	  trace	  amounts	  of	  35S-­‐APS	  (~1	  nM)	  and	  
excess	  protein.	  	  These	  reactions	  can	  typically	  be	  followed	  to	  ≥90%	  completion	  (Appendix	  2.5.6a),	  
and	  the	  reaction	  time	  courses	  fit	  well	  to	  eq.	  1,	   in	  which	  Frac	  P	   is	  the	  fraction	  product,	  k	   is	  the	  
observed	  rate	  constant,	  and	  t	  is	  time:	  
€ 
Frac P =1− exp−kobs t 	   (1)	  
Unless	  otherwise	  specified,	  the	  standard	  reactions	  conditions	  were	  30	  °C	  with	  100	  mM	  bis-­‐tris	  
propane	   at	   pH	   7.5,	  DTT	   (5	  mM),	   and	   thioredoxin	   (10	  µM).	   	   Kinetic	   data	  were	  measured	   in	   at	  
least	  two	  independent	  experiments	  and	  the	  standard	  error	  was	  typically	  less	  than	  15%.	  
	  
The	   affinity	   of	   APR	   (E)	   for	   APS	   was	   determined	   from	   the	   dependence	   of	   the	   observed	   rate	  











	   	   (2)	  
In	  this	  equation,	  kobs	   is	  the	  observed	  rate	  constant	  at	  a	  particular	  protein	  concentration,	  kmax	   is	  
the	  maximal	   rate	   constant	  with	   saturating	   protein,	   and	  K1/2	   is	   the	   protein	   concentration	   that	  
provides	   half	   the	   maximal	   rate.	   	   To	   ensure	   that	   the	   chemical	   step	   was	   rate-­‐determining,	  
reactions	  were	  performed	   in	  NaMes	   (10	  mM)	  at	  pH	  5.5	  and	  control	  experiments	  demonstrate	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that	  the	  enzyme	  is	  stable	  under	  these	  assay	  conditions	  (data	  not	  shown).	  	  Because	  the	  chemical	  
step	  is	  rate-­‐determining	  for	  S-­‐sulfocysteine	  formation	  (kst	  <	  kmax	  is	  equal	  to	  the	  rate	  constant	  for	  
the	  reaction	  of	  the	  E•APS	  complex,	  and	  K1/2	  is	  equal	  to	  the	  dissociation	  constant	  (Kd)	  of	  APS	  for	  
APR.	   	   The	   concentration	   of	   active	   protein	   was	   determined	   by	   direct	   titration	   with	   a	   high	  
concentration	  of	  APS	  (i.e.	   [APS]	  >>	  Kd).	   	   In	  theory,	  the	  binding	  affinity	  of	  APS	  could	   increase	  at	  
physiological	  pH.	  	  However,	  several	  lines	  of	  evidence	  argue	  against	  this	  possibility.	  	  First,	  the	  pKa	  
of	   the	   β-­‐sulfate	   moiety	   is	   less	   than	   2	   and	   thus,	   at	   pH	   5.5,	   the	   sulfonucleotide	   is	   completely	  
ionized.	   	   Second,	   the	   pH	   dependence	   of	   ADP	   binding	   (see	   below)	   reflects	   the	   pKa	   of	   this	  
nucleotide	  in	  solution.	  	  Finally,	  the	  Kd	  measured	  at	  pH	  5.5	  is	   in	  line	  with	  the	  apparent	  Km	  value	  
measured	  at	  pH	  8.0	  [22].	  
The	  affinity	  of	  various	  ligands	  for	  APR	  was	  determined	  by	  inhibition	  methods.	  	  The	  observed	  rate	  
constant	  of	   the	   reaction:	  E	  +	   35S-­‐APS	  →	  products	   (kobs)	  was	  determined	  at	  varying	   inhibitor	   (I)	  
concentrations	   (Appendix	   2.5.6b),	   and	   the	   [I]-­‐dependence	   was	   fit	   to	   a	   simple	   model	   for	  
competitive	   inhibition	  (eq.	  3).	   	   In	  eq.	  3,	  ko	   is	  the	  rate	  of	  the	  reaction	   in	  the	  absence	  of	  analog,	  
and	   Ki	   is	   the	   inhibition	   constant	   of	   the	   analog.	   	   With	   subsaturating	   APR,	   Ki	   is	   equal	   to	   the	  
equilibrium	  dissociation	  constant	  (Kd)	  of	  the	  ligand.	  
€ 









	   	   (3)	  
	  
2.4.7	  pH	  Dependence	  of	   Inhibitor	  Binding.	   	  Values	  of	  Ki	  were	  determined	  by	   inhibition	  of	  APS	  
reduction	  (pH	  6-­‐9.5)	  with	  [35S-­‐APS]	  <<	  K1/2,	  such	  that	  Ki	   is	  expected	  to	  be	  the	  Kd.	   	  The	  following	  
buffers	  were	  used	  for	  the	  indicated	  pH	  ranges:	  NaMES	  (6.0-­‐7.0),	  Bis-­‐Tris	  (6.5-­‐7.5),	  Tris	  (7.5-­‐9.0)	  
and	  CAPS	  (9.0-­‐9.5).	  	  Reactions	  were	  typically	  carried	  out	  with	  100	  mM	  buffer	  and	  the	  standard	  
assays	  and	  conditions	  described	  above	  were	  used	  to	  monitor	  kcat/Km	  for	  reduction	  of	  35S-­‐APS	  in	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the	   presence	   and	   absence	   of	   inhibitor.	   	   The	   rate	   constants	   at	   each	   pH	   value	   for	   multiple	  
reactions	  were	   averaged,	   and	   the	   standard	  deviations	  were	   ≤15%	  of	   the	   average.	   	   pKa	   values	  
were	  determined	  using	  eq.	  4,	  derived	  from	  a	  model	  where	  the	  binding	  of	  the	  ligand	  depends	  on	  
a	  single	  ionizable	  group.	  	  
€ 
Kd ,app =KdHA ×
Ka
Ka +  [H +]
+KdA− ×
[H +]
Ka +  [H +]	   	   (4)	  
	  
2.4.8	  Energetic	  Contribution	  of	  Ligand	  Substituents	  to	  Binding.	  	  The	  energetic	  contributions	  of	  
individual	  ligand	  substituents	  to	  APR	  binding	  were	  expressed	  as	  ∆∆G	  =	  -­‐RTln(Kd1/	  Kd2)	  in	  which	  R	  
is	  the	  gas	  constant,	  T	  is	  the	  temperature	  (303	  K),	  and	  Kd	  is	  the	  equilibrium	  dissociation	  constant.	  	  
A	  negative	  value	  of	  ∆∆G	  indicates	  that	  a	  given	  substituent	  contributes	  to	  ligand	  binding	  by	  APR.	  
	  
2.4.9	  Electrostatic	  Surface	  Potentials.	   	  The	  electrostatic	  surface	  potential	  was	  calculated	  using	  
PM3	   semi-­‐empirical	   molecular	   orbital	   calculations	   implemented	   in	   SPARTAN	   software	  
(Wavefunction,	  Inc)	  for	  the	  fully	  optimized	  structure.	  	  
	  




2.5.1	  Table	  of	  ligand	  dissociation	  constants	  for	  nitrogen-­‐containing	  ligands	  at	  pH	  7.5	  
and	  pH	  9.0	  with	  APR.[a]	  
	  
Ligand	   Structure	   Kd	  pH	  7.5	  
[µM]	  
Kd	  pH	  9.0	  
[µM]	  
∆∆G	  












































410	   56.8	   -­‐1.2	   3.0	  (O),	  8.15	  (N)[c]	  
[a]	  For	  ligands	  in	  this	  table	  values	  of	  Ki	  were	  determined	  at	  pH	  7.5	  or	  9.0	  under	  single	  turnover	  
conditions	   from	   the	   dependence	   of	   the	   observed	   rate	   constant	   at	   a	   given	   inhibitor	  
concentration	  under	  conditions	  of	  subsaturating	  APS,	  such	  that	  Ki	  is	  equal	  to	  the	  Kd.	  	  Each	  value	  
reflects	  the	  average	  of	  at	   least	  two	  independent	  experiments,	  and	  the	  standard	  deviation	  was	  
less	  than	  15%	  of	  the	  value	  of	  the	  mean.	  	  Kinetic	  data	  were	  nonlinear-­‐least	  squares	  fit	  to	  a	  model	  
of	  competitive	  inhibition.	  	  [b]	  Energetic	  difference	  in	  affinity	  of	  ligand	  at	  pH	  9.0	  relative	  to	  pH	  7.5,	  
∆∆G	   =	   -­‐RTln(Kd
9.0/Kd




2.5.2	  Table	  of	   ligand	  dissociation	  constants	   for	  AMP	  and	  ADP	  with	  APR	   in	   the	  presence	  and	  
absence	  of	  MgCl2.[a]	  
	  
Ligand	   MgCl2	  [mM]	   Kd	  [µM]	  
∆∆G	  
[kcal/mol][b]	  
AMP	   0	   5.4	   N/A	  
	   0.5	   21	   0.82	  
	   2.0	   31	   1.0	  
ADP	   0	   4.3	   N/A	  
	   0.5	   7.3	   0.32	  
	   2.0	   20	   0.93	  
[a]	   For	   ligands	   in	   this	   table	   values	   of	   Ki	   were	   determined	   at	   pH	   7.5	   and	   the	   concentration	   of	   MgCl2	  
indicated	  under	  single	  turnover	  conditions	  from	  the	  dependence	  of	  the	  observed	  rate	  constant	  at	  a	  given	  
inhibitor	  concentration	  under	  conditions	  of	  subsaturating	  APS,	  such	  that	  Ki	  is	  equal	  to	  the	  Kd.	  	  Each	  value	  
reflects	  the	  average	  of	  at	   least	  two	  independent	  experiments,	  and	  the	  standard	  deviation	  was	   less	  than	  
15%	  of	   the	  value	  of	   the	  mean.	   	  Kinetic	  data	  were	  nonlinear-­‐least	   squares	   fit	   to	  a	  model	  of	   competitive	  





Appendix	   2.5.3.	   Structure	   based	   sequence	   alignment	   of	   APRs	   from	   Pseudomonas	   aeruginosa,	  
Mycobacterium	  tuberculosis	  and	  Saccharomyces	  cerevisiae.	  
Appendix	  2.5.3	   	  Structure	  based	  sequence	  alignment	  of	  APS	   reductases	   from	  Pseudomonas	  aeruginosa,	  
Mycobacterium	  tuberculosis	   and	   Saccharomyces	  cerevisiae.	   	   The	  ClustalW	  Multiple	  Sequence	  Alignment	  
program	  was	  used.	  	  Strictly	  conserved	  residues	  are	  outlined	  in	  red,	  red	  letters	  indicate	  conserved	  residues	  
and	   conserved	   regions	   are	   boxed	   in	   blue.	   	   Alignment	   picture	  was	   rendered	  with	   the	   server	   ESPript	   2.2	  
(http://espript.ibcp.fr).	  
	  

















Appendix	   2.5.4	   The	   apparent	   affinity,	   K1/2,	   of	   APR	   in	   single	   turnover	   experiment.	   	   The	   affinity	   of	   APS	  
reductase	   (E)	   for	   APS	   was	   determined	   from	   the	   dependence	   of	   the	   observed	   rate	   constant	   for	   S-­‐












.	  	  In	  this	  equation,	  kobs	  is	  
the	  observed	  rate	  constant	  at	  a	  particular	  protein	  concentration,	  kmax	   is	   the	  maximal	  rate	  constant	  with	  
saturating	  protein,	  and	  K1/2	  is	  the	  protein	  concentration	  that	  provides	  half	  the	  maximal	  rate.	  	  Because	  the	  
chemical	  step	  is	  rate-­‐determining	  for	  S-­‐sulfocysteine	  formation,	  kmax	  is	  equal	  to	  the	  rate	  constant	  for	  the	  
reaction	  of	  the	  E•APS	  complex,	  and	  K1/2	  is	  equal	  to	  the	  dissociation	  constant	  (Kd)	  of	  APS	  for	  APS	  reductase.	  	  
The	  concentration	  of	  active	  protein	  was	  determined	  by	  direct	  titration	  with	  a	  high	  concentration	  of	  APS	  










































Appendix	   2.5.5	   pH	   dependence	   for	   ADPβS	   (a)	   and	   AMPS	   (b)	   binding.	   	   The	   association	   equilibrium	  
constant,	   (Ka	  =	  1/Kd)	   is	  plotted	  as	  a	   function	  of	  pH.	   	  Values	  of	  Kd	  were	  determined	  by	   inhibition	  of	  APS	  
reduction	  (pH	  6.0-­‐9.5).	  	  See	  methods	  for	  details.	  	  (a)	  The	  pH	  dependence	  for	  ADPβS	  binding.	  	  Nonlinear-­‐
least-­‐squares	  fit	  of	  the	  data	  to	  a	  model	  for	  a	  single	   ionization	  gave	  pKa	  values	  of	  5.8	  ±	  0.15.	   	  The	  pKa	  of	  
ADPβS	   in	   solution	   is	   5.2	   (Jaffe,	   1978).	   	   (b)	   The	   pH	   dependence	   for	   AMPS	   binding.	   	   The	   dashed	   line	  
represents	  the	  best	  fit	  of	  a	  model	  for	  a	  single	  ionization	  and	  yields	  a	  pKa	  of	  7.7	  ±	  0.15.	  	  The	  pKa	  of	  AMPS	  in	  










































Appendix	   2.5.6	   The	   radioactive	   assay	   for	   APR.	   	   (a)	   The	   reaction	   progress	   curve	   for	   APR.	   	   Under	   the	  
subsaturating	   concentration	   of	   substrate,	   the	   reaction	   is	   described	   by	   the	   apparent	   second-­‐order	   rate	  
constant,	  kcat/Km,	  which	  under	  the	  conditions	  of	  this	  assay	  is	  ~2	  ×	  10
6	  M-­‐1s-­‐1.	  	  (b)	  AMP	  inhibits	  APR	  activity.	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Spectroscopic	  Studies	  on	  the	  [4Fe-­‐4S]	  Cluster	  in	  Adenosine-­‐5'-­‐
phosphosulfate	  Reductase	  from	  Mycobacterium	  tuberculosis	  	  
	  
This	   work	   has	   been	   published	   in	   part	   as	   "Spectroscopic	   Studies	   on	   the	   [4Fe-­‐4S]	   Cluster	   in	  
Adenosine-­‐5'-­‐phosphosulfate	   Reductase	   from	   Mycobacterium	   tuberculosis	   "	   2011	   Journal	   of	  
Biological	  Chemistry	  286;	  1216-­‐1226.	  	  I	  performed	  all	  biochemical,	  kinetic	  and	  EPR	  experiments,	  
and	  prepared	  samples	  for	  Mössbauer	  analyses.	  	  
	  
3.1	  Abstract	  
Mycobacterium	   tuberculosis	   adenosine	   5ʹ′-­‐phosphosulfate	   (APS)	   reductase	   (MtAPR)	   is	   an	   iron-­‐
sulfur	  protein	  and	  a	  validated	  target	  to	  develop	  new	  antitubercular	  agents,	  particularly	  for	  the	  
treatment	  of	   latent	   infection.	   	   The	  enzyme	  harbors	   a	   [4Fe-­‐4S]2+	   cluster	   that	   is	   coordinated	  by	  
four	   cysteinyl	   ligands,	   two	  of	  which	  are	  adjacent	   in	   the	  amino	  acid	   sequence.	   	   The	   iron-­‐sulfur	  
cluster	  is	  essential	  for	  catalysis;	  however,	  the	  precise	  role	  of	  the	  [4Fe-­‐4S]	  cluster	  in	  APR	  remains	  
unknown.	  	  Progress	  in	  this	  area	  has	  been	  hampered	  by	  the	  failure	  to	  generate	  a	  paramagnetic	  
state	   of	   the	   [4Fe-­‐4S]	   cluster	   that	   can	   be	   studied	   by	   electron	   paramagnetic	   resonance	  
spectroscopy.	  	  Herein,	  we	  overcome	  this	  limitation	  and	  report	  the	  EPR	  spectra	  of	  MtAPR	  in	  the	  
[4Fe-­‐4S]+	   state.	   	   The	   EPR	   signal	   is	   rhombic	   and	   consists	   of	   two	   overlapping	   S	   =	   ½	   species.	  	  
Substrate	   binding	   to	  MtAPR	   led	   to	   a	   marked	   increase	   in	   intensity	   and	   resolution	   of	   the	   EPR	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signal,	   and	   to	   minor	   shifts	   in	   principle	   g	   values	   that	   were	   not	   observed	   among	   a	   panel	   of	  
substrate	   analogs,	   including	   adenosine	   5ʹ′-­‐diphosphate.	   	   Using	   site-­‐directed	   mutagenesis,	   in	  
conjunction	  with	  kinetic	  and	  EPR	  studies,	  we	  have	  also	  identified	  an	  essential	  role	  for	  the	  active	  
site	  residue,	  Lys144	  whose	  side	  chain	  interacts	  with	  both	  the	  iron-­‐sulfur	  cluster	  and	  the	  sulfate	  
group	  of	  APS.	   	  The	   implications	  of	   these	   findings	  are	  discussed	  with	  respect	   to	   the	  role	  of	   the	  
iron-­‐sulfur	  cluster	  in	  the	  catalytic	  mechanism	  of	  APR.	  
	  
3.2	  Introduction	  
In	   bacteria	   and	   plants,	   activation	   of	   inorganic	   sulfur	   is	   required	   for	   de	   novo	   biosynthesis	   of	  
cysteine.	  	  To	  this	  end,	  the	  metabolic	  assimilation	  of	  sulfate	  from	  the	  environment	  proceeds	  via	  
adenosine	  5ʹ′-­‐phosphosulfate	  (APS)	  or	  3ʹ′-­‐phosphoadenosine-­‐5ʹ′-­‐phosphosulfate	  (PAPS)	  [1].	  	  These	  
intermediates	   are	   produced	   by	   the	   action	   of	   ATP	   sulfurylase	   (EC	   2.7.7.4),	   which	   condenses	  
sulfate	  and	  ATP	  to	  form	  APS	  [2,3],	  and	  by	  APS	  kinase	  (EC	  2.7.1.25),	  which	  produces	  PAPS	  from	  
ATP	  and	  APS	  [4].	  	  	  
	  
APS	  and	  PAPS	  are	  reduced	  by	  
enzymes	   in	   the	   reductive	  
branch	   of	   the	   sulfate	  
assimilation	   pathway,	  
producing	   sulfite	   and	  
adenosine	  5ʹ′-­‐monophosphate	  
(AMP)	   or	   adenosine	   3ʹ′,5ʹ′-­‐
diphosphate	   (PAP)	   (see	  
Scheme	  3.1).	   	  These	  enzymes	  
	  
	  




Figure	  3.1	  	  Proposed	  mechanism	  of	  sulfonucleotide	  reduction.	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can	  be	  subdivided	  into	  two	  groups	  according	  to	  their	  substrate	  preference,	  the	  APS	  reductases	  
(APR)	   and	   the	   PAPS	   reductases	   (PAPR)	   (EC	   1.8.99.4).	   	   Functional	   and	   structural	   studies	   have	  
been	  used	   to	   investigate	   the	  chemical	   reaction	  mechanism	  of	  APR	  and	  PAPR	  enzymes	   [1,5-­‐8].	  	  
The	  mechanism	  involves	  nucleophilic	  attack	  by	  the	  active	  site	  cysteine	  on	  the	  sulfur	  atom	  of	  APS	  
or	   PAPS	   to	   form	   an	   enzyme	   S-­‐sulfocysteine	   intermediate	   (E-­‐Cys-­‐Sγ-­‐SO3–),	   which	   is	   cleaved	   by	  
thiol-­‐disulfide	   exchange	   with	   thioredoxin	   or	   glutaredoxin	   (Figure	   3.1).	   	   The	   sulfite	   product	   is	  
then	  reduced	  to	  sulfide	  by	  sulfite	  reductase	  (EC	  1.8.7.1)	  and	  utilized	  to	  synthesize	  cysteine	  and	  
other	   essential	   sulfur-­‐containing	   biomolecules	   [9].	   	   In	   the	   human	   pathogen	  Mycobacterium	  
tuberculosis,	  APR	  is	  a	  validated	  target	  against	  the	  latent	  phase	  of	  infection	  [10].	  
	  
Only	  a	  3ʹ′-­‐phosphate	  group	  distinguishes	  PAPS	  from	  APS.	  	  Accordingly,	  APR	  and	  PAPR	  have	  nearly	  
identical	  three-­‐dimensional	  structures	  (1.6–Å	  rms	  deviation	  of	  backbone	  atoms)	  and	  share	  ~20%	  
sequence	   identity,	   including	   the	  active	   site	  motif,	   ECG	  and	   the	   sulfonucleotide	  binding	  pocket	  
[5,11,12].	   	   However,	   a	   key	   difference	   between	   the	   two	   enzymes	   is	   that	   APR	   contains	   two	  
conserved	  cysteine	  motifs,	  CXXC	  and	  CC.	   	  These	  four	  additional	  cysteine	  residues	  coordinate	  a	  
[4Fe-­‐4S]	   cluster,	  which	   is	   essential	   for	   catalytic	   activity	   [1,5,13].	   	   The	  only	   known	  exception	   is	  
Physcomitrella	  patens	  sulfonucleotide	  reductase,	  PpAPR-­‐B	  that	  lacks	  the	  cysteine	  pairs	  required	  
to	  bind	  the	  cofactor,	  but	  can	  utilize	  both	  APS	  and	  PAPS	  as	  substrates	  [14].	   	  However,	  PpAPR-­‐B	  
has	  to	  pay	  a	  significant	  penalty	  for	  the	  absence	  of	  the	  [4Fe-­‐4S]	  cluster	  as	  evidenced	  by	  second-­‐
order	  rate	  constants	  (kcat/Km)	  of	  3,520	  and	  37	  M-­‐1s-­‐1	  with	  APS	  and	  PAPS,	  respectively.	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The	   2.7	   Å	   crystal	   structure	   of	  
Pseudomonas	   aeruginosa	   APR	  
(PaAPR)	   bound	   to	   substrate	   provides	  
valuable	   insights	   into	   the	  
arrangement	   of	   active	   site	   residues	  
that	   are	   conserved	   among	   APRs3	   [5].	  	  
The	   iron-­‐sulfur	   cluster	   is	   coordinated	  
by	   Cys228	   and	   Cys231,	   positioned	   at	  
the	   tip	   of	   a	   β-­‐loop,	   along	   with	   the	  
tandem	   pair,	   Cys139	   and	   Cys140,	  
within	   an	   α-­‐helix	   (Figure	   3.2a).	  	  
Coordination	   by	   sequential	   cysteines	  
is	  highly	  unusual	   for	   [4Fe-­‐4S]	  clusters	  
and	   has	   been	   characterized	   in	   only	  
one	   other	   crystal	   structure	   –	   the	  
NuoB	  subunit	  of	  respiratory	  complex	  I	  
[15].	   	   There	   are	   four	   charged	   and/or	  
polar	  NH⋅⋅⋅S	  or	  OH⋅⋅⋅S	  hydrogen	  bonds	  
involving	   side-­‐chains	   of	   absolutely	  
conserved	   residues	   (Figure	   3.2b	   and	  
c).	   	   In	   particular,	   the	   CysCys	   motif	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3	   Residue	   numbers	   in	   the	   text	   correspond	   to	   the	   PaAPR	   amino	   acid	   sequence.	   	   The	  
corresponding	   residue	   numbers	   in	   MtAPR	   can	   be	   identified	   from	   the	   sequence	   alignment	  
depicted	  in	  Appendix	  3.6.1.	  
	  
Figure	   3.2	   The	   environment	   of	   the	   [4Fe-­‐4S]	   cluster	   in	  
PaAPR.	  	  a.	  The	  structure	  of	  PaAPR	  bound	  to	  substrate	  APS.	  	  
The	  [4Fe-­‐4S]	  cluster	  is	  ligated	  by	  four	  cysteine	  residues	  at	  
positions	   139,	   140,	   228	   and	   231.	   	   PDB	   code:	   2GOY.	   	   b.	  
Four	   conserved	   residues	   participate	   in	   charged	   or	   polar	  
NH…S	  or	  OH…S	  hydrogen	  bonds	  to	  inorganic	  S	  or	  cysteine	  
Sγ	   atoms;	   Thr87,	   Arg143,	   Lys144	   and	   Trp246	   (yellow	  
dashes).	   	   PDB	   code:	   2GOY,	   chain	   A.	   	   c.	   Conserved	   basic	  
residues	   Lys144,	   Arg242	   and	   Arg245	   in	   the	   active	   site	  
interact	   with	   the	   phosphate	   and	   sulfate	   groups	   of	   APS	  
(yellow	  dashes).	  	  Residues	  that	  also	  interact	  with	  APS,	  but	  
are	   not	   depicted	   in	   this	   figure	   are	   Arg171	   and	   His259;	  
these	  residues	  interact	  with	  the	  α-­‐phosphate	  group.	  	  The	  
shortest	   distance	   between	   a	   sulfate	   oxygen	   atom	   and	   a	  
cysteine	  sulfur	  atom	  coordinated	  to	  the	  [4Fe-­‐4S]	  cluster	  is	  
6.0	  Å.	  	  PDB	  code:	  2GOY,	  chain	  B.	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interacts	  with	   a	   pair	   of	   basic	   residues,	   Arg143	   and	   Lys144.	   	   Other	   interactions	  with	   the	   iron-­‐
sulfur	  cluster	   involve	  Thr87	  and	  Trp246.	   	   In	   the	  active	  site	   the	  phosphosulfate	  group	  of	  APS	   is	  
positioned	  opposite	  the	  [4Fe-­‐4S]	  cluster	  and,	  while	  no	  atoms	  intervene,	  the	  sulfate	  moiety	  is	  not	  
in	  direct	  contact	  with	  the	  [4Fe-­‐4S]	  cluster.	  	  
	  
Given	  the	  unusual	  CysCys	  dyad	  coordination	  and	   its	  requirement	  for	  catalytic	  activity,	  defining	  
the	  function	  and	  properties	  of	  the	  iron-­‐sulfur	  cluster	  in	  APR	  has	  generated	  considerable	  interest	  
[1,5,7,16,17].	  	  Most	  proteins	  containing	  [4Fe-­‐4S]	  clusters	  are	  redox-­‐active	  [18-­‐21],	  however,	  the	  
[4Fe-­‐4S]2+	  cluster	  in	  APR	  does	  not	  undergo	  redox	  changes	  during	  the	  catalytic	  cycle	  [1].	  	  A	  purely	  
structural	  role	  also	  appears	  unlikely,	  in	  light	  of	  biophysical	  data	  obtained	  on	  the	  apo	  form	  of	  APR	  
[6,13,16]	  and	  the	  fact	  that	  APR	  and	  PAPR	  share	  a	  common	  protein	  fold	  [5,11,12].	  	  Unfortunately,	  
progress	  in	  this	  area	  has	  been	  hampered	  by	  the	  failure	  to	  generate	  a	  paramagnetic	  state	  of	  the	  
[4Fe-­‐4S]	  cluster	  that	  can	  be	  studied	  by	  electron	  paramagnetic	  resonance	  (EPR)	  spectroscopy	  and	  
related	  methods	  [16,17,22].	  	  
	  
Herein,	  we	  report	  the	  EPR	  spectra	  of	  MtAPR	  in	  the	  [4Fe-­‐4S]+	  state.	  	  The	  EPR	  spectrum	  of	  MtAPR	  
displays	  a	  rhombic	  signal,	  but	  is	  complex	  and	  consists	  of	  at	  least	  two	  overlapping	  S	  =	  ½	  species.	  	  
Mössbauer	   studies	   of	   the	   native	   and	   reduced	   forms	   confirm	   the	   presence	   of	   a	   [4Fe-­‐4S]2+/1+	  
cluster.	   	  APS	  binding	  to	  MtAPR	  is	  accompanied	  by	  marked	  sharpening	  of	  the	  EPR	  signal	  and	  an	  
increase	   in	   intensity,	   which	   is	   not	   observed	   among	   a	   panel	   of	   substrate	   analogs,	   including	  
adenosine	   5ʹ′-­‐diphosphate	   (ADP).	   	   In	   addition,	   kinetic	   and	   EPR	   investigation	   of	   the	   Lys144Ala	  
variant	  of	  MtAPR	  demonstrate	  a	  key	  function	  for	  this	  residue	  in	  catalysis	  and	  as	  a	  link	  between	  
APS	   and	   the	   iron-­‐sulfur	   cluster.	   	   These	   data,	   together	   with	   known	   functional	   and	   structural	  




3.3.1	  Purification	  and	  Spectroscopic	  Characterization	  of	  the	  [4Fe-­‐4S]2+	  Cluster	   in	  MtAPR.	   	  We	  
have	   previously	   reported	   conditions	   for	   the	   purification	   of	  MtAPR	   [1].	   	   However,	   yields	   from	  
these	   preparations	   were	   low	   owing	   to	   the	   large	   quantity	   of	   MtAPR	   present	   in	   the	   insoluble	  
protein	  fraction.	  	  In	  order	  to	  improve	  the	  yield	  and	  stability	  of	  purified	  MtAPR,	  we	  co-­‐expressed	  
the	   MtAPR	   gene	   with	   the	   gene	   products	   of	   the	   isc	   operon	   required	   for	   iron-­‐sulfur	   cluster	  
biosynthesis	   in	  A.	   vinelandii	   [23].	   	   Under	   these	   conditions	   the	   yield	   of	  MtAPR	  was	   typically	   7	  
mg/L	  of	  culture,	  which	  represents	  an	  improvement	  over	  ~1	  mg/L	  obtained	  when	  MtAPR	  is	  over-­‐
expressed	  in	  the	  absence	  of	  the	  isc	  proteins.	  	  The	  specific	  activity	  of	  the	  purified	  enzyme	  was	  5	  
µM	   min-­‐1	   mg	   protein-­‐1	   with	   thioredoxin	   and	   DTT	   as	   reductants.	   	   The	   UV-­‐Vis	   absorbance	  
spectrum	  of	  MtAPR	  showed	  a	  maximum	  in	  the	  visible	  range	  at	  410	  nm	  that	   is	  consistent	  with	  
the	   presence	   of	   bound	   Fe	   (Appendix	   3.6.2).	   	   Analysis	   of	   Fe	   content	   by	   inductively	   coupled	  
plasma	  resonance	  spectrometry	  for	  MtAPR	  indicated	  that	  each	  mole	  of	  protein	  contained	  3.5	  ±	  
0.4	  mol	  of	  Fe,	  which	  is	  indicative	  of	  4	  Fe	  atoms	  in	  the	  cluster.	  	  The	  intensity	  of	  the	  410	  nm	  peak	  
was	   unaffected	   on	   addition	   of	   sodium	   dithionite	   (data	   not	   shown),	   but	   increased	   slightly	   on	  
addition	  of	  APS	  (Appendix	  3.6.2).	  	  These	  results	  are	  analogous	  to	  those	  found	  for	  PaAPR	  [6].	  	  The	  
minor	   increase	   in	   absorption	   at	   410	   nm	   could	   reflect	   substrate-­‐dependent	   conformational	  
changes	  within	  the	  C-­‐terminal	  region	  and	  a	  concomitant	  alteration	  in	  cluster	  environment.	  
	  
The	  4.2-­‐K/53-­‐mT	  Mössbauer	  spectrum	  of	  MtAPR	  confirmed	  the	  presence	  of	  a	  [4Fe-­‐4S]2+	  cluster	  
(Figure	  3.3).	  	  The	  majority	  of	  the	  Fe	  (∼90%)	  gives	  rise	  to	  a	  quadrupole	  doublet	  with	  parameters	  
typical	  of	  [4Fe-­‐4S]2+	  clusters:	   isomer	  shift	  (δ)	  of	  0.45	  mm/s	  and	  quadrupole	  splitting	  parameter	  
(ΔEQ)	   of	   1.09	   mm/s.	   	   The	   appearance	   of	   a	   small	   peak	   at	   ∼0.6	   mm/s	   is	   indicative	   of	   a	   small	  
amount	  of	   [2Fe-­‐2S]2+	   clusters	   (δ	   =	   0.25	  mm/s,	  ΔEQ	   =	   0.55	  mm/s,	  ∼7%	  of	   total	   intensity).	   	   The	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[2Fe-­‐2S]2+	   cluster	   form	   of	   MtAPR	   has	   also	  
been	   observed	   by	   ESI-­‐FT-­‐ICR	   MS	   [13]	   and	   is	  
most	   likely	   caused	   by	   aerobic	   degradation,	  
analogous	   to	   other	   [4Fe-­‐4S]2+	   proteins.	   	   On	  
addition	   of	   APS,	   the	  Mössbauer	   spectrum	   of	  
MtAPR	   was	   nearly	   identical	   to	   that	   in	   the	  
absence	  of	  substrate	  (Appendix	  3.6.3)	  and	  can	  
be	   simulated	   as	   a	   superposition	   of	   two	  
quadrupole	   doublets	   representing	   the	   [4Fe-­‐
4S]2+	   clusters	   (δ	   =	   0.45	   mm/s,	   ∆EQ	   =	   1.12	  
mm/s,	   90%)	   and	   [2Fe-­‐2S]2+	   clusters	   (δ	   =	   0.25	  
mm/s,	  ∆EQ	  =	  0.55	  mm/s,	  10%).	  	  
	  
3.3.2	   Photoreduction	  of	   the	   [4Fe-­‐4S]2+	   cluster	   in	  MtAPR.	   	   As-­‐isolated	  APR	   from	  higher	   plants	  
and	  P.	  aeruginosa	  exhibits	  weak	  isotropic	  signals	  at	  g	  =	  2.01	  attributed	  to	  a	  small	  proportion	  of	  
[3Fe-­‐4S]+	   cluster	   and	   at	  g	   =	   4.3	   from	  high-­‐spin	   Fe(III)	   [16,17,22].	   	  When	  MtAPR	  was	  prepared	  
according	   to	   the	   previous	  method	   [13],	   similar	   resonances	   were	   observed	   (data	   not	   shown).	  	  
However,	   such	  EPR	  signals	  were	  not	  present	   in	   samples	  of	  MtAPR	  produced	  via	   the	   improved	  
co-­‐expression	   system.	   	   Earlier	   attempts	   to	   generate	  new	  EPR	   signals	   in	   assimilatory	  APR	   from	  
higher	  plants	  and	  bacteria	  by	  titrating	  the	  enzyme	  with	  dithionite,	  Ti(III)citrate	  or	  photochemical	  
reduction	  with	   the	  deazaflavin/oxalate	  system	  have	  proven	  unsuccessful	   [16,17,22].	   	  Similarly,	  
our	  earlier	   studies	  of	  MtAPR	   found	  no	  evidence	   for	   the	  presence	  of	   [4Fe-­‐4S]+	   after	   treatment	  
with	  dithionite	  [13].	  	  	  
	  
Figure	  3.3	   	  4.2-­‐K/53-­‐mT	  Mössbauer	   spectra	  of	  1	  
mM	  MtAPR.	   	  Experimental	  spectra	  are	  shown	  as	  
vertical	   bars.	   	   The	   solid	   line	   is	   a	   quadrupole	  
doublet	   simulation	   with	   the	   parameters	   quoted	  
in	   the	   text.	   	   The	   weak	   peak	   at	   ∼0.6	   mm/s	   is	  
indicative	  of	  a	  small	  amount	  of	  [2Fe-­‐2S]2+	  clusters	  
(arrow). 	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In	   the	  present	   study,	  we	   first	   explored	   reduction	  
of	   the	   cluster	   in	  MtAPR	   using	   Ti(III)citrate.	   	   New	  
EPR	   signals	   were	   observed,	   however,	  
interpretation	  of	   the	   spectra	  was	   confounded	  by	  
nonspecifically	   bound	   Ti(III)citrate	   that	   gave	   rise	  
to	  an	  isotropic	  signal	  at	  g	  =	  1.94	  (data	  not	  shown).	  	  
Next,	  we	  tested	  photoreduction	  of	   the	   [4Fe-­‐4S]2+	  
center	   in	   MtAPR	   in	   the	   presence	   of	  
deazaflavin/oxalate.	   	   The	   resulting	   EPR	   spectrum	  
is	   broad,	   but	   shows	   rhombic	   symmetry	   with	  
apparent	  g-­‐values	   of	   2.04,	   1.94	   and	   1.75	   (Figure	  
3.4a).	   	   The	   EPR	   signal	   also	   gives	   evidence	   for	   a	  
second	  component	  with	  apparent	  g-­‐values	  at	  2.13	  
and	   1.85;	   however,	   the	   broad	   resonances	  
precluded	   an	   accurate	   simulation	   of	   the	   two	  
paramagnetic	   species.	   	   Spin	   quantitation	   of	   the	  
EPR	  signals	  from	  g	  =	  2.5	  to	  1.3	   indicate	  0.3	  equiv	  
of	   spins	   per	   mole	   of	   enzyme.	   	   On	   the	   basis	   of	  
observed	   g-­‐values,	   the	   resonances	   can	   be	  
attributed	   to	   either	   an	   S	   =	   ½	   [2Fe-­‐2Fe]+	   or	   [4Fe-­‐
4S]+	  cluster.	  	  The	  temperature	  dependence	  of	  the	  
EPR	  signal	   (data	  not	  shown)	   indicated	  that	   it	  was	  
maximal	   between	   8-­‐10	   K	   and	   was	   no	   longer	  
visible	   at	   temperatures	   above	   12	   K,	   using	   a	  
	  	  
Figure	   3.4	   	   Experimental	   EPR	   spectra	   of	  
photoreduced	   MtAPR.	   	   Anaerobic	   250	  
µM	   MtAPR	   alone	   or	   incubated	   with	   1	  
mM	  ligand	  for	  10	  min	  at	  25	  °C	  was	  then	  
photoreduced	   as	   described	   in	  
Experimental	   Procedures.	   	   Samples:	   A.	  
MtAPR	   alone.	   	   B.	   Cys256Ser	   MtAPR	  
bound	  to	  APS.	  	  C.	  MtAPR	  incubated	  with	  
APS	   to	   generate	   the	   S-­‐sulfocysteine	  
intermediate	  bound	   to	  AMP.	   	  D.	  MtAPR	  
bound	  to	  AMP.	  	  E.	  MtAPR	  bound	  to	  ADP.	  	  
F.	   MtAPR	   bound	   to	   ADPβF.	   	   The	   EPR	  
spectra	   were	   recorded	   at	   10	   K	   and	   the	  
instrument	  parameters	  were:	  microwave	  
power,	   10	   mW;	   receiver	   gain,	   2	   x	   104;	  
modulation	  amplitude,	  10	  G;	  microwave	  
frequency,	  9.43	  GHz.	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microwave	  power	  of	  10	  mW.	  	  This	  behavior	  suggests	  that	  the	  paramagnetic	  signal	  arises	  from	  a	  
[4Fe-­‐4S]+	   cluster.	   	   By	   contrast,	   [2Fe-­‐2S]+	   clusters	   are	   slow	   relaxing	   and	   observable	   by	   EPR	   at	  
temperatures	  above	  70	  K	  [24].	  	  	  
	  
3.3.3	  Interaction	  of	  the	  Photoreduced	  [4Fe-­‐4S]+	  Cluster	  with	  Substrate	  and	  Analogs.	  	  The	  [4Fe-­‐
4S]	  cluster	  at	  the	  active	  site	  of	  APR	  is	  required	  for	  catalytic	  activity	  [1];	  however,	  the	  mechanistic	  
details	  are	  unknown	  and	  remain	  a	  central	  question	  for	  this	  family	  of	  enzymes.	  	  While	  the	  iron-­‐
sulfur	  cluster	  in	  APR	  does	  not	  undergo	  redox	  activity	  during	  the	  catalytic	  cycle	  [1],	  the	  1+	  state	  
of	   APR	   can	   serve	   as	   a	   useful	   tool	   for	   mechanistic	   studies	   analogous	   to	   other	   enzymes	   that	  
harbor	  redox-­‐inactive	  iron-­‐sulfur	  clusters	  such	  as	  aconitase	  [25].	  	  Therefore,	  to	  gain	  insight	  into	  
the	  functional	  role	  of	  the	  cluster	  we	  next	  investigated	  whether	  substrate	  binding	  would	  perturb	  
the	  EPR	  spectrum	  of	  reduced	  MtAPR.	  	  Two	  types	  of	  protein-­‐ligand	  complexes	  were	  prepared:	  (i)	  
wild-­‐type	   MtAPR	   treated	   with	   APS	   to	   afford	   the	   S-­‐sulfocysteine	   intermediate	   form	   of	   the	  
enzyme	   bound	   to	   AMP,	   and	   (ii)	   the	   catalytically	   inactive	   variant,	   Cys256Ser	  MtAPR	   bound	   to	  
APS.	   	   Established	  procedures	   for	   complex	   formation	  were	  performed	   [1,13]	   and	   the	   resultant	  
samples	  were	  then	  subjected	  to	  photoreduction.	  	  
	  
Compared	   to	  wild-­‐type	  MtAPR	   (Figure	  3.4a),	   the	  EPR	  spectrum	  of	  Cys256Ser	  MtAPR	  bound	   to	  
APS	   is	  markedly	   sharper	   in	   appearance	  with	   apparent	   g-­‐values	   of	   2.02,	   1.91	   and	   1.76	   (Figure	  
3.4b).	   The	   EPR	   signal	   of	   the	   enzyme	  S-­‐sulfocysteine	   intermediate	   bound	   to	  AMP	  also	   exhibits	  
increased	  resolution	  with	  apparent	  g-­‐values	  of	  2.03,	  1.91	  and	  1.75	   (Figure	  3.4c).	   	  Additionally,	  
both	  spectra	  (Figure	  3.4b	  and	  c)	  indicate	  the	  presence	  of	  a	  second	  paramagnetic	  species.	  	  Spin	  
quantitation	  of	  EPR	  signals	  from	  g	  =	  2.7	  to	  1.6	   indicate	  a	  respective	  0.45	  and	  0.4	  equiv	  of	  spin	  
per	   mole	   for	   the	   Cys256Ser	   and	   wild-­‐type	   MtAPR	   complexes.	   	   The	   heterogeneity	   of	   these	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samples	  was	  essentially	  unaffected	  by	  the	  addition	  of	  2.5	  
M	  urea,	  changes	  in	  sample	  pH	  between	  the	  ranges	  of	  7.5	  
and	   9.5,	   variation	   in	   temperature	   or	   microwave	   power	  
levels	  (data	  not	  shown).	  	  	  
	  
Simulation	   of	   the	   signal	   from	   wild-­‐type	   MtAPR	   treated	  
with	  APS	  suggests	  that	  it	   is	  the	  sum	  of	  at	  least	  two	  S	  =	  ½	  
components	   (Figure	   3.5).	   	   One	   species	   has	   narrow	   lines	  
and	   g-­‐values	   at	   2.04,	   1.94,	   and	   1.76	   (component	   A),	  
whereas	   the	  other	   has	   broad	   lines	   and	  exhibits	   principle	  
g-­‐values	  at	  2.10	  and	  1.88	  (component	  B)	  with	  an	  intensity	  
ratio	   of	   1:1.2.	   	   Although	   simulated	   and	   experimental	  
spectra	   are	   in	   overall	   agreement,	   some	   discrepancies	  
remain,	   particularly	   with	   respect	   to	   signal	   amplitudes.	  	  
The	   addition	   of	   a	   third	   spectral	   component	   did	   not	  
improve	   the	   fit	   quality.	   	   However,	   residual	   differences	  
between	   the	   simulated	   and	   experimental	   spectra	   may	  
result	   from	   weak	   signal	   intensity,	   minor	   fluctuations	   in	  
temperature	   around	   10	   K,	   or	   the	   large	   number	   of	  
variables	  required	  to	  simulate	  a	  [4Fe-­‐4S]+	  cluster.	  
	  
Next,	   we	   tested	   whether	   the	   observed	   APS-­‐dependent	  
changes	   in	   the	   EPR	   spectra	   of	   reduced	   MtAPR	   were	  
specific	   to	   the	   substrate.	   	   To	   investigate	   this	   possibility,	  
	  	  
Figure	  3.5	  	  Simulated	  EPR	  spectrum	  
of	   photoreduced	   wild-­‐type	   MtAPR	  
after	   addition	   of	   APS.	   	   The	   bottom	  
two	   spectra	   show	   how	   two	  
separate	   species	  might	   combine	   to	  
give	   the	   observed	   signal	   (top	  
spectra,	   solid	   line;	   see	   also	   Figure	  
4c).	   	   The	   dashed	   lines	   denote	   the	  
simulated	   EPR	   spectrum,	   which	   is	  
the	   sum	   of	   two	   components:	  	  
Component	   A	   is	   a	   spectral	  
simulation	   of	   the	   narrow	  
component	   using	   g	   =	   2.04,	   1.94,	  
1.76,	   g	   strain	   (σg)	   =	   0.017,	   0.022,	  
0.020,	   and	   a	   Gaussian	   line	   shape.	  	  
Component	   B	   is	   a	   spectral	  
simulation	  of	  the	  broad	  component	  
using	   g	   =	   2.10,	   1.88,	   1.75,	   g	   strain	  
(σg)	   =	   0.038,	   0.036,	   0.099,	   and	   a	  
Gaussian	   line	   shape.	   	   The	   ratio	   of	  
Component	   A	   to	   Component	   B	   is	  
1:1.2.	   Simulated	   instrument	  
parameters	   are	   as	   reported	   in	   the	  
legend	  of	  Figure	  3.4.	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we	   analyzed	   the	   spectra	   of	   photoreduced	  MtAPR	   bound	   to	   AMP,	   ADP	   and	   ADPβF.	   	   The	   EPR	  
signal	  of	  MtAPR	  bound	  to	  AMP	  (Figure	  3.4d)	  was	  similar	  in	  shape	  and	  intensity	  to	  enzyme	  alone	  
(Figure	   3.4a).	   	   By	   contrast,	   the	   spectrum	   in	   the	   presence	   of	   ADP	   (Figure	   3.4e)	   showed	   a	  
significant	  reduction	  in	  signal	  intensity.	  	  To	  determine	  whether	  the	  observed	  changes	  in	  the	  EPR	  
spectrum	  were	  due	  to	  the	  additional	  negative	  charge	  at	  a	  β-­‐phosphate	  group	  (i.e.,	  ADP)	  relative	  
to	   a	  β-­‐sulfate	   group	   (i.e.,	   APS),	   we	   examined	   fluorine	   substitution	   of	   a	  β-­‐nonbridging	   oxygen	  
atom.	   	   Interestingly,	   however,	   the	  EPR	   spectrum	  of	  MtAPR	  bound	   to	  ADPβF	   (Figure	  3.4f)	  was	  
essentially	  the	  same	  as	  ADP	  (Figure	  3.4e).	  	  Spin	  quantitation	  of	  MtAPR	  bound	  to	  ADP	  or	  ADPβF	  
indicate	  less	  than	  0.1	  equiv	  of	  spins	  per	  mole	  of	  enzyme	  in	  each	  sample.	  	  The	  marked	  increase	  in	  
signal	   resolution	   and	   intensity	   in	   the	   presence	   of	   APS,	   but	   not	   upon	   addition	   of	   substrate	  
analogs	   or	   product	   reflects	   a	   unique	   state	   of	   the	   active	   site	   and	   cluster	   environment,	   which	  
might	  be	  related	  to	  catalytic	  activity.	  	  
	  
3.3.4	  Characterization	  of	  Lys144Ala	  MtAPR.	   	  The	  preceding	  EPR	  data	  support	  the	  existence	  of	  
mid-­‐range	  electrostatic	  interactions	  between	  the	  cluster	  and	  APS.	  	  Given	  that	  the	  side	  chain	  of	  
Lys144	  is	  positioned	  between	  coordinating	  Cys140	  and	  the	  β-­‐sulfate	  group	  of	  APS	  (Figure	  3.2c)	  
we	   reasoned	   that	   this	   residue	   might	   help	   mediate	   this	   interaction.	   	   To	   investigate	   this	  
possibility,	  we	  generated	   the	   Lys144Ala	  MtAPR	  variant	  and	  characterized	   this	  protein	   through	  
kinetic	  and	  EPR	  studies.	  	  An	  effect	  of	  63,000-­‐fold	  on	  kcat/KM	  is	  observed	  upon	  mutation	  of	  Lys144	  
to	   Ala	   (Table	   3.1;	   see	   also	   Appendix	   3.6.4).	   	   Since	   the	   chemical	   step	   (i.e.,	   S-­‐sulfocysteine	  
formation)	   is	   rate	   limiting	   for	   the	   reaction	   of	   APS	   and	  MtAPR	   [26],	   this	   value	   represents	   the	  
effect	  of	   removal	  of	   the	   Lys	   residue	  on	   the	  overall	  binding	  and	  chemical	   transformation.	   	   The	  
mutation	  decreases	  the	  value	  of	  kmax	  by	  270-­‐fold	  suggesting	  that	  the	  Lys	  side	  chain	  stabilizes	  the	  
transition	  state	  relative	  to	  the	  ground	  state	  complex.	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Table	  3.1	  Effect	  of	  Lys144Ala	  Mutation	  on	  APR-­‐Catalyzed	  Reduction	  and	  Binding	  of	  APSa	  
	   kcat/Km	  (M
-­‐1	  s-­‐1)b	   fold	  reduction	   kmax	  (min
-­‐1)c	   fold	  reduction	   Kd	  (µM)
	   fold	  
reduction	  
Wild-­‐type	   2.5	  x	  106	   (1)	   2.7	   (1)	   0.25d	   (1)	  
Lys144Ala	   40	   6.3	  x	  104	   0.01	   270	   ≥100e	   ≥400	  
	  
aRate	  constants	   for	   single-­‐turnover	   reactions	  were	  determined	  at	  30	   °C	   in	  100	  mM	  bis-­‐tris	  
propane	  buffer,	  5	  mM	  DTT,	  10	  µM	  Trx	  as	  described	  in	  Experimental	  Procedures.	  	  In	  all	  cases,	  
the	  protein	  was	  in	  excess	  over	  substrate,	  with	  at	  least	  2.5-­‐fold	  more	  protein	  than	  substrate.	  	  
bIn	   bis-­‐tris	   propane	   at	   pH	   7.5.	   	   cIn	   bis-­‐tris	   propane	   at	   pH	   6.5.	   	   dFrom	   (Hong,	   2009).	   	   eThe	  
apparent	  Kd	  value	  was	  determined	  at	  30	  °C	  in	  100	  mM	  bis-­‐tris	  propane	  pH	  7.5	  as	  described	  in	  
Experimental	  Procedures.	  	  
	  
To	  further	  explore	  the	  molecular	  recognition	  of	  APS,	  we	  measured	  the	  Kd	  value	  of	  the	  substrate	  
for	   Lys144Ala	   MtAPR.	   	   Relative	   to	   wild-­‐type	   MtAPR,	   the	   affinity	   of	   APS	   for	   Lys144Ala	   is	  
decreased	   by	   400-­‐fold.	   	   The	   UV-­‐Vis	   absorbance	   spectrum	   of	   Lys144Ala	   MtAPR	   showed	   a	  
maximum	  in	  the	  visible	  range	  at	  410	  nm	  that	  is	  consistent	  with	  the	  presence	  of	  bound	  Fe	  (data	  
not	  shown).	   	  Analysis	  of	  Fe	  content	  by	   inductively	  coupled	  plasma	  resonance	  spectrometry	  for	  
Lys144Ala	  MtAPR	   indicated	   that	  each	  mole	  of	  protein	   contained	  3.3	  ±	  0.4	  mol	  of	   Fe,	  which	   is	  
consistent	  with	  4	  Fe	  atoms	   in	   the	   cluster.	   	   Photoreduction	  of	   Lys144Ala	  MtAPR	  gave	   rise	   to	  a	  
rhombic	   signal	  with	   resonances	   at	  g	   =	   2.12,	   1.99	   and	  1.82	   (Figure	  3.6a	   and	   c).	   	  However,	   the	  
signal	  intensity	  was	  decreased	  relative	  to	  wild-­‐type	  MtAPR	  and	  spin	  quantitation	  accounted	  for	  
less	  than	  0.05	  equiv	  of	  spins	  per	  mole	  of	  enzyme.	  	  In	  the	  presence	  of	  saturating	  APS,	  the	  feature	  
at	  g	  =	  1.75	  disappears	  and	  the	  remaining	  signal	  exhibits	  g-­‐values	  at	  2.12	  and	  1.99	  (Figure	  3.6b	  
and	  d).	  	  A	  low-­‐field	  isotropic	  Fe3+	  signal	  accounting	  for	  less	  than	  0.01	  equiv	  of	  spin	  per	  mole	  of	  
enzyme	  was	   also	   observed	   in	   the	   presence	   of	   APS,	   consistent	   with	   a	   small	   degree	   of	   cluster	  
degradation	  (data	  not	  shown).	  	  Although	  the	  EPR	  spectra	  for	  both	  samples	  are	  relatively	  broad	  
and	   weak,	   a	   modest	   reduction	   in	   the	   magnetic	   heterogeneity	   of	   MtAPR	   can	   be	   observed.	  	  
Together,	   the	   kinetic	   and	   EPR	   data	   indicate	   a	   key	   role	   for	   Lys144	   in	   chemistry	   and	   substrate	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binding,	  and	  that	  this	  residue	  helps	  modulate	  APS-­‐dependent	  changes	  in	  the	  iron-­‐sulfur	  cluster	  
environment.	  
	  
3.3.5	   Cryoreduction	   of	   the	   [4Fe-­‐4S]2+	   Cluster	   in	  
MtAPR.	   	   Although	   the	   [4Fe-­‐4S]+	   cluster	   serves	   as	   a	  
useful	   spectroscopic	   tool	   in	   the	   study	   of	  MtAPR	   and	  
variants,	  we	  recognize	  that	  it	  is	  not	  the	  native	  form	  of	  
the	  active	  enzyme.	  	  For	  this	  reason,	  we	  attempted	  to	  
probe	  the	  interaction	  of	  substrate	  with	  the	  [4Fe-­‐4S]2+	  
state	  of	  MtAPR	  through	  cryoreduction-­‐EPR	  studies.	  	  In	  
principle,	  γ-­‐irradiation	  of	  the	  frozen	  [4Fe-­‐4S]2+	  cluster	  
affords	   the	   reduced	   state	   [4Fe-­‐4S]+	   trapped	   in	   the	  
geometry	  of	  the	  [4Fe-­‐4S]2+	  oxidized	  state	  [27,28].	   	  To	  
this	  end,	  the	  2+	  state	  of	  MtAPR	  was	  incubated	  in	  the	  
presence	  or	  absence	  of	  APS,	  frozen	  in	   liquid	  nitrogen	  
and	  then	  exposed	  to	  high-­‐energy	  γ-­‐irradiation	  at	  77	  K	  
to	  produce	  the	  [4Fe-­‐4S]+	  cluster.	  	  	  
	  
The	   resulting	   spectrum	   in	   the	   absence	   of	   substrate	  
(Appendix	   3.6.5)	   is	   ill	   defined	   and	   relatively	   broad.	  	  
However,	   the	   addition	   of	   substrate	   APS	   was	  
accompanied	  by	  a	  marked	  increase	  in	  signal	   intensity	  and	  resolution	  with	  apparent	  g-­‐values	  at	  
2.08,	  2.04	  and	  2.02	   (Appendix	  3.6.5).	   	  The	  observation	  of	   substrate-­‐dependent	  changes	   in	   the	  
EPR	   spectrum	   is	   in	   qualitative	   agreement	  with	  our	   experimental	   results	   from	  photoreduction.	  	  
	  	  
Figure	  3.6.	  	  Experimental	  EPR	  spectra	  of	  
photoreduced	   Lys144Ala	   MtAPR.	  	  
Anaerobic	   250	   µM	   Lys144Ala	   MtAPR	  
alone	   (a)	   and	   (c)	   or	   incubated	   with	   1	  
mM	  APS	  (b)	  and	  (d)	  for	  10	  min	  at	  25	  °C	  
was	   then	  photoreduced	  as	  described	   in	  
Experimental	  Procedures.	   	   In	  (a)	  and	  (b)	  
EPR	   signal	   intensities	   have	   been	   scaled	  
to	  match	  those	  in	  Figure	  3.4.	   	   In	  (c)	  and	  
(d)	   the	   intensity	   of	   the	   EPR	   signals	   has	  
been	   scaled	   7.5-­‐fold.	   	   The	   EPR	   spectra	  
were	   recorded	   at	   10	   K	   and	   the	  
instrument	   parameters	   were:	  
microwave	   power,	   10	   mW;	   receiver	  
gain,	  2	  x	  104;	  modulation	  amplitude,	  10	  
G;	  microwave	  frequency,	  9.43	  GHz.	  
 85	  
However,	  we	  note	   that	   the	  EPR	   spectra	  of	   cryoreduced	  MtAPR	  are	  distinct	   from	   those	  of	   the	  
photochemically	   reduced	   enzyme.	   	   These	   findings	   may	   indicate	   that	   the	   substrate	   interacts	  
differently	   with	   the	   cluster	   in	   the	   +2	   and	   +1	   states.	   	   An	   alternative	   possibility	   is	   that	   the	  
observed	   EPR	   signals	   correspond	   to	   a	   thiyl	   radical	   formed	   by	   homolytic	   scission	   of	   the	   S-­‐
sulfocysteine	  bond.	  	  In	  support	  of	  this	  proposal,	  the	  relatively	  high	  g-­‐values	  are	  consistent	  with	  
literature	  data	  for	  a	  sulfur-­‐centered	  species	  [29,30].	  
	  
In	  addition	   to	   the	  aforementioned	  g-­‐values,	   the	   cryoreduced	   samples	   contained	  an	  extremely	  
intense	   signal	   isotropic	   signal	   at	  g	   =	   2,	  which	   could	   arise	   from	  other	   non-­‐specifically	   reduced	  
organic	   radicals	   present	   in	   the	   sample	   (Appendix	   3.6.5).	   	   4.2-­‐K/53-­‐mT	  Mössbauer	   spectra	   of	  
samples	   recorded	   before	   and	   after	   cryoreduction	   (Appendix	   3.6.6)	   indicate	   that	   ~50%	   of	   the	  
[4Fe-­‐4S]2+	   clusters	   were	   reduced	   to	   the	   +1	   state	   under	   these	   conditions.	   	   Thus,	   Mössbauer	  
analysis	  confirms	  the	  presence	  of	  the	  [4Fe-­‐4S]+	  cluster	  in	  cryoreduced	  samples;	  however,	  the	  γ-­‐
irradiation	   also	   appears	   to	   have	   generated	   extremely	   intense,	   new	  paramagnetic	   species	   that	  
are	   distinct	   from	   a	   simple	   one-­‐electron	   reduction	   of	   the	   +2	   cluster.	   	   Lastly,	   no	   significant	  
changes	  in	  the	  Mössbauer	  spectra	  from	  substrate-­‐bound	  and	  substrate-­‐free	  cryoreduced	  MtAPR	  
were	  observed	  (Appendix	  3.6.6).	  
	  
3.3.6	  Ferricyanide	  Oxidation	  of	  the	  [4Fe-­‐4S]2+	  Cluster	  in	  MtAPR.	  	  The	  [4Fe-­‐4S]2+	  cluster	  in	  PaAPR	  
is	   partially	   converted	   to	   the	   [3Fe-­‐4S]+	   form	   by	   treatment	   with	   the	   oxidant	   potassium	  
ferricyanide	   [16].	   	   To	   assess	   this	   possibility	   for	  MtAPR,	   a	   stoichiometric	   amount	   of	   potassium	  
ferricyanide	   was	   added	   to	   the	   enzyme.	   	   The	   resulting	   EPR	   signal	   shows	   a	   well-­‐defined	   EPR	  
resonance	  at	  g	  =	  2.03	  and	  a	  poorly	  resolved	  high-­‐field	  component	  at	  g	  =	  1.99	  (Appendix	  3.6.7).	  	  
This	  pattern	  of	  EPR	  signals	   is	  very	  similar	   to	   those	  of	  S	  =	  ½	   [3Fe-­‐4S]+	  clusters	   in	  aconitase	   [25]	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and	  endonuclease	  III	  [31].	  	  Spin	  quantitation	  of	  the	  EPR	  signals	  from	  g	  =	  2.1	  to	  1.8	  indicate	  less	  
than	  0.1	  equiv	  of	  spins	  per	  mole	  of	  enzyme.	  	  The	  EPR	  spectrum	  of	  oxidized	  MtAPR	  also	  exhibited	  
a	   signal	   accounting	   for	   less	   than	   0.01	   equiv	   of	   spins	   per	   mole	   of	   enzyme	   at	   g	   =	   4.3	   that	   is	  
characteristic	  of	  high-­‐spin	  Fe(III).	   	  When	   ferricyanide	  was	  added	   to	  MtAPR	   that	  had	  been	  pre-­‐
treated	  with	  APS,	  the	  intensity	  of	  the	  signal	  at	  g	  =	  4.3	  was	  increased	  by	  3-­‐fold	  (data	  not	  shown).	  	  
Attempts	  to	  purify	  the	  [3Fe-­‐4S]+	  cluster	  form	  of	  MtAPR	  were	  unsuccessful	  as	  the	  cluster	  rapidly	  
decomposed	  upon	  oxidant	  removal.	  	  Nonetheless,	  these	  data	  are	  consistent	  with	  the	  existence	  
of	  a	   labile	  Fe	  site	  within	  the	  [4Fe-­‐4S]2+	  cluster	  of	  MtAPR.	   	  Given	  the	  constraints	  of	  tandem	  Cys	  
coordination	  [5]	  and	  the	  proximity	  of	  Lys144,	  the	  Fe	  coordinated	  to	  Cys140	  may	  correspond	  to	  
the	  displaced	  atom.	  
 
3.4	  Discussion	  
Iron-­‐sulfur	   clusters	   are	   amazingly	   versatile	   cofactors	  with	   functions	   in	   electron	   transfer,	   Lewis	  
acid-­‐assisted	   enzyme	   catalysis,	   radical	   generation,	   oxidation	   of	   a	   wide	   variety	   of	   substrates	  
under	   anaerobic	   conditions,	   and	   protein	   structure	   [32-­‐37].	   	  While	   numerous	   studies	   indicate	  
that	   the	   iron-­‐sulfur	   cluster	   is	  essential	   for	  APR	  activity	   [1,5,7,13],	   the	   specific	   role	  of	   the	   iron-­‐
sulfur	  cluster	  has	  been	  elusive.	  	  Progress	  on	  this	  front	  has	  been	  limited,	  in	  part,	  by	  the	  inability	  
to	   generate	   a	   paramagnetic	   state	   of	   the	   [4Fe-­‐4S]	   cluster	   that	   can	   be	   studied	   by	   EPR	  
spectroscopy.	  	  The	  present	  study	  is	  the	  first	  reported	  case	  in	  which	  the	  [4Fe-­‐4S]2+	  cluster	  of	  APR	  
has	  been	  reduced	  to	  the	  S	  =	  ½	  [4Fe-­‐4S]+	  form.	  	  
	  
Photoreduction	  in	  the	  presence	  of	  deazaflavin	  and	  oxalate	  turned	  out	  to	  be	  the	  most	  effective	  
method	   to	   generate	   the	   paramagnetic	   1+	   state	   of	   MtAPR.	   	   By	   contrast,	   attempts	   to	  
photochemically	  reduce	  APR	  from	  plants	  and	  bacteria	  such	  as	  P.	  aeruginosa	  and	  B.	  subtilis	  have	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not	  been	  successful	  [13,22].	  	  Active	  site	  residues	  that	  interact	  with	  the	  iron-­‐sulfur	  cluster	  and/or	  
the	  substrate	  (e.g.,	  Thr87,	  Arg143,	  Lys144,	  Arg	  242,	  Arg245,	  Trp246)	  are	  highly	  conserved	  among	  
APRs	  and	  therefore,	  are	  unlikely	  to	  account	  for	  EPR	  behavioral	  differences.	  	  On	  the	  other	  hand	  
MtAPR	   is	   a	   monomer	   in	   solution	   while	   APR	   from	   other	   species	   exists	   as	   a	   homodimer	   or	  
homotetramer	  [1,17].	  	  Along	  these	  lines,	  the	  structure	  of	  PaAPR	  shows	  that	  the	  face	  of	  the	  iron-­‐
sulfur	   cluster	   opposite	   the	   active	   site	   is	   buried	   at	   the	   interface	   between	   two	   monomeric	  
subunits	  [5].	  	  Studies	  on	  the	  effect	  of	  solvent	  on	  redox	  potentials	  of	  model	  clusters	  indicate	  that	  
water	  raises	  the	  reduction	  potential	  of	  the	  [4Fe-­‐4S]2+/+	  couple	  [38,39].	  	  Hence,	  increased	  solvent	  
accessibility	  to	  the	  cluster	  of	  monomeric	  MtAPR	  may	  account	  for	  the	  ability	  to	  generate	  the	  1+	  
state.	  	  	  
	  
The	  EPR	  signal	  of	  reduced	  MtAPR	  arises	  from	  a	  mixture	  of	  [4Fe-­‐4S]+	  clusters	  with	  S	  =	  ½,	  possibly	  
reflecting	   the	   existence	   of	   distinct	   conformational	   states.	   	  Multiple	   S	   =	   ½	   ground	   states	   have	  
been	   observed	   for	   other	   [4Fe-­‐4S]	   iron-­‐sulfur	   enzymes	   such	   as	   the	   corrinoid	   protein	   from	  
Clostridium	   thermoaceticum	   [40],	   human	   DNA	   primase	   [41],	   and	   the	   ribosomal	   RNA	  
methyltransferase,	  RumA	  [42].	  	  The	  apparent	  lack	  of	  changes	  in	  the	  EPR	  spectra	  between	  pH	  6.5	  
and	  9.5	   suggests	   that	   the	   complexity	  does	  not	   result	   from	  differences	   in	  protonation	   state	  of	  
residues	  near	  the	   iron-­‐sulfur	  cluster.	   	  Freezing	  of	  samples	  after	  photoreduction	  can	  also	   led	  to	  
multiple	  signals	   from	  the	  same	  paramagnetic	  center	  –	  one	  from	  aggregated	  protein	  molecules	  
and	   the	  other	   from	  dispersed	  molecules	   [43].	   	   To	   investigate	   this	  possibility,	  we	   recorded	   the	  
EPR	  spectrum	  for	  cryoreduced	  MtAPR.	  	  In	  these	  experiments,	  the	  EPR	  signal	  that	  arises	  from	  the	  
[4Fe-­‐4S]+	   form	   of	   MtAPR	   is	   weak	   relative	   to	   other	   radical	   species	   generated	   during	   the	   γ-­‐
irradition	   process.	   	   Nonetheless,	   magnetic	   heterogeneity	   is	   still	   apparent	   in	   the	   spectrum	  
(Appendix	   3.6.5).	   	   Treatment	   with	   1-­‐2.5	   M	   urea	   has	   also	   been	   reported	   to	   convert	   multiple	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isomeric	   states	   of	   an	   [4Fe-­‐4S]+	   cluster	   into	   a	   single	   one	   [40],	   but	   this	   was	   not	   the	   case	   with	  
MtAPR.	  	  This	  observation	  may	  indicate	  the	  existence	  of	  more	  subtle	  differences	  between	  cluster	  
forms	  in	  MtAPR	  such	  as	  changes	  in	  the	  orientation	  of	  a	  Cys-­‐Sγ-­‐Fe	  bond	  or	  in	  hydrogen	  bonding	  
to	  a	  sulfur	  atom.	  	  	  
	  
Regarding	  possible	   conformational	   changes,	  PaAPR	  has	  been	   fortuitously	   crystallized	  with	  APS	  
bound	  in	  two	  of	  the	  four	  monomeric	  subunits	  [5].	  	  A	  comparison	  of	  bound	  and	  unbound	  states	  
reveals	  minor	  structural	  changes	  in	  residues	  adjacent	  to	  the	  iron-­‐sulfur	  cluster	  (Figure	  3.2b	  and	  
c).	   	   In	   the	  absence	  of	   substrate,	   Lys144	   is	  present	   in	  an	  extended	  conformation	   such	   that	   the	  
distance	  between	   the	   side	  chain	  and	   the	  Sγ	   atom	  of	  Cys140	   is	  ~5	  Å.	   	  By	   contrast,	   the	   subunit	  
with	  APS	  bound	  shows	  that	  the	  side	  chain	  of	  Lys144	  adopts	  a	  bent	  rotamer	  conformation,	  which	  
brings	   this	   residue	  within	   interaction	   range	   (i.e.,	  3.5	  Å)	  of	  Cys140	  Sγ.	   	   In	   turn,	   the	  Cys140	  side	  
chain	   moves	   slightly	   upward	   (i.e.,	   5°	   rotation	   at	   the	   β-­‐carbon).	   	   It	   is	   possible	   then,	   that	   the	  
heterogeneity	   observed	   in	   the	   EPR	   spectra	   may	   be	   related	   to	   conformational	   dynamics	   of	  
Lys144,	  Cys140	  and/or	  Cys256	  within	  the	  C-­‐terminus.	  	  In	  support	  of	  this	  hypothesis,	  a	  decrease	  
in	  EPR	  signal	  complexity	  was	  observed	  with	  Lys144Ala	  MtAPR	  (Figure	  3.6).	  	  Structural	  changes	  at	  
these	   key	   residues	  may	  also	  account	   for	   the	  observation	   that	   the	   iron-­‐sulfur	   cluster	  of	  APR	   is	  
protected	  from	  oxidation	  on	  addition	  of	  APS	  [13]	  and	  that	  the	  resonance	  Raman	  spectra	  exhibit	  
changes	  in	  Fe-­‐Sγ	  stretching	  modes	  when	  substrate	  is	  bound	  [6].	  	  	  
	  
Previous	  models	  for	  the	  role	  of	  the	  iron-­‐sulfur	  cluster	  in	  APR	  catalysis	  have	  postulated	  that	  one	  
or	   two	   non-­‐bridging	   sulfate	   oxygen(s)	   establish	   a	   direct	   interaction	   with	   an	   Fe	   atom	   (i.e.,	  
monodentate	  or	  bidentate	  coordination	  of	   the	  substrate)	   [44].	   	  The	   interacting	  Fe	  atom	  could	  
facilitate	   nucleophilic	   attack	   at	   the	   sulfate	   sulfur	   by	   acting	   as	   a	   Lewis	   acid,	   analogous	   to	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aconitase	  [25].	   	  Since	  the	  cluster	   in	  APR	   is	   ligated	  to	  the	  protein	  via	  four	  cysteine	  residues	  the	  
coordination	  number	  of	   the	   interacting	  Fe	   site	  would	   increase	   to	  5	  or	  6.	   	  Based	  on	   studies	  of	  
direct	   interaction	   between	   substrate	   or	   cofactor	   and	   [4Fe-­‐4S]2+	   clusters	   in	   aconitase	   [25],	  
pyruvate	   formate-­‐lyase	   activase	   [45],	   and	   biotin	   synthase	   [46]	   significant	   perturbation	   of	   the	  
Mössbauer	  parameters	  for	  an	  interacting	  Fe	  site	   in	  MtAPR	  would	  be	  expected	  [45,47,48].	   	  The	  
present	  work,	  however,	  shows	  no	  discernable	  change	  in	  the	  Mössbauer	  spectrum	  upon	  addition	  
of	  APS	  to	  MtAPR	  (Appendix	  3.6.3),	  suggesting	  that	  the	  cluster	  and	  the	  substrate	  do	  not	  establish	  
a	  direct	  interaction.	  	  This	  proposal	  is	  fully	  consistent	  with	  the	  crystal	  structure	  of	  PaAPR	  bound	  
to	  APS,	  which	  shows	  that	  the	  sulfate	  oxygens	  are	  7	  Å	  from	  the	  closest	  Fe	  atom	  and	  6	  Å	  from	  the	  
Sγ	  atom	  of	  Cys140	  (Figure	  3.2b)	  [5].	  
	  
On	   the	   other	   hand,	   substrate	   binding	   to	   MtAPR	   led	   to	   a	   marked	   increase	   in	   intensity	   and	  
resolution	  of	   the	   EPR	   signal,	   and	   to	  minor	   shifts	   in	   principle	  g	   values	   that	  were	  not	   observed	  
with	   closely	   related	   substrate	   analogs,	   ADP	   and	   ADPβF	   (Figure	   3.4).	   	   These	   findings	   correlate	  
with	  observed	  differences	  in	  the	  dissociation	  constants	  (Kds)	  reported	  for	  these	  ligands	  [26]	  and	  
can	  be	  rationalized	  on	  the	  basis	  of	  differences	   in	  anionic	  charges:	  β-­‐sulfate	  has	  a	  net	  negative	  
charge	  of	  one	  distributed	  over	  three	  oxygen	  atoms	  (i.e.,	  -­‐1/3	  charge	  each;	  Kd	  =	  0.25	  µM),	  while	  
β-­‐phosphate	  has	   a	  net	  negative	   charge	  of	   two	  distributed	  over	   three	  oxygen	  atoms	   (i.e.,	   -­‐2/3	  
charge	   each;	  Kd	   =	   5	   µM)	   and	  β-­‐fluorophosphate	   has	   a	   net	   negative	   charge	   of	   one	   distributed	  
over	  two	  oxygen	  atoms	  (i.e.,	  -­‐1/2	  charge	  each;	  Kd	  =	  2.5	  µM).	   	  By	  contrast,	  the	  similarity	  of	  EPR	  
spectra	  obtained	   in	   the	  presence	  or	   absence	  of	  AMP	   (Figure	  3.4a	  and	  d)	   suggests	   that	   the	  α-­‐
phosphate	  group	  is	  too	  distant	  from	  the	  cluster	  to	  exert	  any	  significant	  effect.	  	  Taken	  together,	  
these	  data	  are	  indicative	  of	  mid-­‐range	  electrostatic	  interactions	  between	  the	  iron-­‐sulfur	  cluster	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and	  the	  β-­‐functional	  group	  of	  the	  ligand,	  which	  are	  finely	  attuned	  to	  the	  electrostatic	  properties	  
of	  the	  sulfate	  in	  APS.	  	  
	  
In	   addition	   to	   differences	   in	   formal	   anionic	   charge,	   the	   sulfur	   atom	   of	   sulfate	   is	   larger,	  more	  
electronegative	   and	   forms	   shorter	   bonds	  with	   oxygen	   relative	   to	   a	   phosphorous	   atom.	   	   As	   a	  
consequence,	   the	   oxygen	   atoms	   associated	   with	   a	   β-­‐sulfate	   group	   are	   associated	   with	   less	  
negative	  charge	  density,	  relative	  to	  oxygen	  atoms	  attached	  to	  phosphate	  [49].	  	  As	  compared	  to	  
APS,	   the	   increase	   in	   negative	   charge	   density	   associated	  with	  β-­‐non-­‐bridging	   oxygen	   atoms	   of	  
ADP	  and	  ADPβF	  might	  strengthen	  their	  interaction	  with	  the	  positively	  charged	  Lys144	  side	  chain	  
such	  that	  this	  residue	  moves	  away	  from	  the	  Sγ	  atom	  of	  coordinating	  Cys140.	  	  Alternatively,	  or	  in	  
addition,	   considering	   that	   the	   [4Fe-­‐4S(Cys-­‐Sγ)4]	   cluster	   has	   a	   net	   charge	   of	   -­‐2	   [50],	   repulsive	  
electrostatic	   interactions	   could	  arise	  when	  ADP	  or	  ADPβF	  are	  bound	   in	   the	  active	   site.	   	   Either	  
scenario	   could	  account	   for	   the	  observed	  decrease	   in	  analog	  affinity	  and	  hamper	   the	  ability	  of	  
the	   iron-­‐sulfur	   cluster	   in	  MtAPR	   to	   accept	   an	   additional	   electron	   (i.e.,	   adopt	   the	   reduced	   1+	  
state).	  	  	  
	  
In	   general,	   spin	  quantitation	  of	   the	  EPR	   signals	   revealed	   less	   than	  0.5	   spin/mol	  MtAPR.	   These	  
less	   than	   unitary	   values	   for	   the	   spin	   integration	   of	   the	   reduced	   spectra	   can	   be	   attributed	   to	  
incomplete	  reduction	  of	  the	  [4Fe-­‐4S]2+	  cluster	  that	  may	  result	  from	  insufficient	  light	  intensity	  or	  
illumination	   time.	   	   However,	   changes	   in	   these	   parameters	   were	   accompanied	   by	   noticeable	  
cluster	  degradation	  and	  were	  therefore	  not	  pursued	  further.	   	  Despite	  the	  modest	  efficiency	  of	  
reduction,	   variations	   in	   spin	   quantitation	   between	   substrate-­‐bound	   (or	   substrate	   analog)	   and	  
substrate-­‐free	   states	   of	   MtAPR	   were	   observed.	   	   These	   differences	   are	   likely	   due	   to	   ligand-­‐
dependent	  structural	  and	  electrostatic	  changes	  in	  cluster	  environment,	  as	  discussed	  above.	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The	  positively	   charged	   side	   chain	  of	   Lys144	   interacts	  with	  both	  APS	   and	   coordinating	  Cys140,	  
forming	  a	  link	  between	  the	  substrate	  and	  the	  iron-­‐sulfur	  cluster.	  	  Although	  strict	  conservation	  of	  
Lys144	   implies	   an	   important	   role,	   this	   study	   is	   the	   first	   to	   probe	   the	   precise	   function	   of	   this	  
residue.	   	   Using	   site-­‐directed	  mutagenesis,	   we	   demonstrate	   that	   Lys144	   is	   necessary	   for	   both	  
substrate	   binding	   and	   transition	   state	   stabilization	   (Table	   3.1).	   	   Moreover,	   the	   significant	  
decrease	  in	  EPR	  signal	  intensity	  for	  Lys144Ala	  MtAPR	  (Figure	  3.6)	  suggests	  that	  the	  proximity	  of	  
the	  positively	   charged	   side	   chain	  of	   this	   residue	  may	  be	   an	   important	   factor	   in	   stabilizing	   the	  
reduced	   state	   of	   the	   cluster.	   	   Future	   measurements	   of	   midpoint	   reduction	   potentials	   could	  
provide	  additional	  support	  for	  this	  proposal.	  	  
	  
Comparison	  of	  the	  EPR	  spectra	  between	  wild-­‐type,	  Cys256Ser	  (Figure	  3.4)	  and	  Lys144Ala	  MtAPR	  
(Figure	   3.6)	   shows	   that	   the	   Lys	   residue	   plays	   an	   important	   role	   in	   modulating	   substrate-­‐
dependent	  changes	  in	  signal	  resolution	  and	  intensity.	  	  However,	  we	  note	  that	  the	  EPR	  spectrum	  
of	  Lys144Ala	  still	  exhibits	  subtle	  differences	  in	  the	  presence	  or	  absence	  of	  APS.	  	  In	  particular,	  the	  
APS	  bound	  state	  shows	  small	  changes	  in	  signal	  intensity	  at	  g	  =	  2.12	  and	  1.99,	  and	  a	  decrease	  in	  
the	   spectral	   feature	  at	  g	   =	   1.82.	   	   These	  differences	   in	  EPR	   spectra	  may	  be	  attributable	   to	   the	  
intrinsic	  electrostatic	  interaction	  between	  the	  iron-­‐sulfur	  cluster	  and	  the	  substrate.	  	  	  
	  
On	  the	  basis	  of	  the	  results	  reported	  herein,	  we	  propose	  a	  catalytic	  role	  for	  the	  iron-­‐sulfur	  cluster	  
in	   the	  mechanism	   of	   APS	   reduction,	   specifically	   in	   the	   sequence	   of	   events	   leading	   up	   to	   and	  
through	  sulfuryl	  group	  transfer	  (Figure	  3.7).	  	  Prior	  to	  APS	  binding,	  the	  [4Fe-­‐4S(Cys-­‐Sγ)4]2–	  cluster	  
may	   serve	   to	   pre-­‐organize	   the	   positively	   charged	   side	   chain	   of	   Lys144	   and	   possibly	   Arg245	  
(Figure	  3.2b	  and	  c)	  within	   the	  active	  site,	   so	   that	   the	  substrate	  can	  establish	   interactions	  with	  
these	  residues.	  	  Based	  on	  the	  Mössbauer	  data	  and	  structural	  studies,	  APS	  binds	  to	  the	  [4Fe-­‐4S]2+	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state	   of	   APR,	   but	   does	   not	   appear	   to	   come	   into	   direct	   contact	  with	   the	   cluster.	   	   Rather,	   EPR	  
investigation	   of	   the	   [4Fe-­‐4S]+	   and	   [3Fe-­‐4S]+	   states	   indicate	   that	   mid-­‐range	   electrostatic	  
interactions	   arise	   between	   APS	   and	   the	   iron-­‐sulfur	   cluster.	   The	   charge	   from	   and	   polarization	  
within	   the	   [4Fe-­‐4S(Cys-­‐Sγ)4]2–	   cluster	  could	   serve	   to	  activate	   the	  sulfate	  group	  of	  APS,	   thereby	  
facilitating	  S-­‐OP	  cleavage	  and	  S-­‐S	  bond	  formation	  in	  the	  reaction.	  	  	  
In	   the	   absence	   of	   an	   iron-­‐sulfur	   cluster,	   PAPR	   may	   achieve	   something	   similar	   via	   repulsion	  
between	   the	   extra	   3’-­‐phosphate	   group	  of	   PAPS	   and	   the	   sulfate	   end	  of	   the	   5’-­‐phosphosulfate.	  	  
The	  sulfate	  group	  would	  then	  be	  primed	  for	  nucleophilic	  attack	  by	  Cys256,	  leading	  to	  formation	  
of	   the	   S-­‐sulfocysteine	   enzyme	   intermediate.	   	   In	   support	   of	   this	   proposal,	   experimental	   and	  
theoretical	   studies	   of	   sulfuryl	   group	   transfer	   in	   sulfate	   esters	   [49,51]	   indicate	   the	   need	   for	   a	  
strong	  polarizing	  agent.	   	  Regarding	  Lys144,	  our	  analysis	  demonstrates	  an	  essential	  role	  for	  this	  
residue	  in	  enzyme	  catalysis.	  	  Although	  only	  speculative	  at	  present,	  it	  is	  plausible	  that	  the	  active	  
site	  Lys144	  cation	  may	  orient	   the	   incoming	  Cys	  nucleophile	  with	  respect	   to	   the	  sulfate	  moiety	  
	  
Figure	  3.7	  	  Possible	  reaction	  pathway	  for	  covalent	  S-­‐sulfocysteine	  intermediate	  formation	  catalyzed	  by	  
APR.	  	  The	  C-­‐terminal	  residues	  250-­‐267,	  which	  carry	  the	  catalytically	  essential	  Cys256,	  are	  disordered	  in	  
the	   structure	  of	   PaAPR,	   but	   can	  be	  modeled	   into	   the	   active	   site	   using	   the	   structure	  of	   S.	   cerevisiae	  
PAPR	  (Yu,	  2008).	  	  In	  the	  homology-­‐modeled	  structure	  (Hong,	  2009),	  Cys256	  is	  proximal	  to	  the	  sulfate	  
group	  of	  APS	  as	  well	  as	  the	  side-­‐chains	  of	  Cys140	  and	  Lys144.	  	  Electrostatic	  destabilization	  of	  APS	  may	  
arise	   from	   the	   juxtaposition	   of	   the	   electron	   density	   and	   partial	   negative	   charge	   that	   resides	   on	   the	  
sulfide	   and	   cysteinyl	   sulfur	   atoms	   of	   the	   iron-­‐sulfur	   cluster	   (see	   ref.	   Torres,	   2003	   for	   theoretical	  
treatment	  of	   charge	  distribution	   in	   iron-­‐sulfur	   clusters).	   	  Repulsion	  between	  APS	  and	   the	   iron-­‐sulfur	  
cluster	   could	   be	   partially	   relieved	   in	   the	   transition	   state,	   thereby	   enhancing	   the	   reaction	   rate.	   	   The	  
charge	   build-­‐up	   on	   the	   bridging	   sulfate	   oxygen	   could	   be	   stabilized	   by	   Arg171,	   Arg242	   and	   His259,	  
which	  are	  not	  indicated	  in	  this	  figure	  for	  the	  sake	  of	  simplicity.	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and/or	  act	  as	  a	  “molecular	  guidewire”	  during	  sulfuryl	  transfer;	  either	  possibility	  could	  result	   in	  
transition	  state	  stabilization.	   	  Analogous	  functions	  for	  Lys	  and	  Arg	  residues	  in	  the	  active	  site	  of	  
other	  enzymes	  that	  catalyze	  sulfuryl	  transfer	  have	  been	  described	  [52,53].	  
	  
In	  APR	  from	  Bacillus	  subtilis,	  on	  the	  basis	  of	   its	  short	  half-­‐life	   (t1/2	  ~12	  min)	  an	  oxygen-­‐sensing	  
function	  for	  has	  been	  proposed	  for	  the	  iron-­‐sulfur	  cluster	  [22].	  	  By	  comparison,	  the	  iron-­‐sulfur	  in	  
MtAPR	   is	   significantly	   more	   stable	   with	   a	   half-­‐life	   of	   about	   6	   hrs	   [13].	   	   Nevertheless,	   it	   is	  
important	   to	   note	   that	   the	  model	  we	   have	   proposed	   above	   does	   not	   preclude	   the	   possibility	  
that	  the	  cluster	  plays	  a	  regulatory	  role.	  	  Rather,	  the	  iron-­‐sulfur	  cluster	  of	  APR	  may	  function	  both	  
in	  a	  catalytic	  capacity	  and,	  in	  some	  organisms,	  as	  an	  oxygen-­‐sensitive	  switch.	  	  
	  
In	  summary,	  the	  data	  presented	  in	  this	  work	  are	  consistent	  with	  a	  catalytic	  function	  for	  the	  iron-­‐
sulfur	  cluster	   in	  APR.	   	  On	   the	  basis	  of	   these	  data,	  we	  have	  proposed	   that	   the	  cofactor	  plays	  a	  
role	   in	  pre-­‐organizing	  active	  site	  residues	  and	   in	  substrate	  activation.	   	  Additional	  experimental	  
and	   theoretical	   tests	   of	   these	   proposals	   are	   currently	   underway	   and	   will	   be	   reported	   in	   due	  
course.	  	  Moreover,	  the	  finding	  that	  MtAPR	  can	  be	  reduced	  to	  the	  [4Fe-­‐4S]+	  state	  opens	  the	  door	  
for	  other	  forms	  of	  spectroscopy	  such	  as	  ENDOR	  and	  ESEEM	  that	  can	  provide	  further	  insight	  into	  
the	  relationship	  between	  the	  substrate	  and	  iron-­‐sulfur	  cluster.	  
	  
3.5	  Experimental	  Procedures	  
3.5.1	  Materials.	  APS	   (≥95%)	  was	   obtained	   from	   Biolog	   Life	   Sciences	   Institute.	   	   ADP	   and	   AMP	  
were	  purchased	  from	  Sigma	  Chemical	  Co.	  	  ADPβF	  was	  synthesized	  as	  previously	  described	  [54].	  	  
The	   structure	   and	   purity	   (≥98%)	   was	   confirmed	   by	   1H	   and	   31P	   NMR	   (data	   not	   shown).	   	   10-­‐
Methyl-­‐3-­‐sulfopropyl-­‐5-­‐deazaisoalloxazine	  potassium	  salt	  (deazaflavin)	  was	  a	  generous	  gift	  from	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Prof.	   David	   Ballou	   (University	   of	   Michigan).	   	   Titanium(III)	   citrate	   was	   prepared	   anaerobically	  
from	   a	   15%	   titanium(III)	   chloride	   solution	   in	   1	   M	   HCl	   with	   an	   equimolar	   amount	   of	   citrate	  
(trisodium	  salt),	  and	  neutralized	  to	  pH	  7.0	  with	  saturated	  sodium	  bicarbonate.	  	  
	  
3.5.2	  Mutagenesis	  and	  Protein	  Expression.	  The	  construction	  of	  the	  expression	  vector	  encoding	  
wild-­‐type	   and	   Cys256Ser	   APR	   from	  M.	   tuberculosis	   cloned	   into	   the	   vector	   pET24b	   has	   been	  
previously	   described	   [55].	   	   The	   Lys144Ala	   variant	   was	   generated	   from	   the	   wild-­‐type	   MtAPR	  
template	   using	   the	   Quik-­‐change	   site-­‐directed	   mutagenesis	   kit	   (Stratagene)	   and	   the	   following	  
primer	   sequence:	   5ʹ′-­‐GCTGCCGGTTGCGCAAGGTCGTTCCCCTGGG-­‐3ʹ′.	   	   Plasmids	   encoding	   wild-­‐
type,	   Cys256Ser	   or	   Lys144Ala	   MtAPR	   pET24	   and	   pACYC	   (containing	   genes	   encoding	   the	   isc	  
operon	  of	  six	  accessory	  proteins	  required	  for	  Fe–S	  cluster	  biosynthesis	  in	  A.	  vinelandii	  under	  the	  
control	   of	   an	   arabinose-­‐inducible	   promoter)	   [23]	   were	   co-­‐transformed	   into	   E.	   coli	   BL21(DE3)	  
(Novagen)	   and	   plated	   on	   L-­‐agar	   50	   µg/ml	   kanamycin	   and	   100	   µg/ml	   carbenicillin.	   	   A	   single	  
colony	   was	   picked	   and	   added	   to	   5	   ml	   of	   L-­‐broth	   plus	   antibiotics	   and	   grown	   overnight	   with	  
shaking	  at	  37	  °C.	  	  This	  culture	  was	  used	  as	  a	  0.5%	  1	  L	  of	  L-­‐broth	  plus	  antibiotics	  and	  grown	  with	  
shaking	   at	   37	   °C	  until	   absorbance	   at	   600	   nm	   reached	   approximately	   0.6.	   	   Arabinose	   and	   iron	  
citrate	  were	  added	  to	  final	  concentrations	  of	  20	  mM	  and	  0.8	  mM,	  respectively	  and	  the	  culture	  
grown	  as	  above	  for	  1	  hr.	   	  At	  this	  point	  the	  flasks	  were	  removed	  from	  the	  incubator.	   	   IPTG	  was	  
added	   to	   a	   final	   concentration	   of	   0.3	  mM	  and	   the	   flasks	  were	   returned	   to	   the	   incubator	   and	  
grown	  overnight	  at	  18	  °C	  with	  shaking	  at	  200	  rpm.	  	  Cultures	  were	  harvested	  by	  centrifugation	  (4	  
°C,	  4,300g).	  	  After	  removal	  of	  the	  supernatant	  the	  pellets	  were	  stored	  at	  -­‐80	  °C	  until	  required.	  	  	  
	  
All	  purification	  steps	  were	  carried	  out	  at	  4	  °C.	  	  Cell	  pellets	  were	  resuspended	  in	  30	  ml	  Buffer	  A	  
(20	  mM	  sodium	  phosphate,	  0.5	  M	  NaCl,	  10	  mM	  imidazole;	  pH	  7.4)	  supplemented	  with	  0.1	  mM	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PMSF,	   10µg/ml	   DNase,	   5	  µg/ml	   lysozyme	   and	   lysed	   by	   sonication.	   	   Lysates	   were	   centrifuged	  
(20,000g,	  15	  min)	  and	  loaded	  onto	  a	  5	  ml	  HiTrap	  Chelating	  column	  (GE	  Healthcare,	  Piscataway,	  
NJ)	  equilibrated	  in	  the	  same	  buffer.	   	  Unbound	  material	  was	  washed	  off	  with	  50	  ml	  of	  Buffer	  A	  
and	   bound	   proteins	   then	   eluted	   with	   in	   Buffer	   B	   (20	   mM	   phosphate,	   0.5	   M	   NaCl,	   250	   mM	  
imidazole;	  pH	  7.4).	   	  Fractions	  containing	  wild-­‐type	  or	  Lys144Ala	  were	  pooled,	  concentrated	  by	  
centrifugation	   (Amicon	   10	   kDa	   cutoff,	   Millipore,	   Billerica,	   MA)	   and	   loaded	   onto	   a	   16/60	  
Superdex	   200	   size	   exclusion	   column	   previously	   equilibrated	   in	   Buffer	   C	   (50	  mM	   Tris-­‐HCl,	   150	  
mM	  NaCl,	  5	  mM	  DTT,	  10%	  glycerol;	  pH	  8.5	  at	  4	  °C).	  	  Fractions	  containing	  wild-­‐type	  or	  Lys144Ala	  
MtAPR	  were	  pooled,	  snap-­‐frozen	  in	  liquid	  nitrogen,	  and	  stored	  at	  -­‐80	  °C.	  	  Protein	  concentrations	  
were	   determined	   using	   the	   extinction	   coefficient,	   ε280=36,815	   M-­‐1cm-­‐1,	   obtained	   from	  
quantitative	  amino	  acid	  analysis	  [1].	  	  	  
	  
3.5.3	   Preparation	   of	   MtAPR	   for	   EPR	   and	   Mössbauer	   Spectroscopy.	   Samples	   of	   wild-­‐type,	  
Cys256Ser	   or	   Lys144Ala	   MtAPR	   suitable	   for	   Mössbauer	   or	   EPR	   spectroscopy	   were	   prepared	  
inside	   of	   an	   anaerobic	   chamber	  with	  O2	   levels	   ≤	   1	   ppm.	   	   Purified	  MtAPR	  was	   exchanged	   into	  
anaerobic	  buffer	  containing	  50	  mM	  Tris–HCl,	  150	  mM	  NaCl	  (pH	  8.5	  at	  4	  °C)	  and	  10%	  glycerol.	  	  To	  
reduce	  the	  cluster	  in	  MtAPR,	  reactions	  contained	  250	  µM	  enzyme,	  25	  mM	  sodium	  oxalate,	  250	  
µM	  deazaflavin	   in	  a	   total	  volume	  of	  250	  µL.	   	  When	   included,	   substrate	  or	  other	  analogs	  were	  
added	  to	  a	  final	  concentration	  of	  1	  mM	  and	  incubated	  with	  MtAPR	  for	  10	  min	  at	  25	  °C	  prior	  to	  
photoreduction.	  	  The	  reaction	  mixtures	  were	  transferred	  to	  EPR	  tubes,	  chilled	  in	  an	  ice-­‐salt	  bath	  
(-­‐6	   °C)	   and	   irradiated	   with	   light	   from	   a	   100	   W	   quartz	   halogen	   lamp	   (Applied	   Photophysics,	  
Surrey,	  UK)	  for	  30	  min.	   	  After	   illumination,	  samples	  were	  immediately	  frozen	  in	  liquid	  nitrogen	  
and	   analyzed	   by	   low-­‐temperature	   EPR.	   	   Mössbauer	   spectra	   were	   recorded	   on	   proteins	   that	  
contained	   57Fe	   in	   place	   of	   natural-­‐abundance	   iron.	   	   57Fe	   was	   incorporated	   into	   MtAPR	   via	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supplementation	  of	  E.	  coli	  growth	  media,	  and	  samples	  contained	  1	  mM	  protein,	  and	  2	  mM	  APS	  
when	   appropriate.	   	   After	   10	   min	   incubation	   with	   substrate,	   samples	   were	   transferred	   to	  
Mössbauer	  cups	  and	  frozen	  in	  liquid	  nitrogen.	  
	  
3.5.4	   EPR	   Spectroscopy-­‐	   X-­‐band	   EPR	   spectra	   of	   photoreduced	   samples	   were	   recorded	   on	   a	  
Bruker	   EMX	   spectrometer	   (Billerica,	   MA)	   equipped	   with	   an	   Oxford	   Instruments	   ITC4	  
temperature	  controller,	  a	  Hewlett-­‐Packard	  model	  5340	  automatic	  frequency	  counter	  and	  Bruker	  
gaussmeter.	  	  Figure	  legends	  contain	  relevant	  instrumental	  parameters.	  	  The	  sample	  buffer	  was	  
used	  to	  record	  baselines	  under	  conditions	  identical	  to	  those	  in	  which	  the	  sample	  spectra	  were	  
obtained.	   	   These	   baselines	   were	   subtracted	   from	  MtAPR	   spectra	   shown	   in	   the	   figures.	   	   Spin	  
concentrations	  in	  MtAPR	  samples	  were	  determined	  by	  double	  integration	  of	  the	  EPR	  signal	  over	  
a	  range	  of	  2	  kgauss	  and	  comparison	  with	  double	  integrals	  of	  1	  mM	  Cu(ClO4)2	   in	  sample	  buffer.	  	  
EPR	   spectra	   of	   cryoreduced	   samples	   were	   recorded	   on	   a	   Bruker	   ER-­‐200DSRC	   spectrometer	  
equipped	   with	   an	   Oxford	   Instruments	   ESR	   910	   continuous-­‐flow	   cryostat.	   	   Simulations	   of	   EPR	  
spectra	  were	   performed	   using	   Spin	   Count	   (ver	   2.6.7)	   created	   by	   Professsor	  M.P.	   Hendrich	   at	  
Carnegie	   Mellon	   University.	   Spin	   Count	   is	   available	   at	  
http://www.chem.cmu.edu/groups/hendrich/.	  	  
	  
3.5.5	   Mössbauer	   Spectroscopy.	   	   Mössbauer	   spectra	   were	   recorded	   on	   a	   spectrometer	   from	  
WEB	   research	   (Edina,	   MN)	   operating	   in	   the	   constant	   acceleration	   mode	   in	   transmission	  
geometry.	  	  Spectra	  were	  recorded	  with	  the	  temperature	  of	  the	  sample	  maintained	  at	  4.2	  K	  in	  an	  
externally	  applied	  magnetic	  field	  of	  53	  mT	  oriented	  parallel	  to	  the	  γ-­‐beam.	  	  The	  quoted	  isomer	  
shifts	  were	  relative	  to	  the	  centroid	  of	  the	  spectrum	  of	  a	  foil	  of	  α-­‐Fe	  metal	  at	  room	  temperature.	  	  
Data	  analysis	  was	  performed	  using	  the	  program	  WMOSS	  from	  WEB	  research.	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3.5.6	  Cryoreduction	  of	  MtAPR	  by	  Low-­‐Temperature	  γ -­‐Radiolysis.	   	  Samples	  containing	  250	  µM	  
MtAPR	  were	  loaded	  into	  EPR	  tubes	  or	  Mössbauer	  cups	  and	  flash	  frozen	  in	  liquid	  nitrogen	  inside	  
the	   glovebox.	   	   When	   appropriate,	   APS	   was	   added	   to	   a	   final	   concentration	   of	   1	   mM	   and	  
incubated	  with	  protein	   for	  10	  min	  at	  25	   °C	  prior	   to	   freezing.	   	  Samples	  were	  γ-­‐irradiated	   (60Co;	  
total	   dose	   of	   4	   Mrad)	   at	   the	   γ-­‐irradiation	   facility	   of	   the	   Breazeale	   nuclear	   reactor	   at	   the	  
Pennsylvania	   State	   University.	   	   During	   irradiation,	   samples	   were	   maintained	   at	   77	   K	   by	  
immersion	  in	  liquid	  N2.	  
	  
3.5.7	  MtAPR	  Activity	  Assay.	   	  Reactions	  were	  carried	  out	  at	  30	  °C.	   	  Unless	  otherwise	  indicated,	  
the	  buffer	  consisted	  of	  100	  mM	  bis-­‐tris	  propane	  (pH	  7.5)	  and	  100	  mM	  NaCl	  supplemented	  with	  
5	  mM	  DTT	   and	   10	   µM	  E.	   coli	   thioredoxin.	   	   Production	   of	   35SO32-­‐	   from	   35S-­‐APS	  was	  monitored	  
using	   charcoal-­‐based	   separation	   and	   scintillation	   counting	   as	   previously	   reported	   [26].	   	   The	  
substrate	   was	   incubated	   with	   excess	   enzyme	   to	   ensure	   single-­‐turnover	   conditions	   (>2.5-­‐fold	  
molar	  excess	  of	  enzyme).	   	   The	   reaction	  progress	   curve	  was	  plotted	  as	   the	   fraction	  of	  product	  
versus	  time	  and	  was	  fit	  by	  a	  single	  exponential	  F	  =	  A[1–e(–kobst)],	  where	  F	  is	  the	  fraction	  product,	  
A	   is	   the	   fraction	   of	   substrate	   converted	   to	   product	   at	   completion,	   kobs	   the	   observed	   rate	  
constant,	  and	  t	  time.	   	  Reactions	  were	  followed	  for	  ≥5	  half-­‐lives	  except	  for	  very	  slow	  reactions.	  	  
Under	   single-­‐turnover	   conditions,	   it	   is	   expected	   that	   the	   concentration	   dependence	   of	   the	  
enzyme	  will	  be	  hyperbolic	  (eq	  1).	  	  	  
	  
! 
kobs = kmax[E]K1/ 2 + [E] 	   (1)	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To	  determine	  kcat/Km,	  a	  concentration	  of	  enzyme	  was	  chosen	  that	  was	  at	  least	  5-­‐fold	  below	  the	  
Km	   value.	   	   Although	  we	   refer	   to	   the	  K1/2	   for	  maximal	   activity	   as	  Km,	  we	   note	   that	   the	  K1/2	   for	  
single	  turnover	  is	  not	  necessarily	  the	  same	  as	  the	  Km	  for	  the	  multiple	  turnover	  reaction	  since	  the	  
latter	   can	   be	   affected	   by	   the	   rate	   of	   product	   release.	   	   For	   conditions	   in	   which	   [E]	   <<	   Km	   the	  
second	  order	  rate	  constant,	  kcat/Km	  =	  kobs/[E].	  	  We	  note	  that	  the	  reported	  values	  of	  kcat/Km	  are	  for	  
single-­‐turnover	   conditions,	   but	   the	   measurement	   is	   equivalent	   to	   steady	   state	   kcat/Km.	   	   At	   a	  
saturating	   concentration	   of	   enzyme,	   the	   observed	   single-­‐turnover	   rate	   constant	   reaches	   a	  
maximum,	  kmax.	  	  To	  determine	  kmax,	  the	  concentration	  of	  enzyme	  was	  varied	  by	  at	  least	  3-­‐fold	  to	  
establish	   that	   the	   observed	   rate	  was	   independent	   of	   the	   concentration	   of	   enzyme,	   indicating	  
that	  the	  enzyme	  was	  in	  excess	  and	  at	  a	  saturating	  concentration	  (i.e.,	  kobs	  =	  kmax).	  	  The	  reported	  
values	  of	  kcat/Km	  and	  kmax	  are	  the	  average	  of	  at	  least	  three	  independent	  determinations.	  	  Unless	  
otherwise	  indicated,	  the	  standard	  deviation	  was	  ≤15%	  of	  the	  value	  of	  the	  mean.	  
	  
3.5.8	  Determination	  of	  Substrate	  Affinity.	   	  The	  apparent	  dissociation	  constant	  (Kd)	   for	  35S-­‐APS	  
from	   Lys144Ala	  MtAPR-­‐ligand	   complexes	   was	  measured	   using	   an	   ultrafiltration	   binding	   assay	  
reported	  by	  Hernick	  and	  Fierke	  [56].	  	  Because	  the	  chemical	  step	  (i.e.,	  S-­‐sulfocysteine	  formation)	  
is	   rate-­‐limiting	   [26]	   the	   K1/2	   is	   equal	   to	   Kd	   of	   APS	   for	   Lys144Ala	   MtAPR.	   	   In	   brief,	   the	  
concentration	  of	  substrate	  was	  kept	  low	  (i.e.,	  below	  the	  Kd)	  and	  constant,	  and	  the	  concentration	  
of	   the	   enzyme	  was	   varied	   (0	   to	   80	  µM).	   	   Lys144Ala	  MtAPR	  was	   incubated	   in	   100	  mM	  bis-­‐tris	  
propane,	  pH	  7.5	  at	  30	  °C	  for	  15	  min	  prior	  to	  the	  assay	  to	  allow	  for	   ligand	  equilibration.	   	  Assay	  
mixtures	  were	   then	   transferred	   into	  ultrafiltration	  devices	   (Microcon	  30	   kDa	   cutoff,	  Millipore,	  
Billerica,	  MA),	   and	   the	   free	   and	   bound	   ligand	   separated	   by	   centrifuging	   the	   samples	   at	   3,000	  
rpm	  for	  2.5	  min.	  	  Equal	  volumes	  of	  the	  filtrate	  and	  retentate	  were	  removed	  and	  quantified	  using	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scintillation	  counting.	   	   The	   ratio	  of	  EL/Ltotal	  was	  determined	  as	  a	   function	  of	   [E]total,	   and	   the	  Kd	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3.6	  Appendix	  
Appendix	  3.6.1	  	  Structure	  based	  sequence	  alignment	  of	  17	  APS	  reductases	  from	  prokaryotes	  
	  
	  	  
Appendix	  3.6.1	  	  Structure	  based	  sequence	  alignment	  of	  17	  APS	  reductases	  from	  prokaryotes.	  	  The	  ClustalW	  
Multiple	  Sequence	  Alignment	  program	  was	  used.	  	  The	  bar	  graph	  indicates	  the	  degree	  of	  conservation	  per	  
position.	   	   Strictly	   conserved	   residues	   are	   outlined	   in	   red,	   red	   letters	   indicate	   conserved	   residues	   and	  
conserved	   regions	   are	   boxed	   in	   blue.	   	   Alignment	   pictures	   were	   rendered	   with	   the	   server	   ESPript	   2.2	  
(http://espript.ibcp.fr).	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Appendix	  3.6.2	  	  UV-­‐vis	  absorption	  spectra	  of	  MtAPR	  
	  
	  





Appendix	  3.6.2	   	  UV-­‐vis	  absorption	  spectra	  of	  MtAPR.	   	  UV-­‐vis	  absorption	  of	  10µM	  MtAPR	  in	  50	  mM	  Tris–
HCl,	  150	  mM	  NaCl	   (pH	  8.5	  at	  4	  °C)	  and	  10%	  glycerol,	  before	   (––)	  and	  after	   (••••)	   the	  addition	  of	  2-­‐fold	  
stoichiometric	  excess	  of	  APS.	  	  Inset	  shows	  the	  corresponding	  difference	  spectrum	  resulting	  from	  complex	  
formation	   between	   MtAPR	   and	   APS.	   	   The	   difference	   spectrum	   is	   the	   spectrum	   of	   the	   mixture	   minus	  
spectrum	  of	  enzyme	  alone.	  
	  
Appendix	  3.6.3	  	  4.2-­‐K/53-­‐mT	  Mössbauer	  spectra	  of	  1	  mM	  MtAPR	  in	  the	  absence	  (vertical	  bars)	  or	  presence	  
of	  2	  mM	  APS	  (solid	  line).	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Appendix	  3.6.4	  	  Rate	  and	  equilibrium	  constants	  for	  MtAPR	  
	  	  
Appendix	   3.6.4	   	   Rate	   and	   equilibrium	   constants	   for	   MtAPR.	   	   a.	   Single-­‐turnover	   reduction	   of	   APS	   by	  
Lys144Ala	   MtAPR	   performed	   under	   subsaturating	   conditions	   as	   described	   in	   Experimental	   Procedures.	  	  
Single-­‐turnover	   reaction	   to	   measure	   kcat/Km	   was	   performed	   with	   5	   nM	   wild-­‐type	   MtAPR	   or	   20	   µM	  
Lys144Ala	  MtAPR	  and	  0.25	  nM	  APS.	   	  b.	   Single-­‐turnover	   reduction	  of	  APS	  by	  wild-­‐type	   (filled	  circles)	  and	  
Lys144Ala	   (filled	   triangles)	   MtAPR	   performed	   under	   saturating	   conditions	   as	   described	   in	   Experimental	  
Procedures.	  	  Single-­‐turnover	  reactions	  to	  measure	  kmax	  were	  performed	  with	  150	  µM	  enzyme	  and	  50	  µM	  
APS.	   	   c.	   APS	   binding	   to	   Lys144Ala	   MtAPR	   measured	   by	   ultrafiltration	   as	   described	   in	   Experimental	  
Procedures.	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Appendix	   3.6.5	   	   EPR	   spectra	   of	   radiolytically	   cryoreduced	   250	   µM	  MtAPR	   in	   the	   absence	   (red)	   or	   pre-­‐
incubated	  with	  1	  mM	  APS	  (blue)	  as	  described	  in	  Experimental	  Procedures.	  	  Conditions:	  temperature,	  77	  K;	  
microwave	  frequency,	  9.45	  GHz;	  microwave	  power,	  10	  mW;	  modulation	  frequency,	  100	  kHz;	  modulation	  
amplitude,	  10	  G;	  scan	  time,	  167	  s;	   time	  constant,	  167	  ms.	   	  Asterisks	   indicate	   the	  position	  of	   the	   intense	  
signal	  at	  g	  =	  2	  emanating	  from	  free	  radicals	  generated	  during	  cryoreduction	  and	  the	  position	  of	  the	  peaks	  
of	  hydrogen	  atoms	  formed	  during	  cryoreduction.	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Appendix	  3.6.6.	  	  4.2-­‐K/53-­‐mT	  Mössbauer	  spectra	  of	  250	  µM	  MtAPR	  in	  the	  absence	  (top)	  or	  pre-­‐incubated	  
with	  1	  mM	  APS	  (bottom)	  after	  γ-­‐irradiation	  (vertical	  bars)	  as	  described	  in	  Materials	  and	  Methods.	  	  In	  these	  
experiments,	  50%	  of	  the	  starting	  material	  is	  unchanged	  (red	  solid	  line).	  	  Spectral	  changes	  that	  result	  from	  
different	  orientations	  of	  the	  externally	  applied	  53-­‐mT	  magnetic	  field	  are	  highlighted	  by	  the	  black	  and	  blue	  
arrows.	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Appendix	  3.6.7	  	  EPR	  spectra	  of	  oxidized	  wild-­‐type	  MtAPR.	  	  a.	  Spectra	  of	  250	  µM	  MtAPR	  treated	  with	  a	  
stoichiometric	  amount	  of	  ferricyanide	  in	  buffer	  containing	  50	  mM	  Tris–HCl,	  150	  mM	  NaCl	  (pH	  8.5	  at	  4	  
°C)	  and	  10%	  glycerol.	  b.	  Expanded	  version	  of	  panel	  a	  around	  g	  =	  2.	   	  Prior	   to	   freezing,	   samples	  with	  
protein	  were	  incubated	  with	  ferricyanide	  for	  5	  min	  at	  rt.	  	  Unreacted	  potassium	  ferricyanide	  is	  present	  
in	  the	  sample.	  	  However,	  controls	  reactions	  carried	  out	  in	  the	  absence	  of	  protein	  indicate	  that	  it	  does	  
not	  contribute	  to	  features	  in	  the	  spectrum.	  	  Conditions:	  temperature,	  10	  K;	  microwave	  frequency,	  9.38	  
GHz;	  microwave	  power,	  10	  mW.	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4.1	  Abstract	  
Adenosine-­‐5’-­‐phosphosulfate	   reductase	   (APR)	   is	   an	   iron-­‐sulfur	   protein	   that	   catalyses	   the	  
reduction	  of	  adenosine-­‐5’-­‐phosphosulfate	  (APS)	  to	  sulfite.	  	  APR	  coordinates	  to	  a	  [4Fe-­‐4S]	  cluster	  
via	  a	  conserved	  CC-­‐X~80-­‐CXXC	  motif	  and	  the	  cluster	   is	  essential	   for	  catalysis.	   	  Despite	  extensive	  
functional,	  structural	  and	  spectroscopic	  studies,	   the	  exact	  role	  of	   the	   iron-­‐sulfur	  cluster	   in	  APS	  
reduction	   remains	   unknown.	   	   To	   gain	   an	   understanding	   into	   the	   role	   of	   the	   cluster,	   density	  
functional	   theory	   (DFT)	   analysis	   and	   extended	   X-­‐ray	   fine	   structure	   spectroscopy	   (EXAFS)	   have	  
 111	  
been	   performed	   to	   reveal	   insights	   into	   the	   coordination,	   geometry	   and	   electrostatics	   of	   the	  
[4Fe-­‐4S]	  cluster.	   	  XANES	  data	  confirms	  that	   the	  cluster	   is	   in	   the	   [4Fe-­‐4S]2+	  state	   in	  both	  native	  
and	  substrate-­‐bound	  APR	  while	  EXAFS	  data	  recorded	  at	  ~0.1	  Å	  resolution	  indicates	  that	  there	  is	  
no	  significant	  change	  in	  the	  structure	  of	  the	  [4Fe-­‐4S]	  cluster	  between	  the	  native	  and	  substrate-­‐
bound	   forms	  of	   the	   protein.	   	  On	   the	  other	   hand,	  DFT	   calculations	   provide	   an	   insight	   into	   the	  
subtle	  differences	  between	  the	  geometry	  of	   the	  cluster	   in	   the	  native	  and	  APS-­‐bound	   forms	  of	  
APR.	  	  A	  comparison	  between	  models	  with	  and	  without	  the	  tandem	  cysteine	  pair	  coordination	  of	  
the	   cluster	   suggests	   a	   role	   for	   the	   unique	   coordination	   in	   facilitating	   a	   compact	   geometric	  
structure	  and	  ‘fine-­‐tuning’	  the	  electronic	  structure	  to	  prevent	  reduction	  of	  the	  cluster.	  	  Further,	  
calculations	   using	  models	   in	  which	   residue	   Lys144	   is	  mutated	   to	   Ala	   confirm	   the	   finding	   that	  
Lys144	  serves	  as	  a	  crucial	  link	  in	  the	  interactions	  involving	  the	  [4Fe-­‐4S]	  cluster	  and	  APS.	  	  	  
	  
4.2	  Introduction	  
In	   plants	   and	   many	   species	   of	   bacteria	   such	   as	   Mycobacterium	   tuberculosis	   (Mt)	   and	  
Pseudomonas	  aeruginosa	  (Pa),	  de-­‐novo	  synthesis	  of	  cysteine	  occurs	  via	  the	  sulfate	  assimilation	  
pathway	  [1].	  	  In	  this	  pathway,	  inorganic	  sulfate	  is	  activated	  to	  form	  adenosine-­‐5ʹ′-­‐phosphosulfate	  
(APS),	  which	  is	  subsequently	  reduced	  to	  sulfite	  and	  then	  sulfide,	  and	  incorporated	  into	  cysteine	  
[2,3].	  	  The	  first	  committed	  step	  in	  sulfate	  assimilation	  is	  carried	  out	  by	  the	  enzyme,	  adenosine-­‐
5ʹ′-­‐phosphosulfate	   reductase	   (APR),	   which	   catalyzes	   the	   reduction	   of	   APS	   to	   sulfite	   and	  
adenosine-­‐5ʹ′-­‐monophosphate	  (AMP)	  (Scheme	  4.1)	  using	  reducing	  equivalents	  from	  thioredoxin	  
(Trx),	  a	  protein	  cofactor	  [1,4-­‐6].	  	  APR	  has	  been	  shown	  to	  be	  essential	  for	  survival	  of	  bacteria	  in	  
the	   latent	  phase	  of	   tuberculosis	   infection	   [7]	   and	   since	   there	   is	  no	  human	  homolog	  of	  APR,	   it	  






APRs	   from	  M.	   	   tuberculosis	   (MtAPR)	  and	  P.	   	  aeruginosa	   (PaAPR)	  are	   related	  by	  high	  sequence	  
homology	   (27.2%	   of	   sequence	   identity	   and	   41.4%	   of	   sequence	   similarity,	   Appendix	   4.9.1),	  
particularly	   in	   the	   residues	   that	   line	   the	   active	   site	   [9].	   	   The	   mechanism	   of	   APR	   involves	   a	  
nucleophilic	  attack	  by	  the	  catalytic	  Cys256	  (residue	  numbers	  throughout	  manuscript	  correspond	  
to	  the	  PaAPR	  sequence)	  in	  the	  C-­‐terminal	  tail	  of	  APR	  on	  APS	  to	  form	  an	  enzyme	  S-­‐sulfocysteine	  
intermediate,	  E-­‐Cys−Sγ−SO3−,	  which	   is	  then	  reduced	  to	  sulfite	  and	  AMP	  through	   intermolecular	  
thiol−disulfide	  exchange	  with	  Trx	  (Figure	  4.1)	  [4].	  	  It	  is	  likely	  that	  in	  the	  initial	  Michaelis	  complex	  
APS	   binds	   to	   other	   residues,	   changing	   their	   resulting	   mobility	   within	   the	   substrate-­‐binding	  












Scheme	  4.1	  Reaction	  catalyzed	  by	  APR	  
	  	  
Figure	  4.1.	  	  Proposed	  mechanism	  of	  APR.	  	  APR	  reduces	  adenosine	  5’-­‐phosphosulfate	  
(APS)	   to	   sulfite	   and	   adenosine	   5’-­‐monosulfate	   (AMP)	   using	   reducing	   equivalents	  
from	  the	  protein	  cofactor,	  thioredoxin	  (Trx).	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From	   a	   structural	   perspective,	   APR	   is	   an	  
iron-­‐sulfur	   protein	   with	   a	   conserved	   CC-­‐
X~80-­‐CXXC	   motif,	   correlated	   with	   the	  
presence	   of	   a	   [4Fe-­‐4S]	   cluster.	   	   The	  
cluster	  has	  been	  shown	  to	  be	  essential	  for	  
catalytic	   activity	   in	   both	   plant	   and	  
bacterial	   APRs	   [3,10-­‐12],	   but	   the	   exact	  
role	   of	   the	   cluster	   in	   APS	   reduction	  
remains	   unknown.	   	   Interestingly,	   studies	  
by	   Carroll	   et	   al.	   	   have	   shown	   that	   the	  
[4Fe-­‐4S]2+	   cluster	   in	   APR	   does	   not	  
undergo	   redox	   changes	   during	   the	  
catalytic	   cycle	   [4].	   	   The	   2.7	   Å	   crystal	  
structure	   of	   PaAPR	   bound	   to	   substrate	  
[13]	   shows	   the	   iron-­‐sulfur	   cluster	  
coordinated	   by	   Cys228	   and	   Cys231,	  
positioned	   at	   the	   tip	   of	   a	   β-­‐loop,	   and	   a	  
special	   tandem	   pair,	   Cys139	   and	   Cys140	  
within	   a	   kinked	   helix,	   α6	   (Figure	   4.2a).	  	  
Helix	   α6	   is	   kinked	   where	   Lys144	   is	  
oriented	   into	   the	   active	   site.	   	   Amongst	  
interactions	  of	   the	  cluster,	   there	  are	   four	  
charged	   and/or	   polar	   NH⋅⋅⋅S	   or	   OH⋅⋅⋅S	  
hydrogen	   bonds	   involving	   side	   chains	   of	  
	  
Figure	   4.2	   Environment	   of	   the	   [4Fe-­‐4S]	   cluster	   in	  
PaAPR	   (Bhave,	   2011).	   	   a.	   	   The	   structure	   of	   PaAPR	  
bound	   to	   substrate	  APS	   (subunit	   B	   or	   chain-­‐B).	   	   The	  
[4Fe-­‐4S]	  cluster	  is	  ligated	  by	  four	  cysteine	  residues	  at	  
positions	  139,	   140,	   228	   and	  231.	   	   	   PDB	   code:	   2GOY.	  	  
b.	  	  Three	  conserved	  residues	  participate	  in	  charged	  or	  
polar	  NH·∙·∙·∙S	  or	  OH·∙·∙·∙S	  hydrogen	  bonds	  to	   inorganic	  S	  
or	   cysteine	   Sγ	   atoms;	   Thr87,	   Arg143,	   and	   Trp246	  
(yellow	   dashes).	   	   	   PDB	   code:	   2GOY,	   chain	   A.	   	   c.	  	  
Conserved	  basic	  residues	  Lys144,	  Arg242	  and	  Arg245	  
in	   the	   active	   site	   interact	   with	   the	   phosphate	   and	  
sulfate	   groups	   of	   APS	   (yellow	   dashes).	   	   In	   the	  
presence	   of	   APS,	   Lys144	   makes	   a	   NH·∙·∙·∙S	   hydrogen	  
bond	   to	   the	   Cys140-­‐Sγ	   atom.	   	   Residues	   that	   also	  
interact	  with	  APS,	  but	  are	  not	  depicted	   in	   this	   figure	  
are	   Arg171	   and	  His259;	   these	   residues	   interact	  with	  
the	   α-­‐phosphate	   group.	   	   	   The	   shortest	   distance	  
between	  a	  sulfate	  oxygen	  atom	  and	  a	  cysteine	  sulfur	  
atom	   coordinated	   to	   the	   [4Fe-­‐4S]	   cluster	   is	   6.0	   Å.	  	  	  
PDB	  code:	  2GOY,	  chain	  B.	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absolutely	   conserved	   residues	   (Figure	   4.2b	   and	   c).	   	   The	   CysCys	  motif	   interacts	   with	   a	   pair	   of	  
basic	   residues,	   Arg143	   and	   Lys144.	   	   In	   addition,	   Cys140	   hydrogen	   bonds	   to	   His136.	   	   Other	  
interactions	   with	   the	   iron-­‐sulfur	   cluster	   involve	   the	   side	   chains	   of	   Thr87	   and	   Trp246.	   	   The	  
phosphosulfate	  group	  of	  APS	   is	  positioned	  at	  a	  distance	  of	  approximately	  7	  Å	   to	   the	   iron	  site,	  
which	  coordinates	  to	  Sγ-­‐Cys140,	  and	  as	  such,	  the	  sulfate	  moiety	  is	  not	  in	  direct	  contact	  with	  the	  
[4Fe-­‐4S]	  cluster.	  	  	  Interestingly,	  however,	  both	  cluster	  and	  substrate	  interact	  with	  Lys144	  (Figure	  
4.2c).	  
	  
Coordination	   by	   sequential	   cysteines	   is	   highly	   unusual	   for	   [4Fe-­‐4S]	   clusters	   and	   has	   been	  
characterized	   in	   only	   one	   other	   crystal	   structure	   –	   the	  NuoB	   subunit	   of	   respiratory	   complex	   I	  
[14].	   	   The	   tandem	   cysteines	   also	   reside	   within	   an	   α-­‐helix	   and	   the	   subunit	   of	   NuoB	   exhibits	  
substrate-­‐induced	   conformational	   changes	   [15].	   	   In	   APR,	   constraints	   imposed	   by	   the	   tandem	  
cysteine	  coordination	  do	  not	  affect	  the	  tetrahedral	  symmetry	  of	  the	  cluster,	  but	  the	  side	  chain	  
of	  Cys140	  is	  distorted,	  resulting	  in	  steric	  clashes	  between	  the	  Cα	  proton	  and	  an	  inorganic	  sulfur	  
atom	  of	  the	  cluster	  [13].	  	  	  
	  
In	   addition	   to	   the	   structural	   information	   available,	   based	   on	   differences	   in	   cysteine	   reactivity	  
and	  cluster	  stability,	  biochemical	  and	  mass	  spectrometric	  studies	  with	  MtAPR	  have	  suggested	  a	  
structural	   rearrangement	   in	   the	   S-­‐sulfocysteine	   complex	   and	   AMP-­‐bound	   enzyme	   relative	   to	  
free	  enzyme	  [16].	  	  In	  fact,	  solution	  kinetics	  and	  mass	  spectrometric	  studies	  of	  MtAPR	  performed	  
with	  APS	  (at	  concentrations	  exceeding	  the	  Kd	  of	  APS	  and	  AMP),	  have	  shown	  that	  the	  subsequent	  
formation	  of	  the	  stable	  E-­‐Cys−Sγ−SO3−	  intermediate	  with	  AMP-­‐bound	  and	  C-­‐terminal	  tail	  docked	  
in	  the	  active	  site,	  prevents	  cluster	  degradation	  and	  loss	  of	  APR	  activity	  [4,9,16].	  	  Furthermore,	  a	  
comparison	  of	  Resonance	  Raman	  spectra	  of	  PaAPR	  in	  the	  native	  form	  and	  in	  the	  S-­‐sulfocysteine	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form	  (with	  AMP	  bound	  and	  the	  C-­‐terminal	  tail	  docked	  in	  the	  active	  site	  of	  the	  enzyme)	  shows	  an	  
enhancement	  in	  Fe-­‐Sγ(Cys)	  stretching	  modes	  centered	  near	  355	  and	  369	  cm-­‐1	  [17].	  	  Recently,	  we	  
demonstrated	  that	  APS	  binding	  induced	  an	  increase	  in	  intensity	  and	  resolution	  of	  the	  EPR	  signal	  
of	   reduced	   MtAPR	   that	   was	   not	   observed	   among	   a	   panel	   of	   substrate	   analogs,	   including	  
adenosine	  5ʹ′-­‐diphosphate.	  	  Additionally,	  through	  kinetic	  and	  EPR	  studies,	  Lys144	  was	  identified	  
as	  a	  key	  link	  between	  APS	  and	  the	  iron-­‐sulfur	  cluster	  [18].	  	  Mössbauer	  analyses	  of	  native	  MtAPR	  
confirmed	   the	   presence	   of	   a	   [4Fe-­‐4S]2+	   cluster,	   however,	   no	   change	   was	   observed	   in	   the	  
Mössbauer	   spectra	   of	   MtAPR	   comparing	   samples	   with	   and	   without	   substrate-­‐binding.	  	  
Spectroscopic	  data	  taken	  together	  with	  known	  structural	  and	  functional	   information,	   implicate	  
the	  iron-­‐sulfur	  cluster	  in	  the	  catalytic	  mechanism	  of	  APS	  reduction.	  
	  
The	  goal	  of	  this	  study	  is	  to	  determine	  high-­‐resolution	  geometric	  and	  electronic	  structures	  of	  the	  
[4Fe-­‐4S]	  cluster	   in	  APR.	   	  Although	  the	  crystal	  structure	  of	  PaAPR	  is	  a	  significant	  advance	  in	  the	  
characterization	   of	   this	   enzyme,	   the	   resolution	   of	   the	   structure	   (2.7	   Å)	   is	   close	   to	   the	   Fe-­‐Fe	  
distance	  within	  a	  [4Fe-­‐4S]	  cluster	  [19],	  placing	  a	  significant	  limit	  on	  the	  structural	  features	  that	  
can	  be	   visualized	   in	   electron	  density	  maps	   calculated	  using	   the	   X-­‐ray	   data.	   	  Given	   the	  unique	  
coordination	  of	  the	  [4Fe-­‐4S]	  cluster	  by	  two	  consecutive	  cysteines,	  it	  is	  important	  to	  obtain	  direct	  
confirmation	   of	   the	   apparent	   structure.	   	   In	   particular,	   the	   X-­‐ray	   structure	   shows	   that	   torsion	  
angles	  of	  the	  Cys139	  and	  Cys140	  side	  chains	  are	  significantly	  strained,	  which	  could	  affect	  details	  
of	  Fe-­‐Fe	  and	  Fe-­‐S-­‐(Sγ)	  distances	  in	  various	  states	  of	  the	  catalytic	  cycle	  [13].	  	  EPR	  studies	  on	  one-­‐
electron	  reduced	  MtAPR	  demonstrate	  mid-­‐range	  electrostatic	  interactions	  involving	  the	  cluster,	  
Lys144	  and	  the	  substrate	   that	   implicate	   the	  cluster	   in	  catalysis	   [18].	   	  However,	  changes	   in	   the	  
geometric	  and	  electronic	  structure	  of	  the	  cluster	  during	  catalysis	  have	  not	  been	  determined	  by	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any	   structure	   determination	   technique.	   	   Determining	   these	   high-­‐resolution	   structures	   will	  
ultimately	  further	  our	  understanding	  of	  the	  role	  of	  the	  iron-­‐sulfur	  cluster	  in	  APS	  reduction.	  
	  
The	  work	  described	  here	  combines	  Fe	  K-­‐edge	  
x-­‐ray	   absorption	   spectroscopy	   investigations	  
(both	   extended	   X-­‐ray	   absorption	   fine	  
structure,	   EXAFS,	   and	   X-­‐ray	   absorption	   near-­‐
edge	   structure,	   XANES)	   with	   density	  
functional	   theory	   (DFT)	   calculations	   to	  
determine	  the	   local	  geometric	  structure,	  spin	  
states,	   electrostatic	   potential	   charges,	   and	  
57Fe	   Mössbauer	   properties	   of	   the	   [4Fe-­‐4S]	  
cluster	  of	  APR.	  	  	  XANES	  data	  confirms	  that	  the	  
cluster	   is	   in	   the	   [4Fe-­‐4S]2+	   state	   in	   native	  
MtAPR	   (Figure	   4.3a)	   and	   that	   there	   is	   no	  
detectable	   change	   in	   structure	   when	   APS	  
binds.	   	   	   EXAFS	   data	   recorded	   at	   ~0.1	   Å	  
resolution	   (k	   =	   17	  Å-­‐1)	   (Figure	   4.3b)	   indicates	  
that	   there	   is	  no	  significant	  change	   in	   the	  average	  Fe-­‐S	  and	  Fe-­‐Fe	  bond	   lengths	  of	   the	   [4Fe-­‐4S]	  
cluster	  between	   the	  native	   and	   substrate-­‐bound	   forms	  of	   the	  protein	   (see	  Appendix	   4.9.2	   for	  
comparison	   spectra).	   	   Since	   the	  EXAFS	   structure	   reflects	   the	  average	  over	  all	   four	   irons	   in	   the	  
cluster,	  it	  is	  insensitive	  to	  changes	  at	  individual	  sites	  (e.g.,	  a	  decrease	  in	  one	  Fe-­‐Fe	  distance	  that	  
is	   compensated	   by	   an	   increase	   in	   a	   second	   Fe-­‐Fe	   distance).	   	   To	   explore	   these	   changes,	   DFT	  
calculations	  starting	  from	  the	  experimental	  X-­‐ray	  structure	  of	  PaAPR	  [13]	  were	  used	  to	  provide	  
	  
Figure	   4.3	   XAS	   analysis	   of	  MtAPR.	   	   a.	   	   Iron	  K-­‐
edge	  XANES	  spectrum.	   	  b.	   	  k3	  weighted	  EXAFS	  
(inset)	  and	  Fourier	  transform	  calculated	  over	  a	  
range	  of	  k	  =	  2.35	  ~	  17	  Å-­‐1.	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insight	  into	  the	  subtle	  changes	  within	  the	  geometric	  and	  electronic	  structure	  of	  the	  cluster	  and	  
how	  they	  relate	  to	  the	  role	  of	  the	  [4Fe-­‐4S]	  cluster	  in	  the	  mechanism	  of	  APS	  reduction.	  
	  
4.3	  Quantum	  Cluster	  Models	  for	  DFT	  Calculations	  
4.3.1	   	   Wild-­‐Type	   Models	   with	   and	  
without	  Substrate.	  	  The	  initial	  geometries	  
for	  DFT	  calculations	  of	   the	  wild	   type	  APR	  
active	   site	   models	   including	   the	   [4Fe-­‐4S]	  
cluster	  were	   taken	   from	  the	  X-­‐ray	  crystal	  
structure	   (2GOY.pdb,	  2.7	  Å	   resolution)	  of	  
PaAPR	   [13].	   PaAPR	   was	   serendipitously	  
crystallized	  such	  that	  density	  for	  APS	  was	  
observed	   in	   two	   of	   the	   four	   monomeric	  
subunits.	  	  Thus	  the	  differentially	  occupied	  
subunits	   could	   be	   used	   to	   compare	   the	  
geometry	  and	  electronic	  structure	  of	  the	  [4Fe-­‐4S]	  cluster	  in	  the	  free	  and	  substrate-­‐bound	  forms	  
of	   the	  protein.	   	   The	   cluster	  without	  APS	  was	   taken	   from	   subunit	   A	   (or	   chain-­‐A)	   of	   the	   crystal	  
structure	   (Figure	   4.4).	   	   A	   closer	   look	   at	   the	   [4Fe-­‐4S-­‐4Cys]	   center	   is	   shown	   in	   Figure	   4.5.	   	   The	  
quantum	   cluster	   of	   the	   active	   site	   with	   APS	   was	   taken	   from	   chain-­‐B	   of	   the	   crystal	   structure	  
(Figure	  4.6).	  	  The	  main	  or	  side	  chains	  of	  Cys139,	  Cys140,	  Cys228,	  Cys231,	  Thr87,	  His136,	  Arg143,	  
Lys144,	  Arg242,	  Arg245,	   and	  Trp246	  were	  also	   included	   in	   the	  quantum	  models.	   	   To	   facilitate	  
calculations	  by	  minimizing	  the	  number	  of	  atoms	  in	  the	  model,	  some	  changes	  were	  made	  to	  the	  
residues,	  including	  cleavage	  of	  certain	  bonds,	  addition	  of	  link-­‐H	  atoms	  [20]	  and	  partial	  inclusion	  
of	  neighboring	  residues	  to	  have	  closed	  valence.	  	  Explicitly,	  for	  Thr87,	  Cys139,	  His136	  and	  Cys228,	  
	  
Figure	   4.4	   DFT	   optimized	   quantum	   cluster	  model	   of	  
the	   [4Fe-­‐4S]	   center	   in	   APR	   without	   APS.	   Initial	  
geometry	  was	  taken	  from	  chain-­‐A	  of	  the	  X-­‐ray	  crystal	  
structure	  (PDB	  code:	  2GOY)	  (Chartron,	  2006).	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  Cα-­‐NH	   was	   replaced	   with	   Cα-­‐H.	   	   Since	   the	  
electron	   density	   map	   shows	   δ+	   density	   on	  
His136,	  the	  His136	  side	  chain	  was	  protonated	  
in	  our	  calculations.	  	  For	  Gly88,	  Gly137,	  Gly141,	  
and	   Glu229,	   HN-­‐Cα	   was	   included	   into	   the	  
quantum	   cluster	   and	  Cα	  was	   replaced	  with	  H.	  	  
For	   Ile142	   and	   Pro230,	   Cα-­‐C=O	   was	   included	   in	   the	   cluster	   and	   Cα	   was	   replaced	   with	   H.	   	   For	  
Lys144	  and	  Thr232,	  Cα-­‐C=O	  was	  replaced	  with	  Cα-­‐H.	   	  For	  Arg242	  and	  Arg245,	  Cγ-­‐Cβ	  was	  replaced	  
with	  Cγ-­‐H.	  	  Finally	  for	  Trp246,	  HN-­‐Cα-­‐C=O	  was	  replaced	  with	  H-­‐Cα-­‐H.	  	  	  
	  
	  
Figure	  4.6	  DFT	  optimized	  quantum	  cluster	  model	  of	  the	  [4Fe-­‐4S]	  center	   in	  APR	  
with	  APS.	  Initial	  geometry	  was	  taken	  from	  chain-­‐B	  of	  the	  X-­‐ray	  crystal	  structure	  
(PDB	  code:	  2GOY)	  (Chartron,	  2006).	  
	  
Figure	   4.5	   A	   closer	   look	   of	   the	   [4Fe-­‐4S]	   center	  




The	  following	  three	  H-­‐bonds	  are	  found	  in	  the	  crystal	  structure	  between	  the	  inorganic	  S’s	  and	  Sγ’s	  
of	   the	   [4Fe-­‐4S-­‐4Cys]	   cluster	   and	   the	   protein	   residues	   in	   both	   chain-­‐A	   and	   chain-­‐B:	   S3·∙·∙·∙HNε1-­‐
Trp246,	  Cys139-­‐Sγ·∙·∙·∙HNε-­‐Arg143,	  and	  Cys228-­‐Sγ·∙·∙·∙HOγ1-­‐Thr87.	  	  In	  chain-­‐B	  where	  APS	  is	  bound,	  the	  
side	  chain	  of	  Lys144	  H-­‐bonds	  with	  both	  Sγ-­‐Cys140	  and	  O	  from	  the	  sulfate	  group	  of	  APS.	  	  Model	  
cluster	  for	  chain-­‐A	  (Figure	  4.4)	  has	  eleven	  H-­‐bonds	  and	  a	  total	  of	  211	  atoms.	  	  By	  contrast,	  model	  
cluster	   for	  chain-­‐B	   (Figure	  4.6)	  has	  eighteen	  H-­‐bonds	   (of	  which,	  7	   involve	  the	  substrate)	  and	  a	  
total	   of	   250	   atoms.	   	  Without	   APS,	   the	   Arg242	   side	   chain	   H-­‐bonds	   with	   the	  main	   chain	   -­‐C=O	  
group	  of	  Arg245	  (chain-­‐A,	  Figure	  4.4).	  	  In	  the	  presence	  of	  APS,	  Arg242	  rotates	  to	  form	  H-­‐bonds	  
with	  the	  phosphate	  and	  sulfate	  groups	  of	  APS.	   	  Arg245	  also	  H-­‐bonds	  with	  APS	  (chain-­‐B,	  Figure	  
4.6).	  
	  
4.3.2	   	   No-­‐Tandem	   Models.	   	   	   Since	  
coordination	   by	   sequential	   cysteines	  
in	  PaAPR	  is	  highly	  unusual	  for	  [4Fe-­‐4S]	  
clusters,	   it	   is	   valuable	   to	   determine	  
what	   changes	   would	   occur	   in	   the	  
geometric	  and	  electronic	  structure	  of	  
the	   cluster	   if	   we	   break	   the	   linkage	  
between	  Cys139	  and	  Cys140.	  	  For	  this	  
purpose,	   two	   “no-­‐tandem”	  
computational	   models	   were	  
constructed	   by	   breaking	   the	   HN-­‐CO	  
peptide	   bond	   between	   Cys139	   and	  
Cys140	   in	  both	  chain-­‐A	  (without	  APS)	  
	  
Figure	   4.7	   The	   no-­‐tandem	   model	   cluster.	   	   The	   HN-­‐CO	  
peptide	   bond	   between	   Cys139	   and	   Cys140	   was	   cut	   in	  
order	  to	  study	  the	  “no-­‐tandem”	  structures	  in	  both	  chain-­‐
A	  (without	  substrate)	  and	  chain-­‐B	  (with	  substrate).	  The	  -­‐
CO	   group	   of	   Cys139	   was	   replaced	   by	   hydrogen,	  
meanwhile	   hydrogen	   was	   added	   to	   the	   -­‐NH	   group	   of	  
Cys140	  to	  fill	  the	  open	  valence.	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and	   chain-­‐B	   (with	  APS).	   	   The	   –C=O	  group	  of	   Cys139	  was	   replaced	  by	   a	   hydrogen	   (Figure	   4.7),	  
meanwhile	  a	  hydrogen	  was	  added	  to	  the	  –NH	  group	  of	  Cys140	  to	  fill	  the	  open	  valence.	   	   In	  the	  
absence	   of	   the	   peptide	   bond,	   the	   number	   of	   atoms	   in	   each	   of	   the	  model	   clusters	   remained	  
constant.	  
	  
4.3.3	   	   K144A	   Models.	   	   As	   previously	   mentioned,	   there	   is	   biochemical	   and	   spectroscopic	  
evidence	  to	  show	  that	   the	  stability	  and	  microenvironment	  of	   the	  cluster	   in	  APR	  changes	  upon	  
substrate	  binding	  [4,16,21].	  	  This	  indicates	  that	  APS	  does	  interact	  with	  the	  [4Fe-­‐4S]	  cluster,	  not	  
by	  direct	  contact,	  but	  via	  a	  network	  of	  electrostatic	  interactions.	  	  Lys144,	  Arg242,	  and	  Arg245	  all	  
have	   H-­‐bonding	   interactions	   with	   APS,	   of	   which	   Lys144	   is	   positioned	   between	   the	   [4Fe-­‐4S]	  
cluster	  and	  APS.	  	  Therefore	  we	  constructed	  the	  K144A	  models	  (for	  both	  chain-­‐A	  and	  chain-­‐B)	  by	  
replacing	  Lys144	  with	  Ala	  in	  order	  to	  investigate	  changes	  in	  the	  properties	  of	  the	  [4Fe-­‐4S]	  cluster	  
without	   Lys144.	   	   Explicitly,	   the	  Cβ-­‐Cγ	   bond	  of	   Lys144	  was	   cut	   and	   a	  proton	  was	   added	   to	  Cβ	   to	  
close	   valence,	   resulting	   in	   a	   total	   of	   199	   and	   238	   atoms	   in	   the	   chain-­‐A	   and	   chain-­‐B	   models	  
respectively.	  	  	  
	  
4.4	  	  Computational	  Methodology	  
All	   density	   functional	   spin-­‐unrestricted	   calculations	   were	   performed	   using	   the	   Amsterdam	  
Density	  Functional	  (ADF)	  package	  [22-­‐24]	  with	  the	  OLYP	  functional.	  	  OLYP	  is	  the	  combination	  of	  
Handy’s	   optimized	   exchange	   (OPTX)	   [25]	   and	   LYP	   correlation	   [26].	   	   Swart	   et	   al.	   	   have	   tested	  
different	   functionals	   in	   calculating	   the	   atomization	   energies	   for	   the	   G2-­‐set	   of	   up	   to	   148	  
molecules,	  six	  reaction	  barriers	  of	  SN2	  reactions,	  geometry	  optimizations	  of	  19	  small	  molecules	  
and	   4	   metallocenes,	   and	   zero-­‐point	   vibrational	   energies	   for	   13	   small	   molecules	   [27].	   	   Their	  
examination	   shows	   that	   the	   OPTX	   containing	   functionals	   perform	   better	   than	   the	   regular	  
general	   gradient	   approximation	   functionals	   (GGAs)	   like	  PBE	   [28,29],	  BLYP	   [26,30],	   and	  BP	   [30-­‐
32].	   For	   organic	   systems,	   OLYP	   has	   been	   shown	   to	   function	   as	   well	   as	   the	   hybrid	   functional	  
B3LYP	   [27,33].	   	   Recently,	   Hopmann	   et	   al.	   	   reported	   that	   for	   57Fe	   Mössbauer	   isomer	   shift	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calculations,	   the	   OLYP	   potential	   performs	   comparably	   well	   for	   iron	   nitrosyls	   and	   for	   iron	  
complexes	  in	  general	  [34].	  
	  
The	  resting	  state	  of	  the	  [4Fe-­‐4S]	  core	  in	  APR	  has	  +2	  charge,	  [Fe4S4]2+.	  	  The	  core	  plus	  the	  four	  Cys	  
side	  chains	  has	  a	  net	  charge	  of	  -­‐2,	  [Fe4S4(Sγ-­‐Cys)4]2-­‐.	   	  Therefore	  each	  of	  the	  four	  equivalent	  iron	  
sites	  has	  a	  2.5+	  oxidation	  state	  [19,35].	  	  The	  antiferromagnetically	  (AF)	  coupled	  Stotal	  =	  0	  ground	  
state	  requires	  two	  mixed	  valence	  iron	  pairs	  with	  opposite	  spins.	   	  The	  combinations	  of	  the	  spin	  
states	   can	   be:	   {Fe1↓Fe2↓Fe3↑Fe4↑},	   {Fe1↑Fe2↓Fe3↓Fe4↑},	   and	   {Fe1↑Fe2↓Fe3↑Fe4↓},	   where	   “↑”	   and	   “↓”	  
represent	  spin	  up	  and	  down,	  respectively.	  	  As	  in	  previous	  work,	  we	  perform	  “broken-­‐symmetry”	  
(BS)42-­‐44	   calculations	   to	   represent	   the	   AF-­‐coupled	   spin	   states.	   	   First	   we	   construct	   a	  
ferromagnetically	  (F)	  spin-­‐coupled	  (Stotal	  =	  18/2)	  determinant,	  where	  the	  spins	  on	  the	  four	  irons	  
are	  aligned	  in	  a	  parallel	  fashion.	  	  Then	  we	  rotate	  the	  spin	  vector	  located	  on	  two	  of	  the	  iron	  sites	  
by	   interchanging	   the	  α	   and	  β	   fit	   density	   blocks	   on	   the	   two	   sites	   from	   the	   output	   file	   TAPE21	  
created	  by	  this	  F-­‐coupled	  calculation	  in	  ADF	  to	  get	  the	  starting	  spin	  density	  for	  the	  Stotal	  =	  0	  state.	  	  
These	   BS	   states	   are	   not	   pure	   Stotal	   =	   0	   states.	   	   Instead,	   these	   states	   (and	   their	   energies)	   are	  
weighted	  averages	  of	  the	  pure	  spin	  states,	  strongly	  weighted	  toward	  the	  lower	  Stotal	  states	  based	  
on	  the	  spin	  coupling	  algebra	  [19,35-­‐38].	  	  We	  have	  not	  included	  spin	  projection	  corrections	  in	  the	  
current	  work	   since	  we	  have	   estimated	   that	   these	  will	  make	   very	   small	   differences	   in	   the	  DFT	  
calculated	  relative	  energies	  of	  different	  states.	  	  	  
	  
4.4.1	  	  Geometry	  Optimization.	  	  To	  determine	  which	  one	  of	  the	  three	  spin	  states	  of	  the	  [4Fe-­‐4S]	  
cluster	  in	  APR	  has	  the	  lowest	  energy	  and	  is	  geometrically	  closest	  to	  the	  X-­‐ray	  crystal	  structure,	  
we	  geometry	  optimized	  the	  active	  site	  clusters	  taken	  from	  chain-­‐A	  (without	  substrate	  binding)	  
and	   chain-­‐B	   (with	   substrate	   binding)	   in	   the	   {Fe1↓Fe2↓Fe3↑Fe4↑},	   {Fe1↑Fe2↓Fe3↓Fe4↑},	   and	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{Fe1↑Fe2↓Fe3↑Fe4↓}	   three	  BS	  spin	  states.	   	  All	  calculations	  were	  performed	  within	  the	  conductor-­‐
like	  screening	  (COSMO)	  [39-­‐42]	  solvation	  model	  with	  dielectric	  constant	  ε	  =	  20.	  	  In	  COSMO,	  the	  
quantum	   cluster	   is	   embedded	   in	   a	   molecular	   shaped	   cavity	   surrounded	   by	   a	   continuum	  
dielectric	   medium.	   	   There	   is	   no	   universal	   dielectric	   constant	   for	   COSMO-­‐like	   solvation	  
calculations.	  	  Although	  the	  dielectric	  value	  ε	  =	  4	  is	  commonly	  used	  for	  the	  protein	  interior,	  since	  
this	   is	   the	   value	   for	   the	   dielectric	   constants	   of	   crystalline	   and	   polymeric	   amides	   [43]	   and	   dry	  
protein	   and	   peptide	   powders	   [44-­‐47],	   many	   studies	   show	   that	   higher	   effective	   dielectric	  
constant	  values	  (4-­‐30)	  for	  protein	  interiors	  are	  needed	  in	  reproducing	  the	  pKa	  values	  of	  certain	  
internal	   ionizable	  groups	   [47-­‐54].	  For	   the	  current	  study,	  since	  many	  charged	  groups	  are	   in	   the	  
quantum	  cluster,	  a	   larger	  dielectric	   constant	   (ε	   =	  20)	  was	  chosen	   for	   the	  COSMO	  calculations.	  	  
The	  van	  der	  Waals	  radii	   for	  atoms	  Fe,	  C,	  S,	  P,	  O,	  N,	  and	  H	  were	  taken	  as	  1.5,	  1.7,	  1.8,	  1.8,	  1.4,	  
1.55,	   and	   1.2	   Å,	   respectively	   [55,56].	   The	   probe	   radius	   for	   the	   contact	   surface	   between	   the	  
cluster	  and	   solvent	  was	   set	   to	  2.0	  Å.	   	   The	   triple-­‐z	   (TZP)	   (for	  Fe	  and	  S)	  and	  double-­‐z	   (DZP)	   (for	  
other	   atoms)	   polarization	   Slater-­‐type	   basis	   sets	   with	   frozen	   cores	   (C(1s),	   N(1s),	   O(1s),	  
S(1s,2s,2p),	  P(1s,2s,2p),	  and	  Fe(1s,2s,2p)	  are	   frozen)	  were	  applied	   for	  geometry	  optimizations.	  	  
To	  partially	  apply	  the	  strain	  from	  the	  protein	  environment,	  Cα	  atoms	  on	  Lys144,	  Thr232,	  Arg245,	  
and	  Trp246,	  Cγ	  of	  Arg242,	  and	  the	  link-­‐H	  atoms	  on	  Thr87,	  Gly88,	  His136,	  Gly137,	  Cys139,	  Gly141,	  
Ile142,	  Lys144,	  Cys228,	  Glu229,	  Pro230,	  Thr232,	  Arg242,	  Arg245,	  and	  Trp246,	  were	  fixed	  during	  
geometry	  optimizations.	  	  The	  broken-­‐symmetry	  state	  energies	  obtained	  after	  COSMO	  geometry	  
optimizations	  were	  used	  to	  compare	  the	  relative	  energies	  in	  Section	  6.	  
	  
4.4.2	   	   Mössbauer	   Isomer	   Shift	   and	   Quadrupole	   Splitting	   Calculations.	   	   For	   all	   models,	   we	  
applied	   single-­‐point	   Mössbauer	   isomer	   shift	   and	   quadruple	   splitting	   calculations	   at	   the	  
optimized	  geometries	  using	  all-­‐electron	  (i.e.	  without	  frozen	  core	  approximation)	  all	  TZP	  Slater-­‐
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type	  basis	  sets.	  	  First,	  a	  high-­‐spin	  F-­‐coupled	  single-­‐point	  energy	  calculation	  was	  performed	  at	  the	  
BS	  optimized	  geometry.	   	   Its	  TAPE21	  file	  was	  then	  modified	  accordingly	  by	   interchanging	  the	  α	  
and	  β	  fit	  density	  blocks	  on	  two	  of	  the	  iron	  sites.	  	  Starting	  from	  the	  modified	  TAPE21,	  a	  BS	  state	  
single-­‐point	  energy	  calculation	  in	  COSMO	  again	  with	  all-­‐electron	  TZP	  Slater-­‐type	  basis	  sets	  was	  
performed	   to	  obtain	   the	  electron	  density	   (ρ(0))	   and	   the	  electric	   field	  gradient	   (EFG)	  at	   the	  Fe	  
nucleus.	  
The	  Mössbauer	  isomer	  shifts	  d	  were	  calculated	  based	  on	  ρ(0):	  
	  	  	  	  	  	  	  	  	  	  	  	  δ	  =	  α(ρ(0)	  -­‐	  A)	  +	  C	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (1)	  
where	  A	  =	  11877	  is	  a	  constant.	  	  Our	  previous	  isomer	  shift	  fit	  based	  on	  19	  Fe2.5+,3+,3.5+,4+	  complexes	  
(30	  distinct	  iron	  sites)	  using	  OLYP/all-­‐electron-­‐TZP	  method	  (with	  INTEGRATION	  =	  4.0)	  yielded:	  a	  
=	   -­‐0.307	   and	   C	   =	   0.385	   mm	   s-­‐1	   [57].	   	   The	   numerical	   integration	   accuracy	   parameter	  
INTEGRATION	  =	  4.0	  is	  also	  used	  for	  the	  current	  calculations.	  
	  
For	  calculating	  the	  Mössbauer	  quadrupole	  splittings	  (ΔEQ),	  the	  EFG	  tensors	  V	  were	  diagonalized	  
and	  the	  eigenvalues	  were	  reordered	  so	  that	  |Vzz|	  ≥	  |Vxx|	  ≥	  |Vyy|.	  	  The	  asymmetry	  parameter	  η	  is	  
defined	  as	  
	  	  	  	  	  	  	  	  η	  =	  |(Vxx	  -­‐	  Vyy)/Vzz|	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (2)	  
Then	  the	  ΔEQ	  for	  57Fe	  of	  the	  nuclear	  excited	  state	  (I	  =	  3/2)	  can	  be	  calculated	  as	  
	  	  	  	  	  	  	  ΔEQ	  =	  (½)eQVzz(1	  +	  η2/3)½	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (3)	  
where	  e	   is	   the	  electrical	  charge	  of	  a	  positive	  electron,	  Q	   is	   the	  nuclear	  quadrupole	  moment	  of	  
Fe.	   	  We	   had	   used	  eQ	   =	   0.15	   electron-­‐barn	   [58]	   in	   our	   previous	   publications.	   	   For	   the	   current	  
study,	  we	  applied	  a	  slightly	  different	  eQ	  =	  0.158	  electron-­‐barn	  taken	  from	  the	  careful	  quantum	  
chemical	  calculations	  (non-­‐relativistic)	  by	  Neese’s	  group	  [59].	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4.4.3	  	  Fitting	  Atomic	  Charges	  from	  Electrostatic	  Potentials	  (ESP).	  	  A	  modified	  version	  of	  CHELPG	  
code	  [35,60]	  was	  used	  to	  fit	  the	  atomic	  point	  charges	  from	  the	  molecular	  electrostatic	  potentials	  
(ESP)	  obtained	  from	  the	  final	  all-­‐electron	  all-­‐TZP	  single-­‐point	  energy	  calculations.	   	  The	  singular	  
value	   decomposition	   (SVD)	   method	   [35]	   was	   introduced	   into	   the	   code	   to	   minimize	   the	  
uncertainties	   in	   the	   fitting	   procedure.	   	   The	   total	   net	   charge	   and	   the	   three	   Cartesian	   dipole	  
moment	  components	  of	  each	  cluster	  were	  used	  as	  constraint	  conditions	  for	  the	  fit.	   	  The	  fitted	  
points	  lay	  on	  a	  cubic	  grid	  between	  the	  van	  der	  Waals	  radius	  and	  the	  outer	  atomic	  radius	  with	  a	  
grid	   spacing	   of	   0.2	   Å.	   	   The	   outer	   atomic	   radius	   (5.0	   Å	   here	   for	   all	   atoms)	   defines	   the	   outer	  
boundary	  of	   the	  electrostatic	  potential	   that	  was	  used	   in	   the	  charge	   fitting.	   	  The	  same	  van	  der	  
Waals	  radii	  were	  used	  as	  in	  COSMO	  calculations.	  
	  
4.5	  	  X-­‐ray	  Absorption	  Spectroscopy	  (XAS)	  Results	  and	  Discussion	  
To	  probe	  the	  coordination	  and	  geometry	  of	  the	  [4Fe-­‐4S]	  cluster	  in	  APR	  we	  examined	  MtAPR	  by	  
XAS.	   	  To	   facilitate	  EXAFS	  analyses,	  monomeric	  MtAPR	  was	  used	   instead	  of	  PaAPR	  since	  PaAPR	  
purifies	   as	   a	   tetramer.	   	   In	   order	   to	   determine	   the	   effect	   of	   APS	   binding	   on	   Fe-­‐site	   structure,	  
MtAPR	  was	  incubated	  with	  a	  3-­‐fold	  stoichiometric	  excess	  of	  APS,	  at	  a	  concentration	  exceeding	  
the	  kd	  of	  APS	  and	  AMP	  (0.2	  µM	  and	  5.4	  µM	  respectively	  [9]).	  	  Therefore,	  the	  form	  of	  MtAPR	  in	  
EXAFS	  experiments	  was	  the	  S-­‐sulfocysteine	  state	  with	  AMP	  bound	  and	  the	  C-­‐terminal	  docked	  in	  
the	  active	   site	   (closed	   state).	   	  By	   contrast,	   for	   crystallization	  of	  PaAPR,	  ~60-­‐fold	  excess	  of	  APS	  
over	  enzyme	  was	  added	  and	   the	  stable	   form	  that	  crystallized	  was	   formed	  with	   the	  C-­‐terminal	  
tail	  out	  of	  the	  active	  site	  (open	  state)	  (see	  Figure	  4.6c	  in	  ref	  [13])	  
	  
4.5.1	  	  Fe	  K-­‐Edge	  XAS.	  	  The	  normalized	  Fe	  K-­‐edge	  XANES	  spectrum	  of	  APR	  is	  shown	  in	  Figure	  4.3.	  	  
This	  region	  of	  the	  XAS	  spectra	  (1s	  →	  3d	  transitions)	  provides	  valuable	  information	  about	  metal	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ion	  coordination	  number	  and	  oxidation	  state	  [61].	  The	  Fe	  pre-­‐edge	  area	  calculated	  for	  APR	  (~18	  
×	   10-­‐2	   eV)	   is	   consistent	   with	   a	   four-­‐coordinate	   Fe	   species.	   	   This	   conclusion	   is	   supported	   by	  
Mössbauer	  studies	  for	  native	  MtAPR	  which	  confirm	  the	  presence	  of	  a	  [4Fe-­‐4S]2+	  cluster	  [18].	  The	  
pre-­‐edge	   feature	   observed	   at	   	   ~7112	   eV	   occurs	   due	   to	   an	   electronic	   dipole-­‐forbidden	  
quadrupole-­‐allowed	   transition	   from	  the	  Fe	  1s	  orbital	   to	  valence	  orbitals	  with	   significant	  Fe	  3d	  
character	   [61,62].	   	   The	   increase	   in	   intensity	   of	   this	   formally	   forbidden	   transition	   is	   a	   result	   of	  
mixing	  of	  Fe	  4p-­‐3d	  orbitals	  caused	  by	  deviation	  of	  the	  absorbing	  Fe	  center	  from	  centrosymmetry	  
[63].	  To	   investigate	  changes	   in	  cluster	  geometry	  and	  coordination	  during	  catalysis,	  MtAPR	  was	  
incubated	  with	  APS	  to	  form	  the	  S-­‐sulfocysteine	  intermediate	  with	  AMP	  bound	  in	  the	  active	  site	  
and	  XAS	  was	  recorded	  for	  this	  stable	  conformation	  of	   the	  enzyme	  (Table	  4.1,	  Appendix	  4.9.2).	  	  
No	   shift	   in	   position	   or	   intensity	   of	   the	   pre-­‐edge	   energy	   was	   observed	   for	   the	   MtAPR	   S-­‐
sulfocysteine	   intermediate,	   indicating	   that	   the	   level	  of	  4p	  mixing	   is	   identical	   to	  native	  MtAPR.	  	  
Since	   the	   1s	  →	   3d	   transition	   is	   very	   sensitive	   to	   local	   Fe-­‐site	   structure,	   this	   is	   a	   sensitive	  
indication	  that	  not	  only	  is	  there	  no	  change	  in	  oxidation	  state	  or	  coordination	  number,	  but	  there	  
is	   unlikely	   to	   be	  more	   than	   a	   very	   small	   change	   in	   geometry	   of	   the	   Fe	   in	   the	   [4Fe-­‐4S]	   cluster	  
between	  the	  native	  and	  S-­‐sulfocysteine	  intermediate	  forms	  of	  MtAPR.	  
	  
4.5.2	  	  EXAFS.	  	  The	  EXAFS	  data	  for	  MtAPR,	  reported	  at	  high-­‐resolution	  to	  k	  ~	  17	  Å-­‐1	  was	  shown	  in	  
Figure	  4.3	  (inset).	  	  .	  	  The	  pattern	  in	  the	  data	  reflects	  the	  fact	  that	  there	  are	  at	  least	  two	  shells	  of	  
scatterers,	   sulfur	   and	   iron,	   significantly	   contributing	   to	   the	   EXAFS	   spectrum.	   	   The	   Fourier	  
transform	  (FT)	  of	  MtAPR	   (Figure	  4.3,	  Table	  4.1)	   shows	  an	   intense	   first-­‐shell	  Fe-­‐S	   interaction	  at	  
2.3	   Å	   and	   a	   slightly	   less	   intense	   second-­‐shell	   Fe-­‐Fe	   interaction	   at	   2.73	   Å.	   	   For	   this	   k	   range,	  
resolution	   in	  R	   space	   is	  ~0.1	  Å,	  meaning	  that	   if	   the	  Fe-­‐Fe	  or	  Fe-­‐S	  distances	  differed	  by	  >	  0.1	  Å	  
they	  should,	  in	  principle,	  be	  resolvable,	  and	  that	  if	  the	  distances	  differ	  by	  >	  ~0.12	  Å	  they	  should	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be	  readily	  resolvable	  into	  two	  different	  shells	  of	  scatterers	  (Two	  Fe-­‐Fe	  distances	  that	  differed	  by	  
0.12	  Å	  would	  show	  a	  “beat”	  in	  the	  EXAFS	  at	  ~k	  =	  13	  Å-­‐1	  which	  would	  be	  readily	  detectable).	  	  No	  
improvement	  was	  seen	  for	  multiple	  shell	  fits.	  	  
Table	  4.1	  Extended	  x-­‐ray	  absorption	  fine	  structure	  (EXAFS)	  curve-­‐fitting	  parameters	  for	  Fe	  K-­‐edgea	  
	  
Sample	   Interaction	   N	   R	  (Å)	   σ2	  × 	  103	   F	  
MtAPR	   Fe-­‐S	   4*	   2.297	   3.9	   1.93	  
sample	  1	   Fe-­‐Fe	   3*	   2.726	   2.4	   	  
	   Fe-­‐S	   3.9	   2.297	   3.8	   1.92	  
	   Fe-­‐Fe	   2.1	   2.726	   2.7	   	  
MtAPR	   Fe-­‐S	   4*	   2.294	   3.9	   1.92	  
sample	  2	   Fe-­‐Fe	   3*	   2.729	   2.0	   	  
	   Fe-­‐S	   3.7	   2.294	   3.4	   1.86	  
	   Fe-­‐Fe	   1.7	   2.729	   1.3	   	  
MtAPR	  +	  APS	  b	   Fe-­‐S	   4*	   2.298	   3.9	   1.28	  
sample	  1	   Fe-­‐Fe	   3*	   2.728	   2.2	   	  
	   Fe-­‐S	   3.8	   2.298	   3.6	   0.93	  
	   Fe-­‐Fe	   2.0	   2.728	   2.2	   	  
MtAPR	  +	  APS	  b	   Fe-­‐S	   4*	   2.297	   3.8	   1.48	  
sample	  2	   Fe-­‐Fe	   3*	   2.730	   2.5	   	  
	   Fe-­‐S	   3.6	   2.297	   3.4	   1.44	  
	   Fe-­‐Fe	   1.8	   2.730	   2.0	   	  
aCoordination	   Number	   (N),	   Interatomic	   Distances	   (R),	   Mean-­‐Square	   Deviations	   in	   Interatomic	  
Distance	  (σ2,	  Å2),	  Fit-­‐Error	  Function	  (F)	  is	  Defined	  as	  <{Σk6	  (χcalc*	  –	  χexpt)
2	  /	  Σχ2expt}
1/2>.	  For	  MtAPR	  
the	  k	   Range	  was	  2.35	  ~	  17	   (Filtered	  R	  =	  1.2	  ~	  3);	   for	  MtAPR	  +	  APS	   the	  k	   Range	  was	  2.15	  ~	  17	  
(Filtered	  R	  =	  1.2	  ~	  3);	  giving	  resolution	  ~	  0.	  1	  Å	  and	  ~17	  independent	  degrees	  of	  freedom.	  Fits	  are	  
shown	  both	   for	   fixed	   (marked	  with	  *)	  and	  variable	  N.	   	   bThe	  enzyme	  was	   in	   the	  S-­‐sulfocysteine	  
state	  with	  AMP	  bound	  and	  the	  C-­‐terminal	  docked	  in	  the	  active	  site.	  
	  
It	  is	  possible,	  of	  course,	  that	  there	  are	  not	  two,	  but	  up	  to	  six	  different	  Fe-­‐Fe	  distances	  (Note	  that	  
if	   there	  were	   significant	   disorder,	  with	  multiple	   forms	   of	   the	   Fe/S	   cluster,	   this	   could	   increase	  
further	   the	   number	   of	   Fe-­‐Fe	   distances.	   	   This	   is	   ruled	   out	   by	   the	   absence	   of	   disorder	   in	   the	  
Mössbauer	  spectra).	  	  In	  this	  case,	  individual	  Fe-­‐Fe	  distances	  might	  not	  be	  resolvable.	  	  However,	  
if	   this	   were	   the	   case,	   there	   would	   be	   an	   increase	   in	   the	   Debye-­‐Waller	   factor.	   	   However,	   the	  
observed	  Debye-­‐Waller	  factors	  are	  small,	  indicating	  that	  there	  is,	  at	  most	  a	  very	  small	  (<	  0.12	  Å)	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spread	  in	  Fe-­‐Fe	  distance,	  consistent	  with	  the	  spread	  in	  Fe-­‐Fe	  distances	  that	  is	  found	  in	  the	  DFT	  
calculations	  (Tables	  4.2	  and	  4.3).	  
	  
If	  the	  experimental	  Fe-­‐Fe	  σ2	  value	  of	  ~2.5×10-­‐3	  Å2	  is	  attributed	  solely	  to	  static	  disorder	  and	  if	  the	  
most	   asymmetric	   possible	   distribution	   of	   Fe-­‐Fe	   distances	   is	   assumed	   (i.e.,	   5	   short	   and	   1	   long	  
distance),	  the	  spread	  in	  Fe-­‐Fe	  distances	  is	  ~ 6 σ	  =	  0.12	  Å.	  	  	  A	  more	  reasonable	  estimate	  would	  
recognize	  that	  the	  experimental	  σ2	  is	  the	  sum	  of	  σ2vib	  and	  σ2static.	   	  The	  former	  can	  be	  estimated	  
from	  the	  fitted	  σ2	  value	  for	  Pyrococcus	  furiousus	  ferredoxin,	  2.0	  ×10-­‐3	  Å2.	  	  	  If	  this	  is	  attributed	  to	  
vibrational	  motion,	  the	  apparent	  σ2static	  is	  5.0	  ×10-­‐4	  Å2,	  suggesting	  a	  spread	  in	  Fe-­‐Fe	  distances	  of	  
~0.05	  Å.	  	   	  While	  the	  true	  spread	  in	  Fe-­‐Fe	  distances	  will	  depend	  on	  details	  of	  the	  distribution	  in	  
Fe-­‐Fe	  distances	  and	  the	  vibrational	  contribution	  to	  σ2,	  it	  should	  be	  between	  these	  limits.	  
	  
Coordination	  numbers	  were	   initially	  constrained	  to	  the	  chemically	  correct	  values	  (4	  Fe-­‐S	  and	  3	  
Fe-­‐Fe).	   	   	   These	   gave	   excellent	   fits.	   	   	   Modest	   improvement	   in	   fit	   quality	   was	   possible	   if	   the	  
coordination	  number	  was	  allowed	  to	  vary;	  this	  improvement	  is	  consistent	  with	  that	  expected	  for	  
a	  50%	  increase	  in	  variable	  parameters.	  	  	  To	  confirm	  that	  these	  data	  are	  consistent	  with	  a	  [4Fe-­‐
4S]	  cluster,	  we	  compared	  the	  EXAFS	  and	  FT	  of	  MtAPR	  with	  those	  previously	   reported	  data	   for	  
Pyrococcus	  furiosus	  ferredoxin	  containing	  either	  an	  [3Fe-­‐4S]	  cluster	  or	  a	  [4Fe-­‐4S]	  clusters	  (data	  
provided	  by	  Prof.	  G.N.	  George,	  University	  of	  Saskatoon).	   	  Appendix	  4.9.3	  unambiguously	  shows	  
that	   the	  EXAFS	   spectrum	   for	  MtAPR	   is	   in	   good	  agreement	  with	   the	   spectrum	   for	   the	   [4Fe-­‐4S]	  
cluster	   in	  ferredoxin,	  albeit	  with	  a	  slightly	   less	   intense	  Fe-­‐Fe	  peak,	  suggesting	  somewhat	   larger	  
disorder	  in	  the	  Fe-­‐Fe	  scattering	  in	  MtAPR,	  consistent	  with	  the	  fitting	  results.	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The	  EXAFS	  spectrum	  and	  FT	  of	  the	  MtAPR	  S-­‐sulfocysteine	  intermediate	  are	  identical	  to	  those	  of	  
native	   MtAPR,	   and	   the	   Fe-­‐S	   and	   Fe-­‐Fe	   bond	   lengths	   remain	   consistent	   (Table	   4.1,	   Appendix	  
4.9.2b	  and	  c).	   	  Although	  the	  accuracy	  of	  EXAFS	  bond-­‐lengths	   is	  generally	  taken	  as	  ~0.02	  Å,	  the	  
precision	  is	  much	  better.	  	  	  We	  have	  found	  previously	  that	  the	  precision	  of	  biological	  EXAFS	  data	  
is	   ~0.003	   Å2	   [64];	   this	   is	   reflected	   in	   the	   excellent	   reproducibility	   of	   the	   duplicate	   samples	   in	  
Table	   4.1.	   	   	   This	   precision,	   together	   with	   the	   invariance	   seen	   in	   Table	   4.1,	   indicates	   that	   the	  
average	   core	   structure	   of	   the	   [4Fe-­‐4S]	   cluster	   in	   MtAPR	   is	   unaffected	   in	   the	   S-­‐sulfocysteine	  
conformation	  of	  the	  protein.	  	  Since	  XAS	  spectra	  reflect	  bond-­‐lengths	  that	  are	  averaged	  over	  all	  
the	   atoms	   in	   the	   cluster,	   it	   is	   in	   principle	   possible	   that	   small	   changes	   at	   one	   site	   could	   be	  
compensated	   by	   equal	   but	   opposite	   changes	   at	   another	   site,	   such	   that	   the	   average	   distances	  
remain	   the	   same.	   	   To	   probe	   these	   changes	   at	   high	   resolution,	   density	   functional	   theory	  
calculations	  were	  undertaken.	  
	  
4.6	  	  DFT	  Calculation	  Results	  and	  Discussion	  
4.6.1	   Calculating	   Results	   for	   Wild-­‐Type	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   Models.	   	   The	   main	   calculated	  
properties	   for	   different	   spin	   states	   of	   the	   wild-­‐type	   [4Fe-­‐4S]	   cluster	   without	   and	   with	   the	  
substrate	  are	  given	  in	  Tables	  4.2	  and	  4.3,	  respectively.	  	  The	  calculated	  Fe-­‐Fe	  and	  Fe-­‐S	  distances	  
and	   57Fe	   Mössbauer	   isomer	   shifts	   and	   quadrupole	   splittings	   are	   compared	   with	   available	  
experimental	  results	  [18].	  	  
	  
As	   previously	   reported	   [19,35],	   each	   of	   the	   optimized	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   clusters	   has	   a	  
compression	  structure	  with	  four	  “short”	  (~2.2	  Å)	  and	  eight	  “long”	  (~2.3	  Å)	  Fe-­‐S	  distances.	   	  The	  
two	   irons	  with	   the	   same	  spin	  direction	  are	   in	  an	  Fe2S2	   rhomb	  distorted	  butterfly	   “plane”	  with	  
four	   “long”	   Fe-­‐S	   distances,	   and	   the	   four	   Fe-­‐S	   bonds	   between	   the	   two	   “planes”	   have	   “short”	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distances.	  	  Taking	  the	  {Fe1↓Fe2↓Fe3↑Fe4↑}	  state	  in	  Table	  4.2	  (without	  APS	  binding)	  as	  an	  example,	  
Fe1	  and	  Fe2	  (spin	  down)	  are	  on	  the	  plane	  containing	  Fe1-­‐S1-­‐Fe2-­‐S2,	  and	  Fe3	  and	  Fe4	  (spin	  up)	  
are	  on	  the	  plane	  with	  Fe3-­‐S3-­‐Fe4-­‐S4.	  	  As	  a	  result,	  the	  eight	  Fe-­‐S	  bond	  lengths	  on	  the	  two	  planes	  
are	  long	  (in	  average	  2.32	  Å),	  and	  the	  four	  Fe1-­‐S3,	  Fe2-­‐S4,	  Fe3-­‐S1,	  and	  Fe4-­‐S2	  bonds	  between	  the	  
two	  planes	  are	  shorter	  (in	  average	  2.23	  Å).	  	  Overall,	  the	  spread	  of	  the	  DFT	  calculated	  Fe-­‐S	  (2.20-­‐
2.34	  Å)	  and	  Fe-­‐Fe	  (2.65-­‐2.76	  Å)	  distances	  agree	  with	  the	  EXAFS’s	  results	  of	  ~2.3±0.1	  Å	  and	  ~2.7	  
±0.1	  Å,	  respectively.	   	  Since	  the	  PaAPR	  crystal	  structure	  was	  solved	  at	  2.7	  Å	  resolution	  [13],	  the	  
compression	   structure	   for	   the	   [4Fe-­‐4S]	   cluster	   is	   not	   obvious	   in	   either	   chain-­‐A	   (without	   APS	  
binding)	  or	  chain-­‐B	  (with	  APS	  binding).	  	  It	  is	  also	  not	  reliable	  to	  determine	  the	  spin	  state	  of	  the	  
cluster	  based	  on	  the	  comparison	  between	  the	  calculated	  geometries	  and	  the	  crystal	  structure.	  	  
Since	  the	  {Fe1↓Fe2↓Fe3↑Fe4↑}	  state	  yields	  the	  lowest	  broken-­‐symmetry	  energy	  in	  both	  chain-­‐A	  and	  
chain-­‐B,	   it	   is	   likely	   that	   the	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   cluster	   of	   PaAPR	   is	   in	   the	   {Fe1↓Fe2↓Fe3↑Fe4↑}	   state	  
before	  and	  after	  substrate	  binding.	  
	  
In	  the	  presence	  of	  APS,	  the	  calculated	  distances	  of	  Fe1-­‐Fe2	  and	  Fe3-­‐Fe4	  are	  increased	  by	  0.06	  Å;	  
the	  four	  “short”	  distances	  (Fe1-­‐S3,	  Fe2-­‐S4,	  Fe3-­‐S1,	  and	  Fe4-­‐S2)	  between	  the	  two	  planes	  “Fe1-­‐S1-­‐
Fe2-­‐S2”	  and	  “Fe3-­‐S3-­‐Fe4-­‐S4”	  are	  shortened	  by	  0.02	  Å	  on	  average.	  	  Since	  the	  thiolate	  of	  Cys140	  
now	  has	  a	  direct	  H-­‐bonding	  interaction	  with	  the	  Lys144	  side	  chain	  (Figure	  4.6),	  the	  Fe1-­‐Sγ-­‐Cys140	  
bond	   is	   increased	  by	  0.06	  Å,	  and	   it	  becomes	  the	   longest	  among	  the	  four	  Fe-­‐Sγ-­‐Cys	  bonds.	   	  The	  
elongation	   of	   the	   Fe1-­‐Sγ-­‐Cys140	   distance	   may	   explain	   the	   marked	   change	   in	   Fe-­‐Sγ	   stretching	  





Table	   4.2	   DFT	   results	   for	   Chain-­‐A	   without	   APS.	   	   Fe-­‐Fe	   and	   Fe-­‐ligand	   bond	   lengths	   (Å),	   broken-­‐symmetry	   state	  
energies	   (E,	  eV),	  Fe	  net	  spin	  populations	  (NSP),	  and	  Mössbauer	  properties	   (isomer	  shifts	  δ,	  quadrupole	  splittings	  
ΔEQ,	  mm	   s
-­‐1,	   and	  η)	   of	   the	   resting	   state	   [Fe4S4(Sγ-­‐Cys)4]
2-­‐	   cluster	   in	   wild-­‐type	   PaAPR	  without	   substrate	   binding:	  
comparison	  between	  calculations	  and	  experiments	  (Exp).	  
	  
	   Calculated	  Chain-­‐A	  without	  APS	  
Exp	  a	  
	   Fe1↓Fe2↓Fe3↑Fe4↑	   Fe1↑Fe2↓Fe3↓Fe4↑	   Fe1↑Fe2↓Fe3↑Fe4↓	  
Fe1-­‐Fe2	   2.685	   2.700	   2.651	   2.7	  
Fe1-­‐Fe3	   2.657	   2.687	   2.662	   2.7	  
Fe1-­‐Fe4	   2.707	   2.742	   2.724	   2.7	  
Fe2-­‐Fe3	   2.758	   2.963	   2.767	   2.7	  
Fe2-­‐Fe4	   2.684	   2.711	   2.750	   2.8	  
Fe3-­‐Fe4	   2.646	   2.671	   2.663	   2.8	  
Fe1-­‐S1	   2.309	   2.219	   2.291	   2.2	  
Fe1-­‐S2	   2.323	   2.305	   2.222	   2.2	  
Fe1-­‐S3	   2.232	   2.299	   2.300	   2.2	  
Fe2-­‐S1	   2.339	   2.349	   2.259	   2.3	  
Fe2-­‐S2	   2.293	   2.191	   2.290	   2.3	  
Fe2-­‐S4	   2.269	   2.341	   2.335	   2.2	  
Fe3-­‐S1	   2.211	   2.293	   2.286	   2.3	  
Fe3-­‐S3	   2.313	   2.229	   2.309	   2.3	  
Fe3-­‐S4	   2.330	   2.345	   2.255	   2.3	  
Fe4-­‐S2	   2.201	   2.267	   2.287	   2.3	  
Fe4-­‐S3	   2.314	   2.306	   2.238	   2.3	  
Fe4-­‐S4	   2.322	   2.247	   2.321	   2.3	  
Fe1-­‐Sγ-­‐Cys140	   2.249	   2.270	   2.333	   2.3	  
Fe2-­‐Sγ-­‐Cys139	   2.311	   2.312	   2.267	   2.3	  
Fe3-­‐Sγ-­‐Cys228	   2.301	   2.325	   2.292	   2.3	  
Fe4-­‐Sγ-­‐Cys231	   2.277	   2.298	   2.324	   2.3	  
E	   -­‐1193.735	   -­‐1193.369	   -­‐1193.532	   	  
NSP(Fe1,	  Fe2,	  Fe3,	  Fe4)	   (-­‐3.11,	  -­‐3.18,	  3.16,	  3.11)	   (3.12,	  -­‐3.17,	  -­‐3.17,	  3.14)	   (3.10,	  -­‐3.18,	  3.20,	  -­‐3.15)	   	  
δ(Fe1,	  Fe2,	  Fe3,	  Fe4)	   (0.43,	  0.48,	  0.45,	  0.44)	   (0.42,	  0.46,	  0.46,	  0.44)	   (0.39.	  0.46,	  0.43,	  0.43)	   0.45	  [18]	  
Average	  δ	   0.45	   0.45	   0.43	   	  
ΔEQ(Fe1,	  Fe2,	  Fe3,	  Fe4)	   (1.17,	  1.01,	  0.80,	  -­‐1.01)	   (0.95,	  1.20,	  1.20,	  0.78)	   (0.91,	  0.99,	  1.04,	  1.32)	   1.09	  [18]	  
Average	  |ΔEQ|	   1.00	   1.03	   1.07	   	  
η(Fe1,	  Fe2,	  Fe3,	  Fe4)	   (0.48,	  0.62,	  0.65,	  0.92)	   (1.00,	  0.31,	  0.24,	  0.77)	   (0.96,	  0.46,	  0.55,	  0.35)	   	  
aThe	   crystal	   structure	   of	   PaAPR	  was	   at	   2.7	  Å	   resolution,	   PDB	   code:	   2GOY	   (Chartron,	   2006).	   Distances	   are	   taken	  





Table	   4.3	   DFT	   results	   for	   Chain-­‐B	   with	   APS.	   	   Fe-­‐Fe	   and	   Fe-­‐ligand	   bond	   Lengths	   (Å),	   broken-­‐symmetry	   state	  
energies	  (E,	  eV),	  Fe	  net	  spin	  populations	  (NSP),	  and	  Mössbauer	  properties	  (isomer	  shifts	  δ,	  quadrupole	  splittings	  
ΔEQ,	   mm	   s
-­‐1,	   and	   η)	   of	   the	   resting	   state	   [Fe4S4(Sγ-­‐Cys)4]
2-­‐	   cluster	   in	   wild-­‐type	   PaAPR	   with	   substrate	   binding:	  
comparison	  between	  calculations	  and	  experiments	  (Exp).	  
	  
	   Calculated	  Chain-­‐B	  with	  APS	  
Exp	  a	  
	   Fe1↓Fe2↓Fe3↑Fe4↑	   Fe1↑Fe2↓Fe3↓Fe4↑	   Fe1↑Fe2↓Fe3↑Fe4↓	  
Fe1-­‐Fe2	   2.741	   2.718	   2.669	   2.7	  
Fe1-­‐Fe3	   2.683	   2.690	   2.717	   2.7	  
Fe1-­‐Fe4	   2.727	   2.813	   2.742	   2.7	  
Fe2-­‐Fe3	   2.732	   2.863	   2.750	   2.7	  
Fe2-­‐Fe4	   2.680	   2.708	   2.792	   2.7	  
Fe3-­‐Fe4	   2.728	   2.670	   2.678	   2.7	  
Fe1-­‐S1	   2.304	   2.205	   2.303	   2.3	  
Fe1-­‐S2	   2.333	   2.308	   2.227	   2.3	  
Fe1-­‐S3	   2.209	   2.310	   2.314	   2.3	  
Fe2-­‐S1	   2.313	   2.308	   2.221	   2.3	  
Fe2-­‐S2	   2.267	   2.183	   2.274	   2.2	  
Fe2-­‐S4	   2.247	   2.343	   2.338	   2.3	  
Fe3-­‐S1	   2.178	   2.267	   2.271	   2.2	  
Fe3-­‐S3	   2.310	   2.222	   2.308	   2.2	  
Fe3-­‐S4	   2.305	   2.293	   2.217	   2.2	  
Fe4-­‐S2	   2.193	   2.273	   2.285	   2.3	  
Fe4-­‐S3	   2.290	   2.284	   2.202	   2.3	  
Fe4-­‐S4	   2.310	   2.230	   2.302	   2.3	  
Fe1-­‐Sγ-­‐Cys140	   2.304	   2.329	   2.326	   2.3	  
Fe2-­‐Sγ-­‐Cys139	   2.293	   2.325	   2.315	   2.3	  
Fe3-­‐Sγ-­‐Cys228	   2.290	   2.306	   2.306	   2.3	  
Fe4-­‐Sγ-­‐Cys231	   2.257	   2.289	   2.276	   2.3	  
E	   -­‐1446.545	   -­‐1446.291	   -­‐1446.501	   	  
NSP(Fe1,	  Fe2,	  Fe3,	  Fe4)	   (-­‐3.13,	  -­‐3.11,	  3.12,	  3.07)	   (3.14,	  -­‐3.16,	  -­‐3.12,	  3.13)	   (3.14,	  -­‐3.14,	  3.17,	  -­‐3.13)	   	  
δ(Fe1,	  Fe2,	  Fe3,	  Fe4)	   (0.45,	  0.45,	  0.43,	  0.42)	   (0.46,	  0.45,	  0.43,	  0.43)	   (0.47,	  0.46,	  0.44,	  0.43)	   0.45	  [18]	  
Average	  δ	   0.44	   0.44	   0.45	   	  
ΔEQ(Fe1,	  Fe2,	  Fe3,	  Fe4)	   (1.08,	  0.95,	  0.79,	  -­‐1.03)	   (0.87,	  1.24,	  1.15,	  0.70)	   (0.85,	  1.04,	  0.87,	  1.23)	   1.12	  [18]	  
Average	  |ΔEQ|	   0.96	   0.99	   1.00	   	  
η(Fe1,	  Fe2,	  Fe3,	  Fe4)	   (0.33,	  0.65,	  0.53,	  0.88)	   (0.78,	  0.34,	  0.29,	  0.62)	   (0.89,	  0.64,	  0.42,	  0.33)	   	  
a.The	  crystal	  structure	  was	  at	  2.7	  Å	  resolution,	  PDB	  code:	  2GOY	  (Chartron,	  2006).	  Distances	  are	  taken	  from	  chain-­‐
B	  with	  substrate	  binding	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The	  net	  spin	  populations	  (NSP)	  from	  Mulliken	  population	  analysis	  are	  the	  main	  indication	  of	  the	  
high-­‐spin	   or	   intermediate-­‐spin	   character	   of	   the	   metal	   sites.	   	   In	   the	   ideal	   ionic	   limit,	   the	   net	  
unpaired	   spin	  populations	  are	  5	  and	  4	   for	   the	  high-­‐spin	  Fe3+	   (five	  d-­‐electrons)	   and	  Fe2+	   (six	  d-­‐
electrons)	   sites,	   respectively.	   	   Therefore,	   for	   the	   delocalized	   spins	   between	   the	   high-­‐spin	   Fe3+	  
and	  Fe2+	  sites,	  one	  should	  expect	  the	  average	  net	  spin	  of	  4.5.	  	  However,	  because	  of	  the	  Fe-­‐ligand	  
covalency,	  our	  previous	  calculations	  show	  that	  the	  calculated	  net	  spin	  magnitude	  for	  a	  high-­‐spin	  
Fe3+/Fe2+	   site	   is	  normally	  by	  about	  1	  e-­‐	   smaller	   than	   the	   ionic	   limit	   [19,35,65-­‐68].	   	  The	  current	  
calculated	  net	  spins	  on	  the	  four	  Fe	  sites	  in	  both	  chain-­‐A	  and	  chain-­‐B	  are	  3.1	  ~	  3.2	  (Tables	  4.2	  and	  
4.3),	  about	  1.3	  ~	  1.4	  e-­‐	  smaller	  than	  4.5,	   indicative	  of	  the	  high	  spin	  Fe2.5+	  sites	  with	  substantial	  
Fe-­‐S	  covalency.	  	  The	  opposite	  signs	  for	  the	  spin	  densities	  indicate	  the	  AF-­‐coupling.	  
	  
Experimentally	   derived	   57Fe	   Mössbauer	   parameters	   were	   almost	   identical	   for	   the	   [Fe4S4(Sγ-­‐
Cys)4]2-­‐	   cluster	   for	   native	  APR	   and	   for	   the	  S-­‐sulfocysteine	   intermediate	   form	  with	  AMP	  bound	  
and	  C-­‐terminal	  tail	  docked	  in	  the	  active	  site.	  	  Note	  that	  the	  Mössbauer	  analyses	  on	  MtAPR	  [18]	  
were	   performed	   by	   incubating	   the	   enzyme	   with	   a	   2-­‐fold	   stoichiometric	   excess	   of	   APS	   at	   a	  
concentration	   well	   above	   the	   Kd	   of	   APS	   or	   AMP,	   similar	   to	   the	   current	   EXAFS	   study.	   	   Our	  
calculations	   show	   the	   subtle	   differences	   of	   the	   Mössbauer	   isomer	   shifts	   and	   quadrupole	  
splittings	   for	   each	   Fe	   site	   in	   different	   spin	   states,	   with	   or	   without	   substrate.	   	   However	   the	  
predicted	  isomer	  shifts	  are	  all	  around	  0.45	  mm	  s-­‐1,	  in	  excellent	  agreement	  with	  the	  experiment.	  	  
The	   average	   predicted	   quadrupole	   splitting	   values	   (~1	   mm	   s-­‐1)	   also	   agree	   well	   with	   the	  





Table	  4.4	  ESP	  atomic	  charges.	  	  Comparison	  of	  the	  calculated	  ESP	  atomic	  charges	  of	  the	  [Fe4S4(Sγ-­‐
Cys)4]
2-­‐	  quantum	  cluster	  in	  the	  Fe1↓Fe2↓Fe3↑Fe4↑	  spin	  state	  in	  different	  models.	  
	  
	   Chain-­‐A	  without	  APS	   	   Chain-­‐B	  with	  APS	  
	   wild-­‐type	   no-­‐tandem	   K144A	   	   wild-­‐type	   no-­‐tandem	   K144A	  
Fe1	   0.43 0.43 0.47 	   0.45 0.42 0.50 
Fe2	   0.58 0.58 0.60 	   0.61 0.59 0.61 
Fe3	   0.62 0.63 0.63 	   0.61 0.65 0.61 
Fe4	   0.62 0.60 0.63 	   0.62 0.61 0.64 
S1	   -­‐0.44 -­‐0.46 -­‐0.48 	   -­‐0.44 -­‐0.48 -­‐0.46	  
S2	   -­‐0.45 -­‐0.44 -­‐0.44 	   -­‐0.44 -­‐0.43 -­‐0.46	  
S3	   -­‐0.47	   -­‐0.46 -­‐0.53 	   -­‐0.48 -­‐0.49 -­‐0.54	  
S4	   -­‐0.70 -­‐0.68 -­‐0.70 	   -­‐0.70 -­‐0.67 -­‐0.71 
Sγ-­‐Cys140	   -­‐0.41 -­‐0.40 -­‐0.54 	   -­‐0.45 -­‐0.39 -­‐0.59 
Sγ-­‐Cys139	   -­‐0.63 -­‐0.68 -­‐0.59 	   -­‐0.64 -­‐0.67 -­‐0.66 
Sγ-­‐Cys228	   -­‐0.61 -­‐0.60 -­‐0.66 	   -­‐0.70 -­‐0.70 -­‐0.70 
Sγ-­‐Cys231	   -­‐0.65 -­‐0.67 -­‐0.67 	   -­‐0.63 -­‐0.66 -­‐0.68 
∑total	   -­‐2.11 -­‐2.15 -­‐2.28 	   -­‐2.19 -­‐2.22 -­‐2.44	  
	  
To	  understand	  how	  APS	  binding	   influences	  the	  charge	  distributions	  of	   the	  [4Fe-­‐4S]	  cluster,	  we	  
calculated	  the	  ESP	  atomic	  charges	  of	  the	  [Fe4S4(Sγ-­‐Cys)4]2-­‐	  clusters	  in	  chain-­‐A	  and	  chain-­‐B	  in	  the	  
Fe1↓Fe2↓Fe3↑Fe4↑	   spin	   state.	   	   The	   ESP	   charges	   are	   given	   in	   Table	   4.4	   under	   the	   “wild-­‐type”	  
columns.	   	   In	   chain-­‐A	   without	   APS,	   Fe1	   has	   the	   least	   positive	   charge	   (0.43),	   which	   is	  
approximately	  0.2	   charge	  units	   less	   than	  Fe3	  and	  Fe4.	   	   In	   addition,	   the	  Cys140	   thiolate	  which	  
coordinates	   to	   Fe1	   has	   the	   least	   negative	   charge	   (-­‐0.41),	  which	   is	   also	   by	   0.2	   charge	   units	   in	  
magnitude	   less	   than	   the	   other	   three	   Cys	   residues.	   	   This	   shows	   the	   charge	   transfer	   from	   the	  
Cys140	  thiolate	  to	  the	  nearby	  cationic	  group	  of	  Lys144	  side	  chain.	  	  In	  chain-­‐B	  (Figure	  4.6),	  Lys144	  
is	  in	  between	  Cys140	  and	  APS.	  	  The	  distances	  between	  Sγ-­‐Cys140	  and	  N-­‐Lys144,	  and	  between	  N-­‐
Lys144	   and	   O-­‐APS	   are	   3.16	   Å	   (3.56	   Å)	   and	   3.19	   Å	   (3.03	   Å),	   respectively,	   in	   the	   X-­‐ray	   (DFT	  
optimized)	  structure	  of	  chain-­‐B.	  	  The	  charge	  transfer	  from	  Cys140	  to	  Lys144	  is	  decreased	  in	  the	  
presence	  of	  APS.	   	  As	   a	   result,	   Sγ-­‐Cys140	  becomes	  more	  negative	   from	   -­‐0.41	   (chain-­‐A)	   to	   -­‐0.45	  
(chain-­‐B),	  and	  the	  ESP	  charge	  on	  Fe1	  is	  slightly	  increased	  from	  0.43	  (chain-­‐A)	  to	  0.45	  (chain-­‐B).	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The	  repulsion	  between	  APS	  and	  Cys228	  also	  increases	  the	  magnitude	  of	  the	  negative	  charge	  on	  
Sγ-­‐Cys228	  from	  -­‐0.61	  (chain-­‐A)	  to	  -­‐0.70	  (chain-­‐B).	  	  These	  changes	  result	  in	  a	  subtle	  increase	  in	  the	  
total	   negative	   ESP	   charge	   of	   the	   entire	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   cluster	   from	   -­‐2.11	   (Chain-­‐A)	   to	   -­‐2.19	  
(Chain-­‐B).	   	   Even	   though	  APS	   does	   not	   have	   a	   direct	   interaction	  with	   the	   [4Fe-­‐4S]	   cluster,	   the	  
mid-­‐range	   electrostatic	   interactions	   between	   the	   two	   species	   indeed	   influence	   the	   charge	  
distribution	   and	   the	   detailed	   geometry	   within	   the	   [4Fe-­‐4S]	   cluster,	   although	   the	   geometric	  
changes	  are	  not	  large	  enough	  to	  be	  observed	  in	  EXAFS	  and	  Mössbauer	  experiments.	  
	  
4.6.2	   	   Calculating	   Results	   for	  No-­‐Tandem	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	  Models.	   	  The	  main	   Fe-­‐Fe	   and	   Fe-­‐S	  
distances	  of	   the	  optimized	  no-­‐tandem	  models	   in	   the	  {Fe1↓Fe2↓Fe3↑Fe4↑}	  state	  with	  and	  without	  
APS	   are	   shown	   in	   Table	   4.5,	   in	   the	   columns	   under	   “no-­‐tandem”.	   	   After	   breaking	   the	   peptide	  
bond	  between	  Cys139	  and	  Cys140	  (Figure	  4.7),	  the	  [4Fe-­‐4S]2+	  core	  in	  both	  chain-­‐A	  and	  chain-­‐B	  
expands.	   	   For	   chain-­‐A	  without	   APS,	   the	   Fe1-­‐Fe2	   distance	   is	   increased	   by	   0.08	   Å	   compared	   to	  
wild-­‐type	  (Table	  4.2).	   	  Fe1-­‐Fe3,	  Fe1-­‐Fe4,	  and	  Fe3-­‐Fe4	  are	  also	  increased	  by	  0.03,	  0.04	  and	  0.02	  
Å,	  respectively.	  	  Except	  for	  Fe2-­‐S2,	  Fe2-­‐S4,	  and	  Fe2-­‐Sγ-­‐Cys139,	  which	  are	  decreased	  by	  0.01	  Å,	  all	  
other	   Fe-­‐S	   distances	   are	   increased	  by	   0	   ~	   0.03	  Å.	   	   The	  RMSD	  of	   the	   Fe-­‐Fe	   and	   Fe-­‐S	   distances	  
between	   the	   calculated	   no-­‐tandem	   model	   and	   the	   wild-­‐type	   optimized	   cluster	   of	   chain-­‐A	   is	  
0.022	   Å.	   	   The	   angles	  ∠Fe1-­‐Sγ-­‐Cβ-­‐Cys140	   and	  ∠Fe2-­‐Sγ-­‐Cβ-­‐Cys139	   are	   widened	   from	   112.6°	   and	  
109.6°	  to	  117.3°	  and	  112.4°,	  respectively.	  	  Meanwhile	  the	  distance	  between	  (Sγ-­‐Cys140)	  and	  (Sγ-­‐
Cys139)	  is	  enlarged	  from	  6.19	  Å	  to	  6.43	  Å.	  	  From	  chain-­‐A	  to	  chain-­‐B	  for	  the	  no-­‐tandem	  models,	  
the	  Fe1-­‐Fe2	  distance	  is	  further	  increased	  by	  0.06	  Å,	  and	  reaches	  2.82	  Å,	  which	  is	  the	  longest	  Fe-­‐
Fe	   distance	   for	   the	   {Fe1↓Fe2↓Fe3↑Fe4↑}	   state	   of	   the	   [4Fe-­‐4S]	   cluster	   in	   the	   current	   study.	   	   For	  
chain-­‐B	  with	  APS,	  the	  RMSD	  of	  the	  Fe-­‐Fe	  and	  Fe-­‐S	  distances	  between	  the	  no-­‐tandem	  model	  and	  
the	  optimized	  wild-­‐type	  cluster	  is	  also	  0.022	  Å.	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Table	  4.5	  DFT	  results	  for	  the	  no-­‐tandem	  and	  K144A	  models.	  	  Calculated	  Fe-­‐Fe	  and	  Fe-­‐ligand	  Bond	  Lengths	  
(Å)	   and	   Fe	  Net	   Spin	  Populations	   (NSP)	   for	   the	   [Fe4S4(Sγ-­‐Cys)4]
2-­‐	   quantum	  cluster	   in	   Fe1↓Fe2↓Fe3↑Fe4↑	   spin	  
state	  with	  substrate	  and	  without	  substrate	  binding	  in	  no-­‐tandem	  and	  K144A	  models.	  
	  
	   Chain-­‐A	  without	  APS	   	   Chain-­‐B	  with	  APS	  
	   no-­‐tandem	   K144A	   	   no-­‐tandem	   K144A	  
Fe1-­‐Fe2	   2.755 2.710 	   2.819 2.720 
Fe1-­‐Fe3	   2.683 2.661 	   2.700 2.676 
Fe1-­‐Fe4	   2.745 2.716 	   2.761 2.733 
Fe2-­‐Fe3	   2.742 2.754 	   2.735 2.731 
Fe2-­‐Fe4	   2.680 2.694 	   2.649 2.696 
Fe3-­‐Fe4	   2.662 2.689 	   2.705 2.727 
Fe1-­‐S1	   2.317 2.311 	   2.306 2.303 
Fe1-­‐S2	   2.340 2.323 	   2.326 2.317 
Fe1-­‐S3	   2.238 2.224 	   2.218 2.208 
Fe2-­‐S1	   2.349 2.340 	   2.311 2.317 
Fe2-­‐S2	   2.284 2.298 	   2.272 2.276 
Fe2-­‐S4	   2.253 2.262 	   2.242	   2.251 
Fe3-­‐S1	   2.218 2.203 	   2.210 2.175 
Fe3-­‐S3	   2.325 2.340 	   2.308 2.317 
Fe3-­‐S4	   2.333 2.340 	   2.298 2.302 
Fe4-­‐S2	   2.208 2.203 	   2.199 2.201 
Fe4-­‐S3	   2.326 2.335 	   2.296 2.296 
Fe4-­‐S4	   2.332 2.341 	   2.310 2.318 
Fe1-­‐Sγ-­‐Cys140	   2.279 2.254 	   2.323 2.270 
Fe2-­‐Sγ-­‐Cys139	   2.303 2.313 	   2.281 2.298 
Fe3-­‐Sγ-­‐Cys228	   2.325 2.303 	   2.293 2.284 
Fe4-­‐Sγ-­‐Cys231	   2.288 2.284 	   2.257 2.276 
RMSD	  a	   0.022 0.014 	   0.022 0.012 
NSP(Fe1)	   -­‐3.15 -­‐3.12 	   -­‐3.13 -­‐3.11 
NSP(Fe2)	   -­‐3.16 -­‐3.19 	   -­‐3.11 -­‐3.13 
NSP(Fe3)	   3.18 3.18 	   3.12 3.12 
NSP(Fe4)	   3.14 3.14 	   3.07 3.10 
aRoot	  mean	  squares	  difference	  of	  the	  calculated	  Fe-­‐Fe	  and	  Fe-­‐S	  distances	  between	  the	  current	  modified	  
models	  and	  the	  optimized	  wild-­‐type	  models	  (in	  Fe1↓Fe2↓Fe3↑Fe4↑	  state)	  given	  in	  Table	  4.2	  (for	  chain-­‐A)	  and	  
Table	  4.3	  (for	  chain-­‐B).	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Thus,	   the	   unique	   tandem	  pair	   Cys139	   and	  Cys140	   in	   PaAPR	   keeps	   the	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   cluster	  
more	  compact,	  which	  works	  to	  prevent	  the	  cluster	  from	  being	  reduced.	  	  It	  is	  known	  that,	  once	  
the	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   cluster	   is	   reduced	   (net	   charge	   of	   the	   cluster	   would	   be	   -­‐3),	   the	   repulsion	  
among	  the	  S·∙·∙·∙S	  atoms	  would	  be	  stronger,	   forcing	   the	  expansion	  of	   the	  overall	  cluster	   [19,35].	  
The	  tandem	  structure	  in	  PaAPR	  makes	  the	  expansion	  of	  the	  [4Fe-­‐4S]	  energetically	  unfavorable,	  
which	  explains	  why	  it	  is	  difficult	  to	  reduce	  the	  cluster	  [18].	  After	  several	  attempts,	  we	  were	  able	  
to	  reduce	  the	  [Fe4S4(Sγ-­‐Cys)4]2-­‐	  cluster	  in	  MtAPR	  but	  the	  reduction	  efficiency	  was	  at	  most	  44%	  of	  
the	  total	  protein	  [18].	  	  
	  
The	  calculated	  ESP	  atomic	  charges	   for	   the	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   cluster	   in	   the	  no-­‐tandem	  models	   in	  
both	   chain-­‐A	   and	   chain-­‐B	   are	   given	   in	   Table	   4.4	   in	   the	   columns	  under	   “No-­‐tandem”.	   	   In	   both	  
chain-­‐A	   and	   chain-­‐B,	   Fe1	   still	   holds	   the	   least	   positive	   ESP	   charge.	   	  Overall,	   the	   calculated	   ESP	  
charges	  of	  the	  no-­‐tandem	  models	  are	  similar	  to	  the	  corresponding	  wild-­‐type	  results.	   	  The	  total	  
ESP	  charges	  (∑total)	  of	  the	  no-­‐tandem	  models	  are	  a	  little	  more	  negative	  than	  those	  of	  the	  wild-­‐
type	  cluster,	  which	  increases	  the	  possibility	  of	  one-­‐electron	  oxidation	  of	  the	  [4Fe-­‐4S]	  cluster	   in	  
the	   no-­‐tandem	   form.	   	   The	   propensity	   and	   rate	   of	   cluster	   degradation	   after	   oxidation	   is	   a	  
complex	  multi-­‐step	  problem,	  and	  would	  be	  expected	  to	   involve	  both	  the	  covalent	  Cys	   linkages	  
and	  H-­‐bonding	  interactions	  with	  surrounding	  residues.	  
	  
The	  function	  of	  the	  unique	  tandem	  pair	  Cys139	  and	  Cys140	  in	  PaAPR	  is	  to	  protect	  the	  [4Fe-­‐4S]	  
cluster	  from	  reduction,	  as	  will	  be	  examined	  by	  redox	  potential	  calculations	  in	  Section	  6.4.	  	  Note	  
that	   our	   current	   method	   to	   construct	   the	   no-­‐tandem	   models	   is	   the	   simplest,	   but	   may	   not	  
represent	  the	  best	  approach.	  	  An	  alternative	  possibility	  would	  be	  to	  insert	  one	  or	  more	  residues	  
between	  the	  Cys139	  and	  Cys140	  pair.	  	  However,	  this	  would	  cause	  large	  conformational	  change	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and	  increase	  the	  size	  of	  the	  clusters,	  which	  currently	  contain	  211	  (in	  chain-­‐A)	  and	  250	  (in	  chain-­‐
B)	  atoms,	  and	  approach	   the	   reasonable	   limit	  of	  DFT/COSMO	  calculations.	   	   This	   issue	  could	  be	  
examined	  in	  future	  studies,	  ostensibly	  starting	  with	  a	  smaller	  overall	  cluster	  size.	  
	  
4.6.3	   	   Calculating	   Results	   for	   K144A	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	  Models.	   	   The	   calculated	   Fe-­‐Fe	   and	   Fe-­‐S	  
distances	  of	  the	  optimized	  K144A	  models	   in	  the	  {Fe1↓Fe2↓Fe3↑Fe4↑}	  spin	  state	  with	  and	  without	  
APS	  binding	  are	  shown	  in	  Table	  4.5,	  in	  the	  columns	  under	  “K144A”.	  	  The	  calculated	  ESP	  atomic	  
charges	  for	  the	  [Fe4S4(Sγ-­‐Cys)4]2-­‐	  portion	  of	  the	  K144A	  models	  in	  both	  chain-­‐A	  and	  chain-­‐B	  have	  
also	  been	  shown	  in	  Table	  4.4	  in	  the	  columns	  under	  “K144A”.	  
	  
There	  is	  marked	  anisotropy	  in	  the	  change	  of	  charge	  distribution	  and	  bond	  lengths	  when	  Lys144	  
is	  mutated	  to	  Ala.	  	  In	  particular,	  without	  charge	  transfer	  to	  Lys144,	  the	  negative	  ESP	  charge	  on	  
Sγ-­‐Cys140	  changes	  significantly	  from	  -­‐0.41	  (and	  -­‐0.45)	  in	  the	  wild	  type	  to	  -­‐0.54	  (and	  -­‐0.59)	  in	  the	  
K144A	  model	  of	  chain-­‐A	  (and	  chain-­‐B)	  (Table	  4.4).	   	  This	  influences	  the	  charge	  on	  Fe1	  such	  that	  
Fe1	   is	  more	  positive	  and	   in	   turn,	   the	  charge	  on	  S3	   is	  more	  negative	   in	  both	  models	  of	  K144A,	  
compared	   to	   the	   respective	  wild	   type	  model.	   	  Overall	   the	   total	   charge	  of	   the	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	  
cluster	   becomes	  more	   negative	   from	   -­‐2.11	   in	   the	  wild	   type	   to	   -­‐2.28	   in	   the	   K144A	  models	   for	  
chain-­‐A,	   and	   from	   -­‐2.19	   to	   -­‐2.44	   for	   chain-­‐B,	   respectively	   (Table	   4.4).	   	   The	   increase	   of	   the	  
negative	  charge	  of	  the	  [Fe4S4(Sγ-­‐Cys)4]2-­‐	  cluster,	  in	  combination	  with	  the	  electrostatic	  interaction	  
of	   the	   negatively	   charged	   cluster	  with	   the	   Lys144+	   vs.	   	   neutral	   Ala144,	   explains	  why	   the	   Fe-­‐S	  
cluster	   is	  even	  more	  difficult	   to	  reduce	   in	  K144A	  mutant	  as	  observed	   in	  EPR	  experiments	  [18].	  
The	  reduction	  potential	  of	  the	  K144A	  clusters	  will	  also	  be	  examined	  in	  Section	  6.4.	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In	  chain-­‐B,	  loss	  of	  the	  H-­‐bonding	  interaction	  between	  Sγ-­‐Cys140	  and	  Lys144	  decreases	  the	  Fe1-­‐Sγ-­‐
Cys140	  bond	  length	  by	  0.03	  Å,	  which	  is	  greater	  than	  the	  other	  corresponding	  Fe-­‐Sγ-­‐Cys	  distance	  
changes.	   	   In	  general,	  the	  RMSD	  of	  the	  calculated	  Fe-­‐Fe	  and	  Fe-­‐S	  distances	  between	  the	  K144A	  
model	  and	  the	  optimized	  wild-­‐type	  cluster	  is	  0.014	  Å	  for	  chain-­‐A	  and	  0.012	  Å	  for	  chain-­‐B.	   	  The	  
cluster	   is	  more	   compact	   in	   the	   wild	   type	   protein	   than	   in	   the	   K144A	  model.	   	   For	   instance,	   in	  
chain-­‐A	   without	   APS	   binding,	   except	   for	   Fe2-­‐Fe3,	   Fe1-­‐S2,	   Fe1-­‐S3,	   Fe2-­‐S4,	   and	   Fe3-­‐S1,	   which	  
either	  remain	  unchanged	  or	  are	  decreased	  by	  less	  than	  0.01	  Å,	  all	  other	  Fe-­‐Fe	  and	  Fe-­‐S	  distances	  
are	  increased	  by	  0-­‐0.04	  Å	  from	  the	  wild-­‐type	  cluster	  to	  the	  K144A	  model.	  	  Overall	  the	  cluster	  in	  
K144A	   expands	   compared	   to	   the	   wild-­‐type	   optimized	   cluster,	   which	   is	   consistent	   with	   the	  
increasing	  of	  the	  electron	  density	  over	  the	  [Fe4S4(Sγ-­‐Cys)4]2-­‐	  cluster,	  and	  the	  increasing	  lability	  of	  
the	  cluster	  in	  K144A	  as	  observed	  in	  EPR	  experiments	  [18].	  
	  	  
Additionally,	   a	   comparison	   between	   ESP	   charges	   for	   APS	   in	   the	   wild-­‐type	   and	   K144A	  models	  
shows	  that	  the	  overall	  charge	  on	  APS	  becomes	  more	  negative	  changing	  from	  -­‐1.75	  in	  wild	  type	  
to	  -­‐1.84	  in	  the	  K144A	  model	  (data	  not	  shown).	   	  As	   indicated	  above,	  without	  charge	  transfer	  to	  
Lys144+,	   the	   calculated	   total	   ESP	   charge	   of	   the	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   cluster	   also	   becomes	   more	  
negative	   from	   -­‐2.19	   in	  wild-­‐type	   to	   -­‐2.44	   in	  K144A	   (chain-­‐B).	   	   This	   supports	   the	  crucial	   role	  of	  
Lys144	  such	  that	  in	  the	  absence	  of	  the	  positive	  charge,	  the	  H-­‐bonding	  interactions	  are	  lost	  and	  
the	  negative	  charges	  on	  both	  the	  cluster	  and	  APS	  are	  more	  localized	  making	  the	  cluster	  and	  APS	  
more	   negative	   in	   the	   K144A	   model.	   	   This	   would	   result	   in	   a	   strong	   repulsion	   between	   the	  
[Fe4S4(Sγ-­‐Cys)4]2-­‐	  cluster	  and	  APS	  that	  is	  detrimental	  to	  substrate	  binding	  in	  the	  mutant	  protein.	  	  
In	   fact,	   kinetic	   studies	   show	   that	   there	   is	   a	   400-­‐fold	   decrease	   in	   the	  Kd	   of	   APS	   for	   Lys144Ala	  
MtAPR	  and	  consequently,	  a	  decrease	  in	  the	  catalytic	  efficiency	  of	  the	  mutant	  protein	  by	  almost	  
63,000-­‐fold	  as	  compared	  to	  wild	  type	  MtAPR	  [18].	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  Compared	   to	  wild-­‐type	  chain-­‐B,	   the	  calculated	  distances	  of	   (S-­‐APS)·∙·∙·∙(Sγ-­‐Cys140),	   (S-­‐APS)·∙·∙·∙Fe1,	  
and	   (S-­‐APS)·∙·∙·∙Fe2	   increase	   from	  6.79,	   8.20,	   and	  10.84	  Å,	   respectively	   in	   the	  wild	   type	   to	  7.29,	  
8.57,	   and	   11.15	   Å,	   respectively	   in	   the	   K144A	   model.	   	   Therefore,	   without	   Lys144	   bridging	  
between	  APS	  and	  Cys140,	  repulsion	  causes	  APS	  and	  the	  [Fe4S4(Sγ-­‐Cys)4]2-­‐	  cluster	  to	  move	  away	  
from	  each	  other.	  	  	  
	  
4.6.4	  	  Calculated	  [Fe4S4(Sγ-­‐Cys)4]3-­‐	  Clusters	  and	  the	  Reduction	  potentials	  of	  [Fe4S4(Sγ-­‐Cys)4]2-­‐	  +	  e-­‐	  
→	  [Fe4S4(Sγ-­‐Cys)4]3-­‐	  in	  Different	  Models.	  	  If	  an	  electron	  is	  transferred	  to	  the	  resting	  state	  of	  the	  
[4Fe-­‐4S]2+	   core	   in	  APR,	   the	   core	  will	   change	   to	   [4Fe-­‐4S]1+,	   and	   the	   core	  plus	   the	   four	  Cys	   side	  
chains	  will	  have	  a	  net	  charge	  of	   -­‐3,	   [Fe4S4(Sγ-­‐Cys)4]3-­‐.	   	  Since	  the	  [4Fe-­‐4S]2+	  core	   is	   likely	  to	  be	   in	  
the	   {Fe1↓Fe2↓Fe3↑Fe4↑}	   spin	   state,	   the	  added	  electron	   then	  either	   goes	   to	   the	  pair	   {Fe1,Fe2}	   to	  
form	   the	   {Fe12+↓Fe22+↓Fe32.5+↑Fe42.5+↑}	   state,	   or	   goes	   to	   (Fe3,Fe4}	   to	   form	   the	  
{Fe12.5+↓Fe22.5+↓Fe32+↑Fe42+↑}	  state.	  	  Our	  geometry	  optimizations	  show	  that	  these	  two	  states	  yield	  
very	   similar	   broken-­‐symmetry	   energies	   (less	   than	   2	   kcal	   mol-­‐1	   difference)	   for	   all	   the	   cluster	  
models.	   	   And	   for	   most	   of	   the	   models	   (only	   wild-­‐type	   chain-­‐A	   is	   an	   exception),	   the	  
{Fe12+↓Fe22+↓Fe32.5+↑Fe42.5+↑}	   state	   is	   slightly	   lower	   in	   energy	   than	   the	   corresponding	  
{Fe12.5+↓Fe22.5+↓Fe32+↑Fe42+↑}	   state.	   	   Therefore,	   here	  we	  only	   present	   the	   geometries	   (Tables	   4.6	  







Table	  4.6	  DFT	  results	  for	  the	  [Fe4S4(Sγ-­‐Cys)4]
3-­‐	  quantum	  cluster	  in	  different	  models.	  	  Calculated	  Fe-­‐Fe	  and	  Fe-­‐
ligand	   bond	   lengths	   (Å)	   and	   Fe	   net	   spin	   populations	   (NSP)	   for	   the	   [Fe4S4(Sγ-­‐Cys)4]
3-­‐	   quantum	   cluster	   in	  
{Fe12+↓Fe22+↓Fe32.5+↑Fe42.5+↑}	   state	   with	   and	   without	   substrate	   binding	   in	   wild-­‐type,	   no-­‐tandem	   and	   K144A	  
models.	  
	   Chain-­‐A	  without	  APS	   	   Chain-­‐B	  with	  APS	  
	   wild-­‐type	   no-­‐tandem	   K144A	   	   wild-­‐type	   no-­‐tandem	   K144A	  
Fe1-­‐Fe2	   2.704 2.788 2.706 	   2.755 2.809 2.683 
Fe1-­‐Fe3	   2.661 2.700 2.663 	   2.676 2.708 2.685 
Fe1-­‐Fe4	   2.694 2.730 2.700 	   2.731 2.749 2.740 
Fe2-­‐Fe3	   2.761 2.735 2.750 	   2.746 2.719 2.725 
Fe2-­‐Fe4	   2.729 2.718 2.737 	   2.723 2.705 2.729 
Fe3-­‐Fe4	   2.635 2.636 2.634 	   2.676 2.655 2.672 
Fe1-­‐S1	   2.325 2.327 2.321 	   2.319 2.307 2.306 
Fe1-­‐S2	   2.305 2.321 2.301 	   2.281 2.301 2.297 
Fe1-­‐S3	   2.270 2.294 2.276 	   2.263 2.263 2.265 
Fe2-­‐S1	   2.318 2.324 2.317 	   2.296 2.300 2.291 
Fe2-­‐S2	   2.299 2.295 2.300 	   2.271 2.276 2.279 
Fe2-­‐S4	   2.317 2.292 2.319 	   2.298 2.274 2.317 
Fe3-­‐S1	   2.213 2.226 2.206 	   2.192 2.219 2.184 
Fe3-­‐S3	   2.357 2.348 2.370 	   2.345 2.340 2.348 
Fe3-­‐S4	   2.373 2.358 2.363 	   2.323 2.315 2.321 
Fe4-­‐S2	   2.211	   2.221	   2.211	   	   2.204	   2.212	   2.203	  
Fe4-­‐S3	   2.333	   2.332	   2.368	   	   2.296	   2.300	   2.308	  
Fe4-­‐S4	   2.364	   2.358	   2.340	   	   2.331	   2.323	   2.338	  
Fe1-­‐Sγ-­‐Cys140	   2.296	   2.336	   2.296	   	   2.329	   2.387	   2.313	  
Fe2-­‐Sγ-­‐Cys139	   2.347	   2.329	   2.339	   	   2.330	   2.309	   2.324	  
Fe3-­‐Sγ-­‐Cys228	   2.349	   2.350	   2.351	   	   2.329	   2.337	   2.318	  
Fe4-­‐Sγ-­‐Cys231	   2.338	   2.349	   2.331	   	   2.319	   2.318	   2.322	  
NSP(Fe1)	   -­‐2.93	   -­‐3.01	   -­‐2.92	   	   -­‐2.92	   -­‐2.99	   -­‐2.94	  
NSP(Fe2)	   -­‐3.00	   -­‐2.94	   -­‐3.01	   	   -­‐2.97	   -­‐2.92	   -­‐2.94	  
NSP(Fe3)	   3.26	   3.27	   3.25	   	   3.23	   3.23	   3.21	  
NSP(Fe4)	   3.22	   3.24	   3.23	   	   3.19	   3.20	   3.21	  
	  
 141	  
The	  formal	  net	  spin	  population	  of	  a	  high-­‐spin	  Fe2+	  ion	  is	  4.	  	  Our	  calculated	  magnitudes	  of	  the	  net	  
spins	   (2.92	   ~	   3.01)	   of	   Fe1	   and	   Fe2	   in	   all	   the	   {Fe12+↓Fe22+↓Fe32.5+↑Fe42.5+↑}	   state	   [Fe4S4(Sγ-­‐Cys)4]3-­‐	  
clusters	  are	  about	  1	  e-­‐	  smaller	  than	  4	  (Table	  4.6).	  	  The	  calculated	  net	  spin	  values	  for	  Fe3	  and	  Fe4	  
in	  the	  [Fe4S4(Sγ-­‐Cys)4]3-­‐	  clusters	   (Table	  4.6)	  are	  about	  0.1	   larger	  than	  the	  corresponding	  ones	   in	  
the	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   clusters	   (Tables	   4.2,	   4.3,	   and	   4.5).	   	   One	   measure	   of	   the	   metal-­‐ligand	  
covalency	  is	  the	  ratio	  of	  the	  calculated	  to	  the	  formal	  site	  spin	  population	  (spin	  population	  ratio),	  
and	   lower	  percentages	   represent	  greater	  covalency.	   	   In	  wild-­‐type	  chain-­‐A,	   the	  spin	  population	  
ratios	   of	   the	   four	   iron	   sites	   change	   from	   (69%,	   71%,	   70%,	   69%)	   in	   the	  
{Fe12.5+↓Fe22.5+↓Fe32.5+↑Fe42.5+↑}	   state	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   cluster	   to	   (73%,	   75%,	   72%,	   72%)	   in	   the	  
{Fe12+↓Fe22+↓Fe32.5+↑Fe42.5+↑}	   state	   [Fe4S4(Sγ-­‐Cys)4]3-­‐	   cluster.	   	   Very	   similar	   percentage	   changes	   are	  
also	  obtained	   for	  other	  model	   clusters.	   	   Therefore,	  with	   an	  additional	   electron,	   the	   [4Fe-­‐4S]1+	  
core	  of	   the	   [Fe4S4(Sγ-­‐Cys)4]3-­‐	   cluster	   in	   general	  has	   less	   covalency	   (larger	   spin	  population	   ratio)	  
than	  the	  [4Fe-­‐4S]2+	  core	  of	  the	  [Fe4S4(Sγ-­‐Cys)4]2-­‐	  cluster.	  	  As	  a	  result,	  upon	  1e-­‐	  reduction,	  the	  [4Fe-­‐
4S]	  core	  expands.	   	  This	   is	  seen	  relatively	  easier	  by	  comparing	  the	  average	  (avg)	  Fe-­‐Fe	  and	  Fe-­‐S	  
distances	  (Table	  4.7).	  	  Especially	  for	  the	  wild-­‐type	  chain-­‐A	  model,	  where	  upon	  1e-­‐	  reduction,	  the	  
(Fe-­‐Fe)avg	  elongates	  from	  2.690	  Å	  to	  2.697	  Å,	  the	  average	  of	  the	  four	  Fe-­‐S	  distances	  of	  Fe1-­‐S3,	  
Fe2-­‐S4,	  Fe3-­‐S1,	  and	  Fe4-­‐S2	  is	  increased	  from	  2.228	  Å	  to	  2.253	  Å,	  and	  the	  average	  distance	  of	  the	  
eight	  Fe-­‐S	  bonds	  on	  the	  ‘Fe1-­‐S1-­‐Fe2-­‐S2’	  and	  ‘Fe3-­‐S3-­‐Fe4-­‐S4’	  planes	  is	  also	  increased	  from	  2.318	  
Å	  to	  2.334	  Å.	  	  	  
	  
Based	  on	  the	  OLYP/COSMO	  calculated	  broken-­‐symmetry	  state	  energies	  (E),	  we	  have	  calculated	  
the	  reduction	  potentials	  (E0)	  of	  [Fe4S4(Sγ-­‐Cys)4]2-­‐	  +	  e-­‐	  →	  [Fe4S4(Sγ-­‐Cys)4]3-­‐	  for	  all	  the	  cluster	  models	  
according	  to:	  
E0	  =	  E{[Fe4S4(Sγ-­‐Cys)4]2-­‐}	  -­‐	  E{[Fe4S4(Sγ-­‐Cys)4]3-­‐}	  +	  ΔSHE	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (4)	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where	   ΔSHE	   is	   the	   standard	   hydrogen	   electrode	   potential.	   	   Here	   we	   use	   ΔSHE	   =	   -­‐4.34	   V,	  
obtained	   from	   Lewis	   et	   al’s	   calculations	   based	   solely	   on	   experimental	   data	   plus	   our	   electron	  
energy	   threshold	   correction	   [69-­‐71].	   	   The	   calculated	   reduction	   potentials	   for	   all	   the	   model	  
clusters	  are	  given	  in	  Table	  4.7.	  
	  
Table	  4.7	  Reduction	  potentials	  for	  different	  model	  clusters.	  	  Averages	  (avg)	  of	  the	  calculated	  Fe-­‐Fe	  and	  
Fe-­‐ligand	  bond	  lengths	  (Å),	  broken-­‐symmetry	  state	  energies	  (E,	  eV),	  and	  reduction	  potentials	  (E0,	  V)	  of	  
the	   [Fe4S4(Sγ-­‐Cys)4]
2-­‐/[Fe4S4(Sγ-­‐Cys)4]
3-­‐	   (2-­‐/3-­‐)	   quantum	   clusters	   with	   and	   without	   substrate	   binding	   in	  
wild-­‐type,	  no-­‐tandem	  and	  K144A	  models.	  
	  
	  
Chain-­‐A	  without	  APS	  
	   wild-­‐type	   no-­‐tandem	   K144A	  
	   2-­‐ 3-­‐ 2-­‐ 3-­‐ 2-­‐ 3-­‐	  
6(Fe-­‐Fe)avg
	   2.690 2.697 2.711 2.718 2.704 2.698 
4(Fe-­‐S)avg
	  a	   2.228 2.253 2.229 2.258 2.223 2.253 
8(Fe-­‐S)avg
	  b	   2.318 2.334 2.326 2.333 2.329 2.335 
4(Fe-­‐Sγ)avg	   2.285 2.333 2.299 2.341 2.289 2.329 
E	   -­‐1193.735 -­‐1196.724 -­‐1185.564 -­‐1188.659 -­‐1135.356 -­‐1138.287 
E0	   -­‐1.35 -­‐1.25 -­‐1.41 
	   Chain-­‐B	  with	  APS	  
	   wild-­‐type	   no-­‐tandem	   K144A	  
	   2-­‐ 3-­‐ 2-­‐ 3-­‐ 2-­‐ 3-­‐	  
6(Fe-­‐Fe)avg
	   2.715 2.718 2.728 2.724 2.714 2.706 
4(Fe-­‐S)avg
	  a	   2.207 2.239 2.217 2.242 2.209 2.242 
8(Fe-­‐S)avg
	  b	   2.304	   2.308 2.303 2.308 2.306 2.311 
4(Fe-­‐Sγ)avg	   2.286	   2.327 2.289 2.338 2.282 2.319 
E	   -­‐1446.545 -­‐1449.460 -­‐1438.362 -­‐1441.410 -­‐1387.923 -­‐1390.710 
E0	   -­‐1.43 -­‐1.29	   -­‐1.55 
aThe	  average	  of	  the	  following	  four	  Fe-­‐S	  distances:	  Fe1-­‐S3,	  Fe2-­‐S4,	  Fe3-­‐S1,	  and	  Fe4-­‐S2	  (see	  Figure	  4.5).	  b.	  
The	  average	  of	  the	  following	  eight	  Fe-­‐Fe	  distances:	  Fe1-­‐S1,	  Fe1-­‐S2,	  Fe2-­‐S1,	  Fe2-­‐S2,	  Fe3-­‐S3,	  Fe3-­‐S4,	  Fe4-­‐
S3,	  and	  Fe4-­‐S4.	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The	  measured	  2-­‐/3-­‐	  reduction	  potentials	  of	  the	  [4Fe-­‐4S]	  clusters	  in	  ferredoxins	  are	  from	  -­‐0.28	  to	  
-­‐0.45	  V	   [72-­‐74].	   	   So	   far,	   reduction	   of	   the	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   cluster	   in	   PaAPR	   has	   not	   been	  
successful.	  	  In	  our	  recent	  EPR	  experiment,	  we	  could	  photo	  reduce	  the	  [Fe4S4(Sγ-­‐Cys)4]2-­‐	  cluster	  in	  
MtAPR	  in	  the	  presence	  of	  deazaflavin/oxalate	  with	  at	  most	  44%	  reduction	  efficiency	  [18].	   	   It	   is	  
likely	   that	   the	   2-­‐/3-­‐	  reduction	   potential	   of	   the	   [4Fe-­‐4S]	   cluster	   in	   APR	   is	  much	  more	   negative	  
than	   ferredoxins,	   because	  of	   the	   tandem	  Cys	  pair	   and	   less	  H-­‐bonding	   interactions	   around	   the	  
[4Fe-­‐4S]	   in	   APR.	   	   There	   are	   10	   H-­‐bonding	   interactions	   around	   the	   [4Fe-­‐4S]	   active	   site	   in	  
ferredoxins	  [19].	  	  These	  H-­‐bonds	  are	  expected	  to	  stabilize	  the	  negative	  charges	  of	  the	  [Fe4S4(Sγ-­‐
Cys)4]3-­‐	   cluster,	  making	   the	   1e-­‐	   reduction	   easier.	   	   By	   contrast,	   there	   are	   only	   three	  H-­‐bonding	  
interactions	  with	  S	  or	  Sγ	  in	  the	  crystal	  structure	  of	  PaAPR	  (Figure	  4.4).	  
	  
It	   is	   still	   a	   big	   challenge	   to	   accurately	   predict	   the	   redox	   potentials	   for	   the	   Fe-­‐S	   systems.	   	   The	  
redox	  potentials	  obtained	  from	  quantum	  mechanical	  calculations	  within	  a	  solvation	  model	  vary	  
with	  the	  dielectric	  constant	  of	  the	  solvent	  and	  the	  probe	  radius	  for	  the	  contact	  surface	  between	  
the	  quantum	  cluster	  and	  solvent	  [19,35].	   	   In	  general,	  the	  larger	  the	  dielectric	  constant	  and	  the	  
smaller	   the	   radius,	   the	   reduced	   state	   is	  more	   stabilized,	   and	   the	   reduction	   potential	   is	  more	  
positive	   (or	   less	  negative)	   [19,35].	   	  Our	  previous	  calculations	  also	  show	  that	   the	  DFT/solvation	  
calculations	   systematically	  predict	   the	   redox	  potentials	  of	   the	  Fe-­‐S	   systems	  by	  0	  ~	  0.5	  V	  more	  
negative	  than	  the	  measured	  values	  [19,35].	  	  Our	  current	  predicted	  reduction	  potentials	  for	  the	  
[4Fe-­‐4S]	  cluster	  models	  in	  PaAPR	  are	  also	  very	  negative,	  ranging	  from	  -­‐1.25	  to	  -­‐1.55	  V.	  	  Since	  the	  
experimental	  reduction	  potential	  of	  PaAPR	  is	  not	  available,	  we	  do	  not	  have	  a	  clear	  picture	  if	  or	  
how	  much	  our	  calculations	  overestimate	  (more	  negative)	  these	  reduction	  potentials.	  	  Therefore	  
we	   will	   focus	   on	   the	   relative	   values	   of	   the	   predicted	   E0’s	   to	   see	   how	   the	   APS	   binding,	   the	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breaking	  of	  the	  Cys	  tandem	  pair,	  and	  the	  K144A	  mutation	  will	  change	  the	  reduction	  potential	  of	  
PaAPR.	  
	  
From	  wild-­‐type	  chain-­‐A	  to	  wild-­‐type	  chain-­‐B,	  E0	  is	  more	  negative	  by	  0.08	  V	  (from	  -­‐1.35	  V	  to	  -­‐1.43	  
V).	  	  With	  APS2-­‐	  nearby,	  the	  negatively	  charged	  [Fe4S4(Sγ-­‐Cys)4]2-­‐	  cluster	  is	  then	  even	  more	  difficult	  
to	  accept	  an	  electron	  from	  outside,	  and	  therefore	  is	  more	  difficult	  to	  reduce.	  	  From	  wild-­‐type	  to	  
no-­‐tandem	   model,	   E0	   becomes	   more	   positive	   by	   0.1	   V	   and	   0.14	   V	   in	   chain-­‐A	   and	   chain-­‐B,	  
respectively.	   	  Therefore,	  the	  no-­‐tandem	  cluster	  of	  [Fe4S4(Sγ-­‐Cys)4]2-­‐	   is	  easier	  to	  reduce	  than	  the	  
wild-­‐type.	  	  This	  is	  consistent	  with	  our	  conclusion	  in	  Section	  6.2	  that	  the	  function	  of	  the	  unique	  
tandem	  pair	  Cys139/Cys140	  in	  PaAPR	  is	  to	  keep	  the	  [4Fe-­‐4S]	  cluster	  more	  compact	  and	  protect	  
the	   cluster	   from	   reduction.	   	   In	   chain-­‐A,	   the	   calculated	  E0	   of	   K144A	   is	  more	   negative	   than	   the	  
wild-­‐type	  by	  0.06	  V.	  	  In	  chain-­‐B	  with	  APS,	  the	  K144A	  model	  yields	  the	  most	  negative	  E0	  (-­‐1.55	  V)	  
among	  all	  the	  model	  clusters.	  	  Upon	  the	  Lys144	  →	  Ala144	  mutation,	  there	  is	  no	  negative	  charge	  
transfer	   from	   the	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   cluster	   to	   Lys144,	   the	   cluster	   is	   therefore	  more	   difficult	   to	  
reduce,	  and	   the	   reduction	  becomes	  even	  more	  difficult	  when	  APS2-­‐	   is	  present,	  as	  proposed	   in	  
Section	  6.3.	  	  	  
	  
4.7	  	  Conclusion	  
In	   order	   to	   understand	   the	   role	   of	   [4Fe-­‐4S]	   cluster	   in	   APS	   reduction,	   we	   have	   examined	   the	  
coordination	  and	  geometry	  of	  the	  native	  and	  APS-­‐bound	  forms	  of	  the	  enzyme	  by	  XAS.	  	  Results	  
from	   the	   XANES	   and	   EXAFS	   analysis	   were	   valuable	   in	   indicating	   that	   there	   is	   no	   change	   in	  
coordination	  and	  overall	  geometry	  of	  the	  [4Fe-­‐4S]	  cluster	  between	  both	  forms	  of	  the	  enzyme.	  	  
However,	   in	   terms	   of	   resolving	   subtle	   changes	   in	   the	   geometry	   and	   electrostatics	   DFT	  
calculations	   were	   employed.	   	   Taken	   together,	   the	   EXAFS	   and	   DFT	   analyses	   provide	   a	   more	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complete	  picture	  of	   the	  coordination,	  geometry	  and	  electrostatic	  environment	  of	   the	   [4Fe-­‐4S]	  
cluster	  in	  APR.	  	  This	  is	  the	  first	  report	  of	  the	  application	  of	  both	  of	  these	  techniques	  to	  APR	  and	  
thereby	  contributes	  to	  the	  characterization	  of	  the	  cluster	   in	  APR	  with	  a	  view	  to	  gaining	   insight	  
into	  the	  function	  of	  the	  cluster	  in	  APS	  reduction.	  
	  
Fe	   K-­‐edge	   EXAFS	   analysis	   confirms	   the	   presence	   of	   the	   [4Fe-­‐4S]	   cluster	   and	   a	   comparison	   of	  
samples	  of	  MtAPR	  in	  the	  native	  and	  substrate-­‐bound	  forms	  suggests	  that	  the	  core	  of	  the	  cluster	  
is	   essentially	   unaffected	   during	   catalysis.	   	   This	   is	   supported	   by	   biochemical	   evidence,	   which	  
shows	  that	  the	  cluster	  in	  APR	  has	  no	  redox	  activity	  during	  the	  catalytic	  cycle	  [4]	  and	  hence	  we	  
do	  not	  expect	  any	  change	  in	  the	  oxidation	  state	  of	  the	  cluster	  in	  MtAPR	  with	  and	  without	  APS.	  	  	  
	  
DFT	  geometry	  optimizations	  have	  been	  performed	  on	  the	  [4Fe-­‐4S]	  clusters	  of	  the	  wild-­‐type,	  no-­‐
tandem,	  and	  K144A	  models	   constructed	   starting	   from	   the	  PaAPR	  X-­‐ray	   crystal	   structures	   [13].	  	  
Both	   substrate-­‐free	   and	   substrate-­‐binding	   forms	   for	   each	   type	   of	   the	   models	   were	   studied.	  	  
Calculations	  show	  that	  substrate	  binding	   influences	   the	  geometric	  and	  electronic	  structures	  of	  
the	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   cluster,	   in	   agreement	   with	   the	   resonance	   Raman	   and	   EPR	   spectra	  
experiments	  [11,18].	  	  However,	  the	  geometric	  changes	  of	  the	  [4Fe-­‐4S]	  core	  are	  not	  large	  enough	  
to	  be	  observed	  in	  EXAFS	  and	  Mössbauer	  experiments.	  	  	  
	  
Calculations	  with	   the	   ‘no-­‐tandem’	  models	   show	   that	   the	   coordinating	   tandem	  Cys139-­‐Cys140	  
pair	   in	   PaAPR	   keeps	   the	   [4Fe-­‐4S]	   cluster	  more	   compact	   and	   prevents	   it	   from	   reduction.	   	   The	  
tandem	  pair	  also	  leads	  to	  a	  strain	  in	  the	  geometry	  of	  the	  cysteine	  side	  chains.	  	  Conformations	  of	  
the	  cysteinyl	  ligands	  of	  an	  iron-­‐sulfur	  cluster	  can	  result	  in	  differences	  in	  redox	  energies	  of	  ~100	  
mV	  that	  can	  directly	  influence	  the	  redox	  properties	  of	  the	  cluster	  [75].	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Additionally,	  the	  replacement	  of	  Lys144+	  by	  Ala	  in	  our	  calculations	  has	  a	  two-­‐fold	  effect:	  (1)	  Loss	  
of	  the	  bridging	  charged	  H-­‐bonding	  interactions	  of	  Lys144	  with	  Sγ-­‐Cys140	  and	  the	  terminal	  sulfate	  
moiety	  of	  APS	  destabilizes	   the	  Fe-­‐S	   cluster	  as	   the	  overall	   charge	  of	   the	  cluster	  becomes	  more	  
negative.	  	  The	  calculated	  reduction	  potentials	  of	  the	  clusters	  in	  K144A	  models	  are	  by	  0.06	  ~	  0.12	  
V	  more	  negative	  than	  the	  wild-­‐type	  clusters.	   	   In	  fact,	  the	   lability	  of	  the	  cluster	  and	  difficulty	   in	  
reduction	  have	  been	  observed	  in	  EPR	  experiments	  in	  which	  reduction	  of	  the	  cluster	  in	  the	  K144A	  
mutant	   resulted	   in	   a	   6-­‐fold	   decrease	   of	   signal	   intensity	   and	   the	   appearance	   of	   an	   additional	  
signal	  corresponding	  to	  free	  Fe3+	  formed	  due	  to	  cluster	  degradation,	  compared	  to	  wild	  type	  APR	  
[18].	   (2)	   Loss	   of	   the	   bridging	   Lys144	   cation	   increases	   the	   repulsion	   between	   the	   negatively	  
charged	   APS2-­‐	   and	   the	   [Fe4S4(Sγ-­‐Cys)4]2-­‐	   cluster.	   	   This	   explains	   why	   the	   Lys144Ala	   mutation	   is	  
detrimental	  to	  APS-­‐binding	  and	  catalysis	  [18].	  
	  	  
The	   importance	  of	  Lys144	   in	  stabilizing	  the	  sulfate	  moiety	  of	  APS	   is	  analogous	  to	  the	  role	  of	  a	  
conserved	  Lys	  residue	  in	  sulfotransferases	  which	  acts	  as	  a	  catalytic	  acid,	  stabilizing	  the	  transition	  
state	   of	   the	   substrate,	   phosphoadenosine	   phosphosulfate	   (PAPS),	   by	   interacting	  with	   the	   SO3	  
moiety	  that	  is	  being	  transferred	  [76].	  	  Conversely,	  we	  could	  glean	  a	  role	  for	  the	  [4Fe-­‐4S]	  cluster	  
in	   positioning	   Lys144	   in	   the	   active	   site	   such	   that	   it	   can	   interact	   favorably	   with	   the	   incoming	  
substrate.	   	   In	   addition	   to	   Lys144,	   other	   conserved	  positively	   charged	   residues	   such	   as	  Arg242	  
and	   Arg245,	   and	   Arg171	   (present	   in	   a	   flexible	   ‘Arg-­‐loop’)	   also	   play	   crucial	   roles	   in	   substrate	  
binding	  [9].	   	  Lysines	  and	  arginines	  are	  cations	  with	   long,	   flexible	  and	  mobile	  side	  chains.	   	  They	  
often	   function	   as	   “molecular	   guidewires”	   as	   found	   in	   other	   sulfate	   and	   phosphate	   transfer	  
enzymes	   [77-­‐82].	   	   The	   cationic	   side	   chains	   electrostatically	   screen	   the	   bound	   anions	   during	  
group	  transfer,	  facilitating	  covalent	  bond	  formation.	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It	   should	   also	   be	   noted	   that	   the	   current	   PaAPR	   crystal	   structure	   is	  missing	   the	   disordered	   C-­‐
terminal	   segment	   of	   residues	   250-­‐267,	   which	   carries	   the	   catalytically	   essential	   Cys256	   [13].	  
When	  the	  missing	  segment	  was	  modeled	  into	  the	  active	  site	  of	  PaAPR	  using	  the	  structure	  of	  3'-­‐
phosphoadenosine	  5'-­‐phosphosulfate	  reductase	  from	  Saccharomyces	  cerevisiae,	  it	  was	  observed	  
that	  Cys256	  is	  proximal	  to	  the	  sulfate	  moiety	  of	  APS,	  and	  the	  side	  chains	  of	  Cys140	  and	  Lys144	  
[18].	   	   Thus	  with	   the	   addition	   of	   the	   negatively	   charged,	   nucleophilic	   thiolate	   in	   the	   transition	  
state,	  the	  optimum	  positioning	  of	  Lys144	  and	  other	  cationic	  side	  chains	  to	  make	  key	  H-­‐bonding	  
interactions	  with	  APS,	   is	  required	  to	  maintain	  an	  energetically	  favorable	  charge	  balance	  within	  
the	  active	  site.	  	  	  
	  
In	  summary,	  our	  study	  characterizes	  the	  [4Fe-­‐4S]	  cluster	   in	  APR	  by	  EXAFS	  spectroscopy	  and	  by	  
findings	  from	  our	  DFT	  calculations	  which	  substantiate	  (1)	  modulation	  of	  the	  redox	  potential	  of	  
the	   cluster	   brought	   about	   by	   the	   constrained	   tandem	   cysteine	   coordination,	   (2)	   the	   role	   of	  
Lys144	  as	  a	  critical	  link	  between	  the	  [4Fe-­‐4S]	  cluster	  and	  APS,	  and	  finally,	  (3)	  a	  role	  for	  the	  Fe-­‐S	  
cluster	   in	   contributing	   to	   stabilization	   of	   the	   transition	   state	   via	   positioning	   of	   Lys144	   and	  
maintaining	  charge	  balance	   in	  the	  active	  site	  during	  catalysis.	   	   In	  order	  to	  gain	  further	   insights	  
into	  the	  mechanism	  of	  APS	  reduction,	  efforts	  to	  determine	  the	  structure	  of	  APR	  with	  the	  intact	  
C-­‐terminal	  segment	  are	  currently	  underway.	  
	  
4.8	  Experimental	  Procedures	  
4.8.1	  Materials	  	  E.	  coli	  BL21(DE3)	  used	  for	  expression	  was	  obtained	  from	  Novagen	  (Bad	  Soden,	  
Germany).	   	   APS	  was	   purchased	   from	  Biolog	   Life	   Sciences	   Institute,	   ≥95%	   (Bremen,	  Germany).	  
AMP	  and	  reagents	  for	  the	  buffer	  were	  obtained	  from	  Sigma-­‐Aldrich	  (St.	  Louis,	  MO)	  and	  were	  of	  
the	  highest	  purity	  available.	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4.8.2	   Preparation	   of	   Mt-­‐APSR	   Samples	   for	   EXAFS	   Spectroscopy	   	   Mt-­‐APSR	   was	   purified	   as	  
detailed	   in	  Ref.	  18,	  concentrated	  using	  10,000	  MWCO	  Amicon	  Ultra-­‐4	  centrifugal	   filter	  devices	  
(Millipore	   Corporation,	   Billerica,	   MA)	   and	   used	   at	   a	   final	   concentration	   of	   1	   mM	   in	   buffer	  
containing	   50	   mM	   Tris–HCl,	   150	   mM	   NaCl	   (pH	   8.5	   at	   4	   °C)	   and	   10%	   (v/v)	   glycerol.	   Protein	  
concentrations	  were	  determined	  using	  the	  extinction	  coefficient,	  ε280=36,815	  M-­‐1cm-­‐1,	  obtained	  
by	  quantitative	  amino	  acid	  analysis.	  Analysis	  of	  iron	  content	  by	  inductively	  coupled	  plasma	  (ICP)	  
mass	  spectrometry	  for	  Mt-­‐APSR	  indicated	  that	  each	  mole	  of	  protein	  contained	  3.5	  ±	  0.4	  mol	  of	  
iron,	  as	  expected	  for	  a	   [4Fe-­‐4S]	  cluster.	  The	   iron	  and	  sulfur	  content	  of	  APSR	   is	  consistent	  with	  
the	  incorporation	  of	  four	  irons	  and	  four	  inorganic	  sulfides	  per	  mol	  of	  protein.[4,83]	  The	  specific	  
activity	  of	  the	  purified	  enzyme	  was	  5.2	  µM	  min-­‐1	  mg	  protein-­‐1	  as	  determined	  by	  an	  assay	  using	  
35S-­‐APS	   described	   in	   Ref.	   9	   and	   consistent	  with	   the	   previously	   reported	   value.[4]	   For	   samples	  
with	   ligand,	  1	  mM	  enzyme	  was	   incubated	  with	  3	  mM	  ligand	   for	  15	  min	  at	   room	  temperature,	  
prior	  to	  loading.	  All	  samples	  were	  loaded	  in	  1	  mm	  Lucite	  cells	  with	  37	  µm	  Kapton	  windows	  for	  X-­‐
ray	   absorption	   studies,	   immediately	   frozen	   in	   liquid	   nitrogen,	   and	   maintained	   under	   liquid	  
nitrogen	  conditions	  until	  data	  were	  collected.	  
	  
4.8.3	  EXAFS	  Measurements	  and	  Data	  Analysis	  ⎯	  X-­‐ray	  absorption	  spectra	  were	  recorded	  at	  the	  
Stanford	   Synchrotron	   Radiation	   Laboratory	   (beam	   line	   9-­‐3)	   under	   dedicated	   conditions	   as	  
fluorescence	  excitation	  spectra,	  using	  a	  solid-­‐state	  Ge	  detector	  array	  equipped	  with	  a	  Mn	  filter	  
and	  Soller	  slits	  focused	  on	  the	  sample.	  All	  channels	  of	  each	  scan	  were	  examined	  for	  glitches,	  and	  
the	  good	  channels	  were	  averaged	  for	  each	  sample	  (two	  independent	  samples	  for	  each	  protein	  
composition,	  with	  or	  without	  ligand)	  to	  give	  the	  final	  spectrum.	  During	  data	  collection,	  samples	  
were	  maintained	  at	  a	  temperature	  of	  approximately	  -­‐263	  ˚C	  using	  a	  liquid-­‐helium	  flow	  cryostat.	  
As	  a	  measure	  of	   sample	   integrity,	   XANES	   spectra	  measured	   for	   the	   first	   and	   last	   scan	  of	  each	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sample	  were	  compared.	  No	  changes	  were	  observed	  over	  the	  course	  of	  the	  data	  collection.	  	  Data	  
were	  measured	  with	  an	  integration	  time	  of	  1	  second	  through	  the	  edge,	  and	  between	  1	  and	  25	  
seconds	   in	   the	   post-­‐edge	   region.	   For	   each	   sample,	   between	   5	   and	   10	   35-­‐min	   scans	   were	  
accumulated,	  and	  each	  sample	  was	  measured	   in	  duplicate.	  The	  useful	   fluorescence	  count	  rate	  
per	  channel	  was	  ~104	  counts/second,	  giving	  a	   total	  of	  ~6	  ×	  106	  counts/scan	  at	  k	  =	  17	  Å-­‐1.	   	   For	  
energy	  calibration,	  the	  absorption	  spectrum	  of	  an	  iron	  metal	  foil	  was	  measured	  simultaneously	  
by	  transmittance,	  and	  the	  energy	  was	  calibrated	  with	  reference	  to	  the	  lowest-­‐energy	  inflection	  
points	  of	  the	  foil	  standard,	  which	  was	  assumed	  to	  be	  7111.3	  eV	  for	  iron.	  EXAFSPAK[84]	  was	  used	  
to	  extract	  and	  analyze	  EXAFS	  data,	  using	  ab	   initio	  phase	  and	  amplitude	  parameters	  calculated	  
using	   FEFF	   version	  7.02.[85,86]	  with	   the	   initial	   threshold	  energy	  E0	   defined	  as	  7130	  eV.	   	  Non-­‐
linear	  least	  squares	  fits	  of	  the	  data	  used	  4	  variable	  parameters	  (R	  and	  s2	  for	  each	  shell)	  with	  the	  
amplitude	  correction	   factor	  and	  DE0	   set	   to	  0.9	  and	   -­‐11	  eV	   respectively	  based	  on	   fits	   to	  model	  
Fe/S	   clusters.,	   XANES	   data	   were	   normalized	   to	   tabulated	   absorption	   coefficients[64]	   using	  
MBACK.[87]	  The	  area	  of	  the	  1s	  →	  3d	  transition	  in	  the	  XANES	  region	  was	  calculated	  by	  fitting	  the	  
pre-­‐edge	   region	   (7107-­‐7118	   eV)	   using	   the	   sum	   of	   a	   Gaussian	   and	   an	   arctan	   function;	   for	  
comparison	  with	   previously	   published	   data,	   the	   fitted	  Gausian	   area	  was	   normalized	   to	   the	   K-­‐
edge	  jump	  for	  Fe	  (3.556	  ×	  102	  cm2/g).	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Appendix	   4.9.1	   Structure-­‐based	   sequence	   alignment	   of	   APRs	   from	   Pseudomonas	   aeruginosa	   and	  
Mycobacterium	   tuberculosis.	   	  The	  ClustalW	  multiple	   sequence	  alignment	  program	  was	  used.	   Strictly	  
conserved	  residues	  are	  outlined	  in	  red,	  red	  letters	  indicate	  conserved	  residues	  and	  conserved	  regions	  
are	  boxed	  in	  blue.	  	  Residues	  flanking	  the	  active	  site	  are	  outlined	  in	  green.	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Appendix	  4.9.2	  Comparison	  of	  XAS	  spectra	  for	  MtAPR	  
with	  and	  without	  APS	  bound.	  	  a.	  XANES	  spectra;	  b.	  k3	  
weighted	  EXAFS;	  and	  c.	  Fourier	  transforms.	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Appendix	   4.9.3	  Comparison	   of	   the	   k3	   weighted	   EXAFS	   (top)	   and	   the	   Fourier	   transforms	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5.1	  Abstract	  
Assimilatory	   sulfate	   reduction	   supplies	   prototrophic	   organisms	   with	   reduced	   sulfur	   that	   is	  
required	   for	   the	   biosynthesis	   of	   all	   sulfur-­‐containing	   metabolites,	   including	   the	   amino	   acids	  
cysteine	  and	  methionine.	  	  The	  reduction	  of	  sulfate	  requires	  its	  activation	  via	  an	  ATP-­‐dependent	  
activation	  to	  form	  adenosine-­‐5'-­‐phosphosulfate	  (APS).	  	  Depending	  on	  the	  organism,	  APS	  can	  be	  
reduced	  directly	  to	  sulfite	  by	  APS	  reductase	  (APR)	  or	  undergo	  a	  second	  phosphorylation	  to	  yield	  
3'-­‐phosphoadenosine-­‐5'-­‐phosphosulfate	  (PAPS),	  the	  substrate	  for	  PAPS	  reductase	  (PAPR).	  	  These	  
essential	   enzymes	   have	   no	   human	   homolog,	   rendering	   them	   an	   attractive	   target	   for	   the	  
development	  of	   novel	   antibacterial	   drugs	   and	  herbicides.	   	  APR	  and	  PAPR	   share	   sequence	  and	  
structure	   homology	   as	   well	   as	   a	   common	   catalytic	   mechanism,	   but	   the	   enzymes	   are	  
distinguished	  by	  two	  features,	  namely,	  the	  amino	  acid	  sequence	  of	  the	  phosphate-­‐binding	  loop	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(P-­‐loop)	  and	  an	  iron-­‐sulfur	  cofactor	  in	  APRs.	   	  Based	  on	  the	  crystal	  structures	  of	  APR	  and	  PAPR,	  
two	  P-­‐loop	  residues	  are	  proposed	  to	  determine	  substrate	  specificity;	  however,	   this	  hypothesis	  
has	  not	  been	  tested	  experimentally.	  	  In	  contrast	  to	  this	  prevailing	  view,	  we	  report	  here	  that	  the	  
P-­‐loop	   motif	   has	   a	   modest	   effect	   on	   substrate	   discrimination.	   	   Instead,	   by	   means	   of	  
metalloprotein	  engineering,	  spectroscopic	  and	  kinetic	  analyses,	  we	  demonstrate	  that	   the	   iron-­‐
sulfur	   cluster	   cofactor	   enhances	   APS	   reduction	   by	   nearly	   1000-­‐fold,	   thereby	   playing	   a	   pivotal	  
role	  in	  substrate	  specificity	  and	  catalysis.	  	  These	  findings	  offer	  new	  insights	  into	  the	  evolution	  of	  




Assimilatory	   sulfate	   reduction	   supplies	   prototrophic	   organisms	   with	   reduced	   sulfur	   that	   is	  
required	   for	   the	   biosynthesis	   of	   all	   sulfur-­‐containing	   metabolites,	   including	   the	   amino	   acids	  
cysteine	   and	   methionine	   [1,2]. 	   The	   reduction	   of	   sulfate	   requires	   its	   activation	   by	   an	   ATP-­‐
dependent	   activation	   to	   form	   adenosine-­‐5'-­‐phosphosulfate	   (APS).	   	   For	   incorporation	   of	   sulfur	  
into	   biomolecules,	   the	   sulfate	   in	   APS	   must	   be	   reduced	   to	   sulfite	   and	   finally	   into	   sulfide.	   	   In	  
plants,	  algae,	  and	  many	  bacteria,	  APS	  can	  be	  reduced	  directly	  to	  sulfite	  by	  APS	  reductase	  (APR);	  
alternatively,	   in	   fungi,	   some	   cyanobacteria,	   and	   γ-­‐proteobacteria,	   this	   compound	   requires	   a	  
second	   phosphorylation	  
step	   to	   yield	   3'-­‐
phosphoadenosine-­‐5'-­‐
phosphosulfate	   (PAPS),	  
the	   substrate	   for	   PAPS	  
reductase	   (PAPR;	   Scheme	  
	  	  
Scheme	   5.1	   	   Reaction	   catalyzed	   by	   sulfonucleotide	   reductases.	   	   The	  
reaction	  is	  catalyzed	  by	  APR	  when	  the	  substrate	  is	  APS	  (R	  =	  H)	  and by	  
PAPR	  when	  the	  substrate	  is	  PAPS	  (R	  =	  PO3
2–).	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5.1,	  Table	  5.1	  and	  Figure	  5.1).	   	  These	  essential	  enzymes,	  collectively	  known	  as	  sulfonucleotide	  
reductases	   (SRs),	   have	   no	   human	   homolog,	   rendering	   them	   an	   attractive	   target	   for	   the	  
development	  of	  novel	  antibacterial	  drugs	  and	  herbicides	  [3-­‐6].	  	  	  
	  
The	   importance	   of	   SR	   for	  
microbial	   and	   plant	   survival	   have	  
motivated	   investigations	   of	   their	  
catalytic	   and	   structure	   [6-­‐14].	  	  
These	   studies	   support	   the	  
mechanism	  shown	  in	  Scheme	  5.2,	  
which	  involves	  nucleophilic	  attack	  
by	   a	   conserved	   C-­‐terminal	   cysteine	   residue	   on	   the	   substrate	   leading	   to	   the	   formation	   of	   a	  
covalent	   enzyme	   S-­‐sulfocysteine	   intermediate.	   	   Sulfite	   is	   then	   released	   by	   thiol-­‐disulfide	  
exchange	  with	   free	   thioredoxin	   (Trx)	   in	  bacterial	   and	   fungal	   SRs	  or	   through	   the	  action	  of	   a	  C-­‐
terminal	   Trx-­‐like	   domain	   in	   plants.	   	   Therefore,	   the	   general	   features	   of	   the	   thiol	   reaction	  
chemistry	   are	   shared	   despite	   the	   differences	   in	   substrate.	   	   SRs	   are	   homologous	   in	   sequence	  
(~25%	  identity;	  Appendix	  5.6.3),	  particularly	  within	  active	  site	  residues	  that	   line	  the	  active	  site	  
(~50%	   identity	   and	   75%	   similarity;	   Appendix	   5.6.4)	   and	   share	   a	   common	   three-­‐dimensional	  
structure	  (1.2	  Å	  rms	  deviation;	  Figure	  5.2a)	  [8,15].	  The	  SR	  monomer	  adopts	  a	  Rossman-­‐like	  fold	  
and	  is	  characterized	  by	  four	  conserved	  structural	  elements	  that	  define	  the	  active	  site:	  the	  LTDG	  
motif,	   phosphate-­‐binding	   loop	   (P-­‐loop),	   Arg-­‐loop,	   and	   C-­‐terminal	   ECGLH	   segment	   with	   the	  
catalytic	  cysteine	  (Appendix	  5.6.3).	  
	  
	  	  
Scheme	  5.2	  Proposed	  mechanism	  of	  sulfonucleotide	  reduction	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Upon	   closer	   inspection	   sequence	   and	  
structure	   alignments	   reveal	   two	   key	  
differences	   between	   APR	   and	   PAPR,	  
namely,	   the	   amino	   acid	   sequence	   of	   the	  
P-­‐loop	   and	   the	   presence	   of	   the	   cysteine	  
motif,	   CC…CXXC,	   in	   APR.	   	   The	   P-­‐loop	   of	  
APR	   is	   typically	   comprised	   of	   an	   SFS–
GAED	   motif	   while	   the	   corresponding	  
sequence	   in	   PAPR	   is	   SSSFGIQA	   (Figure	  
5.1a	  and	  b).	  	  In	  contrast	  to	  the	  typical	  role	  
for	   the	   P-­‐loop	   in	   binding	   a	   5'-­‐phosphate	  
group,	  crystal	  structures	  show	  that	  the	  P-­‐
loop	   interacts	  with	   the	   APS	  O3'	   hydroxyl	  
or	   the	   PAPS	   3'-­‐phosphate	   (Figure	   5.2b	  
and	   c).	   	   The	   four	   additional	   cysteine	  
residues	   in	  APR	   coordinate	  an	   iron-­‐sulfur	  
cluster,	   whereas	   the	   cofactor	   is	   replaced	  
by	   the	   YN…DXXT	   motif	   in	   PAPR	   (Figure	  
5.1a	   and	   c	   and	   Figure	   5.2d	   and	   e).	  	  
Functional	   analysis	   indicates	   that	   when	  
the	   [4Fe-­‐4S]	   cofactor	   is	   present,	   it	   is	  
required	   for	   catalytic	   activity;	   however,	  
the	   cluster	   is	   not	   involved	   in	   redox	  
chemistry	   and	   does	   not	   bind	   directly	   to	  
	  
Figure	   5.1	   Domain	   organization	   and	   phylogenetic	  
classification	   in	  the	  sulfonucleotide	  reductase	  family.	  	  
All	   SRs	  have	  a	  catalytic	   cysteine	  at	   the	  end	  of	   the	  C-­‐
terminus.	   	   a)	   Bacterial	   APRs	   possess	   the	   cysteine	  
motif	   CC…CXXC	   that	   coordinates	   a	   [4Fe-­‐4S]	   cluster	  
(blue).	   	   In	   PAPRs,	   conserved	   residues	   replace	   the	  
cysteine	  motif	  (yellow).	  	  The	  phosphate–binding	  loop	  
in	   APR	   is	   terminated	   by	   two	   negatively	   charged	  
residues	   (purple).	   	   The	  3'-­‐phosphate	  moiety	  of	   PAPS	  
can	  be	  accommodated	  by	  the	  P-­‐loop	  motif	  of	  PAPR	  as	  
it	   bears	   residues	   with	   small	   and	   neutral	   side	   chains	  
(green).	   b)	   and	   c)	   Dendrograms	   illustrating	   the	  
sequence	  homology	  between	  enzymes	  within	   the	  SR	  
family.	  	  The	  sequence	  alignment	  was	  performed	  using	  
ClustalW	  (Larkin,	  2007)	  and	  the	  tree	  was	  constructed	  
using	   the	   Geneious	   program	   (Drummond,	   2011).	  	  
Each	   of	   the	   three	   subclasses	   of	   SRs	   is	   clearly	  
delineated:	  APRs	  from	  higher	  plants	  with	  their	  unique	  
C-­‐terminal	   domain	   (A.	   thaliana,	   P.	   patens-­‐APR),	  
bacterial	   APRs	   (P.	   aeruginosa,	   M.	   tuberculosis,	   B.	  
subtilis)	   and	   PAPRs	   (E.	   coli,	   P.	   patens-­‐APR-­‐B	   and	   S.	  
cerevisiae).	   	   Differentiation	   in	   the	   P-­‐loop	   region	   (b)	  
and	  iron-­‐sulfur	  cluster	  coordinating	  residues	  (c)	  of	  the	  
SRs	   is	   indicated	   by	   color:	   purple,	   APR-­‐like;	   green,	  
PAPR-­‐like;	   blue,	   posses	   the	   [4Fe-­‐4S]	   cluster;	   yellow,	  
lack	   the	   [4Fe-­‐4S]	   cluster.	   	   APR	   from	   B.	   subtilis	   is	  
unique	  and	  can	  reduce	  both	  APS	  and	  PAPS.	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APS	  [6,8,16].	  	  Two	  interesting	  exceptions	  exist	  in	  Bacillus	  subtilis,	  which	  harbors	  the	  cluster,	  but	  
can	   utilize	   both	   APS	   and	   PAPS	   as	   substrates	   [Bs(P)APR]	   [17],	   and	   the	   moss	   Physcomitrella	  
patens,	  which	   lacks	   the	   cysteine	   pairs	   and	   associated	   cofactor,	   yet	   can	   reduce	  APS	   (PpAPR-­‐B)	  
[18].	   	  Notably,	  these	  SR	  variants	  exhibit	  100-­‐	  to	  1000-­‐fold	  decreases	  in	  their	  second-­‐order	  rate	  
constants	   (kcat/Km)	   for	   substrate	   reduction	   (Table	   5.1).	   	   Based	   on	   the	   aforementioned	  
observations,	   it	   has	   been	   proposed	   that	   the	   P-­‐loop	   is	   the	   principle	   determinant	   of	   substrate	  
specificity	   in	   these	   enzymes	   [7-­‐10],	   and	   that	   the	   [4Fe-­‐4S]	   cluster	   plays	   a	   structural	   and/or	  
regulatory	  role	  [8,16,17].	  	  
Table	  5.1	  Apparent	  second-­‐order	  rate	  constants	  (kcat/Km)	  for	  assimilatory	  SRs.	   	  Activities	  were	  
measured	   with	   purified	   recombinant	   enzymes,	   as	   production	   of	   sulfite	   from	   varying	  
concentrations	   of	   [35S]-­‐APS	   and	   [35S]-­‐PAPS,	   in	   the	   presence	   of	   DTT	   and	   recombinant	  
thioredoxin	  from	  E.	  coli	  as	  the	  electron	  donor.	  	  
	  
	   Iron-­‐sulfur	  




P.	  aeruginosa	  APRb	   Yes	   APS	   2.0	  x	  108	   APS	  
	   	   PAPS	   1.6	  x	  104	   	  
	  
M.	  tuberculosis	  APRb	   Yes	   APS	   2.5	  x	  108	   APS	  
	   	   PAPS	   6.0	  x	  104	   	  
	  
B.	  subtilis	  APRc	   Yes	   APS	   3.1	  x	  106	   None	  
	   	   PAPS	   1.6	  x	  106	   	  
	  
A.	  thaliana	  APR2d	   Yes	   APS	   3.8	  x	  108	   APS	  
	   	   PAPSd	   1.3	  x	  104	   	  
	  
P.	  patens	  APRd	   Yes	   APS	   3.8	  x	  108	   APS	  
	   	   PAPSd	   3.8	  x	  104	   	  
	  
E.	  coli	  PAPRb	   No	   APS	   7.2	  x	  102	   PAPS	  
	   	   PAPS	   2.3	  x	  108	   	  
	  
P.	  patens	  APR-­‐Bd	   No	   APS	   2.1	  x	  105	   APS	  
	   	   PAPS	   2.2	  x	  102	   	  
	  
aDefined	   as	   difference	   in	   substrate	   utilization	   of	   ≥102.	   	   Values	  measured	   at	   bpH	   8.0,	   cpH	  8.0	  
[17],	  dpH	  9.0	  [18].	  	  eValue	  estimated	  as	  the	  higher	  limit	  from	  ref.	  18.	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Much	  effort	  has	  been	  made	  to	  understand	  substrate	  specificity	  in	  enzymes	  and	  several	  attempts	  
have	  been	  made	   to	   rationally	   alter	   the	   specificity	   of	   an	  enzyme	  with	   sequence	   and	   structural	  
information	   as	   the	   blueprint	   for	   redesign	   [19].	   	   One	   of	   the	   first	   successful	   examples	   was	   of	  
changing	  the	  coenzyme	  specificity	  of	  Escherichia	  coli	  glutathione	  reductase	  from	  NADP	  to	  NAD	  
[20].	   	   Structurally,	   NADP	   and	   NAD	   differ	   by	   a	   phosphate	   group	   at	   the	   3'-­‐postition	   of	   the	  
adenosine	  5'-­‐phosphate	  (AMP)	  moiety,	  reminiscent	  of	  APS	  and	  PAPS.	  	  In	  glutathione	  reductase,	  
the	   switch	   in	   coenzyme	   preference	  was	   accomplished	   by	   changing	   amino	   acids	  within	   the	   P-­‐
loop.	  	  Similarly,	  protein	  engineering	  has	  been	  used	  successfully	  by	  Shokat	  and	  coworkers	  to	  alter	  
the	   nucleotide	   specificity	   of	   the	   prototypical	   tyrosine	   kinase,	   Src,	   to	   accept	   non-­‐native	  
nucleotides	   [21].	   	   This	   concept	   was	   subsequently	   extended	   to	   redesign	   kinase	   active	   sites	   to	  
accept	   unique	   nucleotide	   inhibitors	   to	   facilitate	   direct	   identification	   of	   kinase	   targets	   [22].	  	  
Overall	   these	   studies	   demonstrate	   that	   enzyme	   redesign	   is	   a	   powerful	   tool	   in	   exploiting	  
substrate	  recognition	  elements	  to	  elucidate	  the	  catalytic	  mechanism	  and	  function	  of	  an	  enzyme.	  	  	  
	  
Although	   it	   has	   been	   proposed	   that	   SR	   substrate	   specificity	   is	   dictated	   by	   the	   P-­‐loop,	   this	  
hypothesis	  has	  not	  yet	  been	  tested	  and,	  moreover,	  does	  not	  address	   the	  potential	   role	  of	   the	  
iron-­‐sulfur	   cluster.	   	   To	  gain	   insight	   into	   the	   forces	  driving	   specificity	  and	  catalytic	  efficiency	  of	  
SRs	  we	  have	  employed	  metalloprotein	  engineering,	  spectroscopic	  and	  kinetic	  analyses.	  	  On	  the	  
basis	  of	  our	  findings,	  we	  propose	  that	  the	  iron-­‐sulfur	  cluster	  is	  a	  major	  determinant	  of	  specificity	  
in	  this	  family	  of	  enzymes,	  specifically	  by	  enhancing	  the	  efficacy	  of	  the	  chemical	  step	  of	  catalysis.	  	  
In	  this	  way,	  our	  findings	  offer	  new	  perspectives	  on	  the	  evolution	  of	  SRs,	  the	  function	  of	  protein-­‐
bound	  iron-­‐sulfur	  clusters,	  and	  hold	  value	  for	  the	  development	  of	  inhibitors	  for	  SRs,	  a	  validated	  




The	  P-­‐loop	   residues	   in	  APRs	  have	   the	  SFS–GAED	  motif	  while	   the	   corresponding	  motif	   in	  PAPR	  
consists	  of	  SSSFGIQA.	  	   In	  APR,	  the	  glutamate	  and	  aspartate	  residues	  interact	  with	  three	  P-­‐loop	  
amide	  groups	  and	  are	  positioned	  above	  the	  dipole	  of	  the	  α3	  helix,	  as	  if	  they	  were	  mimicking	  the	  
interaction	  of	  a	  negatively	  charged	  phosphate	  (Figure	  5.2b	  and	  c).	  	  Conversely,	  the	  replacement	  
of	   these	   acidic	   residues	   with	   Gln	   and	   Ala	   in	   PAPR	   would	   facilitate	   interaction	   of	   the	   amide	  
groups	  with	  a	  3'-­‐phosphate	  and	  accommodate	  the	  bulkier	  moiety.	  	  To	  investigate	  this	  proposal,	  
we	   generated	   E65Q,	   D66A	   and	   E65Q	   D66A	   variants	   of	   APR	   from	   Pseudomonas	   aeruginosa	  
(PaAPR)	  as	  well	  as	  Q57E,	  A58D,	  and	  Q57E	  A58D	  variants	  of	  PAPR	  from	  Escherichia	  coli	  (EcPAPR).	  	  
Of	   note,	   the	   enzymes	   from	   these	   particular	   species	   were	   chosen	   on	   the	   basis	   of	   available	  
structural	  and	  functional	  information.	  	  We	  first	  tested	  the	  activity	  of	  the	  variants	  with	  native	  and	  
non-­‐native	  substrates.	   	   Interestingly,	  none	  of	  these	  substitutions	  increased	  kcat/Km	  for	  the	  non-­‐
native	  substrate	  (Appendix	  5.6.1).	  	  In	  addition,	  the	  D66A	  and	  E65Q	  single	  substitutions	  in	  PaAPR	  	  
	  
Figure	  5.2	  Comparison	  of	  putative	  substrate	  binding	  elements	  SRs.	  	  a.	  Superposition	  of	  the	  structures	  
of	  EcPAPR	  in	  charcoal	  (PDB	  deposition	  2O8V)	  and	  PaAPR	  in	  white	  (PDB	  deposition	  2GOY)	  showing	  the	  
positions	  of	  the	  [4Fe-­‐4S]	  cluster,	  P-­‐loop	  region,	  and	  APS	  or	  PAP	  ligand	  (modeled	  from	  PDB	  deposition	  
2OQ2).	   	   The	   carboxyl-­‐	   and	   amino-­‐	   termini	   of	   the	   proteins	   are	   indicated	   by	   C	   and	   N,	   respectively.	  	  
Comparison	   between	   the	   P-­‐loop	   regions	   of	   b.	   PaAPR	   bound	   to	   APS	   and	   c.	   EcPAPR	   bound	   to	   PAP.	  	  
Hydrogen	   bonding	   interactions	   are	   indicated	   by	   yellow	   dashes.	   	   Comparison	   of	   d.	   the	   iron-­‐sulfur	  
cluster	  coordination	  site	  in	  PaAPR	  and	  e.	  the	  corresponding	  semi-­‐conserved	  residues	  in	  EcPAPR.	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had	   at	   most	   a	   10-­‐fold	   effect	   on	   APS	  
reduction,	   whereas	   the	   Q65E	   and	  
A58D	   replacements	   in	   EcPAPR	  
exhibited	   a	   1000-­‐fold	   effect	   on	   the	  
reduction	   of	   PAPS.	   	   All	   double	  
mutants	   were	   significantly	   impaired	  
relative	   to	   their	   wild-­‐type	  
counterparts.	   	   To	   complement	   this	  
analysis,	   we	   measured	   the	  
dissociation	   constants	   (Kd)	   for	   the	  
reaction	   products	   AMP	   and	   3'-­‐
phosphoadenosine-­‐5'-­‐phosphate	  
(PAP)	   for	   the	   P-­‐loop	   variants	   (Figure	   5.3).	   	   PaAPR	   variants	   showed	   at	   most	   a	   2.5-­‐fold	  
enhancement	  in	  PAP	  binding,	  whereas	  no	  EcPAPR	  substitution	  enhanced	  association	  with	  AMP.	  	  
Analogous	  to	  kinetic	  studies,	  the	  binding	  of	  P-­‐loop	  variants	  to	  the	  native	  ligand	  was	  diminished,	  
relative	   to	   the	  wild-­‐type	  enzyme.	   	  Overall,	   this	   analysis	   shows	   that	  modification	  of	   the	  P-­‐loop	  
decreases	  binding	  and	  catalysis	  for	  the	  native	  ligand;	  however,	  the	  converse	  does	  not	  hold	  true	  
as	  amino	  acid	  replacements	  do	  not	  correlate	  with	  enhancements	  for	  the	  non-­‐cognate	  substrate	  
or	  ligand.	  	  	  
	  
As	   the	   P-­‐loop	   substitutions	   did	   not	   succeed	   in	   altering	   substrate	   specificity,	   a	   possible	  
contribution	  of	  the	  iron-­‐sulfur	  cluster	  was	  investigated.	  	  Based	  on	  the	  similar	  three-­‐dimensional	  
fold	  of	  APR	  and	  PAPR,	  we	  reasoned	  that	  EcPAPR	  residues	  (Y131,	  N132,	  D214,	  and	  T218)	  might	  
be	   replaced	  by	  cysteine,	  and	  enable	  coordination	  of	  an	   iron-­‐sulfur	  cluster	   (Figure	  5.2d	  and	  e).	  	  
	  
Figure	  5.3	  Relative	  change	  in	  ligand	  dissociation	  constants	  
for	  wild-­‐type	  APR	  or	  PAPR	  and	  P-­‐loop	  variants.	   	  The	  ratio	  
of	  Kd	  values	  is	  plotted	  relative	  to	  wild-­‐type	  enzymes.	  	  Blue	  
and	   green	   bars	   indicate inhibition	   by	   AMP	   and	   PAP,	  
respectively.	  Kd	  values	  and	  other	  kinetic	  parameters	  for	  all	  
proteins	  are	  presented	  in	  Appendix	  5.6.1.	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Thus,	   site-­‐directed	  mutagenesis	  was	   employed	   and	   the	   resulting	   protein	  was	   co-­‐expressed	   in	  
bacteria	  with	  the	  pDB1282	  plasmid	  that	  harbors	  the	   isc	  operon	  for	  cluster	  assembly	  [25].	   	  This	  
approach	   afforded	   10	   mg	   of	   protein	   per	   liter	   of	   culture.	   	   The	   resulting	   enzyme,	   termed	  
EcPAPR4cys,	  eluted	  as	  a	  dimer	   from	  the	  gel	   filtration	  column,	  analogous	   to	  wild-­‐type	  EcPAPR,	  
and	   the	   purity	   was	   estimated	   to	   be	   greater	   than	   95%	   (Figure	   5.4a,	   inset).	   	   The	   UV-­‐Vis	  
absorbance	  spectrum	  of	  EcPAPR4cys	  showed	  a	  maximum	  in	  the	  visible	  range	  at	  410	  nm,	  which	  
is	   similar	   to	   the	   [4Fe-­‐4S]	   chromophore	   of	   PaAPR	   (Figure	   5.4a)	   [16].	   	   However,	   ICP	   analysis	   of	  
EcPAPR4cys	  showed	  that	  each	  mole	  of	  protein	  contained	  only	  2.3	  mole	  of	  iron.	  	  The	  amount	  of	  
iron	  could	  not	  be	  increased	  by	  reconstitution	  or	  anaerobic	  purification	  (data	  not	  shown).	  	  	  
	  
To	   identify	  the	  types	  and	  relative	  amounts	  of	  the	  Fe/S	  clusters	   in	  EcPAPR4cys,	  we	  employed	  a	  
combination	   of	  Mössbauer	   and	   EPR	   spectroscopies	   and	   analytical	  methods.	   	   ICP	   analysis	   of	   a	  
	   	   	  	  
Figure	  5.4	  Spectroscopic	  characterization	  of	  EcPAPR4cys.	  a.	  UV-­‐vis	  absorption	  spectra	  of	  EcPAPR	  and	  
EcPAPR4cys.	  UV-­‐Vis	  absorption	  of	  10	  µM	  EcPAPR	  (¡)	  or	  EcPAPR4cys	  (l)	   in	  buffer	  containing	  50	  mM	  
Tris–HCl,	  150	  mM	  NaCl	  (pH	  7.4	  at	  25	  °C)	  and	  10%	  (v/v)	  glycerol.	  	  Inset,	  SDS-­‐PAGE	  gel	  with	  Coomassie	  
staining	  that	  shows	  purified	  EcPAPR4cys	  at	  an	  apparent	  molecular	  mass	  of	  ~28	  kDa,	  corresponding	  to	  
the	   molecular	   weight	   of	   the	   monomer.	   b.	   4.2-­‐K/53-­‐mT	   Mössbauer	   spectra	   of	   1	   mM	   EcPAPR4cys.	  
Experimental	  spectra	  are	  shown	  as	  vertical	  bars.	  The	  line	  is	  a	  quadrupole	  doublet	  simulation	  with	  the	  
following	  parameters:	  (–	  –)	  δ1=	  0.45	  mm/s,	  ΔEQ1=	  1.03	  mm/s	  (82%)	  and	  (…)	  δ2=	  0.27	  mm/s,	  ΔEQ,2=	  0.57	  
mm/s	  (15%).	  The	  parameters	  for	  the	  majority	  species	  (–	  –)	  are	  consistent	  with	  a	  [4Fe-­‐4S]2+	  cluster	  and	  
the	  parameters	  for	  the	  minor	  species	  (…)	  are	  consistent	  with	  a	  [2Fe-­‐2S]2+	  cluster.	  The	  remaining	  area	  
of	   the	  spectrum	   is	  a	  broad	   featureless	  absorbing	  species	   that	  accounts	   for	  approximately	  3%	  of	   the	  
total	   area	   of	   the	   spectrum.	   c.	   EPR	   spectrum	   of	   photoreduced	   EcPAPR4cys.	   	   Anaerobic	   EcPAPR4cys	  
(250	   µM)	   was	   photoreduced	   as	   described	   in	   Experimental	   Procedures.	   	   The	   EPR	   spectrum	   was	  
recorded	  at	  10	  K	  and	  the	  instrument	  parameters	  were:	  microwave	  power,	  10	  mW;	  receiver	  gain,	  2	  x	  
104;	  modulation	  amplitude,	  10	  G;	  and	  microwave	  frequency,	  9.43	  GHz.	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sample	   of	   EcPAPR4cys	   enriched	   in	   57Fe	   for	   Mössbauer	   spectroscopy	   reveals	   2.0	   Fe	   per	  
polypeptide.	  	  The	  4.2-­‐K/53-­‐mT	  Mössbauer	  spectrum	  of	  this	  sample	  (Figure	  5.4b)	  shows	  that	  the	  
majority	   (82%)	   of	   the	   iron	   associated	   with	   EcPAPR	   gives	   rise	   to	   a	   quadrupole	   doublet	   with	  
parameters	  typical	  of	  [4Fe-­‐4S]2+	  clusters:	  isomer	  shift	  (δ)	  of	  0.45	  mm/s	  and	  quadrupole	  splitting	  
parameter	  (ΔEQ)	  of	  1.03	  mm/s.	  	  The	  remaining	  iron	  (15%)	  exhibited	  properties	  reminiscent	  of	  a	  
[2Fe-­‐2S]2+	   cluster	   (δ	   =	   0.27	  mm/s,	  ΔEQ	  =	   0.57	  mm/s).	   	   The	   [2Fe-­‐2S]2+	   form	   is	   also	  observed	   in	  
plant	  and	  bacterial	  APRs	  and	  most	  likely	  results	  from	  partial	  degradation	  of	  the	  [4Fe-­‐4S]	  cluster	  
[16,17].	  	  An	  identical	  EPR	  sample	  does	  not	  reveal	  the	  spectroscopic	  signatures	  of	  paramagnetic	  
Fe/S	  clusters	  with	  S	  =	  1/2	  ground	  state	   (data	  not	  shown).	  Taken	  together,	  Mössbauer	  and	   ICP	  
analyses	   indicate	   that	   approximately	   half	   of	   all	   EcPAPR4cys	  monomers	   coordinate	   a	   [4Fe-­‐4S]	  
cluster.	  
	  
Although	  the	   iron-­‐sulfur	  cluster	   in	  APR	  does	  not	  undergo	  redox	  chemistry	  during	  catalysis,	   the	  
reduced	   form	   of	   the	   cluster	   can	   serve	   as	   a	   useful	   tool	   for	   characterization	   and	   mechanistic	  
studies.	  	  Along	  these	  lines,	  we	  have	  recently	  characterized	  the	  1+	  state	  of	  the	  [4Fe-­‐4S]	  cluster	  in	  
APR	   from	  Mycobacterium	   tuberculosis	   (MtAPR)	   using	   electron	   paramagnetic	   resonance	   (EPR)	  
spectroscopy	  [16].	   	  Like	  MtAPR,	  the	  EPR	  signal	  of	  the	  chemically	  reduced	  EcPAPR4cys	  is	  broad,	  
but	   shows	   rhombic	   symmetry	   with	   apparent	   g-­‐values	   of	   2.07,	   1.90	   and	   1.76,	   which	   are	  
characteristic	   of	   a	   [4Fe-­‐4S]	   cluster	   in	   the	   1+	   state	   (Figure	   5.4c).	   	   Spin	   quantitation	   of	   the	   EPR	  
signals	  from	  g	  =	  2.33	  to	  1.58	  indicate	  low	  reduction	  efficiency	  (0.04	  spins/mol	  compared	  to	  0.4	  
spins/mol	  for	  MtAPR).	  	  A	  likely	  explanation	  for	  the	  lower	  signal	  intensity	  is	  that	  the	  constellation	  
of	   residues	   surrounding	   the	   EcPAPR4cys	   cluster	   differs	   from	   MtAPR,	   resulting	   in	   distinct	  
electronic	   environments	   and	   reduction	   potentials	   (Appendix	   5.6.4).	   	   Nonetheless,	   the	   overall	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similarity	   of	   Mössbauer	   and	   EPR	   parameters	   to	   those	   observed	   for	   MtAPR	   provides	   further	  
support	  for	  the	  coordination	  of	  a	  [4Fe-­‐4S]2+	  cluster	  by	  EcPAPR4cys.	  
	  
We	  next	  evaluated	  the	  effect	  of	  the	  [4Fe-­‐4S]	  cluster	  in	  
EcPAPR4cys	   on	   the	   ability	   of	   EcPAPR	   to	   use	   PAPS	   or	  
APS	   as	   substrates.	   	   To	   this	   end,	   we	   first	   monitored	  
formation	   of	   the	   S-­‐sulfocysteine	   intermediate,	  which	  
is	  stable	  in	  plant	  and	  bacterial	  (P)APRs	  in	  the	  absence	  
of	   Trx	   [6,26].	   	   EcPAPR4cys	   was	   incubated	   in	   the	  
presence	  or	  absence	  of	  APS	  or	  PAPS	  and	  the	  mass	  of	  
the	   intact	   protein	   was	   analyzed	   by	   electrospray	  
ionization	   mass	   spectrometry	   (ESI-­‐MS).	   	   The	  
deconvoluted	   m/z	   values	   obtained	   from	   these	  
experiments	   are	   listed	   in	   Appendix	   5.6.2.	   	   In	   the	  
absence	   of	   substrate,	   the	   mass	   spectrum	   of	  
EcPAPR4cys	  is	  consistent	  with	  the	  molecular	  weight	  of	  
the	  apoenzyme	  (Figure	  5.5a,	  solid	  circles).	  	  Incubation	  
of	   EcPAPR4cys	   with	   PAPS	   resulted	   in	   formation	   of	   a	  
new	   series	   of	   ions	   with	   a	   molecular	   weight	   80	   Da	  
higher	   than	   enzyme	   alone,	   corresponding	   to	   the	   S-­‐
sulfocysteine	   adduct	   (Figure	   5.5b,	   asterisks).	   	   In	   the	  
presence	   of	   APS	   two	   series	   of	   ions	   were	   observed	  
corresponding	   to	  molecular	  weight	  of	   the	  apoenzyme	   (Figure	  5.5c,	   solid	   circles)	   and	   to	   the	  S-­‐
sulfocysteine	   intermediate	   (Figure	   5.5c,	   asterisks).	   	   Quantitative	   adduct	   formation	   was	   likely	  
	  	  
Figure	   5.5	   Mass-­‐spectrometric	   analysis	  
of	   intact	  EcPAPR4cys.	   	   ESI	  mass	   spectra	  
of	   EcPAPR4cys	   (10	   µM)	   without	   ligand	  
(a),	  with	  PAPS	  (b)	  and	  with	  APS	  (c).	  	  Ions	  
correspond	  to	  the	  enzyme	  (E,	  )	  and	  the	  
covalent	   enzyme	   S-­‐sulfocysteine	  
intermediate	  (E-­‐SO3
–,	  ∗ ).	  	  The	  calculated	  
masses	   after	   deconvolution	   of	   m/z	  
values	  are	  28829.23	  Da	  (a),	  28908.55	  Da	  
(b),	  28829.23	  and	  28909.54	  Da	   (c).	   	  MS	  
analysis	   was	   performed	   under	  
denaturing	   conditions,	   generating	   the	  
apoenzyme	   without	   the	   iron-­‐sulfur	  
cluster.	  	  See	  also	  Appendix	  5.6.2.	  
 170	  
limited	  by	  our	  finding	  that	  not	  all	  EcPAPR4cys	  monomers	  are	  associated	  with	  a	  [4Fe-­‐4S]	  cluster.	  	  
Control	  experiments	  performed	  with	  wild-­‐type	  enzymes	  and	  native	  substrates	  also	  showed	  the	  
expected	   mass	   shifts	   (Appendix	   5.6.2).	   	   These	   data	   show	   that	   EcPAPR4cys	   can	   generate	   the	  
adduct	  with	  PAPS	  or	  APS	  as	  a	  substrate.	  
	  
As	  reported	  above,	  EcPAPR4cys	  forms	  an	  enzyme	  S-­‐sulfocysteine	  intermediate	  with	  APS,	  which	  
should	   be	   competent	   for	   reduction	   by	   Trx	   to	   generate	   sulfite.	   	   To	   test	   this	   possibility,	   we	  
performed	  gel-­‐labeling	  experiments	  with	  [35S]-­‐labeled	  PAPS	  or	  APS	  (Appendix	  5.6.5).	  	  Incubation	  
of	   [35S]-­‐PAPS	   or	   [35S]-­‐APS	  with	   EcPAPR4Cys,	   and	   analysis	   of	   the	   reaction	   by	   nonreducing	   SDS-­‐
PAGE,	  showed	  a	  radioactive	  band	  at	  the	  molecular	  weight	  of	  EcPAPR	  indicating	  transfer	  of	  the	  
[35S]-­‐label	  to	  the	  enzyme.	  	  Addition	  of	  Trx	  to	  this	  enzyme	  intermediate	  resulted	  in	  the	  complete	  
loss	  of	  radiolabeling,	  as	  expected	  for	  reduction	  of	  the	  thio-­‐sulfate	  bond.	  	  Analogous	  experiments	  
were	  carried	  out	  using	  wild-­‐type	  EcPAPR,	  which	  demonstrated	  comparable	   labeling	  with	   [35S]-­‐
PAPS;	   by	   contrast,	   only	   a	   faint	   band	   was	   seen	   in	   reactions	   that	   contained	   [35S]-­‐APS.	   	   Taken	  
together,	   the	   MS	   and	   radiolabeling	   experiments	   demonstrate	   that	   EcPAPR4cys	   forms	   a	  
catalytically	   competent	   S-­‐sulfocysteine	   intermediate	   with	   PAPS	   or	   APS,	   and	   that	   the	   variant	  
reacts	  with	  APS	  with	  an	  enhanced	  rate	  compared	  with	  wild-­‐type	  protein.	  
	  
Having	   established	   that	   the	   EcPAPR4cys	   iron-­‐sulfur	   protein	   exhibits	   activity,	  we	   proceeded	   to	  
measure	  kinetic	  parameters	  for	  this	  variant.	  	  Table	  5.2	  shows	  the	  resultant	  data	  and	  is	  presented	  
alongside	  data	  obtained	  for	  wild-­‐type	  EcPAPR	  and	  PaAPR	  (see	  also	  Appendix	  5.6.6-­‐5.6.11).	  	  The	  
second-­‐order	   rate	   constant	   also	   known	   as	   the	   specificity	   constant	   (kcat/Km;	   representing	   the	  
reaction	  for	  free	  enzyme	  and	  substrate)	  demonstrates	  that	  EcPAPR4cys	  catalyzes	  APS	  reduction	  
with	  approximately	  600-­‐fold	   less	  efficiency	   relative	   to	  PaAPR.	   	   Importantly,	   however,	   that	   the	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rate	  of	  APS	  reduction	  by	  the	  variant	  protein	  is	  nearly	  1000-­‐fold	  increased	  compared	  to	  wild-­‐type	  
EcPAPR.	  	  On	  the	  other	  hand,	  the	  kcat/Km	  for	  reaction	  of	  EcPAPR4cys	  with	  PAPS	  is	  almost	  the	  same	  
as	  the	  native	  enzyme.	  	  	  
	  




















	   	   APS	   PAPS	   APS	   PAPS	   APSd	   PAPSe	   	   	  
PaAPR	   3.5	   2.2	  x	  107	   1.2	  x	  103	   3.1	   ≤1	  x	  10-­‐3	   0.1	   ≥100f	   35	   8.1	  x	  103	  
EcPAPR	   ≤0.1	   ≤40	   3.2	  x	  106	   ≤1	  x	  10-­‐3	   1.6	   ≥100f	   0.9	   3.4	  x	  103	   1.4	  
EcPAPR4cys	   2.3	   3.9	  x	  104	   6.8	  x	  106	   0.1	  	   1.8	   ≥100f	   0.1	   5.6	  x	  103	   4.3	  
	  
aMeasurements	   represent	   the	  average	  of	   three	  or	  more	   independent	  determinations	  and	   the	  S.	  D.	  was	  
≤15%	  of	  the	  value	  in	  all	  cases.	  	  The	  concentration	  of	  protein	  was	  determined	  by	  quantitative	  amino	  acid	  
analysis	  and	  further	  corrected	  by	  the	  amount	  of	  active	  enzyme	  present.	  	  Unless	  otherwise	  stated,	  reaction	  
conditions	  were	  100	  mM	  Bis-­‐Tris	  propane,	  pH	  6.5,	  5	  mM	  dithiothreitol,	  and	  10	  µM	  thioredoxin	  at	  30	  °C	  
(see	  Experimental	  Procedures).	  	  bkcat/Km	  values	  were	  measured	  as	  described	  in	  Experimental	  Procedures.	  	  
ckmax	  measured	  with	  saturating	  enzyme	  (see	  Experimental	  Procedures).	  	  
d10	  nM	  or	  e1	  µM	  thioredoxin	  was	  
used	   to	   measure	   K1/2	   values	   for	   sulfite	   production,	   by	   varying	   the	   concentration	   of	   enzyme	   (see	  
Experimental	  Procedures).	  	  fAt	  high	  concentrations	  of	  enzyme,	  the	  reactions	  became	  too	  fast	  to	  measure	  
by	  hand.	  	  gKd	  measured	  at	  pH	  7.5	  
	  
The	  preceding	  data	   indicate	   that	   the	   iron-­‐sulfur	   cluster	   in	   EcPAPR4cys	   contributes	   to	   catalytic	  
efficiency	  by	  enhancing	  substrate	  affinity	  and/or	  stabilizing	  the	  catalytic	  transition	  state.	  	  To	  gain	  
further	  insight	  into	  the	  role	  of	  the	  iron-­‐sulfur	  cluster	  in	  these	  rate	  enhancements,	  we	  evaluated	  
the	   saturating	   single-­‐turnover	   rate	   constant	   (kmax)	   and	   the	   K1/2	   for	   EcPAPR4cys	   and	   wild-­‐type	  
enzymes	   (Table	   5.2).	   	   These	   data	   reveal	   that	   EcPAPR4cys	   exhibits	   a	   100-­‐fold	   increase	   in	   the	  
value	  of	  kmax	  for	  APS	  relative	  to	  EcPAPR,	  while	  the	  kmax	  for	  PAPS	  was	  the	  same	  within	  error.	  	  A	  9-­‐
fold	  enhancement	  in	  the	  K1/2	  of	  PAPS	  was	  observed	  for	  EcPAPR4cys	  compared	  to	  wild-­‐type,	  but	  
differences	   in	   the	   K1/2	   of	   APS	   could	   not	   be	   discerned	   due	   to	   the	   limitations	   imparted	   by	   the	  
maximum	  achievable	  enzyme	  concentration.	   	  As	  expected,	  the	  K1/2	  values	  for	  all	  enzymes	  with	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cognate	  substrate	  were	  102-­‐103–fold	  greater	  relative	  to	  the	  non-­‐cognate	  substrate.	  	  The	  binding	  
of	  AMP	  and	  PAP	   to	   the	  aforementioned	  enzymes	  was	  also	  examined.	   	   The	   resulting	  Kd	   values	  
indicate	  that	  incorporation	  of	  the	  iron-­‐sulfur	  cluster	  in	  EcPAPR	  diminishes	  ligand	  binding	  by	  1.5	  
to	   3-­‐fold	   (Table	   5.2),	   suggesting	   that	   increased	   electrostatic	   repulsion	   from	   the	   negatively	  
charged	   [Fe4S4(Cys)4]2-­‐	   center	  may	   hamper	   binding	   of	   the	   5'-­‐phosphate	   dianion.	   	   Collectively,	  
these	  results	  demonstrate	  that	  the	  iron-­‐sulfur	  cluster	  in	  EcPAPR	  enhances	  substrate	  binding	  and	  
APS	  reduction.	  
	  
Finally,	   we	   evaluated	   the	   time-­‐dependent	   inactivation	   of	   EcPAPR	   and	   EcPAPR4cys	   under	  
prolonged	  exposure	  to	  aerobic	  conditions	  (Figure	  5.6).	   	   In	  the	  case	  of	  EcPAPR4cys,	  dissociation	  
of	  the	  iron-­‐sulfur	  cluster	  from	  the	  protein	  scaffold	  could	  also	  be	  monitored	  by	  loss	  of	  absorption	  
at	  410	  nm.	  	  Our	  data	  show	  that	  the	  half-­‐life	  of	  EcPAPR,	  which	  lacks	  the	  cluster,	  was	  ~35	  hours	  
(Figure	   5.6a).	   	   However,	   inactivation	   and	   concomitant	   cluster	   decomposition	   for	   EcPAPR4cys	  
occurred	   at	   an	   enhanced	   rate,	   with	   a	   half-­‐life	   of	   ~10	   hours	   (Figure	   5.6b	   and	   c).	   	   A	   strong	  
correlation	  between	  an	  intact	  iron-­‐sulfur	  cluster	  and	  catalytic	  activity	  is	  consistent	  with	  previous	  
data	  obtained	  from	  plant	  and	  bacterial	  APRs	  [11,17,18,27].	  
	   	   	  	  
Figure	  5.6	  Time-­‐dependent	  inactivation	  of	  SRs.	  	  Proteins	  (10	  µM)	  were	  exposed	  to	  aerobic	  conditions	  
at	  4	  °C	  over	  2	  days.	   	  At	  the	   indicated	  times,	  each	  enzyme	  was	  analyzed	  for	   its	  ability	  to	  catalyze	  the	  
reduction	  of	  APS	  or	   PAPS.	   	   EcPAPR	  with	   PAPS	   (a),	   EcPAPR4cys	  with	  APS	   (b),	   inset	   shows	   the	  UV-­‐vis	  




Assimilatory	  sulfonucleotide	  reductases	  –	  APR	  and	  PAPR	  –	  exhibit	  similar	  sequences,	  structure,	  
and	  thiol	  reaction	  chemistry	  [6-­‐9].	  	  Analysis	  of	  the	  phylogenetic	  distribution	  of	  SRs	  suggests	  that	  
PAPR	   evolved	   from	  APR	   through	   a	   single	   horizontal	   gene	   transfer	   event	   [10].	   	   The	   conserved	  
reaction	  mechanism	  serves	  as	  a	   template	   for	   the	  divergent	  evolution	  of	   these	   two	  subclasses,	  
which	  catalyze	  the	  reduction	  of	  substrates	  that	  differ	  by	  a	  single	  3'-­‐phosphate	  group.	  	  There	  are	  
over	   15	   such	   enzyme	   families	   with	   common	   reaction	   mechanisms	   despite	   differences	   in	  
substrate	   utilization	   [28,29].	   	   In	   divergent	   evolution,	   protein	   folds	   and	   active	   site	   structural	  
features	  are	  frequently	  reused	  amongst	  different	  family	  members	  and	  adapted	  to	  new	  catalytic	  
purposes	  [30].	  	  Indeed,	  a	  closer	  look	  at	  the	  active	  sites	  of	  PaAPR	  and	  EcPAPR	  reveals	  that	  several	  
strictly	   conserved,	   positively	   charged	   lysine	   and	   arginine	   residues	   interact	   with	   the	   sulfate	  
moiety	   or	   α-­‐phosphate	   (Figure	   5.7	   and	   Appendix	   5.6.4).	   	   Moreover,	   the	   C-­‐terminal	   peptide	  
segment	   bearing	   the	   ECGH	  motif,	   which	   includes	   the	   cysteine	   nucleophile,	   is	   also	   conserved.	  	  
However,	   two	   critical	   features	   distinguish	   APR	   and	   PAPR	   active	   sites:	   residues	   in	   the	   P-­‐loop	  
region	  and	   the	  presence/absence	  of	  an	   iron-­‐sulfur	   cluster.	   	   These	  distinctions	  afford	  a	  unique	  
opportunity	   to	   explore	   substrate	   recognition	   and	   identify	   underlying	   principles	   that	   govern	  
specific	   features	   of	   APR	   that	   were	   targeted	   for	   alteration	   during	   the	   specialization	   of	   PAPR	  
function.	  
	  
GTP/ATP-­‐dependent	   proteins	   contain	   a	   glycine-­‐rich	   motif	   with	   the	   sequence,	   GXXGXGKT/S,	  
known	  as	   the	  P-­‐loop	   [7,31,32].	   	   This	   structural	  moiety	   forms	  a	   large	   anion	  hole	   that	   interacts	  
with	  phosphates.	  	  ATP	  pyrophosphatases	  (ATP	  PPases)	  harbor	  a	  modified	  P-­‐loop,	  also	  known	  as	  
the	  PP	  motif	  [33],	  with	  the	  fingerprint	  peptide	  SGGXDS/T.	   	  A	  highly	  modified	  version	  of	  the	  PP	  
motif	  was	  discovered	  in	  EcPAPR	  (SXG),	  which	  is	  also	  found	  in	  enzymes	  with	  homologous	  protein	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folds,	   including	   ATP	   sulfurylase	   and	  GMP	   synthetase	   [33-­‐35].	   	   Among	   ATP	   PPases,	   the	   P-­‐loop	  
interacts	  with	  the	  5'-­‐phosphates	  of	  ATP	  [34,36].	   	   Interestingly,	  however,	  structures	  of	  APR	  and	  
PAPR	   co-­‐crystallized	   with	   nucleotides	   show	   that	   the	   3'-­‐group	   on	   the	   ribose	   interacts	   with	  
residues	  in	  the	  P-­‐loop	  [9].	  	  In	  SRs,	  the	  motif	  is	  characterized	  by	  the	  hydrophobic	  β1-­‐strand	  and	  
α3-­‐helix	   that	   flank	   the	   N-­‐	   and	   C-­‐terminal	   sides	   of	   the	   SFS–GAED	   and	   SSSFGIQA	   sequences	   in	  
PaAPR	   and	   EcPAPR,	   respectively.	   	   Differences	   in	   the	   P-­‐loop	  motif	   have	   also	   been	  observed	   in	  
ATP	   synthases,	   wherein	   the	   sequence	   alterations	   have	   been	   suggested	   to	   imply	   diversity	   in	  
nucleotide	   recognition	   and/or	   catalytic	  mechanism	   [37].	   	   Since	   SRs	   share	   a	   common	   catalytic	  
mechanism	   the	   change	   in	   P-­‐loop	   sequences,	   particularly	   the	   acidic	   residues	   in	   APR,	   could	   be	  
implicated	  in	  substrate	  discrimination.	  	  
	  
In	   this	   study,	   site-­‐directed	  mutagenesis	   of	   the	   P-­‐loop	   entailed	   the	   replacement	   of	   negatively	  
charged	   E65	   and	   D66	   PaAPR	   residues	   with	   corresponding	   neutral	   glutamine	   and	   alanine	  
residues	   found	   in	  EcPAPR	  and	  visa	  versa.	   	  Characterization	  of	   the	   resulting	  variants	  has	   led	   to	  
two	   significant	   observations.	   	   First,	   any	   change	   in	   P-­‐loop	   residues	   had	   an	   adverse	   effect	   on	  
catalytic	   efficiency,	   underscoring	   the	   essential	   nature	   of	   these	   highly	   conserved	  motifs	   in	   the	  
two	  subclasses	  of	  catalysts.	   	  Second,	  variants	  of	  APR	  exhibited	  only	  a	  modest	  enhancement	   in	  
PAP	  binding.	   	  This	   finding	   indicates	  that	  while	  neutral	  P-­‐loop	  residues	  contribute	  somewhat	  to	  
accommodating	  the	  3'-­‐phosphate	  group,	  they	  cannot	  account	  entirely	  for	  substrate	  specificity.	  	  
Moreover,	   P-­‐loop	   variants	   of	   PAPR	   did	   not	   enhance	   binding	   to	   AMP,	   showing	   that	   the	  mere	  
presence	  of	  a	  negatively	  charged	  residue	  in	  the	  P-­‐loop	  sequence	  was	  insufficient.	   	  Along	  these	  
lines,	   it	   is	  possible	  that	  additional	  P-­‐loop	  modifications	  are	  required	  to	  enhance	  the	  binding	  of	  
PAPS.	   	  For	   instance,	  EcPAPR	  S52	  and	  S53	  (of	  the	  SSFGIQA	  sequence)	  establish	  hydrogen	  bonds	  
with	   the	   3'-­‐phosphate	   group	   of	   PAPS,	   whereas	   the	   corresponding	   residues	   in	   PaAPR	   (of	   the	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SFSGAED	   sequence)	   do	   not	   make	   any	   contact	   with	   the	   APS	   3'-­‐hydroxyl	   group.	   	   Future	  
experiments	  will	  be	  required	  to	  delineate	  this	  and	  other	  possibilities.	  
	  
The	   second	   distinguishing	   feature	   among	   SRs	   is	   that	   APR	   contains	   the	   conserved	   cysteine	  
sequence,	  CC…CXXC,	  which	  ligates	  an	  essential	  [4Fe-­‐4S]	  cluster.	  	  In	  place	  of	  this	  cofactor,	  PAPR	  
possesses	  the	  semi-­‐conserved	  motif,	  YN…DXXT	  that	  links	  the	  α7-­‐helix	  and	  C-­‐terminal	  β-­‐turn	  by	  
hydrogen	  bond	  interactions.	  	  In	  the	  course	  of	  our	  study,	  we	  attempted	  to	  substitute	  the	  cysteine	  
pairs	  in	  PaAPR	  with	  the	  YN…DT	  motif;	  however,	  this	  variant	  failed	  to	  express	  in	  E.	  coli	  (data	  not	  
shown).	  	  As	  an	  alternative	  approach	  to	  investigate	  the	  role	  of	  this	  region,	  we	  engineered	  an	  iron-­‐
sulfur	   cluster	   into	   EcPAPR.	   	   Based	   on	   the	   high	   degree	   of	   sequence	   and	   structural	   homology	  
between	  SRs	  an	  empirical	  approach	  was	  adopted	  to	  generate	  the	  new	  metal-­‐binding	  site.	  	  This	  
strategy	  has	  been	  employed	  to	  design	  novel	  metalloproteins,	  including	  the	  creation	  of	  a	  Mn(II)-­‐
binding	   site	   in	   cytochrome	   c	   peroxidase	   based	   on	   structural	   homology	   with	   manganese	  
peroxidase	  [38,39].	  	  Favorable	  protein	  folds	  such	  as	  the	  Trx	  scaffold	  have	  also	  been	  exploited	  to	  
introduce	   a	   cofactor	   and	   alter	   enzyme	   function	   [40].	   	   Assembly	   of	   a	   [2Fe-­‐2S]	   cluster	   through	  
directed	   evolution	   served	   to	   bridge	   two	   monomeric	   Trx	   subunits	   and	   enabled	   the	   resulting	  
dimer	   to	   catalyze	   oxygen-­‐dependent	   sulfhydryl	   oxidation	   [41,42].	   	   In	   another	   instance,	   the	  
second	   cysteine	   residue	   of	   the	   native	   CXXXCXXXC	  motif	   in	   the	   catalytic	   subunit	   of	   dimethyl-­‐
sulfoxide	   reductase	   (DmsA)	  was	   replaced	   leading	   to	   the	   assembly	   of	   a	   paramagnetic	   [3Fe-­‐4S]	  
cluster	  [43].	  	  	  
	  
In	  the	  case	  of	  EcPAPR,	  our	  goal	  was	  to	  introduce	  a	  [4Fe-­‐4S]	  cluster	  in	  order	  to	  probe	  the	  role	  of	  
the	  metallocenter	   in	   sulfonucleotide	   reduction.	   	   Spectroscopy	   (UV-­‐vis,	  Mössbauer,	   EPR,	  mass)	  
and	  single	  turnover	  kinetic	  analysis	  were	  employed	  to	  characterize	  the	  resulting	  variant,	  termed	  
 176	  
EcPAPR4cys.	   	   Though	   we	   did	   not	   identify	   conditions	   that	   permitted	   quantitative	   cluster	  
incorporation	   into	  each	  protein	  monomer,	  our	   spectroscopic	  data	  provides	   strong	   support	   for	  
the	  assignment	  of	  a	   [Fe4S4(Cys)4]2-­‐	   center	  and	  compares	   favorably	  with	   studies	  of	  MtAPR	   [16].	  
Comparison	  of	  kcat/Km	  between	  EcPAPR4cys	  with	  wild-­‐type	  PaAPR	  and	  EcPAPR	  showed	  that	  the	  
installation	  of	  an	  iron-­‐sulfur	  cluster	  dramatically	  improved	  the	  ability	  to	  turnover	  the	  APS	  (~103-­‐
fold).	   	  Further	  studies	  revealed	  a	  minor	  role	   in	  substrate	  binding,	  with	  the	  majority	  of	  the	  rate	  
enhancement	   stemming	   from	   the	   improvement	   in	   kmax,	   which	   reports	   on	   the	   rate	   of	   the	  
chemical	  step.	   	  Furthermore,	  time-­‐dependent	  inactivation	  studies	  also	  showed	  that	  the	  cluster	  
was	  required	  for	  catalytic	  activity.	  	  	  
	  
Previously,	   we	   have	   observed	   mid-­‐range	   electrostatic	   interactions	   between	   the	   iron-­‐sulfur	  
cluster	  and	  the	  ligand	  present	  within	  the	  APR	  active	  site	  [16].	  	  These	  findings	  are	  also	  supported	  
by	   computational	   analysis	   [44].	   	   Based	   on	   these	   data,	   we	   proposed	   that	   the	   cluster	   cofactor	  
plays	  a	  role	  in	  pre-­‐organizing	  positively	  charged	  active	  site	  residues	  and	  in	  substrate	  activation.	  	  
Specifically,	  that	  the	  charge	  from	  and	  polarization	  within	  the	  [Fe4S4(Cys)4]2–	  cluster	  could	  serve	  
to	  activate	  the	  sulfate	  group	  of	  APS,	  thereby	  facilitating	  S-­‐OP	  cleavage	  and	  S-­‐S	  bond	  formation	  in	  
the	  reaction.	  	  In	  the	  absence	  of	  an	  iron-­‐sulfur	  cluster,	  PAPR	  could	  achieve	  something	  similar	  via	  
repulsion	   between	   the	   extra	   3’-­‐phosphate	   group	   of	   PAPS	   and	   the	   sulfate	   end	   of	   the	   5’-­‐
phosphosulfate.	  	  Our	  observation,	  that	  insertion	  of	  an	  iron-­‐sulfur	  cluster	  in	  PAPR	  enhances	  the	  
rate	  of	  APS	  reduction,	  is	  entirely	  consistent	  with	  this	  model.	  	  In	  this	  regard,	  iron-­‐sulfur	  clusters	  
are	   extremely	   versatile	   cofactors	   with	   enzymatic	   functions	   in	   electron	   transfer,	   Lewis-­‐acid	  
assisted	  catalysis,	  radical	  generation,	  and	  source	  of	  sulfur	  during	  biosyntheses	  of	  cofactors	  [45-­‐
52].	  	  This	  present	  study	  extends	  this	  list	  of	  functions	  to	  include	  substrate	  specificity.	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From	  our	  study	  and	  sequence	  analysis,	   it	   is	  clear	   that	   the	  natural	  evolution	  of	  PAPR	  from	  APR	  
involved	  several	  iterations	  of	  mutations.	  	  These	  factors	  are	  not	  easily	  recapitulated,	  and	  we	  note	  
that	   none	   of	   the	   variants	   explored	   in	   this	   study	   resulted	   in	   a	   complete	   change	   of	   substrate	  
specificity.	   	   Functional	   studies	   of	   EcPAPR4cys	   and	   the	   P-­‐loop	   variants	   suggest	   that	   these	  
enzymes	  may	   represent	   intermediates	   in	   the	   evolutionary	   pathway	   of	   SRs	   (Figure	   5.7).	   	   This	  
proposal	  is	  based	  on	  two	  interesting	  observations	  related	  to	  the	  catalytic	  efficiency	  and	  relative	  
stability.	  	  First,	  is	  the	  striking	  similarity	  between	  (P)APR	  from	  B.	  subtilis	  and	  the	  P-­‐loop	  variants	  
of	  PaAPR.	  	  These	  enzymes	  coordinate	  an	  iron-­‐sulfur	  cluster,	  but	  also	  contain	  a	  neutral	  residue	  in	  
the	   position	   equivalent	   to	   residue	   66	   of	   PaAPR	   (or	   position	   58	   of	   EcPAPR).	   	   However,	   these	  
	  
Figure	  5.7	  Model	  for	  divergent	  evolution	  of	  PAPR	  from	  APR.	  	  APR	  and	  PAPR	  can	  be	  considered	  to	  be	  at	  
the	  margins	  of	  divergent	  evolution	  with	  optimum	  catalytic	  efficiency	  for	  APS	  (blue)	  and	  PAPS	  (green),	  
as	   indicated	   by	   the	   color	   spectrum	   in	   the	   arrow.	   A	   comparison	   of	   their	   active	   sites	   reveals	   two	  
consistent	  features,	  namely,	  strictly	  conserved	  positively	  charged	  lysine	  and	  arginine	  residues	  (orange	  
circles)	   that	   interact	  with	   the	   substrate,	   and	   the	   C-­‐terminal	   peptide	   bearing	   the	   ECGH	  motif,	  which	  
includes	  the	  cysteine	  nucleophile,	  is	  also	  conserved	  (pink	  circles).	  The	  catalysts	  differ	  largely	  in	  their	  P-­‐
loop	   sequence	   motifs	   and	   their	   ability	   to	   ligate	   a	   [4Fe-­‐4S]	   cluster	   through	   four	   cysteine	   residues.	  	  
Based	  on	  the	  catalytic	  efficiencies	  for	  APS	  and	  PAPS,	  EcPAPR4cys	  and	  the	  P-­‐loop	  variants	  appear	  to	  be	  
intermediates	   in	  the	  evolutionary	  path	  of	   the	   functional	  divergence	  of	  PAPR	  from	  APR.	  The	  catalytic	  
efficiency	   of	   the	   P-­‐loop	   variants	   of	   EcPAPR	   for	   PAPS	   is	   comparable	   to	   the	  wild-­‐type	   enzyme	   and	   is	  
therefore	  indicated	  by	  a	  break	  in	  the	  arrow.	  Details	  regarding	  the	  kinetic	  parameters	  of	  all	  variants	  are	  
presented	  in	  Table	  5.2	  and	  Appendix	  5.6.1.	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catalysts	   all	   exhibit	   a	   significant	   reduction	   in	   catalytic	   efficiency	  with	  APS	   (≥102),	   compared	   to	  
wild-­‐type	  PaAPR	  (Table	  5.1).	  	  Second,	  like	  APR-­‐B	  from	  P.	  patens,	  the	  EcPAPR	  P-­‐loop	  variants	  lack	  
the	  iron-­‐sulfur	  cluster	  and	  also	  display	  a	  decrease	  in	  enzyme	  activity	  relative	  to	  wild-­‐type	  PaAPR	  
(Table	  5.1).	  	  Interestingly,	  we	  note	  that	  both	  PpAPR-­‐B	  and	  EcPAPR	  gain	  in	  stability	  by	  forfeiting	  
the	  iron-­‐sulfur	  cluster.	  	  EcPAPR	  retains	  enzymatic	  activity	  over	  2	  days	  in	  contrast	  to	  APR,	  which	  
loses	   activity	  within	   half	   a	   day.	   	   Similarly,	   PpAPR-­‐B	   remains	   active	   for	   5	   days	   compared	   to	   its	  
homolog,	  PpAPR,	  which	  harbors	  a	   [4Fe-­‐4S]	   cluster	  and	   is	  only	  active	   for	  2	  days	  under	  aerobic	  
conditions	   [18].	   	   Finally,	   we	   note	   that	   both	   BsAPR	   and	   PpAPR-­‐B	   have	   markedly	   decreased	  
catalytic	   efficiency	   relative	   to	   other	   SRs	   (Table	   5.1),	   indicating	   that	   these	   enzymes	   are	   not	   as	  
specialized	   for	   the	   reductase	   function	   as	   the	   latter	   group	   of	   catalysts.	   	   Taken	   together,	   these	  
observations	  show	  how	  characteristics	  of	  our	  experimentally	  generated	  variants	  resemble	  those	  
of	   SRs	   from	   naturally	   occurring	   species,	   corroborating	   our	   proposal	   that	   the	   variants	   are	  
representative	   of	   intermediates	   in	   the	   path	   of	   divergent	   evolution	   of	   PAPR	   from	   APR	   (Figure	  
5.7).	  
	  
In	   conclusion,	   the	   cysteine	   motif	   that	   coordinates	   the	   [4Fe-­‐4S]	   cluster	   within	   APR	   can	   be	  
accommodated	  by	  the	  PAPR	  scaffold	  and	  confers	  enhanced	  binding	  and	  catalytic	  activity	  for	  the	  
APS	   substrate.	   	   This	   work	   provides	   valuable	   insight	   into	   the	   contribution	   of	   the	   iron-­‐sulfur	  
cluster	   to	   catalysis,	   and	   a	   better	   understanding	   of	   the	  mechanisms	   involved	   in	   the	   divergent	  






5.5	  Experimental	  Procedures	  
APS	  (≥95%)	  was	  obtained	  from	  Biolog	  Life	  Sciences	  Institute	  (Bremen,	  Germany).	   	  PAPS	  (≥88%)	  
was	  obtained	  from	  Calbiochem	  (La	  Jolla,	  CA).	  PAP,	  AMP,	  iron	  (III)	  chloride	  were	  purchased	  from	  
Sigma-­‐Aldrich	  (St.	  Louis,	  MO).	  	  Fe-­‐57	  metal	  was	  purchased	  from	  Isoflex	  USA	  (San	  Francisco,	  CA)	  
and	  micro	  bio-­‐spin	  P30	  columns	  were	  from	  Bio-­‐Rad	  Laboratories	  (Hercules,	  CA).	  	  	  
	  
5.5.1	  Cloning,	  Expression	  and	  Purification	  of	  SRs.	   	  Construction	  of	  the	  expression	  vectors	  encoding	  
wild	  type	  PAPR	  from	  E.coli	  (EcPAPR),	  wild-­‐type	  APR	  from	  M.	  tuberculosis	  (MtAPR)	  and	  wild-­‐type	  APR	  from	  
P.	  aeruginosa	  (PaAPR)	  cloned	  into	  the	  vector	  pET24b	  (Novagen)	  has	  been	  previously	  described	  [4,6].	  	  The	  
EcPAPR4cys	   variant	   was	   generated	   from	   the	   EcPAPR	   template	   using	   the	   Quik-­‐change	   site-­‐directed	  
mutagenesis	  kit	  (Stratagene,	  La	  Jolla,	  CA).	  	  Successful	  cloning	  was	  confirmed	  by	  DNA	  sequencing	  analysis.	  	  
Plasmids	  encoding	  EcPAPR4cys	  or	  PaAPR	  pET24	  and	  pACYC	  [containing	  genes	  encoding	  the	   isc	  operon	  of	  
six	   accessory	   proteins	   required	   for	   Fe–S	   cluster	   biosynthesis	   in	   A.	   vinelandii	   under	   the	   control	   of	   an	  
arabinose-­‐inducible	  promoter	  [53]]	  were	  co-­‐transformed	  into	  E.	  coli	  BL21(DE3)	  (Novagen,	  San	  Diego,	  CA)	  
and	  plated	  on	  L-­‐agar	  50	  µg/ml	  kanamycin	  and	  100	  µg/ml	  carbenicillin.	  	  Plasmid	  encoding	  EcPAPR,	  EcPAPR	  
A58D	   and	   EcPAPR	  Q57E	   pET24	  was	   transformed	   into	   E.	   coli	   BL21(DE3)	   and	   plated	   on	   L-­‐agar	   50	   µg/ml	  
kanamycin.	  	  A	  single	  colony	  was	  picked	  and	  added	  to	  5	  ml	  of	  L-­‐broth	  plus	  antibiotics	  and	  grown	  overnight	  
with	   shaking	   at	   37	   °C.	   	   This	   culture	  was	   used	   as	   a	   0.5%	  1	   L	   of	   L-­‐broth	   plus	   antibiotics	   and	   grown	  with	  
shaking	   at	   37	   °C	   until	   absorbance	   at	   600	   nm	   reached	   approximately	   0.6.	   	   For	   EcPAPR4cys	   and	   PaAPR	  
arabinose	  and	  iron	  citrate	  were	  added	  to	  final	  concentrations	  of	  20	  mM	  and	  0.8	  mM,	  respectively	  and	  the	  
culture	  grown	  as	  above	   for	  1	  hr.	   	  At	   this	  point	   the	   flasks	  were	   removed	   from	   the	   incubator.	   	   IPTG	  was	  
added	   to	   a	   final	   concentration	   of	   0.3	   mM	   and	   the	   flasks	   were	   returned	   to	   the	   incubator	   and	   grown	  
overnight	  at	  18	  °C	  with	  shaking	  at	  200	  rpm.	  	  For	  EcPAPR,	  EcPAPR	  A58D	  and	  EcPAPR	  Q57E	  after	  the	  culture	  
reached	  an	  absorbance	  of	  0.6	  at	  600	  nm,	  IPTG	  was	  added	  to	  a	  final	  concentration	  of	  0.4	  mM,	  the	  flasks	  
returned	  to	  the	  incubator	  and	  grown	  for	  5	  hours	  at	  30˚C.	  	  Cultures	  were	  harvested	  by	  centrifugation	  (4	  °C,	  
4,300	  g).	  	  After	  removal	  of	  the	  supernatant	  the	  pellets	  were	  stored	  at	  -­‐80	  °C	  until	  required.	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All	  purification	  steps	  were	  carried	  out	  at	  4	  °C.	   	  Cell	  pellets	  were	  resuspended	  in	  30	  ml	  Buffer	  A	  (20	  mM	  
sodium	  phosphate,	   0.5	  M	  NaCl,	   10	  mM	   imidazole;	   pH	  7.4)	   supplemented	  with	  0.1	  mM	  PMSF,	   10µg/ml	  
DNase,	  5	  µg/ml	  lysozyme	  and	  lysed	  by	  sonication.	  	  Lysates	  were	  centrifuged	  (20,000g,	  15	  min)	  and	  loaded	  
onto	   a	   5	  ml	  HisTrap	  Chelating	   column	   (GE	  Healthcare,	   Piscataway,	  NJ)	   equilibrated	   in	   the	   same	  buffer.	  	  
Unbound	  material	  was	  washed	  off	  with	  50	  ml	  of	  Buffer	  A	  and	  bound	  proteins	  then	  eluted	  with	  Buffer	  B	  
(20	  mM	  phosphate,	   0.5	  M	  NaCl,	   250	  mM	   imidazole;	   pH	   7.4).	   	   Fractions	   containing	   the	   desired	   protein	  
were	  pooled,	  concentrated	  by	  centrifugation	  (Amicon	  10	  kDa	  cutoff,	  Millipore,	  Billerica,	  MA)	  and	  loaded	  
onto	  a	  16/60	  Superdex	  200	  size	  exclusion	  column	  previously	  equilibrated	  in	  Buffer	  C	  (50	  mM	  Tris-­‐HCl,	  150	  
mM	  NaCl,	  5	  mM	  DTT,	  10%	  glycerol;	  pH	  7.4	  at	  25	  °C).	  	  Fractions	  containing	  sulfonucleotide	  reductase	  were	  
pooled,	  snap-­‐frozen	  in	  liquid	  nitrogen,	  and	  stored	  at	  -­‐80	  °C.	  
	  
Protein	   concentrations	   were	   determined	   by	   quantitative	   amino	   acid	   analysis	   [Molecular	  
Structure	  Facility,	  UC-­‐Davis,	  CA	  and	  Ref.	  [6]]	  and	  corrected	  by	  the	  number	  of	  active	  molecules,	  
as	   determined	   by	   the	   assay	   described	   below.	   	   Iron	   content	   of	   each	   protein	   preparation	   was	  
determined	  in	  duplicate	  by	  inductively	  coupled	  plasma	  (ICP)	  analysis.	  	  
	  
5.5.2	   Chemical	   Reconstitution	   of	   EcPAPR4cys–Reconstitution	   experiments	  were	   performed	   in	  
the	  glove	  box.	   	  EcPAPR4cys	  desalted	   into	  1.5	  mL	  Buffer	  C	  using	  P30	  columns,	  was	  successively	  
incubated,	   with	   gentle	   stirring,	   with	   5	   mM	   DTT	   (30	   min),	   5	   M	   equivalents	   of	   FeCl3	   (added	  
dropwise	  then	   incubated	  for	  45	  min)	  and	  Na2S.9H2O	  (added	  dropwise	  then	   incubated	  for	  2	  h).	  	  
Excess	   ligand	   was	   removed	   from	   the	   reconstitution	   reaction	   by	   desalting	   the	   mixture	   using	  
PD10-­‐Sepharose	  columns,	  GE	  Healthcare)	  into	  Buffer	  C.	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5.5.3	   Preparation	   of	   EcPAPR4cys	   for	   EPR	   and	   Mössbauer	   Spectroscopy.	   	   Samples	   of	  
EcPAPR4cys	  suitable	  for	  EPR	  spectroscopy	  were	  prepared	  inside	  of	  an	  anaerobic	  chamber	  with	  
O2	   levels	  ≤	  1	  ppm.	   	  The	  procedure	   for	  photoreduction	  was	  carried	  out	  as	  previously	  described	  
[16].	  	  Briefly,	  purified	  EcPAPR4cys	  was	  exchanged	  into	  anaerobic	  buffer	  containing	  50	  mM	  Tris–
HCl,	   150	  mM	  NaCl	   (pH	   8.5	   at	   4	   °C)	   and	   10%	   glycerol.	   	   To	   reduce	   the	   cluster	   in	   EcPAPR4cys,	  
reactions	  contained	  250	  µM	  enzyme,	  25	  mM	  sodium	  oxalate,	  and	  250	  µM	  deazaflavin	  in	  a	  total	  
volume	  of	  250	  µL.	   	   The	   reaction	  mixtures	  were	   transferred	   to	  EPR	   tubes,	   chilled	   in	  an	   ice-­‐salt	  
bath	  (-­‐6	  °C)	  and	  irradiated	  with	  light	  from	  a	  100	  W	  quartz	  halogen	  lamp	  (Applied	  Photophysics,	  
Surrey,	  UK)	  for	  30	  min.	   	  After	   illumination,	  samples	  were	  immediately	  frozen	  in	  liquid	  nitrogen	  
and	   analyzed	   by	   low-­‐temperature	   EPR.	   	   Mössbauer	   spectra	   were	   recorded	   on	   proteins	   that	  
contained	   57Fe	   in	  place	  of	  natural-­‐abundance	   iron.	   	   57Fe	  was	   incorporated	   into	  EcPAPR4cys	  by	  
supplementation	   of	   E.	   coli	   growth	   media,	   and	   samples	   contained	   1	   mM	   protein,	   were	  
transferred	  to	  Mössbauer	  cups	  and	  frozen	  in	  liquid	  nitrogen.	  
	  
5.5.4	   EPR	   Spectroscopy.	   	   X-­‐band	   EPR	   spectra	   of	   photoreduced	   samples	   were	   recorded	   on	   a	  
Bruker	   EMX	   spectrometer	   (Billerica,	   MA)	   equipped	   with	   an	   Oxford	   Instruments	   ITC4	  
temperature	  controller,	  a	  Hewlett-­‐Packard	  model	  5340	  automatic	  frequency	  counter	  and	  Bruker	  
gaussmeter.	  	  Figure	  legend	  contains	  relevant	  instrumental	  parameters.	  	  The	  sample	  buffer	  was	  
used	   to	   record	   the	   baseline	   under	   conditions	   identical	   to	   those	   in	   which	   the	   sample	   spectra	  
were	   obtained.	   	   The	   baseline	   was	   subtracted	   from	   the	   EcPAPR4cys	   spectrum	   shown	   in	   the	  
figure.	  	  Spin	  concentration	  in	  EcPAPR4cys	  samples	  was	  determined	  by	  double	  integration	  of	  the	  
EPR	  signal	  over	  a	  range	  of	  2	  kgauss	  and	  comparison	  with	  double	  integrals	  of	  1	  mM	  Cu(ClO4)2	  in	  
sample	  buffer.	   	  Figures	  were	  generated	  using	  Spin	  Count	  (ver	  2.6.7)	  created	  by	  Professor	  M.P.	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Hendrich	   at	   Carnegie	   Mellon	   University.	   	   Spin	   Count	   is	   available	   at	  
http://www.chem.cmu.edu/groups/hendrich/.	  	  
	  
5.5.5	   Mössbauer	   Spectroscopy.	   	   Mössbauer	   spectra	   were	   recorded	   on	   a	   spectrometer	   from	  
WEB	   research	   (Edina,	   MN)	   operating	   in	   the	   constant	   acceleration	   mode	   in	   transmission	  
geometry.	  	  Spectra	  were	  recorded	  with	  the	  temperature	  of	  the	  sample	  maintained	  at	  4.2	  K	  in	  an	  
externally	  applied	  magnetic	  field	  of	  53	  mT	  oriented	  parallel	  to	  the	  γ-­‐beam.	  	  The	  quoted	  isomer	  
shifts	  were	  relative	  to	  the	  centroid	  of	  the	  spectrum	  of	  a	  foil	  of	  α-­‐Fe	  metal	  at	  room	  temperature.	  	  
Data	  analysis	  was	  performed	  using	  the	  program	  WMOSS	  from	  WEB	  research.	  
	  
5.5.6	   Mass	   Spectrometry.	   	   For	   mass	   spectrometric	   analysis,	   samples	   were	   prepared	   by	  
incubating	  10	  µM	  enzyme	  with	  2	  mM	  APS	  or	  PAPS,	  where	  appropriate,	   for	  40	  min	  at	  30	  °C	  to	  
allow	  for	  formation	  of	  S-­‐sulfocysteine	  intermediate.	  	  Subsequently,	  the	  samples	  were	  exchanged	  
into	  0.1%	  formic	  acid	  using	  Micro	  Bio-­‐Spin	  P30	  columns	  (Bio	  Rad).	  	  Intact	  proteins	  samples	  were	  
analyzed	  on	  an	  electrospray	  linear	  ion	  trap	  mass	  spectrometer	  (LTQ-­‐XL,	  Thermo	  Scientific)	  after	  
separation	   on	   an	   Agilent	   Eclipse	   XDB-­‐C8	   2.1	   mm	   x	   15	   mm	   trap	   with	   mobile	   phases	   A	   (0.1%	  
formic	  acid	  in	  water)	  and	  B	  (0.1%	  formic	  acid	  in	  acetonitrile)	  which	  was	  used	  to	  trap,	  desalt	  and	  
elute	  proteins	  onto	  a	  Varian	  2.1	  mm	  x	  50	  mm	  5	  µm	  PLRP-­‐S	  C18	  column	  with	  a	  gradient	  of	  5%	  to	  
100%	  in	  14	  min	  at	  a	  flow	  rate	  of	  200	  µL/min.	  
	  
5.5.7	   Gel-­‐labeling.	   	   In	   this	   experiment	   5	   µM	   EcPAPR	   or	   EcPAPR4cys	  were	   incubated	   at	   room	  
temperature	   in	  50	  mM	  bis-­‐tris	  propane	  (pH	  7.0),	  100	  mM	  NaCl	  with	  [35S]-­‐PAPS	  or	  [35S]-­‐APS;	  or	  
with	  radiolabeled	  substrate	  for	  10	  min	  followed	  by	  the	  addition	  of	  10	  µM	  Trx.	  	  Laemmeli	  sample	  
buffer,	  without	  β-­‐mercaptoethanol,	  was	  added	  to	  terminate	  the	  reaction.	   	  The	  reactions	  were	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heated	   at	   60	   ˚C	   for	   3	  min	   and	   resolved	   by	   SDS-­‐PAGE.	   	   The	   incorporation	   of	   radioactivity	  was	  
analyzed	  with	  a	  Phosphorimager.	  	  
	  
5.5.8	   Kinetics	   Assays.	   	   Reactions	  were	   carried	   out	   at	   30	   °C.	   	   Unless	   otherwise	   indicated,	   the	  
buffer	  consisted	  of	  100	  mM	  bis-­‐tris	  propane	  (pH	  6.5)	  supplemented	  with	  5	  mM	  DTT	  and	  10	  µM	  
E.	   coli	   thioredoxin.	   	   Production	   of	   [35]SO32-­‐	   from	   [35S]-­‐APS	   or	   [35S]-­‐PAPS	   was	   monitored	   using	  
charcoal-­‐based	  separation	  and	  scintillation	  counting	  as	  previously	  reported	  .	  	  The	  substrate	  was	  
incubated	  with	  excess	  enzyme	   to	  ensure	   single-­‐turnover	   conditions	   (>2.5-­‐fold	  molar	  excess	  of	  
enzyme).	   	  The	   reaction	  progress	  curve	  was	  plotted	  as	   the	   fraction	  of	  product	  versus	   time	  and	  
was	   fit	   by	   a	   single	   exponential	   (eq.	   1),	   where	   F	   is	   the	   fraction	   product,	   A	   is	   the	   fraction	   of	  
substrate	  converted	  to	  product	  at	  completion,	  and	  t	  time.	   	  The	  observed	  rate	  constant	  (kobs)	   is	  
the	  product	  of	  the	  enzyme	  concentration	  and	  the	  apparent	  second-­‐order	  rate	  constant	  kcat/Km	  
(eq.	  2).	  	  Under	  these	  conditions,	  the	  observed	  rate	  constant	  is	  linearly	  dependent	  upon	  enzyme	  
concentration,	  and	  independent	  of	  substrate	  concentration,	  which	  demonstrated	  that	  substrate	  
is	   not	   saturating.	   	   The	   reported	   kcat/Km	   values	   are	   for	   single-­‐turnover	   conditions,	   but	   are	  
equivalent	   to	   steady-­‐state	   kcat/Km	   .	   	   Kinetic	   data	  were	  measured	   in	   at	   least	   two	   independent	  
experiments	  and	  the	  standard	  error	  was	  typically	  less	  than	  15%.	  	  
	  
F	  =	  A[1–e(–kobst)]	   (1)	  
	  
kobs	  =	  (kcat/Km)[E]	   (2)	  
	  
The	   maximal	   observed	   rate	   constant	   (kmax)	   was	   determined	   at	   a	   saturating	   concentration	   of	  
enzyme	  ([E]	  >>	  Kd)	  and	  this	  was	  confirmed	  by	  the	  observation	  of	  the	  same	  rate	  constant	  at	  two	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different	  concentrations	  of	  enzyme	  (150	  µM	  and	  300	  µM).	  	  Because	  the	  observed	  rate	  constant	  
is	  independent	  of	  the	  concentration	  of	  enzyme,	  this	  indicates	  that	  the	  observed	  rate	  constant	  is	  
equal	   to	   the	  maximal	   single-­‐turnover	   rate	   constant	   (kobs	   =	   kmax)	   and	   reports	   on	   the	   chemical	  
steps	  after	  substrate	  binding	  (eq.	  1).	  	  
	  
Under	   single-­‐turnover	   conditions,	   it	   is	   expected	   that	   the	   concentration	   dependence	   of	   the	  
enzyme	  will	  be	  hyperbolic	   (eq.	  3).	   	  The	  K1/2	  value	   indicates	   the	  protein	  concentration	  at	  which	  
half	  of	  the	  substrate	  is	  bound.	  	  For	  K1/2	  determinations,	  the	  APR	  concentration	  was	  varied	  over	  a	  
wide	  range	  in	  the	  presence	  of	  Trx.	  
	  
kobs	  =	  kmax[E]/(K1/2	  +	  [E])	   (3)	  
	  
The	   inhibition	   constant	   (Ki)	   was	   measured	   for	   ligands,	   AMP	   and	   PAP	   by	   inhibiting	   the	   APR	  
reaction	  under	  kcat/Km	  conditions	  at	  pH	  7.5	  with	  varying	  concentration	  of	  inhibitor	  (I).	  	  The	  data	  
were	  fit	  to	  a	  simple	  model	  for	  competitive	  inhibition	  (eq.	  4)	  and,	  with	  subsaturating	  APR,	  the	  Ki	  
is	  equal	  to	  the	  equilibrium	  dissociation	  constant	  (Kd)	  of	  the	  inhibitor.	  
	  
(kcat/Km)obs	  =	  (kcat/Km)/(1+	  [I]/Ki)	   (4)	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5.6	  Appendix	  
Appendix	  5.6.1	  Table	  of	  single-­‐turnover	  rate	  and	  dissociation	  constants	  for	  PaAPR,	  EcPAPR	  and	  









	   APS	   PAPS	   	   	  
PaAPR	   1.8	  x	  108	   3.5	  x	  104	   35	  ±	  2	   8.1	  x	  103	  
PaAPR	  
Asp66Ala	  
2.5	  x	  107	   9.6	  x	  103	   57	  ±	  12	   3.3	  x	  103	  
PaAPR	  
Glu65Gln	  





5.0	  x	  105	   2.5	  x	  103	   2.8	  x	  103	   9.7	  x	  10
3	  
EcPAPR	   840	   1.2	  x	  108	   3.4	  x	  103	   1.4	  ±	  0.6	  
EcPAPR	  
Ala58Asp	  
720	   1.3	  x	  105	   1.4	  x	  104	   8.0	  x	  103	  
EcPAPR	  
Gln57Glu	  




420	   2.6	  x	  104	   1.8	  x	  104	   2.4	  x	  103	  
	  
aMeasurements	   represent	   the	  average	  of	   two	  or	  more	   independent	  determinations	  and	   the	  S.D.	  was	  
≤25%	   of	   the	   value	   in	   all	   cases.	   	   Unless	   otherwise	   stated,	   reaction	   conditions	   were	   100	  mM	   Bis-­‐Tris	  
propane,	  pH	  7.5,	  5	  mM	  dithiothreitol,	  and	  10	  µM	  thioredoxin	  at	  30	  °C	  (see	  Experimental	  Procedures).	  	  
bkcat/Km	  values	  were	  measured	  as	  described	  in	  Experimental	  Procedures.	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Appendix	  5.6.2	  Table	  of	  mass	  measurements	  of	  EcPAPR,	  EcPAPR4cys	  and	  MtAPR	  
and	  associated	  enzyme	  S-­‐sulfocysteine	  complexes.	  
	  
Enzymea	   Measured	  mass	  (Da)b	   ∆mc,	  d	  	  
EcPAPR	   28910.41	  (28909.76)	   N/A	  
EcPAPR	  +	  APS	   28990.84	  (28989.76)	   80.43	  
EcPAPR	  +	  PAPS	   28989.97	  (28989.76)	   79.56	  
EcPAPR4cys	   28829.23	  (28828.84)	   N/A	  
EcPAPR4cys	  +	  APS	   28909.54	  (28908.84)	   80.31	  
EcPAPR4cys	  +	  PAPS	   28908.55	  (28908.84)	   79.56	  
MtAPR	   28356.88	  (28356.87)	   N/A	  
MtAPR	  +	  APS	   28437.45	  (28436.87)	   80.57	  
MtAPR	  +	  PAPS	   28436.29	  (28436.87)	   79.41	  
	  
aIn	  reactions	  that	  contained	  APS	  or	  PAPS,	  the	  enzyme	  was	  incubated	  with	  substrate	  prior	  to	  
mass	  analysis,	  as	  described	  in	  Experimental	  Procedures.	  	  bThe	  average	  experimental	  value	  of	  
the	   most	   abundant	   isotopic	   mass	   over	   the	   charge	   state	   distribution,	   calculated	   by	  
deconvolution.	   	  Theoretical	  values	  are	  shown	   in	  parenthesis	  and	  were	  calculated	  based	  on	  
the	   amino	   acid	   sequence.	   	   cThe	  mass	   differences	   in	   this	   table	   have	   been	   calculated	   with	  
respect	  to	  the	  masses	  of	  the	  corresponding	  intact	  protein.	  	  dWith	  the	  exception	  of	  EcPAPR	  +	  
PAPS,	  EcPAPR4cys	  +	  PAPS	  and	  MtAPR	  +	  APS,	  two	  series	  of	  ions	  were	  observed	  corresponding	  
to	  the	  enzyme	  alone	  and	  the	  enzyme	  S-­‐sulfocysteine	  adduct.	   	  Relative	  abundance	  of	  these	  
species	  is	  provided	  in	  the	  text.	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Appendix	  5.6.3	  Primary	  sequence	  alignment	  of	  sulfonucleotide	  reductases	  from	  different	  species.	  
	  
	  
Appendix	   5.6.3	   Primary	   sequence	   alignment	   of	   sulfonucleotide	   reductases	   from	   P.	   aeruginosa,	  M.	  
tuberculosis,	  B.	  subtilis,	  A.	  thaliana,	  P.	  patens	  (two	  isoforms,	  APR	  and	  APR-­‐B),	  E.	  coli,	  and	  S.	  cerevisiae.	  	  
The	  ClustalW2	   (v2.1)	  Multiple	   Sequence	  Alignment	  program	   (Larkin,	   2007)	  was	  used	   to	   align	   all	   the	  
sequences.	  	  Strictly	  conserved	  residues	  are	  outlined	  in	  red,	  red	  letters	  indicate	  conserved	  residues	  and	  
conserved	  regions	  are	  boxed	  in	  blue.	  	  Residues	  flanking	  the	  active	  site	  are	  boxed	  in	  green.	  	  Positions	  of	  
cysteine	  residues	  that	  coordinate	  to	  the	  [4Fe-­‐4S]	  cluster	  are	   indicated	  below	  the	  sequence	  with	   (l).	  	  
Alignment	  pictures	  were	  rendered	  with	  the	  server	  ESPript	  2.2	  (http://espript.ibcp.fr).	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Appendix	  5.6.4	  Comparison	  of	   key	  active	   site	   regions	   in	  PaAPR	  and	  EcPAPR.	   	  Active	   site	   contacts	  of	  
PaAPR	  and	  EcPAPR	  with	  APS	  and	  PAPS	  respectively,	  plotted	  in	  two	  dimensions.	  	  Interactions	  are	  based	  
on	   PaAPR	   (PDB	   deposition	   2GOY)	   and	   EcPAPR	   (PDB	   deposition	   1SUR),	   crystal	   structures,	   prior	  
functional	  studies	  (Hong,	  2009;	  Chartron,	  2006)	  and	  the	  present	  study.	  	  Contacts	  of	  EcPAPR	  with	  PAPS	  
have	   been	   assumed	   from	   the	   coordinates	   of	   PAP	   (ScPAPR,	   PDB	   deposition	   2OQ2)	   and	  APS	   (PaAPR,	  
PDB	  deposition	  2GOY).	  	  Protein	  residues	  in	  proximity	  of	  the	  ligand	  are	  shown,	  with	  hydrogen	  bonding	  
interactions	   indicated	   as	   dotted	   lines	  with	   arrows	   denoting	   the	   direction	   of	   the	   bond.	   	   Interactions	  
from	  the	  substrate	  or	  the	  residue	  backbones	  of	  the	  enzyme are	  distinguished	  from	  interactions	  with	  
residue	  side	  chains	  by	  a	  solid	  dot	  at	  the	  end	  of	  the	  interaction	  line.	  	  Interactions	  highlighted	  in	  red	  are	  
unique	  between	  the	  two	  active	  sites.	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Appendix	  5.6.5	  Gel	   labeling	  of	  wild	   type	  EcPAPR	  and	  EcPAPR4cys.	   	  Gel	   labeling	  of	  wild	   type	  EcPAPR	  
(lanes	   1-­‐4)	   and	   EcPAPR4cys	   (lanes	   5-­‐8)	  with	   either	   [35S]-­‐PAPS	  or	   [35S]-­‐APS,	  with	   or	  without	   Trx,	  was	  
carried	  out	  as	  described	  in	  the	  Experimental	  Procedures.	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Appendix	   5.6.6	   The	   reaction	   progress	   curve	   for	   P-­‐loop	   variants	   of	   PaAPR	   and	   EcPAPR.	   	   Under	  
subsaturating	  concentration	  of	  substrate,	  the	  reaction	  is	  described	  by	  the	  apparent	  second	  order	  rate	  
constant,	   kcat/Km.	   The	   enzyme	   concentration	   was	   varied	   as	   indicated	   due	   to	   the	   linear	   relationship	  
between	  concentration	  and	  activity.	  	  a.	  Reduction	  of	  APS	  with	  PaAPR	  (2	  nM,	  l),	  D66A	  PaAPR	  (10	  nM,	  
n)	  and	  E65Q	  PaAPR	  (20	  nM,	  u).	  	  b.	  Reduction	  of	  APS	  with	  EcPAPR	  (10	  µM,	  l),	  A58D	  EcPAPR	  (10	  µM,	  
n)	  and	  Q57E	  EcPAPR	  (10	  µM,	  u).	  	  c.	  Reduction	  of	  PAPS	  with	  PaAPR	  (5	  µM,	  l),	  D66A	  PaAPR	  (10	  µM,	  
n)	  and	  E65Q	  PaAPR	  (10µM,	  u).	   	  d.	  Reduction	  of	  PAPS	  as	  substrate	  with	  EcPAPR	  (2.5	  nM,	  l),	  A58D	  
EcPAPR	  (0.5	  µM,	  n)	  and	  Q57E	  EcPAPR	  (0.5	  µM,u).	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Appendix	   5.6.7	   Binding	   of	   AMP	   and	   PAP	   to	   P-­‐loop	   variants	   of	   PaAPR	   and	   EcPAPR.	   	  Nonlinear-­‐least-­‐
squares	   fit	   of	   the	   data	   to	   a	   model	   for	   simple	   competitive	   inhibition	   (eq.	   2)	   gave	   the	   dissociation	  
constant	  Kd.	  	  a.	  Kd
AMP	  of	  PaAPR	  (l),	  D66A	  PaAPR	  (n)	  and	  E65Q	  PaAPR	  (u);	  inset,	  E65Q	  PaAPR	  scaled.	  	  
b.	  Kd
AMP	  of	  EcPAPR	  (l),	  A58D	  EcPAPR	  (n)	  and	  Q57E	  EcPAPR	  (u).	   	  c.	  Kd
PAP	  of	  PaAPR	  (l),	  D66A	  PaAPR	  
(n)	  and	  E65Q	  PaAPR	  (u).	  	  d.	  Kd
PAP	  of	  EcPAPR	  (l),	  A58D	  EcPAPR	  (n)	  and	  Q57E	  EcPAPR	  (u);	  inset,	  A58D	  
EcPAPR	  scaled.	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Appendix	  5.6.8	  Reaction	  progress	  curves	  for	  PaAPR,	  EcPAPR	  and	  EcPAPR4cys.	  
	  
	  	  
Appendix	   5.6.8	   Reaction	   progress	   curves	   for	   PaAPR,	   EcPAPR	   and	   EcPAPR4cys	   at	   pH	   6.5.	   	   Under	  
subsaturating	  concentration	  of	  substrate,	  the	  reaction	  is	  described	  by	  the	  apparent	  second-­‐order	  rate	  
constant,	  kcat/Km,	  for	  PaAPR	  (a),	  EcPAPR	  (b)	  and	  EcPAPR4cys	  (c)	  with	  APS	  (l)	  and	  PAPS	  (n).	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Appendix	  5.6.9	  Maximal	  rate	  constant,	  kmax,	  measured	  under	  single	  turnover	  conditions.	  
	  
	  	  
Appendix	   5.6.9	   Maximal	   rate	   constant,	   kmax,	   measured	   under	   single	   turnover	   conditions	   with	  
saturating	  enzyme	  at	  pH	  6.5	   for	  PaAPR	  (a),	  EcPAPR	  (b),	  EcPAPR4cys	   (c)	  with	  APS,	  and	   for	  PaAPR	  (d),	  
EcPAPR	  (e),	  EcPAPR4cys	  (f)	  with	  PAPS.	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Appendix	  5.6.10	  	  The	  apparent	  affinity,	  K1/2,	  under	  single	  turnover	  conditions	  at	  pH	  6.5	  for	  PaAPR	  (a),	  
EcPAPR	  (b)	  and	  EcPAPR4cys	  (c)	  with	  APS,	  and	  for	  PaAPR	  (d),	  EcPAPR	  (e)	  and	  EcPAPR4cys	  (f)	  with	  PAPS.	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Appendix	  5.6.11	  	  Binding	  of	  AMP	  and	  PAP	  to	  EcPAPR4cys	  measured	  at	  pH	  7.5.	   	  The	  average	  of	  three	  
independent	  determinations	  is	  shown,	  and	  the	  error	  bars	  indicate	  the	  standard	  deviations.	  	  Nonlinear-­‐
least-­‐squares	  fit	  of	  the	  data	  to	  a	  model	  for	  simple	  competitive	  inhibition	  (eq.	  4)	  gave	  the	  dissociation	  
constants	  Kd
AMP	  (a)	  and	  Kd
PAP	  (b)	  for	  EcPAPR4cys.	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Chapter	  6	  
Conclusions	  and	  Future	  Directions	  
6.1	  Abstract	  
With	   the	  emergence	  of	  multidrug	   resistant	  and	   latent	   tuberculosis	   infection,	  efforts	  are	  being	  
made	  to	  identify	  new	  antibacterial	  drug	  targets.	  	  Toward	  this	  end,	  adenosine-­‐5'-­‐phosphosulfate	  
reductase	   (APR),	   has	   been	   validated	   as	   a	   target	   against	   persistent	   phase	   tuberculosis.	   	   In	   the	  
previous	  chapters	  we	  focused	  on	  elucidating	  mechanistic	  details	  of	  APR,	  in	  particular	  the	  role	  of	  
its	   essential	   iron-­‐sulfur	   cofactor.	   	   In	   chapters	   3	   and	   4,	   we	   characterized	   the	   electronic	   and	  
geometric	  properties	  of	  the	  [4Fe-­‐4S]	  cluster	  of	  APR	  using	  spectroscopic	  techniques	  and	  density	  
functional	   theory	   calculations.	   	   Additionally,	   we	   investigated	   the	   evolution	   of	   the	   switch	   in	  
substrate	  specificity	  between	  APRs	  and	  PAPRs	  in	  chapter	  5.	  	  In	  this	  chapter	  we	  recapitulate	  the	  
key	   findings	   and	   significance	   of	   this	   work	   and	   discuss	   the	   future	   directions	   to	   further	   our	  
understanding	  of	  the	  role	  of	  the	  iron-­‐sulfur	  cluster	  and	  mechanism	  of	  catalysis	  of	  APR.	  	  	  
	  
6.2	  Conclusions:	  a	  Role	  for	  the	  [4Fe-­‐4S]	  Cluster	  in	  APS	  Reduction	  
In	   the	   past	   decade	   several	   enzymes	   in	   mycobacterial	   sulfur	   metabolic	   pathways	   have	   been	  
identified	   and	   validated	   as	   promising	   drug	   targets	   for	   anti-­‐tubercular	   therapy.	   	   However,	   as	  
described	   in	   chapter	   1,	   many	   fundamental	   aspects	   of	   enzymes	   associated	   with	   sulfur	  
metabolism	  remain	  poorly	  understood.	  	  Adenosine-­‐5'-­‐phosphate	  sulfate	  reductase	  (APR)	  is	  one	  
such	  enzyme	  that	  catalyzes	  the	  first	  committed	  step	  of	  sulfate	  assimilation.	  	  APR	  coordinates	  to	  
a	  [4Fe-­‐4S]	  cluster	  that	  is	  essential	  for	  catalysis	  but	  the	  precise	  role	  of	  the	  cluster	  has	  remained	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largely	   unknown.	   	   The	  overall	   aim	  of	   this	   thesis	  was	   to	  understand	   the	  mechanistic	   details	   of	  
APR	  and	  in	  particular,	  to	  elucidate	  the	  role	  of	  its	  metal	  center.	  	  Toward	  this	  end,	  we	  developed	  
an	  active	  site	  model	  in	  chapter	  2,	  illustrating	  the	  functional	  features	  required	  for	  the	  interaction	  
of	  APR	  with	   a	   ligand.	   	   These	   studies	   also	   provide	   a	   pharmacological	   roadmap	   for	   the	   rational	  
design	  of	  small	  molecules	  as	  potential	  inhibitors	  of	  APR.	  	  	  
	  
Further	  we	   investigated	  the	  role	  of	   the	   [4Fe-­‐4S]	  cluster	  of	  APR	  using	  spectroscopic	   techniques	  
such	   as	   electron	   paramagnetic	   resonance.	   	   Chapter	   3	   detailed	   our	   efforts	   to	   successfully	  
generate	  a	  paramagnetic	  state	  of	  the	  cluster	  as	  we	  reported	  the	  EPR	  spectra	  of	  MtAPR	  for	  the	  
first	  time.	  	  Additionally,	  using	  spectroscopic	  and	  kinetic	  analyses,	  we	  identified	  an	  essential	  role	  
for	   the	   active	   site	   residue,	   Lys144,	   which	   interacts	   with	   both	   the	   iron-­‐sulfur	   cluster	   and	   the	  
substrate,	   APS.	   	   Based	   on	   this	   study,	   we	   proposed	   a	   role	   for	   the	   iron-­‐sulfur	   cluster	   in	   pre-­‐
organizing	  active	  site	  residues	  such	  as	  Lys144	  for	  catalysis	  and	  in	  substrate	  activation.	  	  
	  
In	   chapter	   4,	   we	   characterized	   the	   geometric	   and	   electrostatic	   properties	   of	   the	   iron-­‐sulfur	  
cluster	   in	   APR	   using	   density	   functional	   theory	   analysis	   and	   extended	   X-­‐ray	   fine	   structure	  
spectroscopy.	   	   Findings	   from	   this	   study	   highlighted	   a	   unique	   function	   for	   the	   cysteine	   dyad	  
coordination	   in	   modulating	   the	   redox	   potential	   of	   the	   iron-­‐	   sulfur	   cluster	   and	   a	   role	   for	   the	  
cluster	   in	   stabilizing	   the	   transition	   state	   via	   favorable	   positioning	   of	   Lys144	   in	   the	   active	   site.	  	  
Thus	  the	  study	  also	  confirmed	  the	  critical	  role	  of	  Lys144	  as	  a	  link	  between	  [4Fe-­‐4S]	  cluster	  and	  
APS	  to	  maintain	  charge	  balance	  in	  the	  active	  site.	  
	  
Finally,	  we	  explored	  the	  switch	   in	  substrate	  specificity	  between	  APR	  and	   its	  divergent	  relative,	  
PAPR	   focusing	   on	   the	   influence	   of	   the	   residues	   P-­‐loop	   role	   and	   the	   presence	   of	   the	   [4Fe-­‐4S]	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cluster	   on	   substrate	   recognition.	   	   The	   results	   presented	   in	   the	   study	  underscore	   the	  essential	  
role	   of	   the	   cluster	   in	   APR,	   in	   particular	   its	   contribution	   to	   the	   chemical	   steps	   in	   the	   catalytic	  
mechanism	  of	  APS	  reduction.	  	  
	  
6.3	  Future	  Directions	  
6.3.1	  Exploring	  the	  proximity	  of	  the	  iron-­‐sulfur	  cluster	  to	  the	  substrate	  and	  active	  site	  residues	  
during	  the	  catalytic	  cycle.	  
In	  chapter	  3	  we	  reported	  the	  conditions	  to	  reduce	  the	  [4Fe-­‐4S]2+	  cluster	  in	  MtAPR	  to	  the	  [4Fe-­‐
4S]+	  state	  which	  could	  then	  be	  as	  used	  as	  a	  tool	  for	  mechanistic	  studies	  analogous	  to	  other	  iron-­‐
sulfur	  enzymes	  such	  as	  aconitase	  [1].	  	  Substrate	  binding	  to	  MtAPR	  led	  to	  a	  marked	  sharpening	  of	  
the	   EPR	   signal	   and	   an	   increase	   in	   intensity,	  which	  was	   not	   observed	   for	   a	   panel	   of	   substrate	  
analogs,	   including	   ADP.	   	   Although	   structural	   and	   Mössbauer	   data	   show	   that	   the	   iron-­‐sulfur	  
cluster	  does	  not	  come	  into	  direct	  contact	  with	  the	  substrate,	  EPR	  studies	  indicate	  that	  there	  are	  
mid-­‐range	   electrostatic	   interactions	   between	  
APS	   and	   the	   iron-­‐sulfur	   cluster	   [2].	   Based	   on	  
our	   findings	   we	   have	   proposed	   a	   possible	  
mechanism	   for	   the	   formation	   of	   the	   S-­‐
sulfocysteine	   intermediate	   of	   APR	   with	   APS	  
(Figure	   6.1).	   	   According	   to	   our	   model,	   the	  
iron-­‐sulfur	   cluster	  may	   serve	   to	   pre-­‐organize	  
the	  positively	  side	  chain	  of	  Lys-­‐144	  within	  the	  
active	   site,	   such	   that	   the	   substrate	   can	  
establish	   interactions	   with	   the	   residue.	  	  
Through	   this	   network	   of	   interactions,	   the	  
	  
Figure	   6.1	   Proposed	   reaction	   pathway	   for	  
covalent	   S-­‐sulfocysteine	   intermediate	   formation	  
catalyzed	   by	   APR.	   	   Based	   on	   the	   structure	   of	  
Saccharomyces	   cerevisiae	   PAPR	   (Yu,	   2008)	   ,	   the	  
homology	  model	  of	  PaAPR	   shows	  Cys256	  within	  
hydrogen-­‐bonding	   distance	   of	   the	   sulfate	   group	  
of	  APS	  as	  well	  as	  the	  side	  chain	  of	  Lys-­‐144.	   	  Lys-­‐
144,	   in	   turn,	   is	   proximal	   to	   Cys-­‐140,	   which	  
coordinates	  to	  the	  [4Fe-­‐4S]	  cluster.	  	  Through	  the	  
network	  of	  interactions,	  the	  [4Fe-­‐4S]	  cluster	  may	  
serve	   to	   position	   Lys-­‐144	   and	   activate	   the	  
substrate.	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charge	   from	   and	   polarization	   within	   the	   iron-­‐sulfur	   cluster	   may	   serve	   to	   activate	   the	   sulfate	  
group	   of	   APS	   for	   catalytic	   reduction.	   	   A	   logical	   extension	   of	   the	   observations	   from	   this	   study	  
would	   be	   to	   study	   the	   enzyme	  –	   substrate	   interactions	   by	   electron	  nuclear	   double-­‐resonance	  
(ENDOR)	   spectroscopy.	   	   ENDOR	   spectroscopy	   combines	   the	   principles	   of	   EPR	   and	   NMR	  
spectroscopies	   and	   is	   especially	   useful	   for	   yielding	   information	   about	   nuclei	   that	   have	   weak	  
interactions	  with	  the	  paramagnetic	  site.	  	  By	  using	  suitably	  labeled	  substrate	  (33S-­‐APS	  or	  17O-­‐APS)	  
or	   substrate	   analogs	   (ADP	   or	   ADPβF)	   and	   generating	   the	   paramagnetic	   [4Fe-­‐4S]+	   state	   of	   the	  
cluster,	  ENDOR	  spectroscopy	  could	  be	  applied	  to	  MtAPR	  to	  determine	  the	  proximity	  of	  the	  iron-­‐
sulfur	  center	  with	  ligand	  in	  the	  active	  site	  during	  the	  catalytic	  cycle.	  	  These	  analyses	  would	  thus	  
further	  our	  understanding	  of	  the	  role	  of	  the	  iron-­‐sulfur	  cluster	  in	  catalytic	  cycle	  of	  APR.	  
	  
6.3.2	  Investigating	  the	  electronic	  properties	  of	  the	  iron-­‐sulfur	  cluster	  during	  the	  catalytic	  cycle.	  
As	  discussed	  in	  Chapter	  3,	  APS	  reduction	  proceeds	  via	  nucleophilic	  attack	  by	  the	  catalytic	  Cys256	  
of	   PaAPR	   on	   APS	   to	   form	   a	   S-­‐sulfocysteine	   intermediate	   (E-­‐Cys−Sγ−SO3-­‐).	   	   In	   the	   structure	   of	  
PaAPR,	   crystallization	   was	   performed	   in	   the	   presence	   of	   an	   excess	   (60-­‐fold	   over	   enzyme	  
concentration)	  of	  APS	   [3].	   	  Under	   these	  conditions	   the	   flexible	  C-­‐terminal	  peptide	  bearing	   the	  
Cys−Sγ−SO3-­‐	   moiety	   was	   likely	   positioned	   out	   of	   the	   active	   site	   and	   hence	   disordered	   in	   the	  
protein	   crystals.	   	   This	   hampered	   investigation	   of	   finer	   details	   of	   the	   catalytic	   mechanism,	   in	  
particular	  the	  interactions	  of	  residues	  in	  the	  C-­‐terminal	  peptide	  with	  the	  active	  site.	   	  However,	  
the	  position	  of	  Cys256	  in	  the	  active	  site	  of	  PaAPR	  can	  be	  determined	  via	  homology	  modeling	  of	  
PaAPR	  with	  the	  crystal	  structure	  of	  the	  yeast	  PAPR	  [3-­‐5]	   (Figure	  6.2).	   	   In	  the	  homology	  model,	  
Cys256	  is	  proximal	  to	  the	  sulfate	  group	  of	  APS	  (3.3	  Å	  from	  the	  sulfur	  atom).	  	  Although	  Cys256	  is	  
about	   6	   Å	   away	   from	   the	   closest	   Fe	   atom	   in	   the	   iron-­‐sulfur	   cluster,	   it	   could	   influence	   the	  
electrostatic	   properties	   of	   the	   cluster	   via	   the	   Lys144	   side	   chain	   (3.9	  Å	   from	  Cys256),	  which	   in	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turn	   is	   within	   hydrogen-­‐
bonding	   distance	   of	   the	  
cluster	   coordinating	   Cys140	  
residue.	   	  The	   influence	  of	   the	  
C-­‐terminal	   peptide	   on	   the	  
electrostatics	   of	   the	   active	  
site	   during	   the	   formation	   of	  
the	   S-­‐sulfocysteine	  
intermediate	   can	   be	   studied	  
by	   applying	   DFT	   calculations	  
to	  a	  molecular	  cluster	  based	  on	  the	  homology	  model	  of	  PaAPR	  with	  the	  C-­‐terminal	  residues	  250-­‐
267	  in	  the	  active	  site.	  	  Following	  the	  methodology	  outlined	  in	  chapter	  4	  we	  could	  determine	  the	  
optimized	  geometry	  and	  electrostatic	  potential	  of	  all	  the	  components	  of	  the	  active	  site	  including	  
the	   [4Fe-­‐4S]2+	   cluster,	  Cys256,	  APS,	  and	  key	   residues	   in	   the	  active	   site.	   	   The	   study	  would	  help	  
examine	  previously	  unsolved	  questions	   such	  as	  what	   components	  of	   the	  active	   site	  direct	   the	  
formation	   and	   successive	   reduction	   of	   the	   S-­‐sulfocysteine	   intermediate,	   the	   position	   and	  
function	  of	  the	  iron-­‐sulfur	  cluster	  and	  cationic	  residues	  (Lys144,	  Arg242,	  and	  Arg245)	  during	  the	  
formation	  of	  the	  S-­‐sulfocysteine	  intermediate	  and	  how	  the	  formation	  of	  this	  intermediate	  state	  
protects	  the	  [4Fe-­‐4S]2+	  cluster	  against	  oxidative	  degradation.	  	  Further,	  similar	  calculations	  could	  
be	  done	  replacing	  ADP	  for	  APS	  to	  determine	  factors	  influencing	  substrate	  selectivity.	  	  
	  
6.3.3	  Examining	  the	  PAPR-­‐Trx	  protein-­‐protein	  interface	  
In	  chapter	  5,	  we	  explored	  the	  evolution	  of	  substrate	  selectivity	  between	  APR	  and	  PAPR,	  which	  
share	   sequence	   and	   structural	   homology	   and	   a	   conserved	   reaction	   mechanism.	   	   Both	   the	  
	  
Figure	   6.2	   Homology-­‐modeled	   structure	   of	   PaAPR	   (in	   gray)	  
showing	   the	  position	  of	   the	  C-­‐terminal	  peptide	   (in	  blue)	  over	   the	  
active	  site.	  	  Left,	  homology-­‐model	  of	  PaAPR	  based	  on	  ScPAPR	  (Yu,	  
2008),	   coordinates	   of	   the	   [4Fe-­‐4S]	   cluster	   and	   APS	   are	   from	   the	  
structure	   of	   PaAPR	   (PDB	   entry	   2GOY).	   	   The	   amino	   and	   carboxyl	  
termini	  are	  indicated	  by	  N-­‐	  and	  C-­‐	  respectively.	  Right,	  closer	  look	  at	  
the	  interactions	  of	  Cys256	  with	  the	  sulfate	  moiety	  of	  APS	  and	  the	  
side-­‐chain	  of	  Lys144	  (red	  dashes).	  	  Cys256	  would	  be	  ~6	  Å	  from	  the	  
closest	  Fe	  atom	  in	  the	  [4Fe-­‐4S]	  cluster	  (green	  dashes).	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sulfonucleotide	  reductases	  (SR)	  require	  thioredoxin	  (Trx)	  to	  supply	  the	  electrons	  for	  reduction	  of	  
the	  S-­‐sulfocysteine	  intermediate	  formed	  with	  the	  sulfonucleotides	  (APS	  or	  PAPS)	  in	  the	  first	  step	  
of	   the	   reaction	   [6].	   	   Although	   Trx	   is	   a	   ubiquitous	   reductant	   that	   maintains	   cellular	   redox	  
homeostasis	  by	  interacting	  with	  several	  redox	  enzymes,	  its	  association	  with	  SRs	  is	  unique	  in	  that	  
it	   only	   interacts	   with	   the	   S-­‐sulfocysteine	   intermediate	   form	   of	   the	   enzymes.	   	   The	   co-­‐crystal	  
structure	  of	  PAPR	  with	  Trx	  has	  revealed	  protein-­‐protein	  interaction	  sites,	  as	  highlighted	  in	  figure	  
6.3a	   [7].	   	   The	   first,	   more	   obvious,	   interaction	   is	   between	   Trx	   and	   the	   strictly	   conserved	  
glutathione	  sequence,	  Glu238Cys239Gly240Leu241His242	  on	  PAPR	  (Figure	  6.3b)	  while	  the	  second	  site	  
of	   PAPR-­‐Trx	   interaction	   is	   observed	   near	   the	   PAPR	   active	   site	   and	   adjacent	   to	   the	   C-­‐terminal	  
peptide	  of	  PAPR	  (Figure	  6.3c).	  	  	  
	  
The	  motivation	  for	  investigating	  the	  general	  mechanism	  of	  catalysis	  of	  SRs	  is	  that	  these	  enzymes	  
represent	   potential	   targets	   for	   therapeutic	   intervention,	   as	   they	   are	   essential,	   but	   absent	   in	  
humans.	  	  In	  chapter	  1	  we	  discussed	  how	  APR	  is	  required	  for	  the	  survival	  of	  persistent	  phase	  M.	  
tuberculosis.	  Additionally,	   PAPR	   plays	   a	   role	   in	   the	   sulfate-­‐dependent	   pathways	   in	   pathogens	  
such	  E.	   coli,	  Salmonella	   typhimurium	   and	  Yersinia	  pestis.	   	  A	   closer	   look	  at	   the	  unique	  protein-­‐
protein	   interfaces	  between	  SRs	  and	  Trx	  would	  advance	  our	  understanding	  of	   the	   rationale	   for	  
interaction	  of	   these	  proteins	  as	  well	  as	   facilitate	  the	  design	  of	   inhibitors	   that	  could	  potentially	  
disrupt	  the	  interface.	  	  Due	  to	  the	  absence	  of	  an	  oxygen	  sensitive	  iron-­‐sulfur	  cluster,	  PAPR	  could	  
serve	  as	  a	  model	   to	   study	   the	  specific	   features	  of	   the	  PAPR-­‐Trx	   interface	   that	  dictate	  protein-­‐
protein	   interactions.	   	   From	   the	   co-­‐crystal	   structure	   residues	   on	   PAPR	   that	   are	   involved	   in	  
hydrogen	  bonds	  or	  salt	  bridges	  with	  residues	  on	  Trx	  could	  be	  identified	  [7].	  	  For	  instance,	  Trp205	  
in	  EcPAPR	  hydrogen	  bonds	  with	  the	  carbonyl	  of	  Glu30	  of	  EcTrx,	  and	  EcPAPR	  Asp206	  is	  involved	  
in	  the	  salt	  bridge	  between	  Lys36	  and	  Glu30	  in	  EcTrx.	  	  The	  contribution	  of	  the	  identified	  residues	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towards	   the	  PAPR-­‐Trx	   interaction	  could	  be	  measured	  by	  alanine	   scanning	   followed	  by	  binding	  
and	  kinetic	  assays	  with	  Trx.	  	  	  
Furthermore,	  observations	  from	  the	  structure	  of	  the	  PAPR-­‐Trx	  complex	  suggest	  that	  large-­‐scale	  
conformational	  arrangements	   in	  PAPR	  are	  essential	   for	   sulfonucleotide	   reduction	   to	  occur	   [7].	  	  
For	  SRs,	   these	  conformational	   rearrangements	   include	  allosteric	   transitions	   in	   the	  quarternary	  
structure	  of	  the	  protein	  as	  evidenced	  by	  biochemical	  studies	  as	  well	  as	  the	  movement	  of	  the	  C-­‐
terminal	   peptide	   domain	   carrying	   the	   catalytic	   Cys	   residue	   over	   and	   out	   of	   the	   active	   site	  
signifying	  closed	  and	  open	  conformations	  of	  the	  enzyme	  [3,6].	  To	  evaluate	  these	  conformational	  
changes	  driving	  sulfonucleotide	  reduction,	  a	  truncated	  version	  of	  PAPR	  could	  be	  generated	  that	  
	  
Figure	   6.3	   Co-­‐crystal	   structure	   of	   PAPR-­‐Trx	   complex,	   PDB	   entry	   2O8V	   (Chartron,	   2007).	   a.	   Solvent	  
accessible	   surface	   depiction	   of	   PAPR-­‐Trx	   complex.	   	   EcPAPR	   residues	   2-­‐220	   are	   colored	   gray,	   C-­‐terminal	  
peptide	  residues	  235-­‐244	  are	  colored	  pink,	   interface	  between	  ω-­‐loop	  of	  PAPR	  and	  the	  30s	   loop	  of	  Trx	   is	  
colored	  blue,	  and	  EcTrx	  Cys35Ala	  is	  colored	  green.	  b.	  Specific	  recognition	  at	  the	  interface	  between	  the	  C-­‐
terminal	  peptide	  of	  PAPR	  and	  Trx	   involves	  hydrogen	  bonds,	  hydrophobic	   contacts	  and	  a	  network	  of	   salt	  
bridges.	  c.	  Specific	  recognition	  at	  the	  interface	  between	  ω-­‐loop	  of	  PAPR	  and	  the	  30s	   loop	  of	  Trx	   involves	  
hydrogen	  bonds,	  aromatic	  stacking	  and	  hydrophobic	  interactions.	  	  Trx	  residues	  are	  in	  italics.	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lacks	   C-­‐terminal	   peptide	   (i.e.,	   last	   10	   residues).	   	   The	   C-­‐terminal	   peptide	   could	   be	   synthesized	  
following	  established	  peptide	  synthesis	  strategies.	   	  Finally,	  by	  measuring	  the	  binding	  affinity	  of	  
both	   the	   truncated	  PAPR	  and	   the	  C-­‐terminal	  peptide	   in	   the	  absence	  or	  presence	  of	   substrate,	  
the	   contribution	   of	   each	   of	   these	   components	   toward	   the	   interaction	   with	   Trx	   could	   be	  
determined.	   	  Overall,	  these	  studies	  would	  yield	  insights	   into	  the	  mechanism	  of	  sulfonucleotide	  
reduction	  and	  facilitate	  the	  design	  of	  molecules	  that	  disrupt	  the	  interactions	  of	  SRs	  with	  Trx.	  	  
	  
6.4	  Concluding	  remarks	  
Ever	   since	   its	   discovery	   a	   decade	   ago,	   the	   precise	   role	   of	   the	   [4Fe-­‐4S]2+	   in	  mechanism	  of	   APS	  
reduction	  has	  remained	  elusive.	  	  In	  this	  thesis,	  we	  presented	  for	  the	  first	  time	  the	  generation	  of	  
a	   paramagnetic	   [4Fe-­‐4S]+	   state	   of	   the	   cluster	   which	   served	   as	   a	   useful	   tool	   for	   mechanistic	  
studies	   using	   EPR	   spectroscopy,	   as	   demonstrated,	   and	   opened	   the	   door	   for	   other	   forms	   of	  
spectroscopies	  such	  as	  ENDOR	  and	  electron	  spin	  echo	  envelope	  modulation.	  	  The	  application	  of	  
these	  techniques	  to	  APR	  would	  yield	  valuable	   information	  about	  the	  relationship	  between	  the	  
iron-­‐sulfur	  cluster,	  active	  site	  residues	  and	  the	  substrate.	  	  Based	  on	  observations	  from	  our	  study,	  
we	  were	  able	  to	  directly	  implicate	  the	  iron-­‐sulfur	  cluster	  in	  the	  catalytic	  mechanism	  of	  APR.	  	  We	  
provide	  evidence	  for	  a	  role	  of	  the	  cluster	  in	  pre-­‐organizing	  active	  site	  residues,	  and	  contributing	  
to	   activation	   of	   substrate	   and	   events	   leading	   to	   the	   formation	   of	   the	   S-­‐sulfocysteine	  
intermediate.	  	  Apart	  from	  the	  functional	  relevance	  of	  our	  findings,	  the	  knowledge	  gained	  from	  
this	  study	  have	  important	  implications	  the	  design	  of	  cluster-­‐targeted	  APR	  inhibitors	  that	  would	  
ultimately	   lead	   to	   improved	   anti-­‐tubercular	   therapies.	   	   Our	   study	   also	   provided	   insights	   into	  
substrate	   specificity	   among	   divergent	   evolved	   groups	   of	   sulfonucleotide	   reductases.	  	  
Collectively,	  this	  work	  contributes	  towards	  a	  better	  understanding	  of	  the	  catalytic	  mechanism	  of	  
this	  unique	  class	  of	  enzymes	  and	  the	  significance	  of	  iron-­‐sulfur	  cofactors	  in	  associated	  proteins.	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